id_go,hagrid,go,name,type
27774,1,5886,plasma membrane,C
27773,1,5622,intracellular,C
27772,1,5887,integral component of plasma membrane,C
27771,1,16021,integral component of membrane,C
27770,1,70195,growth hormone receptor complex,C
27769,1,5615,extracellular space,C
27768,1,5615,extracellular space,C
27767,1,5576,extracellular region,C
27766,1,9986,cell surface,C
27765,1,6573,valine metabolic process,P
27764,1,19530,taurine metabolic process,P
27763,1,6105,succinate metabolic process,P
27762,1,40014,regulation of multicellular organism growth,P
27761,1,42523,positive regulation of tyrosine phosphorylation of Stat5 protein,P
27760,1,42517,positive regulation of tyrosine phosphorylation of Stat3 protein,P
27759,1,50731,positive regulation of peptidyl-tyrosine phosphorylation,P
27758,1,40018,positive regulation of multicellular organism growth,P
27757,1,6107,oxaloacetate metabolic process,P
27756,1,44236,multicellular organism metabolic process,P
27755,1,6549,isoleucine metabolic process,P
27754,1,48009,insulin-like growth factor receptor signaling pathway,P
27753,1,60396,growth hormone receptor signaling pathway,P
27752,1,6631,fatty acid metabolic process,P
27751,1,6897,endocytosis,P
27750,1,19221,cytokine-mediated signaling pathway,P
27749,1,46449,creatinine metabolic process,P
27748,1,6600,creatine metabolic process,P
27747,1,6101,citrate metabolic process,P
27746,1,32870,cellular response to hormone stimulus,P
27745,1,255,allantoin metabolic process,P
27744,1,187,activation of MAPK activity,P
27743,1,42977,activation of JAK2 kinase activity,P
27742,1,60397,JAK-STAT cascade involved in growth hormone signaling pathway,P
27741,1,7259,JAK-STAT cascade,P
27740,1,6103,2-oxoglutarate metabolic process,P
27739,1,19901,protein kinase binding,F
27738,1,42803,protein homodimerization activity,F
27737,1,5515,protein binding,F
27736,1,70064,proline-rich region binding,F
27735,1,17046,peptide hormone binding,F
27734,1,4896,cytokine receptor activity,F
27724,2,60124,positive regulation of growth hormone secretion,P
27723,2,60124,positive regulation of growth hormone secretion,P
27722,2,46005,"positive regulation of circadian sleep/wake cycle, REM sleep",P
27721,2,46005,"positive regulation of circadian sleep/wake cycle, REM sleep",P
27720,2,8284,positive regulation of cell proliferation,P
27719,2,30819,positive regulation of cAMP biosynthetic process,P
27718,2,30252,growth hormone secretion,P
27717,2,7267,cell-cell signaling,P
27716,2,19933,cAMP-mediated signaling,P
27715,2,7189,adenylate cyclase-activating G-protein coupled receptor signaling pathway,P
27714,2,7189,adenylate cyclase-activating G-protein coupled receptor signaling pathway,P
27713,2,7189,adenylate cyclase-activating G-protein coupled receptor signaling pathway,P
27712,2,21984,adenohypophysis development,P
27711,2,31770,growth hormone-releasing hormone receptor binding,F
27710,2,16608,growth hormone-releasing hormone activity,F
27699,3,43547,positive regulation of GTPase activity,P
27698,3,45740,positive regulation of DNA replication,P
27697,3,50900,leukocyte migration,P
27696,3,8286,insulin receptor signaling pathway,P
27695,3,8286,insulin receptor signaling pathway,P
27694,3,8286,insulin receptor signaling pathway,P
27693,3,7507,heart development,P
27692,3,7173,epidermal growth factor receptor signaling pathway,P
27691,3,71363,cellular response to growth factor stimulus,P
27690,3,1525,angiogenesis,P
27689,3,187,activation of MAPK activity,P
27688,3,31532,actin cytoskeleton reorganization,P
27687,3,7265,Ras protein signal transduction,P
27686,3,165,MAPK cascade,P
27685,3,165,MAPK cascade,P
27684,3,36498,IRE1-mediated unfolded protein response,P
27683,3,38095,Fc-epsilon receptor signaling pathway,P
27682,3,38128,ERBB2 signaling pathway,P
27681,3,5068,transmembrane receptor protein tyrosine kinase adaptor activity,F
27680,3,5515,protein binding,F
27679,3,5543,phospholipid binding,F
27678,3,5168,neurotrophin TRKA receptor binding,F
27677,3,5159,insulin-like growth factor receptor binding,F
27676,3,5158,insulin receptor binding,F
27675,3,5154,epidermal growth factor receptor binding,F
27674,3,48408,epidermal growth factor binding,F
27673,3,46875,ephrin receptor binding,F
27672,3,5088,Ras guanyl-nucleotide exchange factor activity,F
27658,4,51169,nuclear transport,P
27656,4,8285,negative regulation of cell proliferation,P
27657,4,122,negative regulation of transcription from RNA polymerase II promoter,P
27655,4,8340,determination of adult lifespan,P
27654,4,1708,cell fate specification,P
27653,4,30183,B cell differentiation,P
27652,4,1077,"transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding",F
27651,4,3700,"transcription factor activity, sequence-specific DNA binding",F
27650,4,3714,transcription corepressor activity,F
27649,4,3682,chromatin binding,F
27648,4,1085,RNA polymerase II transcription factor binding,F
27647,4,981,"RNA polymerase II transcription factor activity, sequence-specific DNA binding",F
27646,4,1105,RNA polymerase II transcription coactivator activity,F
27645,4,978,RNA polymerase II core promoter proximal region sequence-specific DNA binding,F
27644,4,1102,RNA polymerase II activating transcription factor binding,F
27633,5,7417,central nervous system development,P
27632,5,16477,cell migration,P
27631,5,60070,canonical Wnt signaling pathway,P
27630,5,1568,blood vessel development,P
27629,5,1206,"transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding",F
27628,5,1205,"transcriptional activator activity, RNA polymerase II distal enhancer sequence-specific binding",F
27627,5,5515,protein binding,F
27626,5,8022,protein C-terminus binding,F
27624,5,8013,beta-catenin binding,F
27625,5,3682,chromatin binding,F
27623,5,980,RNA polymerase II distal enhancer sequence-specific DNA binding,F
27526,6,8270,zinc ion binding,F
27524,6,1228,"transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding",F
27525,6,31625,ubiquitin protein ligase binding,F
27522,6,8134,transcription factor binding,F
27523,6,44212,transcription regulatory region DNA binding,F
27521,6,3700,"transcription factor activity, sequence-specific DNA binding",F
27520,6,43565,sequence-specific DNA binding,F
27519,6,30971,receptor tyrosine kinase binding,F
27518,6,43621,protein self-association,F
27517,6,19903,protein phosphatase binding,F
27516,6,51721,protein phosphatase 2A binding,F
27515,6,19901,protein kinase binding,F
27514,6,46982,protein heterodimerization activity,F
27513,6,5515,protein binding,F
27511,6,2020,protease binding,F
27512,6,47485,protein N-terminus binding,F
27510,6,2039,p53 binding,F
27509,6,42802,identical protein binding,F
27508,6,35035,histone acetyltransferase binding,F
27507,6,19899,enzyme binding,F
27506,6,3690,double-stranded DNA binding,F
27505,6,3684,damaged DNA binding,F
27503,6,5507,copper ion binding,F
27504,6,1046,core promoter sequence-specific DNA binding,F
27501,6,51087,chaperone binding,F
27502,6,3682,chromatin binding,F
27500,6,1085,RNA polymerase II transcription factor binding,F
27499,6,981,"RNA polymerase II transcription factor activity, sequence-specific DNA binding",F
27496,6,5524,ATP binding,F
27497,6,3677,DNA binding,F
27498,6,977,RNA polymerase II regulatory region sequence-specific DNA binding,F
27584,6,45944,positive regulation of transcription from RNA polymerase II promoter,P
27583,6,45944,positive regulation of transcription from RNA polymerase II promoter,P
27582,6,70245,positive regulation of thymocyte apoptotic process,P
27581,6,90200,positive regulation of release of cytochrome c from mitochondria,P
27580,6,2000379,positive regulation of reactive oxygen species metabolic process,P
27579,6,32461,positive regulation of protein oligomerization,P
27578,6,1900740,positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway,P
27577,6,46827,positive regulation of protein export from nucleus,P
27576,6,50731,positive regulation of peptidyl-tyrosine phosphorylation,P
27575,6,43525,positive regulation of neuron apoptotic process,P
27574,6,2001244,positive regulation of intrinsic apoptotic signaling pathway,P
27573,6,31065,positive regulation of histone deacetylation,P
27572,6,10628,positive regulation of gene expression,P
27571,6,1900119,positive regulation of execution phase of apoptosis,P
27570,6,71158,positive regulation of cell cycle arrest,P
27569,6,43065,positive regulation of apoptotic process,P
27568,6,90403,oxidative stress-induced premature senescence,P
27567,6,97252,oligodendrocyte apoptotic process,P
27566,6,6289,nucleotide-excision repair,P
27565,6,45892,"negative regulation of transcription, DNA-templated",P
27564,6,45892,"negative regulation of transcription, DNA-templated",P
27563,6,122,negative regulation of transcription from RNA polymerase II promoter,P
27562,6,51974,negative regulation of telomerase activity,P
27561,6,51097,negative regulation of helicase activity,P
27560,6,48147,negative regulation of fibroblast proliferation,P
27559,6,8285,negative regulation of cell proliferation,P
27558,6,8285,negative regulation of cell proliferation,P
27557,6,8285,negative regulation of cell proliferation,P
27556,6,30308,negative regulation of cell growth,P
27555,6,43066,negative regulation of apoptotic process,P
27554,6,7275,multicellular organism development,P
27553,6,31571,mitotic G1 DNA damage checkpoint,P
27552,6,42771,intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator,P
27551,6,72332,intrinsic apoptotic signaling pathway by p53 class mediator,P
27550,6,97193,intrinsic apoptotic signaling pathway,P
27549,6,43153,entrainment of circadian clock by photoperiod,P
27548,6,8340,determination of adult lifespan,P
27546,6,31497,chromatin assembly,P
27547,6,48512,circadian behavior,P
27545,6,71479,cellular response to ionizing radiation,P
27544,6,71456,cellular response to hypoxia,P
27543,6,42149,cellular response to glucose starvation,P
27542,6,35690,cellular response to drug,P
27541,6,34644,cellular response to UV,P
27540,6,6974,cellular response to DNA damage stimulus,P
27539,6,8283,cell proliferation,P
27538,6,30154,cell differentiation,P
27537,6,7050,cell cycle arrest,P
27536,6,7050,cell cycle arrest,P
27535,6,7569,cell aging,P
27534,6,6284,base-excision repair,P
27533,6,7265,Ras protein signal transduction,P
27532,6,6983,ER overload response,P
27531,6,733,DNA strand renaturation,P
27530,6,6978,"DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator",P
27529,6,6977,"DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest",P
27528,6,30330,"DNA damage response, signal transduction by p53 class mediator",P
27527,6,30330,"DNA damage response, signal transduction by p53 class mediator",P
27432,8,3721,telomerase RNA reverse transcriptase activity,F
27431,8,3721,telomerase RNA reverse transcriptase activity,F
27430,8,3721,telomerase RNA reverse transcriptase activity,F
27429,8,3721,telomerase RNA reverse transcriptase activity,F
27428,8,70034,telomerase RNA binding,F
27427,8,70034,telomerase RNA binding,F
27426,8,49,tRNA binding,F
27425,8,42803,protein homodimerization activity,F
27424,8,42803,protein homodimerization activity,F
27423,8,5515,protein binding,F
27422,8,16779,nucleotidyltransferase activity,F
27421,8,46872,metal ion binding,F
27420,8,3964,RNA-directed DNA polymerase activity,F
27419,8,3968,RNA-directed 5'-3' RNA polymerase activity,F
27418,8,3723,RNA binding,F
27417,8,3677,DNA binding,F
27363,9,71044,histone mRNA catabolic process,P
27362,9,7507,heart development,P
27361,9,7143,female meiotic division,P
27360,9,97695,establishment of macromolecular complex localization to telomere,P
27359,9,97694,establishment of RNA localization to telomere,P
27358,9,6303,double-strand break repair via nonhomologous end joining,P
27357,9,724,double-strand break repair via homologous recombination,P
27356,9,8340,determination of adult lifespan,P
27355,9,71500,cellular response to nitrosative stress,P
27354,9,71480,cellular response to gamma radiation,P
27353,9,71481,cellular response to X-ray,P
27352,9,6974,cellular response to DNA damage stimulus,P
27351,9,7050,cell cycle arrest,P
27350,9,7420,brain development,P
27349,9,33151,V(D)J recombination,P
27348,9,731,DNA synthesis involved in DNA repair,P
27347,9,6260,DNA replication,P
27346,9,6281,DNA repair,P
27345,9,729,DNA double-strand break processing,P
27344,9,6977,"DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest",P
27343,9,6975,DNA damage induced protein phosphorylation,P
27342,9,6975,DNA damage induced protein phosphorylation,P
27341,9,4674,protein serine/threonine kinase activity,F
27340,9,4674,protein serine/threonine kinase activity,F
27339,9,46983,protein dimerization activity,F
27338,9,32403,protein complex binding,F
27337,9,5515,protein binding,F
27336,9,47485,protein N-terminus binding,F
27335,9,4677,DNA-dependent protein kinase activity,F
27334,9,3677,DNA binding,F
27333,9,5524,ATP binding,F
27332,9,16303,1-phosphatidylinositol-3-kinase activity,F
27321,10,2000097,regulation of smooth muscle cell-matrix adhesion,P
27320,10,14910,regulation of smooth muscle cell migration,P
27319,10,10469,regulation of receptor activity,P
27318,10,42127,regulation of cell proliferation,P
27317,10,33628,regulation of cell adhesion mediated by integrin,P
27316,10,6508,proteolysis,P
27315,10,30335,positive regulation of cell migration,P
27314,10,42730,fibrinolysis,P
27313,10,6935,chemotaxis,P
27312,10,7596,blood coagulation,P
27311,10,4252,serine-type endopeptidase activity,F
27310,10,4252,serine-type endopeptidase activity,F
27309,10,5515,protein binding,F
27284,11,6468,protein phosphorylation,P
27283,11,9791,post-embryonic development,P
27282,11,45893,"positive regulation of transcription, DNA-templated",P
27281,11,45944,positive regulation of transcription from RNA polymerase II promoter,P
27280,11,43388,positive regulation of DNA binding,P
27279,11,6293,"nucleotide-excision repair, preincision complex stabilization",P
27278,11,6294,"nucleotide-excision repair, preincision complex assembly",P
27277,11,6296,"nucleotide-excision repair, DNA incision, 5'-to lesion",P
27276,11,6295,"nucleotide-excision repair, DNA incision, 3'-to lesion",P
27275,11,33683,"nucleotide-excision repair, DNA incision",P
27274,11,33683,"nucleotide-excision repair, DNA incision",P
27273,11,717,"nucleotide-excision repair, DNA duplex unwinding",P
27272,11,6289,nucleotide-excision repair,P
27271,11,6289,nucleotide-excision repair,P
27270,11,35264,multicellular organism growth,P
27269,11,1701,in utero embryonic development,P
27268,11,60218,hematopoietic stem cell differentiation,P
27267,11,48820,hair follicle maturation,P
27266,11,35315,hair cell differentiation,P
27265,11,70911,global genome nucleotide-excision repair,P
27264,11,30198,extracellular matrix organization,P
27263,11,43249,erythrocyte maturation,P
27262,11,48568,embryonic organ development,P
27261,11,40016,embryonic cleavage,P
27260,11,7059,chromosome segregation,P
27259,11,32289,central nervous system myelin formation,P
27258,11,8283,cell proliferation,P
27257,11,30282,bone mineralization,P
27256,11,6915,apoptotic process,P
27255,11,7568,aging,P
27254,11,9650,UV protection,P
27253,11,6370,7-methylguanosine mRNA capping,P
27252,11,4672,protein kinase activity,F
27251,11,5515,protein binding,F
27250,11,47485,protein N-terminus binding,F
27249,11,8022,protein C-terminus binding,F
27248,11,46872,metal ion binding,F
27247,11,8353,RNA polymerase II carboxy-terminal domain kinase activity,F
27246,11,8094,DNA-dependent ATPase activity,F
27245,11,8094,DNA-dependent ATPase activity,F
27244,11,3677,DNA binding,F
27243,11,4003,ATP-dependent DNA helicase activity,F
27242,11,5524,ATP binding,F
27241,11,43139,5'-3' DNA helicase activity,F
27240,11,51539,"4 iron, 4 sulfur cluster binding",F
27234,12,31464,Cul4A-RING E3 ubiquitin ligase complex,C
27233,12,6283,transcription-coupled nucleotide-excision repair,P
27232,12,6283,transcription-coupled nucleotide-excision repair,P
27231,12,6283,transcription-coupled nucleotide-excision repair,P
27230,12,6979,response to oxidative stress,P
27228,12,10165,response to X-ray,P
27229,12,6979,response to oxidative stress,P
27227,12,9411,response to UV,P
27226,12,209,protein polyubiquitination,P
27225,12,51865,protein autoubiquitination,P
27224,12,43161,proteasome-mediated ubiquitin-dependent protein catabolic process,P
27223,12,6289,nucleotide-excision repair,P
27222,12,6974,cellular response to DNA damage stimulus,P
27221,12,4842,ubiquitin-protein transferase activity,F
27220,12,32403,protein complex binding,F
27219,12,5515,protein binding,F
27218,12,8094,DNA-dependent ATPase activity,F
27217,12,3678,DNA helicase activity,F
27192,13,6302,double-strand break repair,P
27191,13,9267,cellular response to starvation,P
27190,13,71480,cellular response to gamma radiation,P
27189,13,6974,cellular response to DNA damage stimulus,P
27188,13,7569,cell aging,P
27187,13,7420,brain development,P
27186,13,6284,base-excision repair,P
27185,13,7568,aging,P
27184,13,731,DNA synthesis involved in DNA repair,P
27183,13,731,DNA synthesis involved in DNA repair,P
27182,13,6260,DNA replication,P
27181,13,6260,DNA replication,P
27180,13,6259,DNA metabolic process,P
27179,13,32508,DNA duplex unwinding,P
27178,13,42803,protein homodimerization activity,F
27177,13,32403,protein complex binding,F
27176,13,5515,protein binding,F
27175,13,30145,manganese ion binding,F
27174,13,287,magnesium ion binding,F
27173,13,4386,helicase activity,F
27172,13,9378,four-way junction helicase activity,F
27171,13,4527,exonuclease activity,F
27170,13,3682,chromatin binding,F
27169,13,405,bubble DNA binding,F
27168,13,403,Y-form DNA binding,F
27167,13,51880,G-quadruplex DNA binding,F
27166,13,3678,DNA helicase activity,F
27165,13,3678,DNA helicase activity,F
27164,13,3677,DNA binding,F
27163,13,16887,ATPase activity,F
27162,13,4003,ATP-dependent DNA helicase activity,F
27161,13,43140,ATP-dependent 3'-5' DNA helicase activity,F
27160,13,5524,ATP binding,F
27159,13,8408,3'-5' exonuclease activity,F
27158,13,43138,3'-5' DNA helicase activity,F
27148,14,5829,cytosol,C
27147,14,5737,cytoplasm,C
27146,14,55015,ventricular cardiac muscle cell development,P
27145,14,35105,sterol regulatory element binding protein import into nucleus,P
27144,14,1900180,regulation of protein localization to nucleus,P
27143,14,30334,regulation of cell migration,P
27142,14,34504,protein localization to nucleus,P
27141,14,90343,positive regulation of cell aging,P
27140,14,90201,negative regulation of release of cytochrome c from mitochondria,P
27139,14,72201,negative regulation of mesenchymal cell proliferation,P
27138,14,2001237,negative regulation of extrinsic apoptotic signaling pathway,P
27137,14,7084,mitotic nuclear envelope reassembly,P
27136,14,7077,mitotic nuclear envelope disassembly,P
27135,14,30951,establishment or maintenance of microtubule cytoskeleton polarity,P
27134,14,71456,cellular response to hypoxia,P
27133,14,36498,IRE1-mediated unfolded protein response,P
27132,14,5198,structural molecule activity,F
27131,14,5515,protein binding,F
27128,15,5886,plasma membrane,C
27127,15,16020,membrane,C
27126,15,43231,intracellular membrane-bounded organelle,C
27125,15,5887,integral component of plasma membrane,C
27124,15,35867,alphav-beta3 integrin-IGF-1-IGF1R complex,C
27123,15,7165,signal transduction,P
27122,15,46328,regulation of JNK cascade,P
27121,15,51262,protein tetramerization,P
27120,15,46777,protein autophosphorylation,P
27119,15,8284,positive regulation of cell proliferation,P
27118,15,30335,positive regulation of cell migration,P
27117,15,45740,positive regulation of DNA replication,P
27116,15,48015,phosphatidylinositol-mediated signaling,P
27115,15,14065,phosphatidylinositol 3-kinase signaling,P
27114,15,38083,peptidyl-tyrosine autophosphorylation,P
27113,15,43066,negative regulation of apoptotic process,P
27112,15,48009,insulin-like growth factor receptor signaling pathway,P
27111,15,8286,insulin receptor signaling pathway,P
27110,15,51389,inactivation of MAPKK activity,P
27109,15,6955,immune response,P
27108,15,4713,protein tyrosine kinase activity,F
27107,15,4713,protein tyrosine kinase activity,F
27106,15,4713,protein tyrosine kinase activity,F
27105,15,5515,protein binding,F
27104,15,43548,phosphatidylinositol 3-kinase binding,F
27103,15,5010,insulin-like growth factor-activated receptor activity,F
27102,15,5520,insulin-like growth factor binding,F
27101,15,31994,insulin-like growth factor I binding,F
27100,15,31994,insulin-like growth factor I binding,F
27099,15,43560,insulin receptor substrate binding,F
27098,15,5158,insulin receptor binding,F
27097,15,43559,insulin binding,F
27096,15,42802,identical protein binding,F
27095,15,5524,ATP binding,F
27082,16,30091,protein repair,P
27081,16,51897,positive regulation of protein kinase B signaling,P
27080,16,33138,positive regulation of peptidyl-serine phosphorylation,P
27079,16,43388,positive regulation of DNA binding,P
27078,16,55114,oxidation-reduction process,P
27077,16,15949,nucleobase-containing small molecule interconversion,P
27076,16,122,negative regulation of transcription from RNA polymerase II promoter,P
27075,16,46826,negative regulation of protein export from nucleus,P
27074,16,1903206,negative regulation of hydrogen peroxide-induced cell death,P
27073,16,6928,movement of cell or subcellular component,P
27072,16,6662,glycerol ether metabolic process,P
27070,16,7267,cell-cell signaling,P
27071,16,98869,cellular oxidant detoxification,P
27069,16,45454,cell redox homeostasis,P
27068,16,8283,cell proliferation,P
27067,16,32148,activation of protein kinase B activity,P
27066,16,4791,thioredoxin-disulfide reductase activity,F
27065,16,47134,protein-disulfide reductase activity,F
27064,16,15035,protein disulfide oxidoreductase activity,F
27063,16,5515,protein binding,F
27062,16,44822,poly(A) RNA binding,F
27061,16,15037,peptide disulfide oxidoreductase activity,F
27060,16,16671,"oxidoreductase activity, acting on a sulfur group of donors, disulfide as acceptor",F
27044,17,1901657,glycosyl compound metabolic process,P
27043,17,8543,fibroblast growth factor receptor signaling pathway,P
27042,17,8543,fibroblast growth factor receptor signaling pathway,P
27041,17,6112,energy reserve metabolic process,P
27040,17,5975,carbohydrate metabolic process,P
27039,17,55074,calcium ion homeostasis,P
27038,17,7568,aging,P
27037,17,165,MAPK cascade,P
27036,17,5499,vitamin D binding,F
27035,17,4871,signal transducer activity,F
27034,17,46934,"phosphatidylinositol-4,5-bisphosphate 3-kinase activity",F
27033,17,5179,hormone activity,F
27032,17,5104,fibroblast growth factor receptor binding,F
27030,17,4566,beta-glucuronidase activity,F
27031,17,17134,fibroblast growth factor binding,F
27029,17,8422,beta-glucosidase activity,F
27028,17,5088,Ras guanyl-nucleotide exchange factor activity,F
27027,17,16303,1-phosphatidylinositol-3-kinase activity,F
26948,19,50900,leukocyte migration,P
26947,19,61582,intestinal epithelial cell migration,P
26946,19,7229,integrin-mediated signaling pathway,P
26945,19,48839,inner ear development,P
26944,19,9755,hormone-mediated signaling pathway,P
26943,19,42445,hormone metabolic process,P
26942,19,48873,homeostasis of number of cells within a tissue,P
26941,19,7507,heart development,P
26940,19,42593,glucose homeostasis,P
26939,19,48806,genitalia development,P
26938,19,8543,fibroblast growth factor receptor signaling pathway,P
26937,19,60325,face morphogenesis,P
26936,19,7173,epidermal growth factor receptor signaling pathway,P
26935,19,48013,ephrin receptor signaling pathway,P
26934,19,21697,cerebellar cortex formation,P
26933,19,7420,brain development,P
26932,19,7409,axonogenesis,P
26931,19,36302,atrioventricular canal development,P
26930,19,187,activation of MAPK activity,P
26929,19,33277,abortive mitotic cell cycle,P
26928,19,31295,T cell costimulation,P
26927,19,38127,ERBB signaling pathway,P
26926,19,77,DNA damage checkpoint,P
26925,19,60020,Bergmann glial cell differentiation,P
26924,19,30971,receptor tyrosine kinase binding,F
26923,19,4725,protein tyrosine phosphatase activity,F
26922,19,4725,protein tyrosine phosphatase activity,F
26921,19,19904,protein domain specific binding,F
26920,19,5515,protein binding,F
26919,19,4721,phosphoprotein phosphatase activity,F
26918,19,43274,phospholipase binding,F
26917,19,46934,"phosphatidylinositol-4,5-bisphosphate 3-kinase activity",F
26916,19,51428,peptide hormone receptor binding,F
26915,19,4726,non-membrane spanning protein tyrosine phosphatase activity,F
26914,19,4726,non-membrane spanning protein tyrosine phosphatase activity,F
26913,19,43560,insulin receptor substrate binding,F
26912,19,5158,insulin receptor binding,F
26911,19,50839,cell adhesion molecule binding,F
26910,19,5070,SH3/SH2 adaptor activity,F
26909,19,31748,D1 dopamine receptor binding,F
26908,19,16303,1-phosphatidylinositol-3-kinase activity,F
26894,20,32481,positive regulation of type I interferon production,P
26893,20,45944,positive regulation of transcription from RNA polymerase II promoter,P
26892,20,51092,positive regulation of NF-kappaB transcription factor activity,P
26891,20,122,negative regulation of transcription from RNA polymerase II promoter,P
26890,20,45087,innate immune response,P
26889,20,6954,inflammatory response,P
26888,20,2467,germinal center formation,P
26887,20,2268,follicular dendritic cell differentiation,P
26885,20,7568,aging,P
26886,20,30198,extracellular matrix organization,P
26884,20,38061,NIK/NF-kappaB signaling,P
26883,20,38061,NIK/NF-kappaB signaling,P
26882,20,7249,I-kappaB kinase/NF-kappaB signaling,P
26881,20,1077,"transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding",F
26880,20,3700,"transcription factor activity, sequence-specific DNA binding",F
26879,20,3713,transcription coactivator activity,F
26878,20,5515,protein binding,F
26877,20,3682,chromatin binding,F
26876,20,978,RNA polymerase II core promoter proximal region sequence-specific DNA binding,F
26853,21,40018,positive regulation of multicellular organism growth,P
26852,21,45931,positive regulation of mitotic cell cycle,P
26851,21,45086,positive regulation of interleukin-2 biosynthetic process,P
26850,21,50729,positive regulation of inflammatory response,P
26849,21,45588,positive regulation of gamma-delta T cell differentiation,P
26848,21,45648,positive regulation of erythrocyte differentiation,P
26847,21,42104,positive regulation of activated T cell proliferation,P
26846,21,45579,positive regulation of B cell differentiation,P
26845,21,18108,peptidyl-tyrosine phosphorylation,P
26844,21,6107,oxaloacetate metabolic process,P
26843,21,45647,negative regulation of erythrocyte differentiation,P
26842,21,43066,negative regulation of apoptotic process,P
26841,21,1779,natural killer cell differentiation,P
26840,21,97531,mast cell migration,P
26839,21,1553,luteinization,P
26838,21,19915,lipid storage,P
26837,21,7595,lactation,P
26836,21,6549,isoleucine metabolic process,P
26835,21,7565,female pregnancy,P
26834,21,6631,fatty acid metabolic process,P
26833,21,46544,development of secondary male sexual characteristics,P
26832,21,46543,development of secondary female sexual characteristics,P
26831,21,46449,creatinine metabolic process,P
26830,21,6600,creatine metabolic process,P
26829,21,6101,citrate metabolic process,P
26828,21,32870,cellular response to hormone stimulus,P
26827,21,71363,cellular response to growth factor stimulus,P
26826,21,71364,cellular response to epidermal growth factor stimulus,P
26825,21,255,allantoin metabolic process,P
26824,21,43029,T cell homeostasis,P
26823,21,33077,T cell differentiation in thymus,P
26822,21,48541,Peyer's patch development,P
26821,21,60397,JAK-STAT cascade involved in growth hormone signaling pathway,P
26820,21,60397,JAK-STAT cascade involved in growth hormone signaling pathway,P
26819,21,7259,JAK-STAT cascade,P
26818,21,6103,2-oxoglutarate metabolic process,P
26817,21,1077,"transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding",F
26816,21,3700,"transcription factor activity, sequence-specific DNA binding",F
26815,21,4871,signal transducer activity,F
26814,21,4713,protein tyrosine kinase activity,F
26813,21,19903,protein phosphatase binding,F
26812,21,46983,protein dimerization activity,F
26811,21,5515,protein binding,F
26810,21,35259,glucocorticoid receptor binding,F
26809,21,3682,chromatin binding,F
26808,21,979,RNA polymerase II core promoter sequence-specific DNA binding,F
26748,22,30522,intracellular receptor signaling pathway,P
26747,22,70102,interleukin-6-mediated signaling pathway,P
26746,22,70102,interleukin-6-mediated signaling pathway,P
26745,22,60396,growth hormone receptor signaling pathway,P
26744,22,42593,glucose homeostasis,P
26743,22,1754,eye photoreceptor cell differentiation,P
26742,22,97009,energy homeostasis,P
26741,22,42755,eating behavior,P
26740,22,19221,cytokine-mediated signaling pathway,P
26739,22,71407,cellular response to organic cyclic compound,P
26738,22,44320,cellular response to leptin stimulus,P
26737,22,32870,cellular response to hormone stimulus,P
26736,22,8283,cell proliferation,P
26735,22,48708,astrocyte differentiation,P
26734,22,7568,aging,P
26733,22,6953,acute-phase response,P
26732,22,60397,JAK-STAT cascade involved in growth hormone signaling pathway,P
26731,22,60397,JAK-STAT cascade involved in growth hormone signaling pathway,P
26730,22,7259,JAK-STAT cascade,P
26729,22,1228,"transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding",F
26728,22,1077,"transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding",F
26727,22,44212,transcription regulatory region DNA binding,F
26726,22,8134,transcription factor binding,F
26725,22,3700,"transcription factor activity, sequence-specific DNA binding",F
26724,22,4871,signal transducer activity,F
26723,22,19903,protein phosphatase binding,F
26722,22,19901,protein kinase binding,F
26720,22,5515,protein binding,F
26721,22,46983,protein dimerization activity,F
26719,22,42802,identical protein binding,F
26718,22,35259,glucocorticoid receptor binding,F
26717,22,31490,chromatin DNA binding,F
26716,22,4879,"RNA polymerase II transcription factor activity, ligand-activated sequence-specific DNA binding",F
26715,22,1103,RNA polymerase II repressing transcription factor binding,F
26712,22,31730,CCR5 chemokine receptor binding,F
26713,22,3677,DNA binding,F
26714,22,978,RNA polymerase II core promoter proximal region sequence-specific DNA binding,F
26759,22,2000737,negative regulation of stem cell differentiation,P
26758,22,2001223,negative regulation of neuron migration,P
26757,22,1901215,negative regulation of neuron death,P
26756,22,10730,negative regulation of hydrogen peroxide biosynthetic process,P
26755,22,45820,negative regulation of glycolytic process,P
26754,22,8285,negative regulation of cell proliferation,P
26753,22,43066,negative regulation of apoptotic process,P
26752,22,6928,movement of cell or subcellular component,P
26751,22,35278,miRNA mediated inhibition of translation,P
26750,22,42789,mRNA transcription from RNA polymerase II promoter,P
26749,22,33210,leptin-mediated signaling pathway,P
26711,23,5654,nucleoplasm,C
26710,23,5654,nucleoplasm,C
26709,23,5829,cytosol,C
26708,23,5737,cytoplasm,C
26707,23,6573,valine metabolic process,P
26706,23,6351,"transcription, DNA-templated",P
26705,23,19530,taurine metabolic process,P
26704,23,6105,succinate metabolic process,P
26703,23,6357,regulation of transcription from RNA polymerase II promoter,P
26702,23,40014,regulation of multicellular organism growth,P
26701,23,38161,prolactin signaling pathway,P
26700,23,1938,positive regulation of endothelial cell proliferation,P
26699,23,43536,positive regulation of blood vessel endothelial cell migration,P
26698,23,18108,peptidyl-tyrosine phosphorylation,P
26697,23,6107,oxaloacetate metabolic process,P
26696,23,7595,lactation,P
26695,23,6549,isoleucine metabolic process,P
26694,23,6631,fatty acid metabolic process,P
26693,23,46449,creatinine metabolic process,P
26692,23,6600,creatine metabolic process,P
26691,23,6101,citrate metabolic process,P
26690,23,255,allantoin metabolic process,P
26689,23,60397,JAK-STAT cascade involved in growth hormone signaling pathway,P
26688,23,7259,JAK-STAT cascade,P
26687,23,6103,2-oxoglutarate metabolic process,P
26686,23,3700,"transcription factor activity, sequence-specific DNA binding",F
26685,23,4871,signal transducer activity,F
26684,23,4713,protein tyrosine kinase activity,F
26683,23,5515,protein binding,F
26682,23,3677,DNA binding,F
26548,26,40018,positive regulation of multicellular organism growth,P
26547,26,40018,positive regulation of multicellular organism growth,P
26546,26,43568,positive regulation of insulin-like growth factor receptor signaling pathway,P
26545,26,10535,positive regulation of activation of JAK2 kinase activity,P
26544,26,43406,positive regulation of MAP kinase activity,P
26543,26,46427,positive regulation of JAK-STAT cascade,P
26542,26,60396,growth hormone receptor signaling pathway,P
26541,26,15758,glucose transport,P
26540,26,70977,bone maturation,P
26539,26,60397,JAK-STAT cascade involved in growth hormone signaling pathway,P
26538,26,7259,JAK-STAT cascade,P
26537,26,5515,protein binding,F
26536,26,5148,prolactin receptor binding,F
26535,26,5148,prolactin receptor binding,F
26533,26,5179,hormone activity,F
26534,26,46872,metal ion binding,F
26532,26,5131,growth hormone receptor binding,F
26531,26,5131,growth hormone receptor binding,F
26530,26,8083,growth factor activity,F
26523,27,18,regulation of DNA recombination,P
26522,27,10628,positive regulation of gene expression,P
26521,27,33089,positive regulation of T cell differentiation in thymus,P
26520,27,1915,negative regulation of T cell mediated cytotoxicity,P
26519,27,48535,lymph node development,P
26518,27,38111,interleukin-7-mediated signaling pathway,P
26517,27,2377,immunoglobulin production,P
26516,27,6955,immune response,P
26515,27,48872,homeostasis of number of cells,P
26514,27,7166,cell surface receptor signaling pathway,P
26513,27,902,cell morphogenesis,P
26512,27,16049,cell growth,P
26511,27,30217,T cell differentiation,P
26510,27,42100,B cell proliferation,P
26509,27,5515,protein binding,F
26508,27,4917,interleukin-7 receptor activity,F
26507,27,3823,antigen binding,F
26478,28,33160,"positive regulation of protein import into nucleus, translocation",P
26477,28,14068,positive regulation of phosphatidylinositol 3-kinase signaling,P
26476,28,50731,positive regulation of peptidyl-tyrosine phosphorylation,P
26475,28,45669,positive regulation of osteoblast differentiation,P
26474,28,45840,positive regulation of mitotic nuclear division,P
26473,28,43568,positive regulation of insulin-like growth factor receptor signaling pathway,P
26472,28,10560,positive regulation of glycoprotein biosynthetic process,P
26471,28,45821,positive regulation of glycolytic process,P
26470,28,45725,positive regulation of glycogen biosynthetic process,P
26469,28,46326,positive regulation of glucose import,P
26468,28,48146,positive regulation of fibroblast proliferation,P
26467,28,50679,positive regulation of epithelial cell proliferation,P
26466,28,8284,positive regulation of cell proliferation,P
26465,28,8284,positive regulation of cell proliferation,P
26464,28,30335,positive regulation of cell migration,P
26463,28,61051,positive regulation of cell growth involved in cardiac muscle cell development,P
26462,28,61051,positive regulation of cell growth involved in cardiac muscle cell development,P
26461,28,10613,positive regulation of cardiac muscle hypertrophy,P
26460,28,10613,positive regulation of cardiac muscle hypertrophy,P
26459,28,70886,positive regulation of calcineurin-NFAT signaling cascade,P
26458,28,42104,positive regulation of activated T cell proliferation,P
26457,28,46579,positive regulation of Ras protein signal transduction,P
26456,28,43410,positive regulation of MAPK cascade,P
26455,28,45740,positive regulation of DNA replication,P
26454,28,45740,positive regulation of DNA replication,P
26453,28,43388,positive regulation of DNA binding,P
26452,28,2576,platelet degranulation,P
26451,28,48015,phosphatidylinositol-mediated signaling,P
26450,28,14065,phosphatidylinositol 3-kinase signaling,P
26449,28,34392,negative regulation of smooth muscle cell apoptotic process,P
26448,28,90201,negative regulation of release of cytochrome c from mitochondria,P
26447,28,60283,negative regulation of oocyte development,P
26446,28,2001237,negative regulation of extrinsic apoptotic signaling pathway,P
26445,28,43066,negative regulation of apoptotic process,P
26444,28,14904,myotube cell development,P
26443,28,51450,myoblast proliferation,P
26442,28,45445,myoblast differentiation,P
26441,28,7517,muscle organ development,P
26440,28,14896,muscle hypertrophy,P
26439,28,6928,movement of cell or subcellular component,P
26438,28,48009,insulin-like growth factor receptor signaling pathway,P
26437,28,9441,glycolate metabolic process,P
26435,28,8283,cell proliferation,P
26436,28,44267,cellular protein metabolic process,P
26434,28,1775,cell activation,P
26433,28,35630,bone mineralization involved in bone maturation,P
26432,28,32148,activation of protein kinase B activity,P
26431,28,187,activation of MAPK activity,P
26430,28,7265,Ras protein signal transduction,P
26428,28,6260,DNA replication,P
26429,28,70371,ERK1 and ERK2 cascade,P
26427,28,5515,protein binding,F
26426,28,5178,integrin binding,F
26425,28,5159,insulin-like growth factor receptor binding,F
26424,28,5159,insulin-like growth factor receptor binding,F
26423,28,5159,insulin-like growth factor receptor binding,F
26422,28,5158,insulin receptor binding,F
26421,28,5179,hormone activity,F
26420,28,8083,growth factor activity,F
26407,29,50731,positive regulation of peptidyl-tyrosine phosphorylation,P
26406,29,45840,positive regulation of mitotic nuclear division,P
26405,29,46628,positive regulation of insulin receptor signaling pathway,P
26404,29,45725,positive regulation of glycogen biosynthetic process,P
26403,29,2000467,positive regulation of glycogen (starch) synthase activity,P
26402,29,8284,positive regulation of cell proliferation,P
26401,29,51781,positive regulation of cell division,P
26400,29,43085,positive regulation of catalytic activity,P
26399,29,42104,positive regulation of activated T cell proliferation,P
26398,29,43410,positive regulation of MAPK cascade,P
26396,29,1503,ossification,P
26397,29,2576,platelet degranulation,P
26395,29,7275,multicellular organism development,P
26394,29,38028,insulin receptor signaling pathway via phosphatidylinositol 3-kinase,P
26393,29,8286,insulin receptor signaling pathway,P
26392,29,6006,glucose metabolic process,P
26391,29,44267,cellular protein metabolic process,P
26390,29,30546,receptor activator activity,F
26389,29,43539,protein serine/threonine kinase activator activity,F
26388,29,5515,protein binding,F
26387,29,5159,insulin-like growth factor receptor binding,F
26386,29,5158,insulin receptor binding,F
26385,29,5179,hormone activity,F
26384,29,8083,growth factor activity,F
26355,30,46628,positive regulation of insulin receptor signaling pathway,P
26354,30,45821,positive regulation of glycolytic process,P
26353,30,45821,positive regulation of glycolytic process,P
26352,30,45725,positive regulation of glycogen biosynthetic process,P
26351,30,46326,positive regulation of glucose import,P
26350,30,10628,positive regulation of gene expression,P
26349,30,50715,positive regulation of cytokine secretion,P
26348,30,32270,positive regulation of cellular protein metabolic process,P
26347,30,8284,positive regulation of cell proliferation,P
26346,30,30335,positive regulation of cell migration,P
26345,30,30307,positive regulation of cell growth,P
26344,30,45597,positive regulation of cell differentiation,P
26343,30,90336,positive regulation of brown fat cell differentiation,P
26342,30,51092,positive regulation of NF-kappaB transcription factor activity,P
26341,30,43410,positive regulation of MAPK cascade,P
26339,30,45908,negative regulation of vasodilation,P
26340,30,45740,positive regulation of DNA replication,P
26338,30,60266,negative regulation of respiratory burst involved in inflammatory response,P
26337,30,45861,negative regulation of proteolysis,P
26336,30,50709,negative regulation of protein secretion,P
26335,30,32460,negative regulation of protein oligomerization,P
26334,30,42177,negative regulation of protein catabolic process,P
26333,30,1902176,negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway,P
26332,30,50995,negative regulation of lipid catabolic process,P
26331,30,50995,negative regulation of lipid catabolic process,P
26330,30,45818,negative regulation of glycogen catabolic process,P
26329,30,45721,negative regulation of gluconeogenesis,P
26328,30,2000252,negative regulation of feeding behavior,P
26327,30,45922,negative regulation of fatty acid metabolic process,P
26326,30,2674,negative regulation of acute inflammatory response,P
26325,30,33861,negative regulation of NAD(P)H oxidase activity,P
26324,30,8286,insulin receptor signaling pathway,P
26323,30,8286,insulin receptor signaling pathway,P
26322,30,15758,glucose transport,P
26321,30,6006,glucose metabolic process,P
26320,30,42593,glucose homeostasis,P
26319,30,55089,fatty acid homeostasis,P
26318,30,44267,cellular protein metabolic process,P
26317,30,7267,cell-cell signaling,P
26316,30,46631,alpha-beta T cell activation,P
26315,30,6953,acute-phase response,P
26314,30,32148,activation of protein kinase B activity,P
26313,30,165,MAPK cascade,P
26312,30,7186,G-protein coupled receptor signaling pathway,P
26311,30,6888,ER to Golgi vesicle-mediated transport,P
26310,30,5515,protein binding,F
26309,30,2020,protease binding,F
26308,30,5159,insulin-like growth factor receptor binding,F
26307,30,5158,insulin receptor binding,F
26306,30,5158,insulin receptor binding,F
26305,30,42802,identical protein binding,F
26302,30,5179,hormone activity,F
26303,30,5179,hormone activity,F
26304,30,5179,hormone activity,F
26301,31,5576,extracellular region,C
26300,31,5576,extracellular region,C
26299,31,5768,endosome,C
26298,31,5796,Golgi lumen,C
26297,31,7169,transmembrane receptor protein tyrosine kinase signaling pathway,P
26296,31,45664,regulation of neuron differentiation,P
26295,31,43281,regulation of cysteine-type endopeptidase activity involved in apoptotic process,P
26294,31,10628,positive regulation of gene expression,P
26293,31,50772,positive regulation of axonogenesis,P
26292,31,43065,positive regulation of apoptotic process,P
26291,31,46579,positive regulation of Ras protein signal transduction,P
26290,31,48015,phosphatidylinositol-mediated signaling,P
26289,31,48011,neurotrophin TRK receptor signaling pathway,P
26288,31,48812,neuron projection morphogenesis,P
26287,31,32455,nerve growth factor processing,P
26286,31,43524,negative regulation of neuron apoptotic process,P
26285,31,43154,negative regulation of cysteine-type endopeptidase activity involved in apoptotic process,P
26284,31,43066,negative regulation of apoptotic process,P
26283,31,7018,microtubule-based movement,P
26282,31,8625,extrinsic apoptotic signaling pathway via death domain receptors,P
26281,31,7267,cell-cell signaling,P
26280,31,6919,activation of cysteine-type endopeptidase activity involved in apoptotic process,P
26279,31,186,activation of MAPKK activity,P
26278,31,5515,protein binding,F
26277,31,5163,nerve growth factor receptor binding,F
26276,31,8191,metalloendopeptidase inhibitor activity,F
26275,31,8083,growth factor activity,F
26261,32,46628,positive regulation of insulin receptor signaling pathway,P
26260,32,45725,positive regulation of glycogen biosynthetic process,P
26259,32,45725,positive regulation of glycogen biosynthetic process,P
26258,32,10907,positive regulation of glucose metabolic process,P
26257,32,2001275,positive regulation of glucose import in response to insulin stimulus,P
26256,32,46326,positive regulation of glucose import,P
26255,32,32000,positive regulation of fatty acid beta-oxidation,P
26254,32,8284,positive regulation of cell proliferation,P
26253,32,43547,positive regulation of GTPase activity,P
26252,32,48015,phosphatidylinositol-mediated signaling,P
26251,32,36092,phosphatidylinositol-3-phosphate biosynthetic process,P
26250,32,46854,phosphatidylinositol phosphorylation,P
26249,32,14065,phosphatidylinositol 3-kinase signaling,P
26248,32,46676,negative regulation of insulin secretion,P
26247,32,46627,negative regulation of insulin receptor signaling pathway,P
26246,32,48009,insulin-like growth factor receptor signaling pathway,P
26245,32,8286,insulin receptor signaling pathway,P
26244,32,8286,insulin receptor signaling pathway,P
26243,32,8286,insulin receptor signaling pathway,P
26242,32,42593,glucose homeostasis,P
26241,32,32869,cellular response to insulin stimulus,P
26240,32,165,MAPK cascade,P
26239,32,5068,transmembrane receptor protein tyrosine kinase adaptor activity,F
26238,32,4871,signal transducer activity,F
26237,32,5080,protein kinase C binding,F
26236,32,5515,protein binding,F
26235,32,46934,"phosphatidylinositol-4,5-bisphosphate 3-kinase activity",F
26234,32,43548,phosphatidylinositol 3-kinase binding,F
26233,32,43548,phosphatidylinositol 3-kinase binding,F
26232,32,5159,insulin-like growth factor receptor binding,F
26231,32,5158,insulin receptor binding,F
26230,32,42169,SH2 domain binding,F
26229,32,5088,Ras guanyl-nucleotide exchange factor activity,F
26228,32,16303,1-phosphatidylinositol-3-kinase activity,F
26202,33,43407,negative regulation of MAP kinase activity,P
26201,33,70373,negative regulation of ERK1 and ERK2 cascade,P
26200,33,8286,insulin receptor signaling pathway,P
26199,33,30968,endoplasmic reticulum unfolded protein response,P
26198,33,98609,cell-cell adhesion,P
26197,33,6987,activation of signaling protein activity involved in unfolded protein response,P
26196,33,7257,activation of JUN kinase activity,P
26195,33,31532,actin cytoskeleton reorganization,P
26194,33,60397,JAK-STAT cascade involved in growth hormone signaling pathway,P
26193,33,36498,IRE1-mediated unfolded protein response,P
26192,33,8270,zinc ion binding,F
26191,33,30971,receptor tyrosine kinase binding,F
26190,33,4725,protein tyrosine phosphatase activity,F
26189,33,4725,protein tyrosine phosphatase activity,F
26188,33,51721,protein phosphatase 2A binding,F
26187,33,19901,protein kinase binding,F
26186,33,5515,protein binding,F
26185,33,44822,poly(A) RNA binding,F
26184,33,5158,insulin receptor binding,F
26183,33,46875,ephrin receptor binding,F
26182,33,19899,enzyme binding,F
26181,33,98641,cadherin binding involved in cell-cell adhesion,F
26162,34,43547,positive regulation of GTPase activity,P
26161,34,30890,positive regulation of B cell proliferation,P
26160,34,48015,phosphatidylinositol-mediated signaling,P
26159,34,36092,phosphatidylinositol-3-phosphate biosynthetic process,P
26158,34,46854,phosphatidylinositol phosphorylation,P
26157,34,10748,negative regulation of plasma membrane long-chain fatty acid transport,P
26156,34,33673,negative regulation of kinase activity,P
26155,34,2903,negative regulation of B cell apoptotic process,P
26154,34,30879,mammary gland development,P
26153,34,55088,lipid homeostasis,P
26152,34,8286,insulin receptor signaling pathway,P
26151,34,8286,insulin receptor signaling pathway,P
26150,34,6006,glucose metabolic process,P
26149,34,32869,cellular response to insulin stimulus,P
26148,34,71333,cellular response to glucose stimulus,P
26147,34,8283,cell proliferation,P
26146,34,7420,brain development,P
26145,34,165,MAPK cascade,P
26144,34,4871,signal transducer activity,F
26143,34,19903,protein phosphatase binding,F
26142,34,19901,protein kinase binding,F
26141,34,19904,protein domain specific binding,F
26140,34,5515,protein binding,F
26139,34,46934,"phosphatidylinositol-4,5-bisphosphate 3-kinase activity",F
26138,34,43548,phosphatidylinositol 3-kinase binding,F
26137,34,5158,insulin receptor binding,F
26136,34,5088,Ras guanyl-nucleotide exchange factor activity,F
26135,34,71889,14-3-3 protein binding,F
26134,34,16303,1-phosphatidylinositol-3-kinase activity,F
25999,35,30030,cell projection organization,P
25998,35,30154,cell differentiation,P
25997,35,8637,apoptotic mitochondrial changes,P
25996,35,7568,aging,P
25995,35,6924,activation-induced cell death of T cells,P
25994,35,31295,T cell costimulation,P
25993,35,7186,G-protein coupled receptor signaling pathway,P
25992,35,38128,ERBB2 signaling pathway,P
25991,35,4712,protein serine/threonine/tyrosine kinase activity,F
25990,35,4674,protein serine/threonine kinase activity,F
25989,35,4674,protein serine/threonine kinase activity,F
25988,35,4674,protein serine/threonine kinase activity,F
25987,35,51721,protein phosphatase 2A binding,F
25986,35,4672,protein kinase activity,F
25985,35,5080,protein kinase C binding,F
25984,35,5515,protein binding,F
25983,35,43325,"phosphatidylinositol-3,4-bisphosphate binding",F
25982,35,5547,"phosphatidylinositol-3,4,5-trisphosphate binding",F
25974,35,71889,14-3-3 protein binding,F
25975,35,5524,ATP binding,F
25976,35,5524,ATP binding,F
25977,35,32794,GTPase activating protein binding,F
25978,35,19899,enzyme binding,F
25979,35,42802,identical protein binding,F
25980,35,16301,kinase activity,F
25981,35,30235,nitric-oxide synthase regulator activity,F
26061,35,43536,positive regulation of blood vessel endothelial cell migration,P
26059,35,30168,platelet activation,P
26060,35,43065,positive regulation of apoptotic process,P
26058,35,16310,phosphorylation,P
26057,35,48015,phosphatidylinositol-mediated signaling,P
26056,35,32287,peripheral nervous system myelin maintenance,P
26055,35,18107,peptidyl-threonine phosphorylation,P
26054,35,18105,peptidyl-serine phosphorylation,P
26053,35,18105,peptidyl-serine phosphorylation,P
26052,35,1649,osteoblast differentiation,P
26051,35,6809,nitric oxide biosynthetic process,P
26050,35,90201,negative regulation of release of cytochrome c from mitochondria,P
26049,35,45861,negative regulation of proteolysis,P
26048,35,100002,negative regulation of protein kinase activity by protein phosphorylation,P
26047,35,6469,negative regulation of protein kinase activity,P
26046,35,6469,negative regulation of protein kinase activity,P
26045,35,10748,negative regulation of plasma membrane long-chain fatty acid transport,P
26044,35,1902176,negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway,P
26043,35,1901215,negative regulation of neuron death,P
26042,35,10629,negative regulation of gene expression,P
26041,35,31999,negative regulation of fatty acid beta-oxidation,P
26040,35,2001240,negative regulation of extrinsic apoptotic signaling pathway in absence of ligand,P
26039,35,10951,negative regulation of endopeptidase activity,P
26038,35,43154,negative regulation of cysteine-type endopeptidase activity involved in apoptotic process,P
26037,35,45792,negative regulation of cell size,P
26036,35,10507,negative regulation of autophagy,P
26035,35,43066,negative regulation of apoptotic process,P
26034,35,46329,negative regulation of JNK cascade,P
26033,35,1893,maternal placenta development,P
26032,35,60644,mammary gland epithelial cell differentiation,P
26031,35,72656,maintenance of protein location in mitochondrion,P
26030,35,31663,lipopolysaccharide-mediated signaling pathway,P
26029,35,60716,labyrinthine layer blood vessel development,P
26028,35,35556,intracellular signal transduction,P
26027,35,35655,interleukin-18-mediated signaling pathway,P
26026,35,48009,insulin-like growth factor receptor signaling pathway,P
26025,35,8286,insulin receptor signaling pathway,P
26024,35,6954,inflammatory response,P
26023,35,30212,hyaluronan metabolic process,P
26022,35,60709,glycogen cell differentiation involved in embryonic placenta development,P
26020,35,15758,glucose transport,P
26021,35,5978,glycogen biosynthetic process,P
26019,35,6006,glucose metabolic process,P
26017,35,7281,germ cell development,P
26018,35,42593,glucose homeostasis,P
26016,35,97194,execution phase of apoptosis,P
26015,35,72655,establishment of protein localization to mitochondrion,P
26014,35,31018,endocrine pancreas development,P
26013,35,99565,"chemical synaptic transmission, postsynaptic",P
26012,35,35924,cellular response to vascular endothelial growth factor stimulus,P
26011,35,71380,cellular response to prostaglandin E stimulus,P
26010,35,71407,cellular response to organic cyclic compound,P
26009,35,1990090,cellular response to nerve growth factor stimulus,P
26008,35,71260,cellular response to mechanical stimulus,P
26007,35,32869,cellular response to insulin stimulus,P
26006,35,32869,cellular response to insulin stimulus,P
26005,35,71456,cellular response to hypoxia,P
26004,35,97011,cellular response to granulocyte macrophage colony-stimulating factor stimulus,P
26003,35,71364,cellular response to epidermal growth factor stimulus,P
26002,35,6974,cellular response to DNA damage stimulus,P
26001,35,6464,cellular protein modification process,P
26000,35,8283,cell proliferation,P
25952,36,14065,phosphatidylinositol 3-kinase signaling,P
25951,36,50900,leukocyte migration,P
25950,36,7156,homophilic cell adhesion via plasma membrane adhesion molecules,P
25949,36,1935,endothelial cell proliferation,P
25948,36,40016,embryonic cleavage,P
25947,36,6935,chemotaxis,P
25946,36,6874,cellular calcium ion homeostasis,P
25945,36,16477,cell migration,P
25944,36,6914,autophagy,P
25943,36,60055,angiogenesis involved in wound healing,P
25942,36,187,activation of MAPK activity,P
25941,36,50852,T cell receptor signaling pathway,P
25940,36,7186,G-protein coupled receptor signaling pathway,P
25939,36,38096,Fc-gamma receptor signaling pathway involved in phagocytosis,P
25938,36,38095,Fc-epsilon receptor signaling pathway,P
25937,36,5515,protein binding,F
25936,36,46934,"phosphatidylinositol-4,5-bisphosphate 3-kinase activity",F
25935,36,46934,"phosphatidylinositol-4,5-bisphosphate 3-kinase activity",F
25934,36,35004,phosphatidylinositol 3-kinase activity,F
25933,36,16301,kinase activity,F
25932,36,43560,insulin receptor substrate binding,F
25931,36,5524,ATP binding,F
25930,36,35005,1-phosphatidylinositol-4-phosphate 3-kinase activity,F
25929,36,16303,1-phosphatidylinositol-3-kinase activity,F
25908,37,48011,neurotrophin TRK receptor signaling pathway,P
25907,37,10977,negative regulation of neuron projection development,P
25906,37,43154,negative regulation of cysteine-type endopeptidase activity involved in apoptotic process,P
25905,37,1903588,negative regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis,P
25904,37,50771,negative regulation of axonogenesis,P
25903,37,43066,negative regulation of apoptotic process,P
25902,37,31293,membrane protein intracellular domain proteolysis,P
25901,37,6886,intracellular protein transport,P
25900,37,6954,inflammatory response,P
25898,37,42593,glucose homeostasis,P
25899,37,6955,immune response,P
25897,37,32922,circadian regulation of gene expression,P
25896,37,7411,axon guidance,P
25895,37,97190,apoptotic signaling pathway,P
25894,37,6919,activation of cysteine-type endopeptidase activity involved in apoptotic process,P
25893,37,6919,activation of cysteine-type endopeptidase activity involved in apoptotic process,P
25892,37,31625,ubiquitin protein ligase binding,F
25891,37,5031,tumor necrosis factor-activated receptor activity,F
25890,37,4888,transmembrane signaling receptor activity,F
25889,37,4871,signal transducer activity,F
25888,37,4872,receptor activity,F
25887,37,5515,protein binding,F
25886,37,48406,nerve growth factor binding,F
25885,37,17137,Rab GTPase binding,F
25869,38,1900029,positive regulation of ruffle assembly,P
25868,38,1934,positive regulation of protein phosphorylation,P
25867,38,2000630,positive regulation of miRNA metabolic process,P
25866,38,32729,positive regulation of interferon-gamma production,P
25865,38,50679,positive regulation of epithelial cell proliferation,P
25864,38,8284,positive regulation of cell proliferation,P
25863,38,30335,positive regulation of cell migration,P
25862,38,2000251,positive regulation of actin cytoskeleton reorganization,P
25861,38,46579,positive regulation of Ras protein signal transduction,P
25860,38,43410,positive regulation of MAPK cascade,P
25859,38,43406,positive regulation of MAP kinase activity,P
25858,38,46330,positive regulation of JNK cascade,P
25857,38,43547,positive regulation of GTPase activity,P
25856,38,70374,positive regulation of ERK1 and ERK2 cascade,P
25855,38,45740,positive regulation of DNA replication,P
25854,38,43524,negative regulation of neuron apoptotic process,P
25853,38,10629,negative regulation of gene expression,P
25852,38,8285,negative regulation of cell proliferation,P
25851,38,34260,negative regulation of GTPase activity,P
25850,38,7093,mitotic cell cycle checkpoint,P
25849,38,50900,leukocyte migration,P
25848,38,97193,intrinsic apoptotic signaling pathway,P
25847,38,7173,epidermal growth factor receptor signaling pathway,P
25846,38,48013,ephrin receptor signaling pathway,P
25845,38,6897,endocytosis,P
25844,38,42832,defense response to protozoan,P
25843,38,6935,chemotaxis,P
25842,38,90398,cellular senescence,P
25841,38,7166,cell surface receptor signaling pathway,P
25840,38,8283,cell proliferation,P
25838,38,7050,cell cycle arrest,P
25839,38,7050,cell cycle arrest,P
25837,38,7411,axon guidance,P
25836,38,9887,animal organ morphogenesis,P
25835,38,42088,T-helper 1 type immune response,P
25834,38,50852,T cell receptor signaling pathway,P
25833,38,7265,Ras protein signal transduction,P
25832,38,7265,Ras protein signal transduction,P
25831,38,165,MAPK cascade,P
25830,38,38095,Fc-epsilon receptor signaling pathway,P
25829,38,38128,ERBB2 signaling pathway,P
25828,38,5515,protein binding,F
25827,38,8022,protein C-terminus binding,F
25826,38,3924,GTPase activity,F
25825,38,5525,GTP binding,F
25801,39,50679,positive regulation of epithelial cell proliferation,P
25800,39,43280,positive regulation of cysteine-type endopeptidase activity involved in apoptotic process,P
25799,39,8284,positive regulation of cell proliferation,P
25798,39,2000573,positive regulation of DNA biosynthetic process,P
25797,39,15671,oxygen transport,P
25796,39,122,negative regulation of transcription from RNA polymerase II promoter,P
25795,39,32873,negative regulation of stress-activated MAPK cascade,P
25794,39,45656,negative regulation of monocyte differentiation,P
25793,39,48147,negative regulation of fibroblast proliferation,P
25792,39,51782,negative regulation of cell division,P
25791,39,43066,negative regulation of apoptotic process,P
25790,39,44346,fibroblast apoptotic process,P
25789,39,6112,energy reserve metabolic process,P
25788,39,51276,chromosome organization,P
25787,39,6338,chromatin remodeling,P
25786,39,35690,cellular response to drug,P
25785,39,34644,cellular response to UV,P
25783,39,6879,cellular iron ion homeostasis,P
25784,39,6974,cellular response to DNA damage stimulus,P
25782,39,7050,cell cycle arrest,P
25781,39,60070,canonical Wnt signaling pathway,P
25780,39,1658,branching involved in ureteric bud morphogenesis,P
25779,39,1904837,beta-catenin-TCF complex assembly,P
25777,39,165,MAPK cascade,P
25778,39,7219,Notch signaling pathway,P
25776,39,1077,"transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding",F
25775,39,8134,transcription factor binding,F
25774,39,3700,"transcription factor activity, sequence-specific DNA binding",F
25773,39,70491,repressing transcription factor binding,F
25772,39,46983,protein dimerization activity,F
25771,39,32403,protein complex binding,F
25770,39,5515,protein binding,F
25769,39,978,RNA polymerase II core promoter proximal region sequence-specific DNA binding,F
25768,39,70888,E-box binding,F
25767,39,3677,DNA binding,F
25766,39,3677,DNA binding,F
25678,40,43066,negative regulation of apoptotic process,P
25677,40,60571,morphogenesis of an epithelial fold,P
25676,40,7494,midgut development,P
25675,40,10960,magnesium ion homeostasis,P
25674,40,30324,lung development,P
25673,40,97421,liver regeneration,P
25672,40,7611,learning or memory,P
25671,40,42743,hydrogen peroxide metabolic process,P
25670,40,1942,hair follicle development,P
25669,40,61029,eyelid development in camera-type eye,P
25668,40,7173,epidermal growth factor receptor signaling pathway,P
25667,40,7173,epidermal growth factor receptor signaling pathway,P
25666,40,1892,embryonic placenta development,P
25665,40,16101,diterpenoid metabolic process,P
25664,40,48546,digestive tract morphogenesis,P
25663,40,7623,circadian rhythm,P
25662,40,21795,cerebral cortex cell migration,P
25661,40,71260,cellular response to mechanical stimulus,P
25660,40,71392,cellular response to estradiol stimulus,P
25659,40,71364,cellular response to epidermal growth factor stimulus,P
25658,40,35690,cellular response to drug,P
25657,40,71549,cellular response to dexamethasone stimulus,P
25656,40,71230,cellular response to amino acid stimulus,P
25655,40,7166,cell surface receptor signaling pathway,P
25654,40,8283,cell proliferation,P
25653,40,48143,astrocyte activation,P
25652,40,7202,activation of phospholipase C activity,P
25650,40,186,activation of MAPKK activity,P
25651,40,43006,activation of phospholipase A2 activity by calcium-mediated signaling,P
25649,40,165,MAPK cascade,P
25648,40,38128,ERBB2 signaling pathway,P
25647,40,31625,ubiquitin protein ligase binding,F
25646,40,4888,transmembrane signaling receptor activity,F
25645,40,4714,transmembrane receptor protein tyrosine kinase activity,F
25644,40,4716,"signal transducer, downstream of receptor, with protein tyrosine kinase activity",F
25643,40,4713,protein tyrosine kinase activity,F
25642,40,4713,protein tyrosine kinase activity,F
25641,40,4713,protein tyrosine kinase activity,F
25638,40,19901,protein kinase binding,F
25639,40,19903,protein phosphatase binding,F
25640,40,4713,protein tyrosine kinase activity,F
25637,40,46982,protein heterodimerization activity,F
25636,40,5515,protein binding,F
25635,40,46934,"phosphatidylinositol-4,5-bisphosphate 3-kinase activity",F
25634,40,30235,nitric-oxide synthase regulator activity,F
25633,40,5178,integrin binding,F
25632,40,42802,identical protein binding,F
25631,40,1948,glycoprotein binding,F
25630,40,5006,epidermal growth factor-activated receptor activity,F
25629,40,5006,epidermal growth factor-activated receptor activity,F
25628,40,5006,epidermal growth factor-activated receptor activity,F
25627,40,48408,epidermal growth factor binding,F
25626,40,19899,enzyme binding,F
25625,40,3690,double-stranded DNA binding,F
25624,40,3682,chromatin binding,F
25623,40,5516,calmodulin binding,F
25622,40,98641,cadherin binding involved in cell-cell adhesion,F
25621,40,51015,actin filament binding,F
25620,40,5088,Ras guanyl-nucleotide exchange factor activity,F
25619,40,4709,MAP kinase kinase kinase activity,F
25618,40,5524,ATP binding,F
25590,41,45943,positive regulation of transcription from RNA polymerase I promoter,P
25589,41,90314,positive regulation of protein targeting to membrane,P
25588,41,1934,positive regulation of protein phosphorylation,P
25587,41,50679,positive regulation of epithelial cell proliferation,P
25586,41,30307,positive regulation of cell growth,P
25585,41,45785,positive regulation of cell adhesion,P
25584,41,43406,positive regulation of MAP kinase activity,P
25583,41,43547,positive regulation of GTPase activity,P
25582,41,48015,phosphatidylinositol-mediated signaling,P
25581,41,46854,phosphatidylinositol phosphorylation,P
25580,41,14065,phosphatidylinositol 3-kinase signaling,P
25579,41,7422,peripheral nervous system development,P
25578,41,18108,peptidyl-tyrosine phosphorylation,P
25577,41,48709,oligodendrocyte differentiation,P
25576,41,7528,neuromuscular junction development,P
25575,41,33088,negative regulation of immature T cell proliferation in thymus,P
25574,41,42552,myelination,P
25573,41,8045,motor neuron axon guidance,P
25572,41,7507,heart development,P
25571,41,7167,enzyme linked receptor protein signaling pathway,P
25570,41,71363,cellular response to growth factor stimulus,P
25569,41,71364,cellular response to epidermal growth factor stimulus,P
25568,41,7166,cell surface receptor signaling pathway,P
25567,41,8283,cell proliferation,P
25566,41,165,MAPK cascade,P
25565,41,38128,ERBB2 signaling pathway,P
25564,41,4888,transmembrane signaling receptor activity,F
25563,41,4714,transmembrane receptor protein tyrosine kinase activity,F
25562,41,4716,"signal transducer, downstream of receptor, with protein tyrosine kinase activity",F
25561,41,4713,protein tyrosine kinase activity,F
25560,41,4713,protein tyrosine kinase activity,F
25559,41,4713,protein tyrosine kinase activity,F
25558,41,19903,protein phosphatase binding,F
25557,41,46982,protein heterodimerization activity,F
25556,41,46982,protein heterodimerization activity,F
25555,41,46983,protein dimerization activity,F
25554,41,5515,protein binding,F
25553,41,8022,protein C-terminus binding,F
25552,41,46934,"phosphatidylinositol-4,5-bisphosphate 3-kinase activity",F
25551,41,42802,identical protein binding,F
25550,41,19838,growth factor binding,F
25549,41,5088,Ras guanyl-nucleotide exchange factor activity,F
25548,41,1042,RNA polymerase I core binding,F
25547,41,43125,ErbB-3 class receptor binding,F
25546,41,5524,ATP binding,F
25517,42,46326,positive regulation of glucose import,P
25516,42,48639,positive regulation of developmental growth,P
25515,42,8284,positive regulation of cell proliferation,P
25514,42,8284,positive regulation of cell proliferation,P
25513,42,30335,positive regulation of cell migration,P
25512,42,43410,positive regulation of MAPK cascade,P
25511,42,43410,positive regulation of MAPK cascade,P
25510,42,45740,positive regulation of DNA replication,P
25509,42,18108,peptidyl-tyrosine phosphorylation,P
25508,42,38083,peptidyl-tyrosine autophosphorylation,P
25507,42,30238,male sex determination,P
25506,42,8584,male gonad development,P
25505,42,8286,insulin receptor signaling pathway,P
25504,42,8286,insulin receptor signaling pathway,P
25503,42,3007,heart morphogenesis,P
25502,42,42593,glucose homeostasis,P
25501,42,31017,exocrine pancreas development,P
25500,42,8544,epidermis development,P
25499,42,32869,cellular response to insulin stimulus,P
25498,42,71363,cellular response to growth factor stimulus,P
25497,42,5975,carbohydrate metabolic process,P
25496,42,30325,adrenal gland development,P
25495,42,32147,activation of protein kinase activity,P
25494,42,32148,activation of protein kinase B activity,P
25493,42,187,activation of MAPK activity,P
25492,42,7186,G-protein coupled receptor signaling pathway,P
25491,42,4716,"signal transducer, downstream of receptor, with protein tyrosine kinase activity",F
25490,42,4713,protein tyrosine kinase activity,F
25489,42,4713,protein tyrosine kinase activity,F
25488,42,5515,protein binding,F
25487,42,43548,phosphatidylinositol 3-kinase binding,F
25486,42,5159,insulin-like growth factor receptor binding,F
25485,42,31995,insulin-like growth factor II binding,F
25484,42,31994,insulin-like growth factor I binding,F
25483,42,5009,insulin-activated receptor activity,F
25482,42,43560,insulin receptor substrate binding,F
25481,42,43559,insulin binding,F
25480,42,43559,insulin binding,F
25479,42,51425,PTB domain binding,F
25478,42,5525,GTP binding,F
25477,42,5524,ATP binding,F
26649,24,46579,positive regulation of Ras protein signal transduction,P
26648,24,43547,positive regulation of GTPase activity,P
26647,24,48015,phosphatidylinositol-mediated signaling,P
26646,24,46854,phosphatidylinositol phosphorylation,P
26645,24,7422,peripheral nervous system development,P
26644,24,18108,peptidyl-tyrosine phosphorylation,P
26643,24,48709,oligodendrocyte differentiation,P
26642,24,45213,neurotransmitter receptor metabolic process,P
26641,24,48663,neuron fate commitment,P
26640,24,14032,neural crest cell development,P
26639,24,7399,nervous system development,P
26638,24,45892,"negative regulation of transcription, DNA-templated",P
26637,24,51048,negative regulation of secretion,P
26636,24,42177,negative regulation of protein catabolic process,P
26635,24,2001223,negative regulation of neuron migration,P
26634,24,30879,mammary gland development,P
26633,24,7626,locomotory behavior,P
26632,24,35556,intracellular signal transduction,P
26631,24,21781,glial cell fate commitment,P
26630,24,60956,endocardial cell differentiation,P
26629,24,9790,embryo development,P
26628,24,21842,chemorepulsion involved in interneuron migration from the subpallium to the cortex,P
26627,24,902,cell morphogenesis,P
26626,24,7154,cell communication,P
26625,24,60379,cardiac muscle cell myoblast differentiation,P
26624,24,55007,cardiac muscle cell differentiation,P
26623,24,3161,cardiac conduction system development,P
26622,24,8366,axon ensheathment,P
26621,24,7171,activation of transmembrane receptor protein tyrosine kinase activity,P
26620,24,32148,activation of protein kinase B activity,P
26619,24,187,activation of MAPK activity,P
26618,24,165,MAPK cascade,P
26617,24,38128,ERBB2 signaling pathway,P
26616,24,38127,ERBB signaling pathway,P
26615,24,38127,ERBB signaling pathway,P
26614,24,30297,transmembrane receptor protein tyrosine kinase activator activity,F
26613,24,3712,transcription cofactor activity,F
26612,24,30971,receptor tyrosine kinase binding,F
26611,24,4713,protein tyrosine kinase activity,F
26610,24,46934,"phosphatidylinositol-4,5-bisphosphate 3-kinase activity",F
26609,24,5178,integrin binding,F
26608,24,8083,growth factor activity,F
26607,24,5125,cytokine activity,F
26606,24,45499,chemorepellent activity,F
26605,24,5088,Ras guanyl-nucleotide exchange factor activity,F
26604,24,43125,ErbB-3 class receptor binding,F
26603,24,5176,ErbB-2 class receptor binding,F
25349,46,8284,positive regulation of cell proliferation,P
25348,46,30307,positive regulation of cell growth,P
25347,46,42104,positive regulation of activated T cell proliferation,P
25346,46,43547,positive regulation of GTPase activity,P
25345,46,30890,positive regulation of B cell proliferation,P
25344,46,1933,negative regulation of protein phosphorylation,P
25343,46,50672,negative regulation of lymphocyte proliferation,P
25342,46,50728,negative regulation of inflammatory response,P
25341,46,45822,negative regulation of heart contraction,P
25340,46,43066,negative regulation of apoptotic process,P
25339,46,2903,negative regulation of B cell apoptotic process,P
25338,46,30101,natural killer cell activation,P
25337,46,6955,immune response,P
25336,46,97192,extrinsic apoptotic signaling pathway in absence of ligand,P
25335,46,7267,cell-cell signaling,P
25334,46,7155,cell adhesion,P
25333,46,2250,adaptive immune response,P
25332,46,30217,T cell differentiation,P
25331,46,165,MAPK cascade,P
25330,46,19209,kinase activator activity,F
25329,46,31851,kappa-type opioid receptor binding,F
25328,46,5134,interleukin-2 receptor binding,F
25326,46,8083,growth factor activity,F
25327,46,5134,interleukin-2 receptor binding,F
25325,46,43208,glycosphingolipid binding,F
25324,46,5125,cytokine activity,F
25323,46,30246,carbohydrate binding,F
25322,46,5088,Ras guanyl-nucleotide exchange factor activity,F
25291,47,45840,positive regulation of mitotic nuclear division,P
25290,47,35793,positive regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway,P
25289,47,2000591,positive regulation of metanephric mesenchymal cell migration,P
25288,47,1900127,positive regulation of hyaluronan biosynthetic process,P
25287,47,72126,positive regulation of glomerular mesangial cell proliferation,P
25286,47,3104,positive regulation of glomerular filtration,P
25285,47,10628,positive regulation of gene expression,P
25284,47,48146,positive regulation of fibroblast proliferation,P
25283,47,1938,positive regulation of endothelial cell proliferation,P
25282,47,45737,positive regulation of cyclin-dependent protein serine/threonine kinase activity,P
25281,47,50921,positive regulation of chemotaxis,P
25280,47,8284,positive regulation of cell proliferation,P
25279,47,30335,positive regulation of cell migration,P
25278,47,51781,positive regulation of cell division,P
25277,47,90280,positive regulation of calcium ion import,P
25276,47,43536,positive regulation of blood vessel endothelial cell migration,P
25275,47,43410,positive regulation of MAPK cascade,P
25274,47,43406,positive regulation of MAP kinase activity,P
25273,47,43547,positive regulation of GTPase activity,P
25272,47,70374,positive regulation of ERK1 and ERK2 cascade,P
25271,47,45740,positive regulation of DNA replication,P
25270,47,2000573,positive regulation of DNA biosynthetic process,P
25269,47,50918,positive chemotaxis,P
25268,47,48008,platelet-derived growth factor receptor signaling pathway,P
25267,47,2576,platelet degranulation,P
25266,47,48015,phosphatidylinositol-mediated signaling,P
25265,47,46854,phosphatidylinositol phosphorylation,P
25264,47,18108,peptidyl-tyrosine phosphorylation,P
25263,47,18105,peptidyl-serine phosphorylation,P
25262,47,38001,paracrine signaling,P
25261,47,1905064,negative regulation of vascular smooth muscle cell differentiation,P
25260,47,45892,"negative regulation of transcription, DNA-templated",P
25259,47,32091,negative regulation of protein binding,P
25258,47,1902894,negative regulation of pri-miRNA transcription from RNA polymerase II promoter,P
25257,47,10544,negative regulation of platelet activation,P
25256,47,10512,negative regulation of phosphatidylinositol biosynthetic process,P
25254,47,2548,monocyte chemotaxis,P
25255,47,10629,negative regulation of gene expression,P
25253,47,72255,metanephric glomerular mesangial cell development,P
25251,47,30097,hemopoiesis,P
25252,47,35655,interleukin-18-mediated signaling pathway,P
25250,47,7507,heart development,P
25249,47,30198,extracellular matrix organization,P
25247,47,71506,cellular response to mycophenolic acid,P
25248,47,1892,embryonic placenta development,P
25246,47,71363,cellular response to growth factor stimulus,P
25245,47,60326,cell chemotaxis,P
25244,47,32147,activation of protein kinase activity,P
25243,47,32148,activation of protein kinase B activity,P
25242,47,165,MAPK cascade,P
25241,47,16176,superoxide-generating NADPH oxidase activator activity,F
25240,47,42803,protein homodimerization activity,F
25239,47,46982,protein heterodimerization activity,F
25238,47,5515,protein binding,F
25237,47,5161,platelet-derived growth factor receptor binding,F
25236,47,5161,platelet-derived growth factor receptor binding,F
25235,47,5161,platelet-derived growth factor receptor binding,F
25234,47,48407,platelet-derived growth factor binding,F
25233,47,46934,"phosphatidylinositol-4,5-bisphosphate 3-kinase activity",F
25232,47,42802,identical protein binding,F
25231,47,8083,growth factor activity,F
25230,47,5518,collagen binding,F
25229,47,42056,chemoattractant activity,F
25228,47,5088,Ras guanyl-nucleotide exchange factor activity,F
25203,48,21940,positive regulation of cerebellar granule cell precursor proliferation,P
25202,48,8284,positive regulation of cell proliferation,P
25201,48,35413,positive regulation of catenin import into nucleus,P
25200,48,43406,positive regulation of MAP kinase activity,P
25199,48,43547,positive regulation of GTPase activity,P
25198,48,43388,positive regulation of DNA binding,P
25197,48,2576,platelet degranulation,P
25196,48,48015,phosphatidylinositol-mediated signaling,P
25195,48,46854,phosphatidylinositol phosphorylation,P
25194,48,18108,peptidyl-tyrosine phosphorylation,P
25193,48,51048,negative regulation of secretion,P
25192,48,42059,negative regulation of epidermal growth factor receptor signaling pathway,P
25191,48,90370,negative regulation of cholesterol efflux,P
25190,48,60749,mammary gland alveolus development,P
25189,48,7173,epidermal growth factor receptor signaling pathway,P
25188,48,60070,canonical Wnt signaling pathway,P
25187,48,48754,branching morphogenesis of an epithelial tube,P
25186,48,1525,angiogenesis,P
25185,48,7171,activation of transmembrane receptor protein tyrosine kinase activity,P
25184,48,186,activation of MAPKK activity,P
25183,48,187,activation of MAPK activity,P
25182,48,44332,Wnt signaling pathway involved in dorsal/ventral axis specification,P
25180,48,165,MAPK cascade,P
25181,48,7262,STAT protein import into nucleus,P
25178,48,38128,ERBB2 signaling pathway,P
25179,48,70371,ERK1 and ERK2 cascade,P
25177,48,6260,DNA replication,P
25176,48,30297,transmembrane receptor protein tyrosine kinase activator activity,F
25175,48,4713,protein tyrosine kinase activity,F
25173,48,5515,protein binding,F
25174,48,4713,protein tyrosine kinase activity,F
25172,48,46934,"phosphatidylinositol-4,5-bisphosphate 3-kinase activity",F
25171,48,8083,growth factor activity,F
25170,48,5154,epidermal growth factor receptor binding,F
25169,48,5509,calcium ion binding,F
25168,48,17147,Wnt-protein binding,F
25167,48,42813,Wnt-activated receptor activity,F
25166,48,5088,Ras guanyl-nucleotide exchange factor activity,F
25156,49,35771,interleukin-4-mediated signaling pathway,P
25155,49,38110,interleukin-2-mediated signaling pathway,P
25154,49,6955,immune response,P
25153,49,165,MAPK cascade,P
25152,49,5515,protein binding,F
25151,49,4917,interleukin-7 receptor activity,F
25150,49,4913,interleukin-4 receptor activity,F
25149,49,4911,interleukin-2 receptor activity,F
25148,49,19976,interleukin-2 binding,F
25147,49,5088,Ras guanyl-nucleotide exchange factor activity,F
25127,50,42493,response to drug,P
25126,50,34097,response to cytokine,P
25124,50,9409,response to cold,P
25125,50,51412,response to corticosterone,P
25123,50,51591,response to cAMP,P
25122,50,6357,regulation of transcription from RNA polymerase II promoter,P
25121,50,51090,regulation of sequence-specific DNA binding transcription factor activity,P
25120,50,45893,"positive regulation of transcription, DNA-templated",P
25119,50,45944,positive regulation of transcription from RNA polymerase II promoter,P
25118,50,1902895,positive regulation of pri-miRNA transcription from RNA polymerase II promoter,P
25117,50,45672,positive regulation of osteoclast differentiation,P
25116,50,7399,nervous system development,P
25115,50,6954,inflammatory response,P
25114,50,7565,female pregnancy,P
25113,50,1661,conditioned taste aversion,P
25112,50,34614,cellular response to reactive oxygen species,P
25111,50,32870,cellular response to hormone stimulus,P
25110,50,31668,cellular response to extracellular stimulus,P
25109,50,71277,cellular response to calcium ion,P
25108,50,7568,aging,P
25107,50,60395,SMAD protein signal transduction,P
25106,50,38095,Fc-epsilon receptor signaling pathway,P
25105,50,6306,DNA methylation,P
25104,50,1077,"transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding",F
25103,50,44212,transcription regulatory region DNA binding,F
25102,50,8134,transcription factor binding,F
25101,50,3700,"transcription factor activity, sequence-specific DNA binding",F
25100,50,982,"transcription factor activity, RNA polymerase II core promoter proximal region sequence-specific binding",F
25099,50,46982,protein heterodimerization activity,F
25098,50,5515,protein binding,F
25097,50,3682,chromatin binding,F
25096,50,979,RNA polymerase II core promoter sequence-specific DNA binding,F
25095,50,978,RNA polymerase II core promoter proximal region sequence-specific DNA binding,F
25094,50,70412,R-SMAD binding,F
25057,51,35793,positive regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway,P
25056,51,2000491,positive regulation of hepatic stellate cell activation,P
25055,51,48146,positive regulation of fibroblast proliferation,P
25054,51,32967,positive regulation of collagen biosynthetic process,P
25053,51,50921,positive regulation of chemotaxis,P
25052,51,38091,positive regulation of cell proliferation by VEGF-activated platelet derived growth factor receptor signaling pathway,P
25051,51,8284,positive regulation of cell proliferation,P
25050,51,30335,positive regulation of cell migration,P
25049,51,90280,positive regulation of calcium ion import,P
25048,51,43065,positive regulation of apoptotic process,P
25047,51,35025,positive regulation of Rho protein signal transduction,P
25046,51,43406,positive regulation of MAP kinase activity,P
25045,51,43547,positive regulation of GTPase activity,P
25044,51,70374,positive regulation of ERK1 and ERK2 cascade,P
25043,51,70374,positive regulation of ERK1 and ERK2 cascade,P
25042,51,2000573,positive regulation of DNA biosynthetic process,P
25041,51,35791,platelet-derived growth factor receptor-beta signaling pathway,P
25040,51,48008,platelet-derived growth factor receptor signaling pathway,P
25039,51,48015,phosphatidylinositol-mediated signaling,P
25038,51,48015,phosphatidylinositol-mediated signaling,P
25037,51,46854,phosphatidylinositol phosphorylation,P
25036,51,46488,phosphatidylinositol metabolic process,P
25035,51,18108,peptidyl-tyrosine phosphorylation,P
25034,51,43066,negative regulation of apoptotic process,P
25033,51,72075,metanephric mesenchyme development,P
25032,51,35789,metanephric mesenchymal cell migration,P
25031,51,72262,metanephric glomerular mesangial cell proliferation involved in metanephros development,P
25030,51,72277,metanephric glomerular capillary formation,P
25029,51,72278,metanephric comma-shaped body morphogenesis,P
25026,51,60437,lung growth,P
25027,51,8584,male gonad development,P
25028,51,72284,metanephric S-shaped body morphogenesis,P
25025,51,48839,inner ear development,P
25024,51,6024,glycosaminoglycan biosynthetic process,P
25023,51,36120,cellular response to platelet-derived growth factor stimulus,P
25022,51,35441,cell migration involved in vasculogenesis,P
25020,51,16477,cell migration,P
25021,51,60981,cell migration involved in coronary angiogenesis,P
25019,51,60326,cell chemotaxis,P
25018,51,55003,cardiac myofibril assembly,P
25016,51,7568,aging,P
25017,51,35909,aorta morphogenesis,P
25015,51,165,MAPK cascade,P
25014,51,7186,G-protein coupled receptor signaling pathway,P
25013,51,38085,vascular endothelial growth factor binding,F
25012,51,5102,receptor binding,F
25011,51,4713,protein tyrosine kinase activity,F
25010,51,19901,protein kinase binding,F
25009,51,5515,protein binding,F
25008,51,5017,platelet-derived growth factor-activated receptor activity,F
25007,51,5161,platelet-derived growth factor receptor binding,F
25006,51,48407,platelet-derived growth factor binding,F
25005,51,48407,platelet-derived growth factor binding,F
25004,51,5019,platelet-derived growth factor beta-receptor activity,F
25003,51,5019,platelet-derived growth factor beta-receptor activity,F
25002,51,4992,platelet activating factor receptor activity,F
25001,51,46934,"phosphatidylinositol-4,5-bisphosphate 3-kinase activity",F
25000,51,43548,phosphatidylinositol 3-kinase binding,F
24999,51,19899,enzyme binding,F
24998,51,5088,Ras guanyl-nucleotide exchange factor activity,F
24997,51,5524,ATP binding,F
24994,52,7165,signal transduction,P
24993,52,7507,heart development,P
27811,261,712,resolution of meiotic recombination intermediates,P
24992,52,46697,decidualization,P
24991,52,7420,brain development,P
24990,52,42802,identical protein binding,F
24989,52,4900,erythropoietin receptor activity,F
24988,52,5887,integral component of plasma membrane,C
24987,52,5576,extracellular region,C
24980,53,42493,response to drug,P
24979,53,43200,response to amino acid,P
24978,53,10447,response to acidic pH,P
24977,53,30334,regulation of cell migration,P
24976,53,8285,negative regulation of cell proliferation,P
24975,53,6972,hyperosmotic response,P
24974,53,8628,hormone-mediated apoptotic signaling pathway,P
24973,53,7586,digestion,P
24972,53,7268,chemical synaptic transmission,P
24971,53,7267,cell-cell signaling,P
24970,53,7166,cell surface receptor signaling pathway,P
24969,53,7186,G-protein coupled receptor signaling pathway,P
24968,53,5179,hormone activity,F
24942,54,1900163,positive regulation of phospholipid scramblase activity,P
24941,54,2000753,positive regulation of glucosylceramide catabolic process,P
24940,54,32079,positive regulation of endodeoxyribonuclease activity,P
24939,54,2000304,positive regulation of ceramide biosynthetic process,P
24938,54,2001235,positive regulation of apoptotic signaling pathway,P
24937,54,30168,platelet activation,P
24936,54,18108,peptidyl-tyrosine phosphorylation,P
24935,54,18107,peptidyl-threonine phosphorylation,P
24934,54,18105,peptidyl-serine phosphorylation,P
24933,54,42119,neutrophil activation,P
24932,54,32091,negative regulation of protein binding,P
24931,54,90331,negative regulation of platelet aggregation,P
24930,54,50732,negative regulation of peptidyl-tyrosine phosphorylation,P
24929,54,46627,negative regulation of insulin receptor signaling pathway,P
24928,54,46627,negative regulation of insulin receptor signaling pathway,P
24927,54,50728,negative regulation of inflammatory response,P
24926,54,34351,negative regulation of glial cell apoptotic process,P
24925,54,51490,negative regulation of filopodium assembly,P
24924,54,30837,negative regulation of actin filament polymerization,P
24923,54,43407,negative regulation of MAP kinase activity,P
24922,54,8631,intrinsic apoptotic signaling pathway in response to oxidative stress,P
24921,54,32615,interleukin-12 production,P
24920,54,32613,interleukin-10 production,P
24919,54,60333,interferon-gamma-mediated signaling pathway,P
24918,54,16064,immunoglobulin mediated immune response,P
24917,54,16572,histone phosphorylation,P
24916,54,42742,defense response to bacterium,P
24915,54,90398,cellular senescence,P
24914,54,71447,cellular response to hydroperoxide,P
24913,54,70301,cellular response to hydrogen peroxide,P
24912,54,1904385,cellular response to angiotensin,P
24911,54,6921,cellular component disassembly involved in execution phase of apoptosis,P
24910,54,7049,cell cycle,P
24909,54,60326,cell chemotaxis,P
24908,54,6915,apoptotic process,P
24907,54,32147,activation of protein kinase activity,P
24906,54,7202,activation of phospholipase C activity,P
24905,54,38096,Fc-gamma receptor signaling pathway involved in phagocytosis,P
24904,54,42100,B cell proliferation,P
24903,54,4674,protein serine/threonine kinase activity,F
24902,54,4674,protein serine/threonine kinase activity,F
24901,54,4674,protein serine/threonine kinase activity,F
24900,54,19901,protein kinase binding,F
24899,54,4672,protein kinase activity,F
24898,54,4697,protein kinase C activity,F
24897,54,4697,protein kinase C activity,F
24896,54,5515,protein binding,F
24895,54,4715,non-membrane spanning protein tyrosine kinase activity,F
24894,54,46872,metal ion binding,F
24893,54,19900,kinase binding,F
24892,54,43560,insulin receptor substrate binding,F
24891,54,19899,enzyme binding,F
24890,54,19899,enzyme binding,F
24889,54,8047,enzyme activator activity,F
24888,54,4699,calcium-independent protein kinase C activity,F
24887,54,4699,calcium-independent protein kinase C activity,F
24886,54,5524,ATP binding,F
24857,55,45820,negative regulation of glycolytic process,P
24856,55,10887,negative regulation of cholesterol storage,P
24855,55,45776,negative regulation of blood pressure,P
24853,55,42157,lipoprotein metabolic process,P
24854,55,32099,negative regulation of appetite,P
24852,55,6629,lipid metabolic process,P
24851,55,30522,intracellular receptor signaling pathway,P
24850,55,7507,heart development,P
24849,55,15908,fatty acid transport,P
24848,55,6631,fatty acid metabolic process,P
24847,55,8544,epidermis development,P
24846,55,70166,enamel mineralization,P
24845,55,32922,circadian regulation of gene expression,P
24844,55,44255,cellular lipid metabolic process,P
24843,55,35095,behavioral response to nicotine,P
24842,55,8270,zinc ion binding,F
24841,55,31624,ubiquitin conjugating enzyme binding,F
24840,55,1078,"transcriptional repressor activity, RNA polymerase II core promoter proximal region sequence-specific binding",F
24839,55,1190,"transcriptional activator activity, RNA polymerase II transcription factor binding",F
24838,55,1077,"transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding",F
24837,55,8134,transcription factor binding,F
24836,55,3700,"transcription factor activity, sequence-specific DNA binding",F
24835,55,3700,"transcription factor activity, sequence-specific DNA binding",F
24834,55,1223,transcription coactivator binding,F
24833,55,3707,steroid hormone receptor activity,F
24832,55,43565,sequence-specific DNA binding,F
24831,55,19904,protein domain specific binding,F
24830,55,32403,protein complex binding,F
24828,55,19902,phosphatase binding,F
24829,55,5515,protein binding,F
24827,55,8289,lipid binding,F
24826,55,8144,drug binding,F
24825,55,4879,"RNA polymerase II transcription factor activity, ligand-activated sequence-specific DNA binding",F
24824,55,1103,RNA polymerase II repressing transcription factor binding,F
24823,55,978,RNA polymerase II core promoter proximal region sequence-specific DNA binding,F
24822,55,51525,NFAT protein binding,F
24821,55,97371,MDM2/MDM4 family protein binding,F
24820,55,3677,DNA binding,F
24791,56,2001241,positive regulation of extrinsic apoptotic signaling pathway in absence of ligand,P
24790,56,45793,positive regulation of cell size,P
24789,56,30335,positive regulation of cell migration,P
24788,56,33630,positive regulation of cell adhesion mediated by integrin,P
24787,56,43547,positive regulation of GTPase activity,P
24786,56,18108,peptidyl-tyrosine phosphorylation,P
24785,56,42551,neuron maturation,P
24784,56,7158,neuron cell-cell adhesion,P
24783,56,1755,neural crest cell migration,P
24782,56,33619,membrane protein proteolysis,P
24780,56,60384,innervation,P
24781,56,97021,lymphocyte migration into lymphoid organs,P
24779,56,7156,homophilic cell adhesion via plasma membrane adhesion molecules,P
24777,56,1838,embryonic epithelial tube formation,P
24778,56,48484,enteric nervous system development,P
24776,56,71300,cellular response to retinoic acid,P
24775,56,61146,Peyer's patch morphogenesis,P
24774,56,165,MAPK cascade,P
24773,56,4714,transmembrane receptor protein tyrosine kinase activity,F
24772,56,4872,receptor activity,F
24771,56,4713,protein tyrosine kinase activity,F
24769,56,5509,calcium ion binding,F
24770,56,5515,protein binding,F
24768,56,5088,Ras guanyl-nucleotide exchange factor activity,F
24767,56,5524,ATP binding,F
24756,57,30168,platelet activation,P
24755,57,9395,phospholipid catabolic process,P
24754,57,6661,phosphatidylinositol biosynthetic process,P
24753,57,43069,negative regulation of programmed cell death,P
24752,57,32959,inositol trisphosphate biosynthetic process,P
24751,57,43647,inositol phosphate metabolic process,P
24750,57,2316,follicular B cell differentiation,P
24749,57,19722,calcium-mediated signaling,P
24748,57,32237,activation of store-operated calcium channel activity,P
24747,57,16055,Wnt signaling pathway,P
24746,57,50852,T cell receptor signaling pathway,P
24745,57,38096,Fc-gamma receptor signaling pathway involved in phagocytosis,P
24744,57,38095,Fc-epsilon receptor signaling pathway,P
24743,57,50853,B cell receptor signaling pathway,P
24742,57,30183,B cell differentiation,P
24741,57,4871,signal transducer activity,F
24740,57,5515,protein binding,F
24739,57,4629,phospholipase C activity,F
24738,57,4435,phosphatidylinositol phospholipase C activity,F
24737,57,4435,phosphatidylinositol phospholipase C activity,F
24761,57,32496,response to lipopolysaccharide,P
24760,57,51209,release of sequestered calcium ion into cytosol,P
24759,57,10468,regulation of gene expression,P
24758,57,32481,positive regulation of type I interferon production,P
24757,57,2092,positive regulation of receptor internalization,P
24736,58,43234,protein complex,C
24735,58,5777,peroxisome,C
24734,58,5778,peroxisomal membrane,C
24733,58,16020,membrane,C
24732,58,5737,cytoplasm,C
24731,58,45046,protein import into peroxisome membrane,P
24730,58,16560,"protein import into peroxisome matrix, docking",P
24729,58,16558,protein import into peroxisome matrix,P
24728,58,16558,protein import into peroxisome matrix,P
24727,58,16558,protein import into peroxisome matrix,P
24726,58,1901094,negative regulation of protein homotetramerization,P
24725,58,31267,small GTPase binding,F
24724,58,5515,protein binding,F
24723,58,47485,protein N-terminus binding,F
24722,58,268,peroxisome targeting sequence binding,F
24721,58,5052,peroxisome matrix targeting signal-1 binding,F
24720,58,5052,peroxisome matrix targeting signal-1 binding,F
24719,58,19899,enzyme binding,F
26584,25,1934,positive regulation of protein phosphorylation,P
26583,25,32008,positive regulation of TOR signaling,P
26582,25,45892,"negative regulation of transcription, DNA-templated",P
26581,25,122,negative regulation of transcription from RNA polymerase II promoter,P
26580,25,122,negative regulation of transcription from RNA polymerase II promoter,P
26579,25,10832,negative regulation of myotube differentiation,P
26578,25,43066,negative regulation of apoptotic process,P
26577,25,46329,negative regulation of JNK cascade,P
26576,25,70932,histone H3 deacetylation,P
26575,25,7623,circadian rhythm,P
26574,25,6325,chromatin organization,P
26573,25,71498,cellular response to fluid shear stress,P
26572,25,44255,cellular lipid metabolic process,P
26571,25,8134,transcription factor binding,F
26570,25,8134,transcription factor binding,F
26569,25,3714,transcription corepressor activity,F
26568,25,3714,transcription corepressor activity,F
26567,25,33558,protein deacetylase activity,F
26566,25,5515,protein binding,F
26565,25,42826,histone deacetylase binding,F
26564,25,4407,histone deacetylase activity,F
26563,25,4407,histone deacetylase activity,F
26562,25,19899,enzyme binding,F
26561,25,30332,cyclin binding,F
26560,25,3682,chromatin binding,F
26559,25,51059,NF-kappaB binding,F
26558,25,32041,NAD-dependent histone deacetylase activity (H3-K14 specific),F
24623,60,6974,cellular response to DNA damage stimulus,P
24622,60,6281,DNA repair,P
24621,60,51103,DNA ligation involved in DNA repair,P
24620,60,42769,"DNA damage response, detection of DNA damage",P
24619,60,1990966,ATP generation from poly-ADP-D-ribose,P
24618,60,8270,zinc ion binding,F
24617,60,8134,transcription factor binding,F
24616,60,19901,protein kinase binding,F
24615,60,5515,protein binding,F
24613,60,44822,poly(A) RNA binding,F
24614,60,47485,protein N-terminus binding,F
24612,60,42802,identical protein binding,F
24611,60,42826,histone deacetylase binding,F
24610,60,30331,estrogen receptor binding,F
24609,60,19899,enzyme binding,F
24608,60,70412,R-SMAD binding,F
24607,60,3950,NAD+ ADP-ribosyltransferase activity,F
24606,60,3950,NAD+ ADP-ribosyltransferase activity,F
24605,60,51287,NAD binding,F
24604,60,3910,DNA ligase (ATP) activity,F
24603,60,3677,DNA binding,F
24557,61,45892,"negative regulation of transcription, DNA-templated",P
24556,61,2000378,negative regulation of reactive oxygen species metabolic process,P
24555,61,33147,negative regulation of intracellular estrogen receptor signaling pathway,P
24554,61,35067,negative regulation of histone acetylation,P
24553,61,51573,negative regulation of histone H3-K9 methylation,P
24552,61,51572,negative regulation of histone H3-K4 methylation,P
24551,61,45717,negative regulation of fatty acid biosynthetic process,P
24550,61,1902042,negative regulation of extrinsic apoptotic signaling pathway via death domain receptors,P
24549,61,46600,negative regulation of centriole replication,P
24548,61,8630,intrinsic apoptotic signaling pathway in response to DNA damage,P
24547,61,6633,fatty acid biosynthetic process,P
24546,61,6303,double-strand break repair via nonhomologous end joining,P
24545,61,724,double-strand break repair via homologous recombination,P
24544,61,6302,double-strand break repair,P
24543,61,6302,double-strand break repair,P
24542,61,9048,dosage compensation by inactivation of X chromosome,P
24541,61,7059,chromosome segregation,P
24540,61,31052,chromosome breakage,P
24539,61,43009,chordate embryonic development,P
24538,61,7098,centrosome cycle,P
24537,61,71356,cellular response to tumor necrosis factor,P
24536,61,71681,cellular response to indole-3-methanol,P
24534,61,6915,apoptotic process,P
24535,61,6974,cellular response to DNA damage stimulus,P
24533,61,30521,androgen receptor signaling pathway,P
24532,61,31572,G2 DNA damage checkpoint,P
24531,61,731,DNA synthesis involved in DNA repair,P
24530,61,6260,DNA replication,P
24529,61,729,DNA double-strand break processing,P
24528,61,6978,"DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator",P
24527,61,8270,zinc ion binding,F
24526,61,4842,ubiquitin-protein transferase activity,F
24525,61,31625,ubiquitin protein ligase binding,F
24524,61,15631,tubulin binding,F
24523,61,44212,transcription regulatory region DNA binding,F
24522,61,3713,transcription coactivator activity,F
24521,61,5515,protein binding,F
24520,61,19899,enzyme binding,F
24519,61,3684,damaged DNA binding,F
24518,61,50681,androgen receptor binding,F
24517,61,3723,RNA binding,F
24516,61,3677,DNA binding,F
24488,62,30512,negative regulation of transforming growth factor beta receptor signaling pathway,P
24487,62,42177,negative regulation of protein catabolic process,P
24486,62,32091,negative regulation of protein binding,P
24485,62,43524,negative regulation of neuron apoptotic process,P
24484,62,2000146,negative regulation of cell motility,P
24483,62,70373,negative regulation of ERK1 and ERK2 cascade,P
24481,62,5515,protein binding,F
24482,62,7049,cell cycle,P
24480,62,50816,phosphothreonine binding,F
24479,62,50816,phosphothreonine binding,F
24478,62,50815,phosphoserine binding,F
24477,62,3755,peptidyl-prolyl cis-trans isomerase activity,F
24476,62,3755,peptidyl-prolyl cis-trans isomerase activity,F
24475,62,3774,motor activity,F
24474,62,31434,mitogen-activated protein kinase kinase binding,F
24473,62,8013,beta-catenin binding,F
24472,62,8013,beta-catenin binding,F
24471,62,32794,GTPase activating protein binding,F
24349,63,51800,"phosphatidylinositol-3,4-bisphosphate 3-phosphatase activity",F
24348,63,51800,"phosphatidylinositol-3,4-bisphosphate 3-phosphatase activity",F
24347,63,16314,"phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase activity",F
24346,63,16314,"phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase activity",F
24344,63,8289,lipid binding,F
24345,63,287,magnesium ion binding,F
24338,63,30165,PDZ domain binding,F
24339,63,10997,anaphase-promoting complex binding,F
24340,63,19899,enzyme binding,F
24341,63,42802,identical protein binding,F
24342,63,51717,"inositol-1,3,4,5-tetrakisphosphate 3-phosphatase activity",F
24343,63,51717,"inositol-1,3,4,5-tetrakisphosphate 3-phosphatase activity",F
24412,63,2000808,negative regulation of synaptic vesicle clustering,P
24411,63,90071,negative regulation of ribosome biogenesis,P
24410,63,1933,negative regulation of protein phosphorylation,P
24409,63,1933,negative regulation of protein phosphorylation,P
24408,63,51898,negative regulation of protein kinase B signaling,P
24407,63,14067,negative regulation of phosphatidylinositol 3-kinase signaling,P
24406,63,50765,negative regulation of phagocytosis,P
24405,63,46621,negative regulation of organ growth,P
24404,63,31642,negative regulation of myelination,P
24403,63,51895,negative regulation of focal adhesion assembly,P
24402,63,90394,negative regulation of excitatory postsynaptic potential,P
24401,63,50680,negative regulation of epithelial cell proliferation,P
24400,63,61002,negative regulation of dendritic spine morphogenesis,P
24399,63,31658,negative regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle,P
24398,63,45792,negative regulation of cell size,P
24397,63,8285,negative regulation of cell proliferation,P
24396,63,8285,negative regulation of cell proliferation,P
24395,63,30336,negative regulation of cell migration,P
24394,63,90344,negative regulation of cell aging,P
24393,63,60044,negative regulation of cardiac muscle cell proliferation,P
24392,63,50771,negative regulation of axonogenesis,P
24391,63,48681,negative regulation of axon regeneration,P
24390,63,43066,negative regulation of apoptotic process,P
24389,63,2000134,negative regulation of G1/S transition of mitotic cell cycle,P
24388,63,70373,negative regulation of ERK1 and ERK2 cascade,P
24387,63,33555,multicellular organismal response to stress,P
24386,63,7613,memory,P
24385,63,42711,maternal behavior,P
24384,63,60179,male mating behavior,P
24383,63,60291,long-term synaptic potentiation,P
24382,63,60292,long term synaptic depression,P
24381,63,7626,locomotory behavior,P
24380,63,45475,locomotor rhythm,P
24379,63,7611,learning or memory,P
24378,63,43647,inositol phosphate metabolic process,P
24377,63,46855,inositol phosphate dephosphorylation,P
24376,63,7507,heart development,P
24375,63,48853,forebrain morphogenesis,P
24374,63,43542,endothelial cell migration,P
24373,63,21542,dentate gyrus development,P
24372,63,60997,dendritic spine morphogenesis,P
24371,63,21955,central nervous system neuron axonogenesis,P
24369,63,7417,central nervous system development,P
24370,63,32286,central nervous system myelin maintenance,P
24367,63,8283,cell proliferation,P
24368,63,71456,cellular response to hypoxia,P
24366,63,16477,cell migration,P
24365,63,48738,cardiac muscle tissue development,P
24364,63,60070,canonical Wnt signaling pathway,P
24363,63,48854,brain morphogenesis,P
24362,63,6915,apoptotic process,P
24361,63,1525,angiogenesis,P
24360,63,7568,aging,P
24359,63,30534,adult behavior,P
24358,63,50852,T cell receptor signaling pathway,P
24357,63,8138,protein tyrosine/serine/threonine phosphatase activity,F
24356,63,4725,protein tyrosine phosphatase activity,F
24355,63,4722,protein serine/threonine phosphatase activity,F
24354,63,19901,protein kinase binding,F
24353,63,5515,protein binding,F
24352,63,5161,platelet-derived growth factor receptor binding,F
24351,63,4721,phosphoprotein phosphatase activity,F
24350,63,4438,phosphatidylinositol-3-phosphatase activity,F
24315,64,32481,positive regulation of type I interferon production,P
24313,64,45893,"positive regulation of transcription, DNA-templated",P
24314,64,45893,"positive regulation of transcription, DNA-templated",P
24312,64,45944,positive regulation of transcription from RNA polymerase II promoter,P
24309,64,16573,histone acetylation,P
24310,64,42592,homeostatic process,P
24311,64,122,negative regulation of transcription from RNA polymerase II promoter,P
24308,64,42733,embryonic digit morphogenesis,P
24307,64,34644,cellular response to UV,P
24306,64,44255,cellular lipid metabolic process,P
24305,64,1904837,beta-catenin-TCF complex assembly,P
24304,64,7219,Notch signaling pathway,P
24303,64,18076,N-terminal peptidyl-lysine acetylation,P
24302,64,8270,zinc ion binding,F
24301,64,1191,"transcriptional repressor activity, RNA polymerase II transcription factor binding",F
24300,64,1078,"transcriptional repressor activity, RNA polymerase II core promoter proximal region sequence-specific binding",F
24299,64,8134,transcription factor binding,F
24298,64,3700,"transcription factor activity, sequence-specific DNA binding",F
24297,64,3713,transcription coactivator activity,F
24296,64,3713,transcription coactivator activity,F
24295,64,3713,transcription coactivator activity,F
24294,64,4871,signal transducer activity,F
24293,64,5515,protein binding,F
24292,64,34212,peptide N-acetyltransferase activity,F
24291,64,2039,p53 binding,F
24290,64,4402,histone acetyltransferase activity,F
24289,64,3684,damaged DNA binding,F
24288,64,987,core promoter proximal region sequence-specific DNA binding,F
24287,64,3682,chromatin binding,F
24286,64,16407,acetyltransferase activity,F
24285,64,16407,acetyltransferase activity,F
24284,64,1085,RNA polymerase II transcription factor binding,F
24283,64,1105,RNA polymerase II transcription coactivator activity,F
24282,64,1102,RNA polymerase II activating transcription factor binding,F
24281,64,43426,MRF binding,F
24238,65,10628,positive regulation of gene expression,P
24236,65,10634,positive regulation of epithelial cell migration,P
24237,65,45648,positive regulation of erythrocyte differentiation,P
24235,65,1938,positive regulation of endothelial cell proliferation,P
24234,65,70101,positive regulation of chemokine-mediated signaling pathway,P
24233,65,32722,positive regulation of chemokine production,P
24232,65,45766,positive regulation of angiogenesis,P
24231,65,45766,positive regulation of angiogenesis,P
24230,65,32364,oxygen homeostasis,P
24229,65,3151,outflow tract morphogenesis,P
24228,65,21502,neural fold elevation formation,P
24227,65,1755,neural crest cell migration,P
24226,65,70244,negative regulation of thymocyte apoptotic process,P
24225,65,2000378,negative regulation of reactive oxygen species metabolic process,P
24224,65,1903377,negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway,P
24223,65,2001054,negative regulation of mesenchymal cell apoptotic process,P
24222,65,45926,negative regulation of growth,P
24221,65,30502,negative regulation of bone mineralization,P
24220,65,32007,negative regulation of TOR signaling,P
24219,65,46716,muscle cell cellular homeostasis,P
24217,65,7595,lactation,P
24218,65,42789,mRNA transcription from RNA polymerase II promoter,P
24216,65,6089,lactate metabolic process,P
24215,65,61072,iris morphogenesis,P
24214,65,60574,intestinal epithelial cell maturation,P
24212,65,42541,hemoglobin biosynthetic process,P
24213,65,97411,hypoxia-inducible factor-1alpha signaling pathway,P
24211,65,1947,heart looping,P
24210,65,42593,glucose homeostasis,P
24209,65,1837,epithelial to mesenchymal transition,P
24208,65,61030,epithelial cell differentiation involved in mammary gland alveolus development,P
24207,65,1892,embryonic placenta development,P
24206,65,35162,embryonic hemopoiesis,P
24205,65,51541,elastin metabolic process,P
24204,65,71542,dopaminergic neuron differentiation,P
24203,65,48546,digestive tract morphogenesis,P
24202,65,2248,connective tissue replacement involved in inflammatory response wound healing,P
24201,65,32963,collagen metabolic process,P
24200,65,21987,cerebral cortex development,P
24199,65,71347,cellular response to interleukin-1,P
24198,65,71456,cellular response to hypoxia,P
24197,65,71456,cellular response to hypoxia,P
24196,65,6879,cellular iron ion homeostasis,P
24195,65,51216,cartilage development,P
24194,65,3208,cardiac ventricle morphogenesis,P
24193,65,19896,axonal transport of mitochondrion,P
24192,65,1525,angiogenesis,P
24191,65,1922,B-1 B cell homeostasis,P
24190,65,31625,ubiquitin protein ligase binding,F
24189,65,1228,"transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding",F
24188,65,1077,"transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding",F
24187,65,8134,transcription factor binding,F
24186,65,989,"transcription factor activity, transcription factor binding",F
24185,65,3700,"transcription factor activity, sequence-specific DNA binding",F
24184,65,3700,"transcription factor activity, sequence-specific DNA binding",F
24183,65,1076,"transcription factor activity, RNA polymerase II transcription factor binding",F
24182,65,3705,"transcription factor activity, RNA polymerase II distal enhancer sequence-specific binding",F
24180,65,43565,sequence-specific DNA binding,F
24181,65,3705,"transcription factor activity, RNA polymerase II distal enhancer sequence-specific binding",F
24179,65,19901,protein kinase binding,F
24178,65,46982,protein heterodimerization activity,F
24177,65,46982,protein heterodimerization activity,F
24176,65,5515,protein binding,F
24175,65,35257,nuclear hormone receptor binding,F
24174,65,42826,histone deacetylase binding,F
24173,65,35035,histone acetyltransferase binding,F
24172,65,19899,enzyme binding,F
24171,65,51879,Hsp90 protein binding,F
24170,65,70888,E-box binding,F
25518,42,46326,positive regulation of glucose import,P
25476,43,17053,transcriptional repressor complex,C
25475,43,5876,spindle microtubule,C
25474,43,5634,nucleus,C
25473,43,5634,nucleus,C
25472,43,5654,nucleoplasm,C
25471,43,790,nuclear chromatin,C
25470,43,16020,membrane,C
25469,43,118,histone deacetylase complex,C
25468,43,16580,Sin3 complex,C
25466,43,51225,spindle assembly,P
25467,43,6366,transcription from RNA polymerase II promoter,P
25465,43,72368,regulation of lipid transport by negative regulation of transcription from RNA polymerase II promoter,P
25464,43,72362,regulation of glycolytic process by negative regulation of transcription from RNA polymerase II promoter,P
25463,43,2000191,regulation of fatty acid transport,P
25462,43,122,negative regulation of transcription from RNA polymerase II promoter,P
25461,43,122,negative regulation of transcription from RNA polymerase II promoter,P
25459,43,46329,negative regulation of JNK cascade,P
25460,43,1903799,negative regulation of production of miRNAs involved in gene silencing by miRNA,P
25457,43,7623,circadian rhythm,P
25458,43,16569,covalent chromatin modification,P
25456,43,44255,cellular lipid metabolic process,P
25455,43,44212,transcription regulatory region DNA binding,F
25454,43,3714,transcription corepressor activity,F
25453,43,3714,transcription corepressor activity,F
25452,43,46966,thyroid hormone receptor binding,F
25451,43,5515,protein binding,F
25450,43,35257,nuclear hormone receptor binding,F
25449,43,16922,ligand-dependent nuclear receptor binding,F
25448,43,42826,histone deacetylase binding,F
25447,43,1102,RNA polymerase II activating transcription factor binding,F
24063,67,6295,"nucleotide-excision repair, DNA incision, 3'-to lesion",P
24062,67,33683,"nucleotide-excision repair, DNA incision",P
24061,67,6297,"nucleotide-excision repair, DNA gap filling",P
24060,67,6289,nucleotide-excision repair,P
24059,67,6298,mismatch repair,P
24058,67,6298,mismatch repair,P
24057,67,36297,interstrand cross-link repair,P
24056,67,42276,error-prone translesion synthesis,P
24055,67,70987,error-free translesion synthesis,P
24054,67,724,double-strand break repair via homologous recombination,P
24053,67,6284,base-excision repair,P
24052,67,82,G1/S transition of mitotic cell cycle,P
24051,67,6261,DNA-dependent DNA replication,P
24050,67,6260,DNA replication,P
24049,67,6260,DNA replication,P
24048,67,6281,DNA repair,P
24047,67,6310,DNA recombination,P
24046,67,42769,"DNA damage response, detection of DNA damage",P
24045,67,3697,single-stranded DNA binding,F
24044,67,5515,protein binding,F
24043,67,46872,metal ion binding,F
24042,67,3684,damaged DNA binding,F
24023,68,51259,protein oligomerization,P
24022,68,45893,"positive regulation of transcription, DNA-templated",P
24021,68,51782,negative regulation of cell division,P
24020,68,45910,negative regulation of DNA recombination,P
24019,68,7095,mitotic G2 DNA damage checkpoint,P
24018,68,724,double-strand break repair via homologous recombination,P
24017,68,724,double-strand break repair via homologous recombination,P
24016,68,71479,cellular response to ionizing radiation,P
24015,68,72711,cellular response to hydroxyurea,P
24014,68,72757,cellular response to camptothecin,P
24013,68,6974,cellular response to DNA damage stimulus,P
24012,68,6974,cellular response to DNA damage stimulus,P
24011,68,731,DNA synthesis involved in DNA repair,P
24010,68,733,DNA strand renaturation,P
24008,68,6281,DNA repair,P
24009,68,6260,DNA replication,P
24007,68,6310,DNA recombination,P
24006,68,32508,DNA duplex unwinding,P
24005,68,729,DNA double-strand break processing,P
24004,68,3697,single-stranded DNA binding,F
24003,68,5515,protein binding,F
24002,68,2039,p53 binding,F
24001,68,4386,helicase activity,F
23999,68,405,bubble DNA binding,F
24000,68,9378,four-way junction helicase activity,F
23998,68,36310,annealing helicase activity,F
23997,68,51880,G-quadruplex DNA binding,F
23996,68,16887,ATPase activity,F
23995,68,8026,ATP-dependent helicase activity,F
23994,68,4003,ATP-dependent DNA helicase activity,F
23993,68,4003,ATP-dependent DNA helicase activity,F
23992,68,43140,ATP-dependent 3'-5' DNA helicase activity,F
23991,68,5524,ATP binding,F
23883,69,21747,cochlear nucleus development,P
23882,69,71310,cellular response to organic substance,P
23881,69,71456,cellular response to hypoxia,P
23880,69,42149,cellular response to glucose starvation,P
23879,69,6974,cellular response to DNA damage stimulus,P
23878,69,16049,cell growth,P
23877,69,7569,cell aging,P
23876,69,1658,branching involved in ureteric bud morphogenesis,P
23875,69,1662,behavioral fear response,P
23874,69,7409,axonogenesis,P
23873,69,31103,axon regeneration,P
23872,69,6915,apoptotic process,P
23871,69,7015,actin filament organization,P
23870,69,43029,T cell homeostasis,P
23869,69,33077,T cell differentiation in thymus,P
23868,69,43375,"CD8-positive, alpha-beta T cell lineage commitment",P
23867,69,50853,B cell receptor signaling pathway,P
23866,69,42100,B cell proliferation,P
23865,69,2326,B cell lineage commitment,P
23864,69,1782,B cell homeostasis,P
23863,69,31625,ubiquitin protein ligase binding,F
23862,69,8134,transcription factor binding,F
23861,69,43565,sequence-specific DNA binding,F
23860,69,51721,protein phosphatase 2A binding,F
23852,69,51434,BH3 domain binding,F
23853,69,15267,channel activity,F
23854,69,16248,channel inhibitor activity,F
23855,69,42802,identical protein binding,F
23856,69,2020,protease binding,F
23857,69,5515,protein binding,F
23858,69,46982,protein heterodimerization activity,F
23859,69,42803,protein homodimerization activity,F
23941,69,33138,positive regulation of peptidyl-serine phosphorylation,P
23940,69,14042,positive regulation of neuron maturation,P
23939,69,40018,positive regulation of multicellular organism growth,P
23938,69,45636,positive regulation of melanocyte differentiation,P
23937,69,2001244,positive regulation of intrinsic apoptotic signaling pathway,P
23936,69,30307,positive regulation of cell growth,P
23935,69,43085,positive regulation of catalytic activity,P
23934,69,30890,positive regulation of B cell proliferation,P
23933,69,48753,pigment granule organization,P
23932,69,18107,peptidyl-threonine phosphorylation,P
23931,69,18105,peptidyl-serine phosphorylation,P
23930,69,1541,ovarian follicle development,P
23928,69,35265,organ growth,P
23929,69,1503,ossification,P
23927,69,48599,oocyte development,P
23926,69,51402,neuron apoptotic process,P
23925,69,46671,negative regulation of retinal cell programmed cell death,P
23924,69,2000378,negative regulation of reactive oxygen species metabolic process,P
23923,69,33689,negative regulation of osteoblast proliferation,P
23922,69,30279,negative regulation of ossification,P
23921,69,43524,negative regulation of neuron apoptotic process,P
23920,69,33033,negative regulation of myeloid cell apoptotic process,P
23919,69,51902,negative regulation of mitochondrial depolarization,P
23918,69,2001243,negative regulation of intrinsic apoptotic signaling pathway,P
23917,69,2001240,negative regulation of extrinsic apoptotic signaling pathway in absence of ligand,P
23916,69,32848,negative regulation of cellular pH reduction,P
23915,69,30336,negative regulation of cell migration,P
23914,69,30308,negative regulation of cell growth,P
23913,69,10523,negative regulation of calcium ion transport into cytosol,P
23911,69,2001234,negative regulation of apoptotic signaling pathway,P
23912,69,10507,negative regulation of autophagy,P
23910,69,43066,negative regulation of apoptotic process,P
23909,69,43066,negative regulation of apoptotic process,P
23908,69,43066,negative regulation of apoptotic process,P
23907,69,2000811,negative regulation of anoikis,P
23906,69,2000134,negative regulation of G1/S transition of mitotic cell cycle,P
23905,69,1656,metanephros development,P
23904,69,14031,mesenchymal cell development,P
23903,69,30318,melanocyte differentiation,P
23902,69,6582,melanin metabolic process,P
23901,69,8584,male gonad development,P
23900,69,2320,lymphoid progenitor cell differentiation,P
23899,69,8631,intrinsic apoptotic signaling pathway in response to oxidative stress,P
23898,69,70059,intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress,P
23897,69,8630,intrinsic apoptotic signaling pathway in response to DNA damage,P
23896,69,6959,humoral immune response,P
23895,69,48873,homeostasis of number of cells within a tissue,P
23894,69,31069,hair follicle morphogenesis,P
23893,69,32835,glomerulus development,P
23892,69,22612,gland morphogenesis,P
23891,69,48041,focal adhesion assembly,P
23890,69,7565,female pregnancy,P
23889,69,8625,extrinsic apoptotic signaling pathway via death domain receptors,P
23888,69,97192,extrinsic apoptotic signaling pathway in absence of ligand,P
23887,69,32469,endoplasmic reticulum calcium ion homeostasis,P
23886,69,43583,ear development,P
23885,69,48546,digestive tract morphogenesis,P
23884,69,51607,defense response to virus,P
23836,70,43123,positive regulation of I-kappaB kinase/NF-kappaB signaling,P
23835,70,2001015,negative regulation of skeletal muscle cell differentiation,P
23834,70,7613,memory,P
23833,70,60291,long-term synaptic potentiation,P
23832,70,7611,learning or memory,P
23831,70,45087,innate immune response,P
23830,70,7417,central nervous system development,P
23829,70,71456,cellular response to hypoxia,P
23828,70,8283,cell proliferation,P
23827,70,7409,axonogenesis,P
23826,70,48708,astrocyte differentiation,P
23825,70,8270,zinc ion binding,F
23824,70,48156,tau protein binding,F
23823,70,42803,protein homodimerization activity,F
23822,70,42803,protein homodimerization activity,F
23821,70,5515,protein binding,F
23820,70,42802,identical protein binding,F
23819,70,48306,calcium-dependent protein binding,F
23818,70,5509,calcium ion binding,F
23817,70,44548,S100 protein binding,F
23816,70,50786,RAGE receptor binding,F
23696,73,43065,positive regulation of apoptotic process,P
23695,73,43410,positive regulation of MAPK cascade,P
23694,73,1649,osteoblast differentiation,P
23693,73,48662,negative regulation of smooth muscle cell proliferation,P
23692,73,14912,negative regulation of smooth muscle cell migration,P
23691,73,9968,negative regulation of signal transduction,P
23690,73,1933,negative regulation of protein phosphorylation,P
23689,73,8285,negative regulation of cell proliferation,P
23687,73,6915,apoptotic process,P
23688,73,44267,cellular protein metabolic process,P
23686,73,8160,protein tyrosine phosphatase activator activity,F
23685,73,5515,protein binding,F
23684,73,46872,metal ion binding,F
23683,73,5520,insulin-like growth factor binding,F
23682,73,31995,insulin-like growth factor II binding,F
23681,73,31994,insulin-like growth factor I binding,F
23680,73,1968,fibronectin binding,F
23657,74,46677,response to antibiotic,P
23656,74,31396,regulation of protein ubiquitination,P
23655,74,43254,regulation of protein complex assembly,P
23654,74,50999,regulation of nitric-oxide synthase activity,P
23653,74,1900034,regulation of cellular response to heat,P
23652,74,6898,receptor-mediated endocytosis,P
23651,74,43335,protein unfolding,P
23650,74,50821,protein stabilization,P
23649,74,50821,protein stabilization,P
23648,74,42026,protein refolding,P
23647,74,45040,protein import into mitochondrial outer membrane,P
23646,74,45429,positive regulation of nitric oxide biosynthetic process,P
23645,74,18108,peptidyl-tyrosine phosphorylation,P
23644,74,6839,mitochondrial transport,P
23643,74,51131,chaperone-mediated protein complex assembly,P
23642,74,61684,chaperone-mediated autophagy,P
23641,74,86,G2/M transition of mitotic cell cycle,P
23640,74,38096,Fc-gamma receptor signaling pathway involved in phagocytosis,P
23639,74,38128,ERBB2 signaling pathway,P
23638,74,51082,unfolded protein binding,F
23637,74,1990782,protein tyrosine kinase binding,F
23636,74,4713,protein tyrosine kinase activity,F
23635,74,42803,protein homodimerization activity,F
23634,74,5515,protein binding,F
23633,74,44822,poly(A) RNA binding,F
23632,74,166,nucleotide binding,F
23631,74,30235,nitric-oxide synthase regulator activity,F
23630,74,42802,identical protein binding,F
23629,74,42826,histone deacetylase binding,F
23628,74,30911,TPR domain binding,F
23627,74,30911,TPR domain binding,F
23626,74,23026,MHC class II protein complex binding,F
23625,74,51020,GTPase binding,F
23624,74,16887,ATPase activity,F
23623,74,5524,ATP binding,F
23622,74,5524,ATP binding,F
23579,76,32868,response to insulin,P
23577,76,9749,response to glucose,P
23578,76,1666,response to hypoxia,P
23576,76,61418,regulation of transcription from RNA polymerase II promoter in response to hypoxia,P
23575,76,33233,regulation of protein sumoylation,P
23574,76,2000182,regulation of progesterone biosynthetic process,P
23573,76,42981,regulation of apoptotic process,P
23572,76,45893,"positive regulation of transcription, DNA-templated",P
23571,76,45944,positive regulation of transcription from RNA polymerase II promoter,P
23570,76,45944,positive regulation of transcription from RNA polymerase II promoter,P
23569,76,45944,positive regulation of transcription from RNA polymerase II promoter,P
23568,76,50725,positive regulation of interleukin-1 beta biosynthetic process,P
23567,76,46886,positive regulation of hormone biosynthetic process,P
23566,76,72303,positive regulation of glomerular metanephric mesangial cell proliferation,P
23565,76,45080,positive regulation of chemokine biosynthetic process,P
23564,76,122,negative regulation of transcription from RNA polymerase II promoter,P
23563,76,90090,negative regulation of canonical Wnt signaling pathway,P
23562,76,70498,interleukin-1-mediated signaling pathway,P
23561,76,72110,glomerular mesangial cell proliferation,P
23560,76,44849,estrous cycle,P
23559,76,71506,cellular response to mycophenolic acid,P
23558,76,98759,cellular response to interleukin-8,P
23557,76,71504,cellular response to heparin,P
23555,76,30217,T cell differentiation,P
23556,76,71480,cellular response to gamma radiation,P
23554,76,30509,BMP signaling pathway,P
23553,76,8270,zinc ion binding,F
23552,76,1077,"transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding",F
23551,76,976,transcription regulatory region sequence-specific DNA binding,F
23550,76,3700,"transcription factor activity, sequence-specific DNA binding",F
23549,76,43565,sequence-specific DNA binding,F
23548,76,5515,protein binding,F
23547,76,1990841,promoter-specific chromatin binding,F
23546,76,35035,histone acetyltransferase binding,F
23545,76,44729,hemi-methylated DNA-binding,F
23544,76,10385,double-stranded methylated DNA binding,F
23543,76,977,RNA polymerase II regulatory region sequence-specific DNA binding,F
23542,76,3677,DNA binding,F
23446,77,60948,cardiac vascular smooth muscle cell development,P
23445,77,48739,cardiac muscle fiber development,P
23444,77,48593,camera-type eye morphogenesis,P
23443,77,48754,branching morphogenesis of an epithelial tube,P
23442,77,1569,branching involved in blood vessel morphogenesis,P
23441,77,48844,artery morphogenesis,P
23440,77,1525,angiogenesis,P
23439,77,32147,activation of protein kinase activity,P
23438,77,38190,VEGF-activated neuropilin signaling pathway,P
23437,77,5172,vascular endothelial growth factor receptor binding,F
23436,77,43184,vascular endothelial growth factor receptor 2 binding,F
23435,77,43183,vascular endothelial growth factor receptor 1 binding,F
23434,77,48018,receptor agonist activity,F
23433,77,42803,protein homodimerization activity,F
23420,77,42056,chemoattractant activity,F
23421,77,5125,cytokine activity,F
23422,77,5125,cytokine activity,F
23423,77,50840,extracellular matrix binding,F
23424,77,1968,fibronectin binding,F
23425,77,8083,growth factor activity,F
23426,77,8083,growth factor activity,F
23427,77,8201,heparin binding,F
23428,77,8201,heparin binding,F
23429,77,42802,identical protein binding,F
23430,77,5161,platelet-derived growth factor receptor binding,F
23431,77,5515,protein binding,F
23432,77,46982,protein heterodimerization activity,F
23504,77,1900745,positive regulation of p38MAPK cascade,P
23503,77,2052,positive regulation of neuroblast proliferation,P
23502,77,2053,positive regulation of mesenchymal cell proliferation,P
23501,77,2687,positive regulation of leukocyte migration,P
23500,77,1901727,positive regulation of histone deacetylase activity,P
23499,77,10628,positive regulation of gene expression,P
23498,77,51894,positive regulation of focal adhesion assembly,P
23497,77,50679,positive regulation of epithelial cell proliferation,P
23496,77,1938,positive regulation of endothelial cell proliferation,P
23495,77,1938,positive regulation of endothelial cell proliferation,P
23494,77,10595,positive regulation of endothelial cell migration,P
23493,77,38033,positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway,P
23492,77,51272,positive regulation of cellular component movement,P
23491,77,38091,positive regulation of cell proliferation by VEGF-activated platelet derived growth factor receptor signaling pathway,P
23490,77,8284,positive regulation of cell proliferation,P
23489,77,8284,positive regulation of cell proliferation,P
23488,77,90050,positive regulation of cell migration involved in sprouting angiogenesis,P
23487,77,30335,positive regulation of cell migration,P
23485,77,45785,positive regulation of cell adhesion,P
23486,77,51781,positive regulation of cell division,P
23483,77,43536,positive regulation of blood vessel endothelial cell migration,P
23484,77,90190,positive regulation of branching involved in ureteric bud morphogenesis,P
23482,77,48842,positive regulation of axon extension involved in axon guidance,P
23481,77,45766,positive regulation of angiogenesis,P
23480,77,45766,positive regulation of angiogenesis,P
23479,77,43406,positive regulation of MAP kinase activity,P
23478,77,32793,positive regulation of CREB transcription factor activity,P
23477,77,50918,positive chemotaxis,P
23476,77,2576,platelet degranulation,P
23475,77,1541,ovarian follicle development,P
23474,77,3151,outflow tract morphogenesis,P
23473,77,7399,nervous system development,P
23472,77,122,negative regulation of transcription from RNA polymerase II promoter,P
23471,77,43154,negative regulation of cysteine-type endopeptidase activity involved in apoptotic process,P
23470,77,43066,negative regulation of apoptotic process,P
23469,77,30224,monocyte differentiation,P
23468,77,7498,mesoderm development,P
23467,77,60749,mammary gland alveolus development,P
23466,77,30225,macrophage differentiation,P
23465,77,36303,lymph vessel morphogenesis,P
23463,77,7595,lactation,P
23464,77,30324,lung development,P
23462,77,1822,kidney development,P
23460,77,1701,in utero embryonic development,P
23461,77,50930,induction of positive chemotaxis,P
23459,77,3007,heart morphogenesis,P
23458,77,40007,growth,P
23457,77,42462,eye photoreceptor cell development,P
23456,77,30855,epithelial cell differentiation,P
23455,77,35767,endothelial cell chemotaxis,P
23454,77,71542,dopaminergic neuron differentiation,P
23453,77,3169,coronary vein morphogenesis,P
23452,77,60982,coronary artery morphogenesis,P
23451,77,71679,commissural neuron axon guidance,P
23450,77,35924,cellular response to vascular endothelial growth factor stimulus,P
23449,77,71456,cellular response to hypoxia,P
23448,77,2042,cell migration involved in sprouting angiogenesis,P
23447,77,48469,cell maturation,P
23337,78,1903351,cellular response to dopamine,P
23336,78,6974,cellular response to DNA damage stimulus,P
23335,78,6464,cellular protein modification process,P
23334,78,7050,cell cycle arrest,P
23333,78,6914,autophagy,P
23332,78,46632,alpha-beta T cell differentiation,P
23331,78,1990051,activation of protein kinase C activity,P
23330,78,50798,activated T cell proliferation,P
23329,78,90135,actin filament branching,P
23328,78,30036,actin cytoskeleton organization,P
23327,78,38096,Fc-gamma receptor signaling pathway involved in phagocytosis,P
23326,78,6975,DNA damage induced protein phosphorylation,P
23325,78,60020,Bergmann glial cell differentiation,P
23324,78,1922,B-1 B cell homeostasis,P
23323,78,50853,B cell receptor signaling pathway,P
23322,78,2322,B cell proliferation involved in immune response,P
23321,78,19905,syntaxin binding,F
23320,78,5102,receptor binding,F
23319,78,4713,protein tyrosine kinase activity,F
23318,78,4713,protein tyrosine kinase activity,F
23317,78,4713,protein tyrosine kinase activity,F
23316,78,4713,protein tyrosine kinase activity,F
23315,78,4672,protein kinase activity,F
23314,78,5080,protein kinase C binding,F
23313,78,5515,protein binding,F
23312,78,8022,protein C-terminus binding,F
23311,78,70064,proline-rich region binding,F
23310,78,70064,proline-rich region binding,F
23309,78,4715,non-membrane spanning protein tyrosine kinase activity,F
23308,78,4515,nicotinate-nucleotide adenylyltransferase activity,F
23307,78,51019,mitogen-activated protein kinase binding,F
23306,78,30145,manganese ion binding,F
23305,78,287,magnesium ion binding,F
23304,78,3785,actin monomer binding,F
23303,78,51015,actin filament binding,F
23302,78,17124,SH3 domain binding,F
23301,78,3677,DNA binding,F
23300,78,5524,ATP binding,F
23276,79,1990426,mitotic recombination-dependent replication fork processing,P
23275,79,7141,male meiosis I,P
23274,79,42771,intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator,P
23272,79,43967,histone H4 acetylation,P
23273,79,1833,inner cell mass cell proliferation,P
23271,79,43966,histone H3 acetylation,P
23270,79,30097,hemopoiesis,P
23269,79,8585,female gonad development,P
23268,79,70200,establishment of protein localization to telomere,P
23267,79,724,double-strand break repair via homologous recombination,P
23266,79,724,double-strand break repair via homologous recombination,P
23265,79,6302,double-strand break repair,P
23264,79,910,cytokinesis,P
23263,79,31052,chromosome breakage,P
23262,79,51298,centrosome duplication,P
23261,79,7569,cell aging,P
23260,79,7420,brain development,P
23259,79,731,DNA synthesis involved in DNA repair,P
23258,79,6978,"DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator",P
23257,79,3697,single-stranded DNA binding,F
23256,79,5515,protein binding,F
23255,79,8022,protein C-terminus binding,F
23254,79,2020,protease binding,F
23253,79,4402,histone acetyltransferase activity,F
23252,79,43015,gamma-tubulin binding,F
23251,79,10485,H4 histone acetyltransferase activity,F
23250,79,10484,H3 histone acetyltransferase activity,F
23230,80,45870,positive regulation of single stranded viral RNA replication via double stranded DNA intermediate,P
23229,80,43065,positive regulation of apoptotic process,P
23228,80,6312,mitotic recombination,P
23227,80,44774,mitotic DNA integrity checkpoint,P
23226,80,2244,hematopoietic progenitor cell differentiation,P
23225,80,40016,embryonic cleavage,P
23224,80,7059,chromosome segregation,P
23223,80,6974,cellular response to DNA damage stimulus,P
23222,80,30263,apoptotic chromosome condensation,P
23221,80,6268,DNA unwinding involved in DNA replication,P
23220,80,6265,DNA topological change,P
23219,80,6266,DNA ligation,P
23218,80,43130,ubiquitin binding,F
23217,80,5080,protein kinase C binding,F
23216,80,42803,protein homodimerization activity,F
23215,80,46982,protein heterodimerization activity,F
23214,80,5515,protein binding,F
23213,80,8022,protein C-terminus binding,F
23211,80,287,magnesium ion binding,F
23212,80,44822,poly(A) RNA binding,F
23210,80,42826,histone deacetylase binding,F
23209,80,19899,enzyme binding,F
23208,80,8144,drug binding,F
23207,80,3682,chromatin binding,F
23206,80,8094,DNA-dependent ATPase activity,F
23205,80,3918,DNA topoisomerase type II (ATP-hydrolyzing) activity,F
23204,80,8301,"DNA binding, bending",F
23203,80,3677,DNA binding,F
23202,80,5524,ATP binding,F
23189,81,1764,neuron migration,P
23188,81,6312,mitotic recombination,P
23187,81,44774,mitotic DNA integrity checkpoint,P
23186,81,30900,forebrain development,P
23185,81,7409,axonogenesis,P
23184,81,6268,DNA unwinding involved in DNA replication,P
23183,81,6265,DNA topological change,P
23182,81,5080,protein kinase C binding,F
23181,81,46982,protein heterodimerization activity,F
23180,81,8022,protein C-terminus binding,F
23179,81,46872,metal ion binding,F
23178,81,42826,histone deacetylase binding,F
23177,81,19899,enzyme binding,F
23176,81,3682,chromatin binding,F
23175,81,3918,DNA topoisomerase type II (ATP-hydrolyzing) activity,F
23174,81,8301,"DNA binding, bending",F
23173,81,5524,ATP binding,F
23148,82,10957,negative regulation of vitamin D biosynthetic process,P
23147,82,122,negative regulation of transcription from RNA polymerase II promoter,P
23146,82,122,negative regulation of transcription from RNA polymerase II promoter,P
23145,82,122,negative regulation of transcription from RNA polymerase II promoter,P
23144,82,45083,negative regulation of interleukin-12 biosynthetic process,P
23143,82,50728,negative regulation of inflammatory response,P
23142,82,10629,negative regulation of gene expression,P
23141,82,32375,negative regulation of cholesterol transport,P
23140,82,32269,negative regulation of cellular protein metabolic process,P
23139,82,10956,negative regulation of calcidiol 1-monooxygenase activity,P
23138,82,43066,negative regulation of apoptotic process,P
23137,82,31293,membrane protein intracellular domain proteolysis,P
23136,82,45087,innate immune response,P
23135,82,6954,inflammatory response,P
23134,82,71375,cellular response to peptide hormone stimulus,P
23133,82,71316,cellular response to nicotine,P
23132,82,71260,cellular response to mechanical stimulus,P
23131,82,71222,cellular response to lipopolysaccharide,P
23130,82,71354,cellular response to interleukin-6,P
23129,82,71347,cellular response to interleukin-1,P
23128,82,71359,cellular response to dsRNA,P
23127,82,6915,apoptotic process,P
23126,82,50852,T cell receptor signaling pathway,P
23125,82,38061,NIK/NF-kappaB signaling,P
23124,82,7249,I-kappaB kinase/NF-kappaB signaling,P
23123,82,38095,Fc-epsilon receptor signaling pathway,P
23122,82,1227,"transcriptional repressor activity, RNA polymerase II transcription regulatory region sequence-specific binding",F
23121,82,1205,"transcriptional activator activity, RNA polymerase II distal enhancer sequence-specific binding",F
23120,82,976,transcription regulatory region sequence-specific DNA binding,F
23119,82,44212,transcription regulatory region DNA binding,F
23118,82,8134,transcription factor binding,F
23117,82,3700,"transcription factor activity, sequence-specific DNA binding",F
23116,82,975,regulatory region DNA binding,F
23115,82,42803,protein homodimerization activity,F
23114,82,46982,protein heterodimerization activity,F
23113,82,5515,protein binding,F
23112,82,42802,identical protein binding,F
23111,82,3682,chromatin binding,F
23110,82,42805,actinin binding,F
23109,82,977,RNA polymerase II regulatory region sequence-specific DNA binding,F
23108,82,980,RNA polymerase II distal enhancer sequence-specific DNA binding,F
23096,83,12501,programmed cell death,P
23095,83,16310,phosphorylation,P
23094,83,40016,embryonic cleavage,P
23093,83,7623,circadian rhythm,P
23092,83,32922,circadian regulation of gene expression,P
23091,83,7059,chromosome segregation,P
23090,83,6338,chromatin remodeling,P
23089,83,6265,DNA topological change,P
23088,83,6260,DNA replication,P
23087,83,5515,protein binding,F
23086,83,44822,poly(A) RNA binding,F
23085,83,1046,core promoter sequence-specific DNA binding,F
23084,83,3682,chromatin binding,F
23083,83,3917,DNA topoisomerase type I activity,F
23082,83,3917,DNA topoisomerase type I activity,F
23081,83,3677,DNA binding,F
23035,84,71480,cellular response to gamma radiation,P
23034,84,72719,cellular response to cisplatin,P
23033,84,72757,cellular response to camptothecin,P
23032,84,6974,cellular response to DNA damage stimulus,P
23031,84,6974,cellular response to DNA damage stimulus,P
23030,84,6268,DNA unwinding involved in DNA replication,P
23029,84,731,DNA synthesis involved in DNA repair,P
23028,84,6281,DNA repair,P
23027,84,6310,DNA recombination,P
23026,84,730,DNA recombinase assembly,P
23025,84,730,DNA recombinase assembly,P
23024,84,43142,single-stranded DNA-dependent ATPase activity,F
23023,84,43142,single-stranded DNA-dependent ATPase activity,F
23022,84,3697,single-stranded DNA binding,F
23021,84,3697,single-stranded DNA binding,F
23020,84,150,recombinase activity,F
23019,84,5515,protein binding,F
23018,84,8022,protein C-terminus binding,F
23017,84,42802,identical protein binding,F
23016,84,400,four-way junction DNA binding,F
23015,84,4520,endodeoxyribonuclease activity,F
23014,84,3690,double-stranded DNA binding,F
23013,84,3690,double-stranded DNA binding,F
23012,84,3682,chromatin binding,F
23011,84,70182,DNA polymerase binding,F
23010,84,5524,ATP binding,F
22994,85,43123,positive regulation of I-kappaB kinase/NF-kappaB signaling,P
22993,85,45892,"negative regulation of transcription, DNA-templated",P
22992,85,122,negative regulation of transcription from RNA polymerase II promoter,P
22991,85,7067,mitotic nuclear division,P
22990,85,70911,global genome nucleotide-excision repair,P
22989,85,7059,chromosome segregation,P
22987,85,51301,cell division,P
22988,85,6464,cellular protein modification process,P
22985,85,61630,ubiquitin protein ligase activity,F
22986,85,31625,ubiquitin protein ligase binding,F
22983,85,5515,protein binding,F
22984,85,8134,transcription factor binding,F
22981,85,16874,ligase activity,F
22982,85,44822,poly(A) RNA binding,F
22980,85,19899,enzyme binding,F
22979,85,19789,SUMO transferase activity,F
22978,85,19789,SUMO transferase activity,F
22977,85,61656,SUMO conjugating enzyme activity,F
22976,85,71535,RING-like zinc finger domain binding,F
22975,85,43398,HLH domain binding,F
22974,85,5524,ATP binding,F
22856,86,72577,endothelial cell apoptotic process,P
22855,86,48566,embryonic digestive tract development,P
22854,86,50830,defense response to Gram-positive bacterium,P
22853,86,71550,death-inducing signaling complex assembly,P
22852,86,30866,cortical actin cytoskeleton organization,P
22851,86,2439,chronic inflammatory response to antigenic stimulus,P
22850,86,71407,cellular response to organic cyclic compound,P
22849,86,71316,cellular response to nicotine,P
22848,86,71230,cellular response to amino acid stimulus,P
22847,86,6919,activation of cysteine-type endopeptidase activity involved in apoptotic process,P
22846,86,185,activation of MAPKKK activity,P
22845,86,187,activation of MAPK activity,P
22844,86,165,MAPK cascade,P
22843,86,7254,JNK cascade,P
22842,86,7249,I-kappaB kinase/NF-kappaB signaling,P
22841,86,5164,tumor necrosis factor receptor binding,F
22840,86,44212,transcription regulatory region DNA binding,F
22838,86,2020,protease binding,F
22839,86,5515,protein binding,F
22836,86,5125,cytokine activity,F
22837,86,42802,identical protein binding,F
22923,86,32757,positive regulation of interleukin-8 production,P
22922,86,45416,positive regulation of interleukin-8 biosynthetic process,P
22921,86,32755,positive regulation of interleukin-6 production,P
22920,86,32729,positive regulation of interferon-gamma production,P
22919,86,2925,positive regulation of humoral immune response mediated by circulating immunoglobulin,P
22918,86,34116,positive regulation of heterotypic cell-cell adhesion,P
22917,86,51798,positive regulation of hair follicle development,P
22916,86,10628,positive regulation of gene expression,P
22915,86,10628,positive regulation of gene expression,P
22914,86,31622,positive regulation of fever generation,P
22913,86,50715,positive regulation of cytokine secretion,P
22912,86,1819,positive regulation of cytokine production,P
22911,86,43280,positive regulation of cysteine-type endopeptidase activity involved in apoptotic process,P
22910,86,2876,positive regulation of chronic inflammatory response to antigenic stimulus,P
22909,86,32722,positive regulation of chemokine production,P
22908,86,45080,positive regulation of chemokine biosynthetic process,P
22907,86,2000343,positive regulation of chemokine (C-X-C motif) ligand 2 production,P
22906,86,2000304,positive regulation of ceramide biosynthetic process,P
22905,86,45785,positive regulation of cell adhesion,P
22904,86,60559,positive regulation of calcidiol 1-monooxygenase activity,P
22903,86,2000334,positive regulation of blood microparticle formation,P
22902,86,43065,positive regulation of apoptotic process,P
22901,86,43065,positive regulation of apoptotic process,P
22900,86,1901224,positive regulation of NIK/NF-kappaB signaling,P
22899,86,51533,positive regulation of NFAT protein import into nucleus,P
22898,86,51092,positive regulation of NF-kappaB transcription factor activity,P
22897,86,51092,positive regulation of NF-kappaB transcription factor activity,P
22896,86,42346,positive regulation of NF-kappaB import into nucleus,P
22895,86,43406,positive regulation of MAP kinase activity,P
22894,86,43507,positive regulation of JUN kinase activity,P
22893,86,43123,positive regulation of I-kappaB kinase/NF-kappaB signaling,P
22892,86,70374,positive regulation of ERK1 and ERK2 cascade,P
22891,86,30316,osteoclast differentiation,P
22890,86,45071,negative regulation of viral genome replication,P
22889,86,45892,"negative regulation of transcription, DNA-templated",P
22888,86,122,negative regulation of transcription from RNA polymerase II promoter,P
22887,86,43242,negative regulation of protein complex disassembly,P
22886,86,45668,negative regulation of osteoblast differentiation,P
22885,86,35509,negative regulation of myosin-light-chain-phosphatase activity,P
22884,86,45662,negative regulation of myoblast differentiation,P
22883,86,45930,negative regulation of mitotic cell cycle,P
22882,86,10888,negative regulation of lipid storage,P
22881,86,50995,negative regulation of lipid catabolic process,P
22880,86,32715,negative regulation of interleukin-6 production,P
22879,86,44130,negative regulation of growth of symbiont in host,P
22878,86,46325,negative regulation of glucose import,P
22877,86,10629,negative regulation of gene expression,P
22876,86,45599,negative regulation of fat cell differentiation,P
22875,86,2001240,negative regulation of extrinsic apoptotic signaling pathway in absence of ligand,P
22874,86,1937,negative regulation of endothelial cell proliferation,P
22873,86,2740,negative regulation of cytokine secretion involved in immune response,P
22872,86,61048,negative regulation of branching involved in lung morphogenesis,P
22871,86,1903347,negative regulation of bicellular tight junction assembly,P
22870,86,10693,negative regulation of alkaline phosphatase activity,P
22869,86,97527,necroptotic signaling pathway,P
22868,86,31663,lipopolysaccharide-mediated signaling pathway,P
22867,86,50901,leukocyte tethering or rolling,P
22866,86,8630,intrinsic apoptotic signaling pathway in response to DNA damage,P
22865,86,6954,inflammatory response,P
22864,86,6959,humoral immune response,P
22863,86,6006,glucose metabolic process,P
22862,86,8625,extrinsic apoptotic signaling pathway via death domain receptors,P
22861,86,8625,extrinsic apoptotic signaling pathway via death domain receptors,P
22860,86,97191,extrinsic apoptotic signaling pathway,P
22859,86,30198,extracellular matrix organization,P
22858,86,90002,establishment of protein localization to plasma membrane,P
22857,86,60664,epithelial cell proliferation involved in salivary gland morphogenesis,P
22489,91,48839,inner ear development,P
22488,91,6954,inflammatory response,P
22487,91,30214,hyaluronan catabolic process,P
22486,91,2244,hematopoietic progenitor cell differentiation,P
22485,91,3179,heart valve morphogenesis,P
22484,91,7507,heart development,P
22483,91,8354,germ cell migration,P
22482,91,60364,frontal suture morphogenesis,P
22481,91,7565,female pregnancy,P
22480,91,60325,face morphogenesis,P
22479,91,97191,extrinsic apoptotic signaling pathway,P
22478,91,85029,extracellular matrix assembly,P
22477,91,19049,evasion or tolerance of host defenses by virus,P
22476,91,1837,epithelial to mesenchymal transition,P
22475,91,7173,epidermal growth factor receptor signaling pathway,P
22474,91,7492,endoderm development,P
22473,91,1990402,embryonic liver development,P
22472,91,48565,digestive tract development,P
22471,91,9817,"defense response to fungus, incompatible interaction",P
22470,91,2248,connective tissue replacement involved in inflammatory response wound healing,P
22469,91,7182,common-partner SMAD protein phosphorylation,P
22468,91,2062,chondrocyte differentiation,P
22467,91,71560,cellular response to transforming growth factor beta stimulus,P
22466,91,71560,cellular response to transforming growth factor beta stimulus,P
22465,91,71407,cellular response to organic cyclic compound,P
22464,91,71260,cellular response to mechanical stimulus,P
22463,91,71479,cellular response to ionizing radiation,P
22462,91,1990314,cellular response to insulin-like growth factor stimulus,P
22461,91,71549,cellular response to dexamethasone stimulus,P
22460,91,6874,cellular calcium ion homeostasis,P
22459,91,45216,cell-cell junction organization,P
22458,91,16477,cell migration,P
22457,91,16049,cell growth,P
22456,91,7050,cell cycle arrest,P
22455,91,60751,branch elongation involved in mammary gland duct branching,P
22454,91,7568,aging,P
22453,91,2460,adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,P
22452,91,46732,active induction of host immune response by virus,P
22451,91,43029,T cell homeostasis,P
22450,91,60395,SMAD protein signal transduction,P
22449,91,7184,SMAD protein import into nucleus,P
22448,91,7183,SMAD protein complex assembly,P
22447,91,7219,Notch signaling pathway,P
22446,91,165,MAPK cascade,P
22445,91,6754,ATP biosynthetic process,P
22444,91,34714,type III transforming growth factor beta receptor binding,F
22443,91,34714,type III transforming growth factor beta receptor binding,F
22442,91,5114,type II transforming growth factor beta receptor binding,F
22427,91,3823,antigen binding,F
22428,91,5125,cytokine activity,F
22429,91,19899,enzyme binding,F
22430,91,1948,glycoprotein binding,F
22431,91,8083,growth factor activity,F
22432,91,47485,protein N-terminus binding,F
22433,91,5515,protein binding,F
22434,91,46982,protein heterodimerization activity,F
22435,91,42803,protein homodimerization activity,F
22436,91,43539,protein serine/threonine kinase activator activity,F
22437,91,5160,transforming growth factor beta receptor binding,F
22438,91,34713,type I transforming growth factor beta receptor binding,F
22439,91,34713,type I transforming growth factor beta receptor binding,F
22440,91,5114,type II transforming growth factor beta receptor binding,F
22441,91,5114,type II transforming growth factor beta receptor binding,F
22544,91,43065,positive regulation of apoptotic process,P
22543,91,60391,positive regulation of SMAD protein import into nucleus,P
22542,91,51092,positive regulation of NF-kappaB transcription factor activity,P
22541,91,1901666,positive regulation of NAD+ ADP-ribosyltransferase activity,P
22540,91,43406,positive regulation of MAP kinase activity,P
22539,91,70374,positive regulation of ERK1 and ERK2 cascade,P
22538,91,2576,platelet degranulation,P
22537,91,6796,phosphate-containing compound metabolic process,P
22536,91,60389,pathway-restricted SMAD protein phosphorylation,P
22535,91,43932,ossification involved in bone remodeling,P
22534,91,14003,oligodendrocyte development,P
22533,91,21915,neural tube development,P
22532,91,1843,neural tube closure,P
22531,91,30512,negative regulation of transforming growth factor beta receptor signaling pathway,P
22530,91,45892,"negative regulation of transcription, DNA-templated",P
22529,91,122,negative regulation of transcription from RNA polymerase II promoter,P
22528,91,48642,negative regulation of skeletal muscle tissue development,P
22527,91,51280,negative regulation of release of sequestered calcium ion into cytosol,P
22526,91,1933,negative regulation of protein phosphorylation,P
22525,91,1903077,negative regulation of protein localization to plasma membrane,P
22524,91,1903799,negative regulation of production of miRNAs involved in gene silencing by miRNA,P
22523,91,50765,negative regulation of phagocytosis,P
22522,91,30279,negative regulation of ossification,P
22521,91,7406,negative regulation of neuroblast proliferation,P
22520,91,45662,negative regulation of myoblast differentiation,P
22519,91,45930,negative regulation of mitotic cell cycle,P
22518,91,10936,negative regulation of macrophage cytokine production,P
22517,91,32700,negative regulation of interleukin-17 production,P
22516,91,1900126,negative regulation of hyaluronan biosynthetic process,P
22515,91,60965,negative regulation of gene silencing by miRNA,P
22514,91,10629,negative regulation of gene expression,P
22513,91,10629,negative regulation of gene expression,P
22512,91,45599,negative regulation of fat cell differentiation,P
22511,91,10716,negative regulation of extracellular matrix disassembly,P
22510,91,50680,negative regulation of epithelial cell proliferation,P
22509,91,50680,negative regulation of epithelial cell proliferation,P
22508,91,22408,negative regulation of cell-cell adhesion,P
22507,91,8285,negative regulation of cell proliferation,P
22506,91,30308,negative regulation of cell growth,P
22505,91,45596,negative regulation of cell differentiation,P
22504,91,45786,negative regulation of cell cycle,P
22503,91,43537,negative regulation of blood vessel endothelial cell migration,P
22502,91,42130,negative regulation of T cell proliferation,P
22501,91,8156,negative regulation of DNA replication,P
22500,91,43011,myeloid dendritic cell differentiation,P
22499,91,42552,myelination,P
22498,91,32943,mononuclear cell proliferation,P
22497,91,7093,mitotic cell cycle checkpoint,P
22496,91,31293,membrane protein intracellular domain proteolysis,P
22495,91,60744,mammary gland branching involved in thelarche,P
22494,91,10742,macrophage derived foam cell differentiation,P
22493,91,48535,lymph node development,P
22492,91,97421,liver regeneration,P
22491,91,31663,lipopolysaccharide-mediated signaling pathway,P
22490,91,70306,lens fiber cell differentiation,P
22409,92,32784,"regulation of DNA-templated transcription, elongation",P
22408,92,6290,pyrimidine dimer repair,P
22407,92,61098,positive regulation of protein tyrosine kinase activity,P
22406,92,45815,"positive regulation of gene expression, epigenetic",P
22405,92,32786,"positive regulation of DNA-templated transcription, elongation",P
22404,92,45494,photoreceptor cell maintenance,P
22403,92,35264,multicellular organism growth,P
22402,92,8630,intrinsic apoptotic signaling pathway in response to DNA damage,P
22401,92,6284,base-excision repair,P
22400,92,7257,activation of JUN kinase activity,P
22399,92,7256,activation of JNKK activity,P
22398,92,30296,protein tyrosine kinase activator activity,F
22397,92,32403,protein complex binding,F
22396,92,5515,protein binding,F
22395,92,47485,protein N-terminus binding,F
22394,92,8022,protein C-terminus binding,F
22393,92,3682,chromatin binding,F
22392,92,8094,DNA-dependent ATPase activity,F
22391,92,3678,DNA helicase activity,F
22390,92,3677,DNA binding,F
22389,92,5524,ATP binding,F
22362,93,10508,positive regulation of autophagy,P
22361,93,18107,peptidyl-threonine phosphorylation,P
22360,93,18105,peptidyl-serine phosphorylation,P
22359,93,7399,nervous system development,P
22358,93,51055,negative regulation of lipid biosynthetic process,P
22357,93,60770,negative regulation of epithelial cell proliferation involved in prostate gland development,P
22356,93,8285,negative regulation of cell proliferation,P
22355,93,30308,negative regulation of cell growth,P
22354,93,1904262,negative regulation of TORC1 signaling,P
22353,93,72332,intrinsic apoptotic signaling pathway by p53 class mediator,P
22352,93,42593,glucose homeostasis,P
22351,93,30010,establishment of cell polarity,P
22350,93,97484,dendrite extension,P
22349,93,71493,cellular response to UV-B,P
22348,93,6974,cellular response to DNA damage stimulus,P
22347,93,30154,cell differentiation,P
22346,93,7050,cell cycle arrest,P
22344,93,60070,canonical Wnt signaling pathway,P
22345,93,7050,cell cycle arrest,P
22343,93,7409,axonogenesis,P
22342,93,6914,autophagy,P
22341,93,43276,anoikis,P
22340,93,32147,activation of protein kinase activity,P
22339,93,36399,TCR signalosome assembly,P
22338,93,50852,T cell receptor signaling pathway,P
22337,93,51645,Golgi localization,P
22336,93,4674,protein serine/threonine kinase activity,F
22335,93,4674,protein serine/threonine kinase activity,F
22334,93,30295,protein kinase activator activity,F
22333,93,5515,protein binding,F
22332,93,2039,p53 binding,F
22331,93,287,magnesium ion binding,F
22330,93,30275,LRR domain binding,F
22329,93,5524,ATP binding,F
22279,94,6915,apoptotic process,P
22278,94,9887,animal organ morphogenesis,P
22277,94,7219,Notch signaling pathway,P
22276,94,18076,N-terminal peptidyl-lysine acetylation,P
22275,94,6977,"DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest",P
22274,94,30183,B cell differentiation,P
22273,94,8270,zinc ion binding,F
22272,94,16746,"transferase activity, transferring acyl groups",F
22271,94,1228,"transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding",F
22270,94,8134,transcription factor binding,F
22269,94,3713,transcription coactivator activity,F
22268,94,3713,transcription coactivator activity,F
22267,94,5515,protein binding,F
22266,94,8022,protein C-terminus binding,F
22264,94,34212,peptide N-acetyltransferase activity,F
22265,94,97157,pre-mRNA intronic binding,F
22263,94,2039,p53 binding,F
22262,94,35257,nuclear hormone receptor binding,F
22261,94,4468,"lysine N-acetyltransferase activity, acting on acetyl phosphate as donor",F
22260,94,4402,histone acetyltransferase activity,F
22259,94,4402,histone acetyltransferase activity,F
22257,94,1047,core promoter binding,F
22258,94,3684,damaged DNA binding,F
22255,94,3682,chromatin binding,F
22256,94,3682,chromatin binding,F
22253,94,8013,beta-catenin binding,F
22254,94,31490,chromatin DNA binding,F
22252,94,50681,androgen receptor binding,F
22250,94,16407,acetyltransferase activity,F
22251,94,33613,activating transcription factor binding,F
22249,94,16407,acetyltransferase activity,F
22248,94,16407,acetyltransferase activity,F
22247,94,979,RNA polymerase II core promoter sequence-specific DNA binding,F
22246,94,1102,RNA polymerase II activating transcription factor binding,F
22245,94,3677,DNA binding,F
22193,96,10522,regulation of calcium ion transport into cytosol,P
22192,96,16925,protein sumoylation,P
22191,96,6461,protein complex assembly,P
22190,96,43161,proteasome-mediated ubiquitin-dependent protein catabolic process,P
22189,96,45944,positive regulation of transcription from RNA polymerase II promoter,P
22188,96,32206,positive regulation of telomere maintenance,P
22187,96,48146,positive regulation of fibroblast proliferation,P
22186,96,2001238,positive regulation of extrinsic apoptotic signaling pathway,P
22185,96,45345,positive regulation of MHC class I biosynthetic process,P
22184,96,1902187,negative regulation of viral release from host cell,P
22183,96,45892,"negative regulation of transcription, DNA-templated",P
22182,96,2000059,negative regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process,P
22181,96,50713,negative regulation of interleukin-1 beta secretion,P
22180,96,8285,negative regulation of cell proliferation,P
22179,96,30308,negative regulation of cell growth,P
22177,96,30099,myeloid cell differentiation,P
22178,96,16525,negative regulation of angiogenesis,P
22176,96,51457,maintenance of protein location in nucleus,P
22175,96,8631,intrinsic apoptotic signaling pathway in response to oxidative stress,P
22174,96,70059,intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress,P
22173,96,42771,intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator,P
22172,96,60333,interferon-gamma-mediated signaling pathway,P
22171,96,45087,innate immune response,P
22170,96,10761,fibroblast migration,P
22169,96,97191,extrinsic apoptotic signaling pathway,P
22168,96,43153,entrainment of circadian clock by photoperiod,P
22167,96,32469,endoplasmic reticulum calcium ion homeostasis,P
22166,96,51607,defense response to virus,P
22165,96,7182,common-partner SMAD protein phosphorylation,P
22164,96,32922,circadian regulation of gene expression,P
22163,96,90398,cellular senescence,P
22162,96,71353,cellular response to interleukin-4,P
22161,96,45165,cell fate commitment,P
22160,96,7050,cell cycle arrest,P
22159,96,60444,branching involved in mammary gland duct morphogenesis,P
22158,96,6919,activation of cysteine-type endopeptidase activity involved in apoptotic process,P
22157,96,7184,SMAD protein import into nucleus,P
22156,96,30578,PML body organization,P
22155,96,6977,"DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest",P
22154,96,8270,zinc ion binding,F
22153,96,31625,ubiquitin protein ligase binding,F
22152,96,42803,protein homodimerization activity,F
22151,96,5515,protein binding,F
22150,96,32183,SUMO binding,F
22149,96,46332,SMAD binding,F
22148,96,3677,DNA binding,F
22109,97,1954,positive regulation of cell-matrix adhesion,P
22108,97,2000727,positive regulation of cardiac muscle cell differentiation,P
22107,97,45773,positive regulation of axon extension,P
22106,97,43547,positive regulation of GTPase activity,P
22105,97,18107,peptidyl-threonine phosphorylation,P
22104,97,18105,peptidyl-serine phosphorylation,P
22103,97,2000077,negative regulation of type B pancreatic cell development,P
22102,97,1900181,negative regulation of protein localization to nucleus,P
22101,97,31333,negative regulation of protein complex assembly,P
22100,97,32091,negative regulation of protein binding,P
22099,97,10977,negative regulation of neuron projection development,P
22098,97,14043,negative regulation of neuron maturation,P
22097,97,45719,negative regulation of glycogen biosynthetic process,P
22096,97,2000466,negative regulation of glycogen (starch) synthase activity,P
22095,97,1904339,negative regulation of dopaminergic neuron differentiation,P
22094,97,10614,negative regulation of cardiac muscle hypertrophy,P
22093,97,90090,negative regulation of canonical Wnt signaling pathway,P
22092,97,90090,negative regulation of canonical Wnt signaling pathway,P
22091,97,43066,negative regulation of apoptotic process,P
22090,97,51534,negative regulation of NFAT protein import into nucleus,P
22089,97,7520,myoblast fusion,P
22088,97,70059,intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress,P
22087,97,35556,intracellular signal transduction,P
22086,97,35556,intracellular signal transduction,P
22085,97,44027,hypermethylation of CpG island,P
22084,97,21766,hippocampus development,P
22083,97,5977,glycogen metabolic process,P
22082,97,45444,fat cell differentiation,P
22081,97,97192,extrinsic apoptotic signaling pathway in absence of ligand,P
22080,97,1837,epithelial to mesenchymal transition,P
22079,97,7212,dopamine receptor signaling pathway,P
22078,97,7623,circadian rhythm,P
22077,97,99565,"chemical synaptic transmission, postsynaptic",P
22076,97,36016,cellular response to interleukin-3,P
22074,97,16477,cell migration,P
22075,97,35729,cellular response to hepatocyte growth factor stimulus,P
22073,97,44337,canonical Wnt signaling pathway involved in positive regulation of apoptotic process,P
22072,97,60070,canonical Wnt signaling pathway,P
22071,97,60070,canonical Wnt signaling pathway,P
22070,97,60070,canonical Wnt signaling pathway,P
22069,97,1904886,beta-catenin destruction complex disassembly,P
22067,97,7409,axonogenesis,P
22068,97,1904885,beta-catenin destruction complex assembly,P
22066,97,9887,animal organ morphogenesis,P
22065,97,16055,Wnt signaling pathway,P
22064,97,6983,ER overload response,P
22063,97,31625,ubiquitin protein ligase binding,F
22062,97,50321,tau-protein kinase activity,F
22061,97,4674,protein serine/threonine kinase activity,F
22060,97,4674,protein serine/threonine kinase activity,F
22059,97,4674,protein serine/threonine kinase activity,F
22058,97,19901,protein kinase binding,F
22057,97,4672,protein kinase activity,F
22056,97,34236,protein kinase A catalytic subunit binding,F
22055,97,5515,protein binding,F
22054,97,2020,protease binding,F
22053,97,2039,p53 binding,F
22052,97,16301,kinase activity,F
22051,97,16301,kinase activity,F
22050,97,8013,beta-catenin binding,F
22049,97,1085,RNA polymerase II transcription factor binding,F
22047,97,5524,ATP binding,F
22048,97,51059,NF-kappaB binding,F
22110,97,1901030,positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway,P
22046,98,43234,protein complex,C
22045,98,5634,nucleus,C
22044,98,5654,nucleoplasm,C
22043,98,5770,late endosome,C
22042,98,5783,endoplasmic reticulum,C
22041,98,30425,dendrite,C
22040,98,5829,cytosol,C
22039,98,30659,cytoplasmic vesicle membrane,C
22038,98,5737,cytoplasm,C
22037,98,5814,centriole,C
22036,98,30424,axon,C
22035,98,5776,autophagosome,C
22034,98,5794,Golgi apparatus,C
22033,98,42297,vocal learning,P
22032,98,47496,vesicle transport along microtubule,P
22031,98,6890,"retrograde vesicle-mediated transport, Golgi to ER",P
22030,98,34047,regulation of protein phosphatase type 2A activity,P
22029,98,1903599,positive regulation of mitophagy,P
22028,98,1904504,positive regulation of lipophagy,P
22027,98,31587,"positive regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity",P
22026,98,45724,positive regulation of cilium assembly,P
22025,98,1905337,positive regulation of aggrephagy,P
22024,98,2001237,negative regulation of extrinsic apoptotic signaling pathway,P
22023,98,132,establishment of mitotic spindle orientation,P
22022,98,6915,apoptotic process,P
22021,98,48513,animal organ development,P
22020,98,7030,Golgi organization,P
22019,98,8134,transcription factor binding,F
22018,98,5515,protein binding,F
22017,98,5522,profilin binding,F
22016,98,2039,p53 binding,F
22015,98,19900,kinase binding,F
22014,98,44325,ion channel binding,F
22013,98,42802,identical protein binding,F
22012,98,45505,dynein intermediate chain binding,F
22011,98,34452,dynactin binding,F
22010,98,48487,beta-tubulin binding,F
22009,99,5886,plasma membrane,C
22008,99,5886,plasma membrane,C
22007,99,48471,perinuclear region of cytoplasm,C
22006,99,5654,nucleoplasm,C
22005,99,5739,mitochondrion,C
22004,99,31966,mitochondrial membrane,C
22003,99,70062,extracellular exosome,C
22002,99,5783,endoplasmic reticulum,C
22001,99,5829,cytosol,C
22000,99,5829,cytosol,C
21999,99,5737,cytoplasm,C
21998,99,70555,response to interleukin-1,P
21997,99,90330,regulation of platelet aggregation,P
21996,99,43488,regulation of mRNA stability,P
21995,99,50796,regulation of insulin secretion,P
21994,99,6468,protein phosphorylation,P
21993,99,45931,positive regulation of mitotic cell cycle,P
21992,99,45651,positive regulation of macrophage differentiation,P
21991,99,31666,positive regulation of lipopolysaccharide-mediated signaling pathway,P
21990,99,1938,positive regulation of endothelial cell proliferation,P
21989,99,10595,positive regulation of endothelial cell migration,P
21988,99,2000707,positive regulation of dense core granule biogenesis,P
21987,99,30335,positive regulation of cell migration,P
21986,99,45785,positive regulation of cell adhesion,P
21985,99,10613,positive regulation of cardiac muscle hypertrophy,P
21984,99,43536,positive regulation of blood vessel endothelial cell migration,P
21983,99,45766,positive regulation of angiogenesis,P
21982,99,70374,positive regulation of ERK1 and ERK2 cascade,P
21981,99,30168,platelet activation,P
21980,99,18105,peptidyl-serine phosphorylation,P
21979,99,34351,negative regulation of glial cell apoptotic process,P
21978,99,7194,negative regulation of adenylate cyclase activity,P
21977,99,7077,mitotic nuclear envelope disassembly,P
21976,99,35556,intracellular signal transduction,P
21975,99,35408,histone H3-T6 phosphorylation,P
21974,99,2159,desmosome assembly,P
21973,99,7155,cell adhesion,P
21972,99,97190,apoptotic signaling pathway,P
21971,99,1525,angiogenesis,P
21970,99,7190,activation of adenylate cyclase activity,P
21969,99,8270,zinc ion binding,F
21968,99,4674,protein serine/threonine kinase activity,F
21967,99,4674,protein serine/threonine kinase activity,F
21966,99,4672,protein kinase activity,F
21965,99,4697,protein kinase C activity,F
21964,99,4697,protein kinase C activity,F
21963,99,5515,protein binding,F
21962,99,35403,histone kinase activity (H3-T6 specific),F
21961,99,19899,enzyme binding,F
21960,99,4698,calcium-dependent protein kinase C activity,F
21959,99,5524,ATP binding,F
21948,100,8628,hormone-mediated apoptotic signaling pathway,P
21947,100,30900,forebrain development,P
21945,100,21549,cerebellum development,P
21946,100,7268,chemical synaptic transmission,P
21944,100,71385,cellular response to glucocorticoid stimulus,P
21943,100,71392,cellular response to estradiol stimulus,P
21942,100,7267,cell-cell signaling,P
21941,100,7187,"G-protein coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger",P
21940,100,4994,somatostatin receptor activity,F
21939,100,5102,receptor binding,F
21938,100,5515,protein binding,F
21937,100,42923,neuropeptide binding,F
21849,103,44822,poly(A) RNA binding,F
21848,103,2039,p53 binding,F
21847,103,98641,cadherin binding involved in cell-cell adhesion,F
21846,103,51015,actin filament binding,F
21845,103,3924,GTPase activity,F
21844,103,5525,GTP binding,F
21843,103,8097,5S rRNA binding,F
21816,104,6293,"nucleotide-excision repair, preincision complex stabilization",P
21815,104,6294,"nucleotide-excision repair, preincision complex assembly",P
21814,104,6296,"nucleotide-excision repair, DNA incision, 5'-to lesion",P
21813,104,6295,"nucleotide-excision repair, DNA incision, 3'-to lesion",P
21812,104,33683,"nucleotide-excision repair, DNA incision",P
21811,104,33683,"nucleotide-excision repair, DNA incision",P
21810,104,717,"nucleotide-excision repair, DNA duplex unwinding",P
21809,104,717,"nucleotide-excision repair, DNA duplex unwinding",P
21808,104,6289,nucleotide-excision repair,P
21807,104,35315,hair cell differentiation,P
21806,104,70911,global genome nucleotide-excision repair,P
21805,104,48568,embryonic organ development,P
21804,104,6915,apoptotic process,P
21803,104,9650,UV protection,P
21802,104,6265,DNA topological change,P
21801,104,6281,DNA repair,P
21800,104,6370,7-methylguanosine mRNA capping,P
21799,104,8134,transcription factor binding,F
21798,104,4672,protein kinase activity,F
21797,104,5515,protein binding,F
21796,104,47485,protein N-terminus binding,F
21795,104,8022,protein C-terminus binding,F
21794,104,42277,peptide binding,F
21793,104,4386,helicase activity,F
21791,104,32564,dATP binding,F
21792,104,3684,damaged DNA binding,F
21790,104,8353,RNA polymerase II carboxy-terminal domain kinase activity,F
21789,104,5525,GTP binding,F
21788,104,8094,DNA-dependent ATPase activity,F
21786,104,3677,DNA binding,F
21787,104,8094,DNA-dependent ATPase activity,F
21785,104,16887,ATPase activity,F
21784,104,4003,ATP-dependent DNA helicase activity,F
21783,104,5524,ATP binding,F
21782,104,43138,3'-5' DNA helicase activity,F
21781,104,43138,3'-5' DNA helicase activity,F
21771,105,5737,cytoplasm,C
21770,105,31627,telomeric loop formation,P
21769,105,7004,telomere maintenance via telomerase,P
21768,105,7004,telomere maintenance via telomerase,P
21767,105,723,telomere maintenance,P
21766,105,16233,telomere capping,P
21765,105,42493,response to drug,P
21764,105,1904792,positive regulation of telosome assembly,P
21763,105,32211,negative regulation of telomere maintenance via telomerase,P
21762,105,32214,negative regulation of telomere maintenance via semi-conservative replication,P
21761,105,51974,negative regulation of telomerase activity,P
21760,105,1904850,negative regulation of establishment of protein localization to telomere,P
21759,105,1904914,negative regulation of establishment of macromolecular complex localization to telomere,P
21758,105,1904911,negative regulation of establishment of RNA localization to telomere,P
21757,105,8156,negative regulation of DNA replication,P
21756,105,7067,mitotic nuclear division,P
21755,105,45141,meiotic telomere clustering,P
21754,105,51301,cell division,P
21753,105,43130,ubiquitin binding,F
21752,105,42162,telomeric DNA binding,F
21751,105,3720,telomerase activity,F
21750,105,42803,protein homodimerization activity,F
21749,105,42803,protein homodimerization activity,F
21748,105,5515,protein binding,F
21747,105,3691,double-stranded telomeric DNA binding,F
21746,105,98505,G-rich strand telomeric DNA binding,F
21745,105,8301,"DNA binding, bending",F
21744,105,3677,DNA binding,F
21709,106,8630,intrinsic apoptotic signaling pathway in response to DNA damage,P
21708,106,33152,immunoglobulin V(D)J recombination,P
21707,106,7507,heart development,P
21706,106,35234,ectopic germ cell programmed cell death,P
21705,106,6303,double-strand break repair via nonhomologous end joining,P
21704,106,97681,double-strand break repair via alternative nonhomologous end joining,P
21703,106,6302,double-strand break repair,P
21702,106,32869,cellular response to insulin stimulus,P
21701,106,6464,cellular protein modification process,P
21700,106,8283,cell proliferation,P
21699,106,7420,brain development,P
21698,106,33153,T cell receptor V(D)J recombination,P
21697,106,2360,T cell lineage commitment,P
21696,106,33077,T cell differentiation in thymus,P
21695,106,2326,B cell lineage commitment,P
21694,106,8134,transcription factor binding,F
21693,106,4674,protein serine/threonine kinase activity,F
21692,106,4674,protein serine/threonine kinase activity,F
21691,106,4672,protein kinase activity,F
21690,106,5515,protein binding,F
21689,106,44822,poly(A) RNA binding,F
21688,106,19899,enzyme binding,F
21687,106,3690,double-stranded DNA binding,F
21686,106,4677,DNA-dependent protein kinase activity,F
21685,106,5524,ATP binding,F
21646,107,51262,protein tetramerization,P
21645,107,51289,protein homotetramerization,P
21644,107,14068,positive regulation of phosphatidylinositol 3-kinase signaling,P
21643,107,51781,positive regulation of cell division,P
21642,107,51092,positive regulation of NF-kappaB transcription factor activity,P
21641,107,1649,osteoblast differentiation,P
21640,107,43066,negative regulation of apoptotic process,P
21639,107,32088,negative regulation of NF-kappaB transcription factor activity,P
21638,107,42744,hydrogen peroxide catabolic process,P
21637,107,20027,hemoglobin metabolic process,P
21636,107,8203,cholesterol metabolic process,P
21635,107,71363,cellular response to growth factor stimulus,P
21633,107,7568,aging,P
21634,107,98869,cellular oxidant detoxification,P
21632,107,9060,aerobic respiration,P
21631,107,9650,UV protection,P
21630,107,5102,receptor binding,F
21629,107,42803,protein homodimerization activity,F
21628,107,16684,"oxidoreductase activity, acting on peroxide as acceptor",F
21627,107,46872,metal ion binding,F
21626,107,20037,heme binding,F
21625,107,19899,enzyme binding,F
21624,107,4096,catalase activity,F
21623,107,4096,catalase activity,F
21622,107,16209,antioxidant activity,F
21621,107,4046,aminoacylase activity,F
21620,107,50661,NADP binding,F
12897,304,5515,protein binding,F
12898,304,8283,cell proliferation,P
12899,304,7166,cell surface receptor signaling pathway,P
12900,304,7267,cell-cell signaling,P
12901,304,48861,leukemia inhibitory factor signaling pathway,P
12902,304,7517,muscle organ development,P
12903,304,7399,nervous system development,P
12937,302,3677,DNA binding,F
12953,301,2020,protease binding,F
21606,109,6295,"nucleotide-excision repair, DNA incision, 3'-to lesion",P
21605,109,6295,"nucleotide-excision repair, DNA incision, 3'-to lesion",P
21604,109,6295,"nucleotide-excision repair, DNA incision, 3'-to lesion",P
21603,109,33683,"nucleotide-excision repair, DNA incision",P
21602,109,43066,negative regulation of apoptotic process,P
21601,109,9650,UV protection,P
21600,109,3697,single-stranded DNA binding,F
21599,109,42803,protein homodimerization activity,F
21598,109,5515,protein binding,F
21597,109,47485,protein N-terminus binding,F
21596,109,46872,metal ion binding,F
21595,109,4520,endodeoxyribonuclease activity,F
21594,109,4520,endodeoxyribonuclease activity,F
21593,109,3690,double-stranded DNA binding,F
21592,109,405,bubble DNA binding,F
21558,110,60769,positive regulation of epithelial cell proliferation involved in prostate gland development,P
21557,110,8284,positive regulation of cell proliferation,P
21556,110,45597,positive regulation of cell differentiation,P
21555,110,51092,positive regulation of NF-kappaB transcription factor activity,P
21554,110,43410,positive regulation of MAPK cascade,P
21553,110,45720,negative regulation of integrin biosynthetic process,P
21552,110,2001237,negative regulation of extrinsic apoptotic signaling pathway,P
21551,110,50680,negative regulation of epithelial cell proliferation,P
21550,110,8285,negative regulation of cell proliferation,P
21549,110,35264,multicellular organism growth,P
21548,110,60571,morphogenesis of an epithelial fold,P
21547,110,60749,mammary gland alveolus development,P
21545,110,48808,male genitalia morphogenesis,P
21546,110,19102,male somatic sex determination,P
21544,110,60599,lateral sprouting involved in mammary gland duct morphogenesis,P
21543,110,30522,intracellular receptor signaling pathway,P
21542,110,1701,in utero embryonic development,P
21541,110,3382,epithelial cell morphogenesis,P
21540,110,60742,epithelial cell differentiation involved in prostate gland development,P
21539,110,7267,cell-cell signaling,P
21538,110,8283,cell proliferation,P
21537,110,16049,cell growth,P
21536,110,48645,animal organ formation,P
21535,110,30521,androgen receptor signaling pathway,P
21534,110,60520,activation of prostate induction by androgen receptor signaling pathway,P
21533,110,33327,Leydig cell differentiation,P
21532,110,8270,zinc ion binding,F
21531,110,1077,"transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding",F
21530,110,44212,transcription regulatory region DNA binding,F
21529,110,8134,transcription factor binding,F
21528,110,3700,"transcription factor activity, sequence-specific DNA binding",F
21526,110,5496,steroid binding,F
21527,110,3700,"transcription factor activity, sequence-specific DNA binding",F
21525,110,5102,receptor binding,F
21523,110,5515,protein binding,F
21524,110,46983,protein dimerization activity,F
21522,110,19899,enzyme binding,F
21521,110,3682,chromatin binding,F
21520,110,8013,beta-catenin binding,F
21519,110,8013,beta-catenin binding,F
21518,110,8013,beta-catenin binding,F
21517,110,4882,androgen receptor activity,F
21516,110,4882,androgen receptor activity,F
21515,110,4882,androgen receptor activity,F
21514,110,4882,androgen receptor activity,F
21513,110,5497,androgen binding,F
21512,110,5497,androgen binding,F
21511,110,1085,RNA polymerase II transcription factor binding,F
21510,110,4879,"RNA polymerase II transcription factor activity, ligand-activated sequence-specific DNA binding",F
21509,110,978,RNA polymerase II core promoter proximal region sequence-specific DNA binding,F
21508,110,70974,POU domain binding,F
21507,110,3677,DNA binding,F
21506,110,51117,ATPase binding,F
21489,111,6468,protein phosphorylation,P
21488,111,6293,"nucleotide-excision repair, preincision complex stabilization",P
21487,111,6294,"nucleotide-excision repair, preincision complex assembly",P
21486,111,6296,"nucleotide-excision repair, DNA incision, 5'-to lesion",P
21485,111,6295,"nucleotide-excision repair, DNA incision, 3'-to lesion",P
21484,111,33683,"nucleotide-excision repair, DNA incision",P
21483,111,717,"nucleotide-excision repair, DNA duplex unwinding",P
21482,111,6289,nucleotide-excision repair,P
21481,111,70911,global genome nucleotide-excision repair,P
21480,111,2031,G-protein coupled receptor internalization,P
21479,111,6370,7-methylguanosine mRNA capping,P
21478,111,8270,zinc ion binding,F
21477,111,8135,"translation factor activity, RNA binding",F
21476,111,3700,"transcription factor activity, sequence-specific DNA binding",F
21475,111,4672,protein kinase activity,F
21474,111,5515,protein binding,F
21473,111,47485,protein N-terminus binding,F
21472,111,3676,nucleic acid binding,F
21471,111,8353,RNA polymerase II carboxy-terminal domain kinase activity,F
21470,111,8094,DNA-dependent ATPase activity,F
21445,112,71480,cellular response to gamma radiation,P
21444,112,71398,cellular response to fatty acid,P
21443,112,71481,cellular response to X-ray,P
21442,112,71475,cellular hyperosmotic salinity response,P
21441,112,8283,cell proliferation,P
21440,112,7420,brain development,P
21439,112,6310,DNA recombination,P
21438,112,32508,DNA duplex unwinding,P
21437,112,31625,ubiquitin protein ligase binding,F
21436,112,44212,transcription regulatory region DNA binding,F
21435,112,42162,telomeric DNA binding,F
21434,112,42162,telomeric DNA binding,F
21433,112,5515,protein binding,F
21432,112,8022,protein C-terminus binding,F
21431,112,44822,poly(A) RNA binding,F
21430,112,44877,macromolecular complex binding,F
21429,112,3691,double-stranded telomeric DNA binding,F
21428,112,3690,double-stranded DNA binding,F
21427,112,3684,damaged DNA binding,F
21426,112,3677,DNA binding,F
21425,112,4003,ATP-dependent DNA helicase activity,F
21424,112,5524,ATP binding,F
21423,112,51575,5'-deoxyribose-5-phosphate lyase activity,F
21384,113,42276,error-prone translesion synthesis,P
21383,113,70987,error-free translesion synthesis,P
21382,113,30855,epithelial cell differentiation,P
21381,113,70301,cellular response to hydrogen peroxide,P
21380,113,34644,cellular response to UV,P
21379,113,8283,cell proliferation,P
21378,113,82,G1/S transition of mitotic cell cycle,P
21377,113,6271,DNA strand elongation involved in DNA replication,P
21376,113,6977,"DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest",P
21375,113,42769,"DNA damage response, detection of DNA damage",P
21374,113,30971,receptor tyrosine kinase binding,F
21372,113,5515,protein binding,F
21373,113,701,purine-specific mismatch base pair DNA N-glycosylase activity,F
21371,113,42802,identical protein binding,F
21370,113,35035,histone acetyltransferase binding,F
21369,113,30331,estrogen receptor binding,F
21368,113,19899,enzyme binding,F
21367,113,32139,dinucleotide insertion or deletion binding,F
21366,113,3684,damaged DNA binding,F
21365,113,3682,chromatin binding,F
21364,113,32405,MutLalpha complex binding,F
21363,113,30337,DNA polymerase processivity factor activity,F
21362,113,70182,DNA polymerase binding,F
21344,114,43137,"DNA replication, removal of RNA primer",P
21343,114,6260,DNA replication,P
21342,114,6281,DNA repair,P
21341,114,5515,protein binding,F
21340,114,46872,metal ion binding,F
21339,114,48256,flap endonuclease activity,F
21338,114,4527,exonuclease activity,F
21337,114,4519,endonuclease activity,F
21336,114,8309,double-stranded DNA exodeoxyribonuclease activity,F
21335,114,3690,double-stranded DNA binding,F
21334,114,3684,damaged DNA binding,F
21333,114,4523,RNA-DNA hybrid ribonuclease activity,F
21332,114,3677,DNA binding,F
21331,114,17108,5'-flap endonuclease activity,F
21330,114,17108,5'-flap endonuclease activity,F
21329,114,17108,5'-flap endonuclease activity,F
21328,114,8409,5'-3' exonuclease activity,F
21150,118,6297,"nucleotide-excision repair, DNA gap filling",P
21149,118,6297,"nucleotide-excision repair, DNA gap filling",P
21148,118,6297,"nucleotide-excision repair, DNA gap filling",P
21147,118,6298,mismatch repair,P
21146,118,55089,fatty acid homeostasis,P
21145,118,34644,cellular response to UV,P
21144,118,6287,"base-excision repair, gap-filling",P
21143,118,731,DNA synthesis involved in DNA repair,P
21142,118,731,DNA synthesis involved in DNA repair,P
21141,118,6271,DNA strand elongation involved in DNA replication,P
21140,118,45004,DNA replication proofreading,P
21139,118,6260,DNA replication,P
21138,118,6281,DNA repair,P
21137,118,42769,"DNA damage response, detection of DNA damage",P
21136,118,5515,protein binding,F
21135,118,166,nucleotide binding,F
21134,118,46872,metal ion binding,F
21133,118,19899,enzyme binding,F
21132,118,3684,damaged DNA binding,F
21131,118,3682,chromatin binding,F
21130,118,3887,DNA-directed DNA polymerase activity,F
21129,118,3887,DNA-directed DNA polymerase activity,F
21128,118,3677,DNA binding,F
21127,118,51539,"4 iron, 4 sulfur cluster binding",F
21126,118,8296,3'-5'-exodeoxyribonuclease activity,F
21225,116,1904430,negative regulation of t-circle formation,P
21224,116,1904430,negative regulation of t-circle formation,P
21223,116,10629,negative regulation of gene expression,P
21222,116,2000773,negative regulation of cellular senescence,P
21220,116,90398,cellular senescence,P
21221,116,1903770,negative regulation of beta-galactosidase activity,P
21219,116,7049,cell cycle,P
21218,116,42162,telomeric DNA binding,F
21217,116,3720,telomerase activity,F
21216,116,42803,protein homodimerization activity,F
21215,116,5515,protein binding,F
21214,116,8022,protein C-terminus binding,F
21213,116,44877,macromolecular complex binding,F
21212,116,3691,double-stranded telomeric DNA binding,F
21211,116,3691,double-stranded telomeric DNA binding,F
21210,116,98505,G-rich strand telomeric DNA binding,F
21189,117,75713,establishment of integrated proviral latency,P
21188,117,6303,double-strand break repair via nonhomologous end joining,P
21187,117,6303,double-strand break repair via nonhomologous end joining,P
21186,117,97680,double-strand break repair via classical nonhomologous end joining,P
21185,117,71480,cellular response to gamma radiation,P
21184,117,71481,cellular response to X-ray,P
21183,117,71475,cellular hyperosmotic salinity response,P
21182,117,7420,brain development,P
21181,117,6310,DNA recombination,P
21180,117,6266,DNA ligation,P
21179,117,32508,DNA duplex unwinding,P
21177,117,5515,protein binding,F
21178,117,44212,transcription regulatory region DNA binding,F
21176,117,8022,protein C-terminus binding,F
21175,117,44822,poly(A) RNA binding,F
21174,117,44877,macromolecular complex binding,F
21173,117,3691,double-stranded telomeric DNA binding,F
21172,117,3690,double-stranded DNA binding,F
21171,117,3684,damaged DNA binding,F
21170,117,3677,DNA binding,F
21169,117,4003,ATP-dependent DNA helicase activity,F
21168,117,5524,ATP binding,F
21167,117,51575,5'-deoxyribose-5-phosphate lyase activity,F
17204,199,61684,chaperone-mediated autophagy,P
17203,199,61684,chaperone-mediated autophagy,P
17202,199,51085,chaperone mediated protein folding requiring cofactor,P
17201,199,9267,cellular response to starvation,P
17200,199,98609,cell-cell adhesion,P
17199,199,46034,ATP metabolic process,P
17198,199,51082,unfolded protein binding,F
17197,199,31625,ubiquitin protein ligase binding,F
17196,199,5515,protein binding,F
17195,199,44822,poly(A) RNA binding,F
17194,199,1786,phosphatidylserine binding,F
17193,199,31072,heat shock protein binding,F
17192,199,19899,enzyme binding,F
17191,199,98641,cadherin binding involved in cell-cell adhesion,F
17190,199,23026,MHC class II protein complex binding,F
17189,199,1664,G-protein coupled receptor binding,F
17188,199,55131,C3HC4-type RING finger domain binding,F
17187,199,42623,"ATPase activity, coupled",F
17186,199,16887,ATPase activity,F
17185,199,5524,ATP binding,F
21007,119,51434,BH3 domain binding,F
21006,119,51434,BH3 domain binding,F
21072,119,2904,positive regulation of B cell apoptotic process,P
21071,119,1541,ovarian follicle development,P
21070,119,42475,odontogenesis of dentin-containing tooth,P
21069,119,1764,neuron migration,P
21068,119,51402,neuron apoptotic process,P
21067,119,32091,negative regulation of protein binding,P
21066,119,33137,negative regulation of peptidyl-serine phosphorylation,P
21065,119,43524,negative regulation of neuron apoptotic process,P
21064,119,48147,negative regulation of fibroblast proliferation,P
21063,119,32471,negative regulation of endoplasmic reticulum calcium ion concentration,P
21062,119,2001234,negative regulation of apoptotic signaling pathway,P
21061,119,2262,myeloid cell homeostasis,P
21060,119,70584,mitochondrion morphogenesis,P
21059,119,8053,mitochondrial fusion,P
21058,119,43653,mitochondrial fragmentation involved in apoptotic process,P
21057,119,1822,kidney development,P
21056,119,70059,intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress,P
21055,119,70059,intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress,P
21054,119,8630,intrinsic apoptotic signaling pathway in response to DNA damage,P
21053,119,72332,intrinsic apoptotic signaling pathway by p53 class mediator,P
21052,119,97193,intrinsic apoptotic signaling pathway,P
21051,119,21854,hypothalamus development,P
21050,119,48873,homeostasis of number of cells within a tissue,P
21048,119,7281,germ cell development,P
21049,119,6687,glycosphingolipid metabolic process,P
21047,119,9566,fertilization,P
21046,119,8625,extrinsic apoptotic signaling pathway via death domain receptors,P
21045,119,97192,extrinsic apoptotic signaling pathway in absence of ligand,P
21044,119,97191,extrinsic apoptotic signaling pathway,P
21043,119,10248,establishment or maintenance of transmembrane electrochemical gradient,P
21042,119,32469,endoplasmic reticulum calcium ion homeostasis,P
21041,119,35234,ectopic germ cell programmed cell death,P
21040,119,45136,development of secondary sexual characteristics,P
21039,119,21987,cerebral cortex development,P
21038,119,34644,cellular response to UV,P
21037,119,1974,blood vessel remodeling,P
21036,119,97190,apoptotic signaling pathway,P
21035,119,1902263,apoptotic process involved in embryonic digit morphogenesis,P
21034,119,1902262,apoptotic process involved in blood vessel morphogenesis,P
21032,119,6915,apoptotic process,P
21033,119,6915,apoptotic process,P
21031,119,6915,apoptotic process,P
21030,119,8637,apoptotic mitochondrial changes,P
21029,119,6987,activation of signaling protein activity involved in unfolded protein response,P
21028,119,97296,activation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway,P
21027,119,8635,activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c,P
21026,119,6919,activation of cysteine-type endopeptidase activity involved in apoptotic process,P
21025,119,6919,activation of cysteine-type endopeptidase activity involved in apoptotic process,P
21024,119,1777,T cell homeostatic proliferation,P
21023,119,60011,Sertoli cell proliferation,P
21022,119,6977,"DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest",P
21021,119,1990117,B cell receptor apoptotic signaling pathway,P
21020,119,2352,B cell negative selection,P
21019,119,2358,B cell homeostatic proliferation,P
21018,119,1782,B cell homeostasis,P
21017,119,1783,B cell apoptotic process,P
21016,119,42803,protein homodimerization activity,F
21015,119,42803,protein homodimerization activity,F
21014,119,46982,protein heterodimerization activity,F
21013,119,5515,protein binding,F
21012,119,8289,lipid binding,F
21011,119,42802,identical protein binding,F
21010,119,51087,chaperone binding,F
21009,119,15267,channel activity,F
21008,119,30544,Hsp70 protein binding,F
20978,120,42551,neuron maturation,P
20977,120,51402,neuron apoptotic process,P
20976,120,45892,"negative regulation of transcription, DNA-templated",P
20975,120,45892,"negative regulation of transcription, DNA-templated",P
20974,120,71930,negative regulation of transcription involved in G1/S transition of mitotic cell cycle,P
20973,120,7070,negative regulation of transcription from RNA polymerase II promoter during mitotic cell cycle,P
20972,120,45879,negative regulation of smoothened signaling pathway,P
20971,120,43433,negative regulation of sequence-specific DNA binding transcription factor activity,P
20970,120,6469,negative regulation of protein kinase activity,P
20969,120,10629,negative regulation of gene expression,P
20968,120,50680,negative regulation of epithelial cell proliferation,P
20967,120,2000134,negative regulation of G1/S transition of mitotic cell cycle,P
20966,120,45445,myoblast differentiation,P
20965,120,7093,mitotic cell cycle checkpoint,P
20964,120,34088,maintenance of mitotic sister chromatid cohesion,P
20963,120,97284,hepatocyte apoptotic process,P
20962,120,34349,glial cell apoptotic process,P
20960,120,48565,digestive tract development,P
20961,120,43353,enucleate erythrocyte differentiation,P
20958,120,6338,chromatin remodeling,P
20959,120,16569,covalent chromatin modification,P
20957,120,71466,cellular response to xenobiotic stimulus,P
20956,120,48667,cell morphogenesis involved in neuron differentiation,P
20955,120,51301,cell division,P
20954,120,75,cell cycle checkpoint,P
20953,120,7050,cell cycle arrest,P
20952,120,30521,androgen receptor signaling pathway,P
20951,120,7265,Ras protein signal transduction,P
20950,120,82,G1/S transition of mitotic cell cycle,P
20949,120,31625,ubiquitin protein ligase binding,F
20948,120,8134,transcription factor binding,F
20947,120,3700,"transcription factor activity, sequence-specific DNA binding",F
20946,120,3713,transcription coactivator activity,F
20944,120,51219,phosphoprotein binding,F
20945,120,5515,protein binding,F
20943,120,19900,kinase binding,F
20942,120,42802,identical protein binding,F
20941,120,1047,core promoter binding,F
20940,120,50681,androgen receptor binding,F
20939,120,1102,RNA polymerase II activating transcription factor binding,F
20938,120,3677,DNA binding,F
20925,121,60828,regulation of canonical Wnt signaling pathway,P
20924,121,46827,positive regulation of protein export from nucleus,P
20923,121,48147,negative regulation of fibroblast proliferation,P
20922,121,35414,negative regulation of catenin import into nucleus,P
20921,121,7517,muscle organ development,P
20920,121,6936,muscle contraction,P
20919,121,7084,mitotic nuclear envelope reassembly,P
20918,121,7077,mitotic nuclear envelope disassembly,P
20917,121,71363,cellular response to growth factor stimulus,P
20916,121,98609,cell-cell adhesion,P
20915,121,5515,protein binding,F
20914,121,98641,cadherin binding involved in cell-cell adhesion,F
20913,121,48487,beta-tubulin binding,F
20912,121,3779,actin binding,F
20884,122,50900,leukocyte migration,P
20883,122,8286,insulin receptor signaling pathway,P
20882,122,8286,insulin receptor signaling pathway,P
20881,122,8543,fibroblast growth factor receptor signaling pathway,P
20880,122,7173,epidermal growth factor receptor signaling pathway,P
20879,122,71479,cellular response to ionizing radiation,P
20878,122,7267,cell-cell signaling,P
20876,122,7411,axon guidance,P
20877,122,60670,branching involved in labyrinthine layer morphogenesis,P
20875,122,48646,anatomical structure formation involved in morphogenesis,P
20874,122,7568,aging,P
20873,122,31295,T cell costimulation,P
20872,122,7265,Ras protein signal transduction,P
20871,122,165,MAPK cascade,P
20870,122,38096,Fc-gamma receptor signaling pathway involved in phagocytosis,P
20869,122,38095,Fc-epsilon receptor signaling pathway,P
20868,122,38128,ERBB2 signaling pathway,P
20867,122,19903,protein phosphatase binding,F
20866,122,19901,protein kinase binding,F
20865,122,5515,protein binding,F
20864,122,44822,poly(A) RNA binding,F
20863,122,1784,phosphotyrosine binding,F
20862,122,46934,"phosphatidylinositol-4,5-bisphosphate 3-kinase activity",F
20861,122,5168,neurotrophin TRKA receptor binding,F
20860,122,43560,insulin receptor substrate binding,F
20859,122,42802,identical protein binding,F
20858,122,5154,epidermal growth factor receptor binding,F
20857,122,46875,ephrin receptor binding,F
20856,122,5070,SH3/SH2 adaptor activity,F
20855,122,17124,SH3 domain binding,F
20854,122,5088,Ras guanyl-nucleotide exchange factor activity,F
20853,122,16303,1-phosphatidylinositol-3-kinase activity,F
20818,123,34599,cellular response to oxidative stress,P
20817,123,1990090,cellular response to nerve growth factor stimulus,P
20816,123,71456,cellular response to hypoxia,P
20815,123,71333,cellular response to glucose stimulus,P
20814,123,71386,cellular response to corticosterone stimulus,P
20813,123,1904646,cellular response to beta-amyloid,P
20812,123,48854,brain morphogenesis,P
20810,123,7568,aging,P
20811,123,1547,antral ovarian follicle growth,P
20809,123,30330,"DNA damage response, signal transduction by p53 class mediator",P
20808,123,1227,"transcriptional repressor activity, RNA polymerase II transcription regulatory region sequence-specific binding",F
20807,123,1228,"transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding",F
20806,123,3700,"transcription factor activity, sequence-specific DNA binding",F
20805,123,1221,transcription cofactor binding,F
20804,123,43565,sequence-specific DNA binding,F
20803,123,19901,protein kinase binding,F
20802,123,5515,protein binding,F
20801,123,1047,core promoter binding,F
20800,123,31490,chromatin DNA binding,F
20799,123,8013,beta-catenin binding,F
20798,123,3677,DNA binding,F
20770,124,8286,insulin receptor signaling pathway,P
20771,124,43066,negative regulation of apoptotic process,P
20772,124,90090,negative regulation of canonical Wnt signaling pathway,P
20769,124,45444,fat cell differentiation,P
20768,124,31018,endocrine pancreas development,P
20767,124,70166,enamel mineralization,P
20766,124,9267,cellular response to starvation,P
20765,124,9267,cellular response to starvation,P
20764,124,34599,cellular response to oxidative stress,P
20763,124,71732,cellular response to nitric oxide,P
20762,124,32869,cellular response to insulin stimulus,P
20761,124,71455,cellular response to hyperoxia,P
20760,124,70301,cellular response to hydrogen peroxide,P
20759,124,71549,cellular response to dexamethasone stimulus,P
20758,124,70417,cellular response to cold,P
20757,124,6974,cellular response to DNA damage stimulus,P
20756,124,1678,cellular glucose homeostasis,P
20755,124,1568,blood vessel development,P
20754,124,6914,autophagy,P
20753,124,6915,apoptotic process,P
20752,124,31625,ubiquitin protein ligase binding,F
20751,124,1078,"transcriptional repressor activity, RNA polymerase II core promoter proximal region sequence-specific binding",F
20750,124,989,"transcription factor activity, transcription factor binding",F
20749,124,1223,transcription coactivator binding,F
20748,124,43565,sequence-specific DNA binding,F
20747,124,51721,protein phosphatase 2A binding,F
20745,124,3682,chromatin binding,F
20746,124,5515,protein binding,F
20744,124,8013,beta-catenin binding,F
20743,124,981,"RNA polymerase II transcription factor activity, sequence-specific DNA binding",F
20689,125,3700,"transcription factor activity, sequence-specific DNA binding",F
20688,125,98847,sequence-specific single stranded DNA binding,F
20687,125,43621,protein self-association,F
20686,125,19901,protein kinase binding,F
20685,125,5515,protein binding,F
20684,125,1990841,promoter-specific chromatin binding,F
20683,125,42802,identical protein binding,F
20682,125,31072,heat shock protein binding,F
20681,125,97677,STAT family protein binding,F
20680,125,1162,RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding,F
20679,125,979,RNA polymerase II core promoter sequence-specific DNA binding,F
20678,125,978,RNA polymerase II core promoter proximal region sequence-specific DNA binding,F
20677,125,3677,DNA binding,F
20654,126,8630,intrinsic apoptotic signaling pathway in response to DNA damage,P
20653,126,70911,global genome nucleotide-excision repair,P
20652,126,6284,base-excision repair,P
20651,126,70914,UV-damage excision repair,P
20650,126,42803,protein homodimerization activity,F
20649,126,19904,protein domain specific binding,F
20648,126,5515,protein binding,F
20647,126,46872,metal ion binding,F
20646,126,3684,damaged DNA binding,F
20635,127,6555,methionine metabolic process,P
20634,127,6464,cellular protein modification process,P
20633,127,8113,peptide-methionine (S)-S-oxide reductase activity,F
20622,128,6310,DNA recombination,P
20621,128,32508,DNA duplex unwinding,P
20620,128,5515,protein binding,F
20619,128,9378,four-way junction helicase activity,F
20618,128,405,bubble DNA binding,F
20617,128,36310,annealing helicase activity,F
20616,128,43140,ATP-dependent 3'-5' DNA helicase activity,F
20615,128,5524,ATP binding,F
20644,127,5739,mitochondrion,C
20643,127,16020,membrane,C
20642,127,70062,extracellular exosome,C
20641,127,5829,cytosol,C
20640,127,5737,cytoplasm,C
20639,127,15629,actin cytoskeleton,C
20638,127,6979,response to oxidative stress,P
20637,127,30091,protein repair,P
20636,127,55114,oxidation-reduction process,P
20632,128,5634,nucleus,C
20631,128,16020,membrane,C
20630,128,5737,cytoplasm,C
20629,128,5694,chromosome,C
20628,128,7275,multicellular organism development,P
20627,128,6302,double-strand break repair,P
20626,128,6284,base-excision repair,P
20625,128,733,DNA strand renaturation,P
20623,128,6281,DNA repair,P
20624,128,6260,DNA replication,P
20614,129,5739,mitochondrion,C
20613,129,5759,mitochondrial matrix,C
20612,129,70062,extracellular exosome,C
20611,129,3069,vasodilation by acetylcholine involved in regulation of systemic arterial blood pressure,P
20610,129,6801,superoxide metabolic process,P
20609,129,303,response to superoxide,P
20608,129,302,response to reactive oxygen species,P
20607,129,19430,removal of superoxide radicals,P
20606,129,1836,release of cytochrome c from mitochondria,P
20605,129,6357,regulation of transcription from RNA polymerase II promoter,P
20604,129,8217,regulation of blood pressure,P
20603,129,51289,protein homotetramerization,P
20602,129,32364,oxygen homeostasis,P
20601,129,55114,oxidation-reduction process,P
20600,129,1902176,negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway,P
20599,129,43524,negative regulation of neuron apoptotic process,P
20598,129,8285,negative regulation of cell proliferation,P
20597,129,1315,age-dependent response to reactive oxygen species,P
20595,129,4784,superoxide dismutase activity,F
20596,129,4784,superoxide dismutase activity,F
20594,129,30145,manganese ion binding,F
20593,129,30145,manganese ion binding,F
20592,129,42802,identical protein binding,F
20546,130,1975,response to amphetamine,P
20545,130,19430,removal of superoxide radicals,P
20544,130,19430,removal of superoxide radicals,P
20543,130,60087,relaxation of vascular smooth muscle,P
20542,130,45859,regulation of protein kinase activity,P
20541,130,46620,regulation of organ growth,P
20540,130,40014,regulation of multicellular organism growth,P
20539,130,51881,regulation of mitochondrial membrane potential,P
20538,130,8217,regulation of blood pressure,P
20537,130,33081,regulation of T cell differentiation in thymus,P
20536,130,43087,regulation of GTPase activity,P
20535,130,72593,reactive oxygen species metabolic process,P
20534,130,32930,positive regulation of superoxide anion generation,P
20533,130,1902177,positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway,P
20532,130,1819,positive regulation of cytokine production,P
20531,130,43085,positive regulation of catalytic activity,P
20530,130,43065,positive regulation of apoptotic process,P
20529,130,2576,platelet degranulation,P
20528,130,1890,placenta development,P
20527,130,32287,peripheral nervous system myelin maintenance,P
20526,130,55114,oxidation-reduction process,P
20524,130,60052,neurofilament cytoskeleton organization,P
20525,130,1541,ovarian follicle development,P
20523,130,43524,negative regulation of neuron apoptotic process,P
20522,130,45541,negative regulation of cholesterol biosynthetic process,P
20521,130,2262,myeloid cell homeostasis,P
20520,130,46716,muscle cell cellular homeostasis,P
20519,130,7626,locomotory behavior,P
20518,130,50665,hydrogen peroxide biosynthetic process,P
20517,130,50665,hydrogen peroxide biosynthetic process,P
20516,130,60047,heart contraction,P
20515,130,6749,glutathione metabolic process,P
20514,130,7566,embryo implantation,P
20513,130,7566,embryo implantation,P
20512,130,35865,cellular response to potassium ion,P
20511,130,71276,cellular response to cadmium ion,P
20510,130,71318,cellular response to ATP,P
20509,130,6879,cellular iron ion homeostasis,P
20508,130,7569,cell aging,P
20507,130,60088,auditory receptor cell stereocilium organization,P
20506,130,8089,anterograde axonal transport,P
20505,130,187,activation of MAPK activity,P
20504,130,8270,zinc ion binding,F
20503,130,4784,superoxide dismutase activity,F
20502,130,4784,superoxide dismutase activity,F
20501,130,4784,superoxide dismutase activity,F
20500,130,30346,protein phosphatase 2B binding,F
20499,130,42803,protein homodimerization activity,F
20498,130,5515,protein binding,F
20497,130,42802,identical protein binding,F
20496,130,5507,copper ion binding,F
20495,130,51087,chaperone binding,F
20494,130,48365,Rac GTPase binding,F
20550,130,34465,response to carbon monoxide,P
20548,130,97332,response to antipsychotic drug,P
20549,130,48678,response to axon injury,P
20547,130,46677,response to antibiotic,P
20493,131,5634,nucleus,C
20492,131,5654,nucleoplasm,C
20490,131,5737,cytoplasm,C
20491,131,5654,nucleoplasm,C
20489,131,6351,"transcription, DNA-templated",P
20488,131,2000377,regulation of reactive oxygen species metabolic process,P
20487,131,71156,regulation of cell cycle arrest,P
20486,131,51726,regulation of cell cycle,P
20485,131,46578,regulation of Ras protein signal transduction,P
20484,131,45893,"positive regulation of transcription, DNA-templated",P
20483,131,45944,positive regulation of transcription from RNA polymerase II promoter,P
20482,131,45944,positive regulation of transcription from RNA polymerase II promoter,P
20481,131,2000781,positive regulation of double-strand break repair,P
20480,131,8284,positive regulation of cell proliferation,P
20479,131,45892,"negative regulation of transcription, DNA-templated",P
20478,131,122,negative regulation of transcription from RNA polymerase II promoter,P
20477,131,32873,negative regulation of stress-activated MAPK cascade,P
20476,131,90344,negative regulation of cell aging,P
20475,131,86,G2/M transition of mitotic cell cycle,P
20473,131,6281,DNA repair,P
20474,131,86,G2/M transition of mitotic cell cycle,P
20472,131,6978,"DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator",P
20471,131,43565,sequence-specific DNA binding,F
20470,131,19901,protein kinase binding,F
20469,131,5515,protein binding,F
20468,131,981,"RNA polymerase II transcription factor activity, sequence-specific DNA binding",F
20554,130,9408,response to heat,P
20553,130,45471,response to ethanol,P
20552,130,42493,response to drug,P
20467,132,5634,nucleus,C
20551,130,46688,response to copper ion,P
20466,132,5743,mitochondrial inner membrane,C
20465,132,6744,ubiquinone biosynthetic process,P
20464,132,55114,oxidation-reduction process,P
20463,132,5515,protein binding,F
20462,132,4497,monooxygenase activity,F
20461,132,46872,metal ion binding,F
20436,133,7204,positive regulation of cytosolic calcium ion concentration,P
20435,133,7204,positive regulation of cytosolic calcium ion concentration,P
20434,133,42133,neurotransmitter metabolic process,P
20433,133,7274,neuromuscular synaptic transmission,P
20432,133,50885,neuromuscular process controlling balance,P
20431,133,43524,negative regulation of neuron apoptotic process,P
20430,133,32353,negative regulation of hormone biosynthetic process,P
20429,133,50883,"musculoskeletal movement, spinal reflex action",P
20428,133,86010,membrane depolarization during action potential,P
20427,133,51899,membrane depolarization,P
20426,133,42445,hormone metabolic process,P
20425,133,6006,glucose metabolic process,P
20424,133,7214,gamma-aminobutyric acid signaling pathway,P
20423,133,14051,gamma-aminobutyric acid secretion,P
20422,133,48813,dendrite morphogenesis,P
20421,133,21590,cerebellum maturation,P
20420,133,21679,cerebellar molecular layer development,P
20419,133,21702,cerebellar Purkinje cell differentiation,P
20418,133,30644,cellular chloride ion homeostasis,P
20416,133,8219,cell death,P
20417,133,16049,cell growth,P
20415,133,48791,calcium ion-regulated exocytosis of neurotransmitter,P
20414,133,70588,calcium ion transmembrane transport,P
20413,133,48266,behavioral response to pain,P
20412,133,7628,adult walking behavior,P
20411,133,5245,voltage-gated calcium channel activity,F
20410,133,5245,voltage-gated calcium channel activity,F
20409,133,5245,voltage-gated calcium channel activity,F
20408,133,19905,syntaxin binding,F
20407,133,5515,protein binding,F
20406,133,46872,metal ion binding,F
20405,133,8331,high voltage-gated calcium channel activity,F
20404,133,8331,high voltage-gated calcium channel activity,F
20403,133,5262,calcium channel activity,F
20389,134,42359,vitamin D metabolic process,P
20388,134,3281,ventricular septum development,P
20387,134,1523,retinoid metabolic process,P
20386,134,6898,receptor-mediated endocytosis,P
20385,134,6486,protein glycosylation,P
20384,134,42953,lipoprotein transport,P
20383,134,6629,lipid metabolic process,P
20382,134,30900,forebrain development,P
20381,134,6897,endocytosis,P
20380,134,60976,coronary vasculature development,P
20379,134,8283,cell proliferation,P
20378,134,35904,aorta development,P
20377,134,5515,protein binding,F
20376,134,5041,low-density lipoprotein receptor activity,F
20375,134,42954,lipoprotein transporter activity,F
20374,134,5509,calcium ion binding,F
20373,134,17124,SH3 domain binding,F
20355,135,90650,cellular response to oxygen-glucose deprivation,P
20354,135,71732,cellular response to nitric oxide,P
20353,135,70301,cellular response to hydrogen peroxide,P
20351,135,1904045,cellular response to aldosterone,P
20352,135,71392,cellular response to estradiol stimulus,P
20350,135,45454,cell redox homeostasis,P
20349,135,6915,apoptotic process,P
20348,135,6919,activation of cysteine-type endopeptidase activity involved in apoptotic process,P
20347,135,46983,protein dimerization activity,F
20346,135,5515,protein binding,F
20345,135,16651,"oxidoreductase activity, acting on NAD(P)H",F
20344,135,16174,NAD(P)H oxidase activity,F
20343,135,71949,FAD binding,F
20342,135,3677,DNA binding,F
20325,136,43161,proteasome-mediated ubiquitin-dependent protein catabolic process,P
20324,136,50905,neuromuscular process,P
20323,136,43407,negative regulation of MAP kinase activity,P
20322,136,48747,muscle fiber development,P
20321,136,42755,eating behavior,P
20320,136,8283,cell proliferation,P
20319,136,19896,axonal transport of mitochondrion,P
20318,136,7412,axon target recognition,P
20317,136,7628,adult walking behavior,P
20316,136,31625,ubiquitin protein ligase binding,F
20315,136,43130,ubiquitin binding,F
20314,136,4843,thiol-dependent ubiquitin-specific protease activity,F
20313,136,5515,protein binding,F
20312,136,8242,omega peptidase activity,F
20311,136,16874,ligase activity,F
20310,136,4197,cysteine-type endopeptidase activity,F
20309,136,31694,alpha-2A adrenergic receptor binding,F
20258,137,6468,protein phosphorylation,P
20257,137,45944,positive regulation of transcription from RNA polymerase II promoter,P
20256,137,10952,positive regulation of peptidase activity,P
20255,137,45931,positive regulation of mitotic cell cycle,P
20254,137,10971,positive regulation of G2/M transition of mitotic cell cycle,P
20253,137,2576,platelet degranulation,P
20252,137,16322,neuron remodeling,P
20251,137,31175,neuron projection development,P
20250,137,51402,neuron apoptotic process,P
20249,137,50885,neuromuscular process controlling balance,P
20248,137,45665,negative regulation of neuron differentiation,P
20247,137,10951,negative regulation of endopeptidase activity,P
20246,137,7617,mating behavior,P
20245,137,6378,mRNA polyadenylation,P
20244,137,7626,locomotory behavior,P
20243,137,35235,ionotropic glutamate receptor signaling pathway,P
20242,137,45087,innate immune response,P
20241,137,30900,forebrain development,P
20240,137,30198,extracellular matrix organization,P
20239,137,30198,extracellular matrix organization,P
20237,137,16358,dendrite development,P
20238,137,6897,endocytosis,P
20236,137,48669,collateral sprouting in absence of injury,P
20235,137,8203,cholesterol metabolic process,P
20234,137,71874,cellular response to norepinephrine stimulus,P
20233,137,1990090,cellular response to nerve growth factor stimulus,P
20232,137,71320,cellular response to cAMP,P
20231,137,44267,cellular protein metabolic process,P
20230,137,9987,cellular process,P
20229,137,6878,cellular copper ion homeostasis,P
20228,137,7155,cell adhesion,P
20227,137,7409,axonogenesis,P
20226,137,16199,axon midline choice point recognition,P
20225,137,8088,axo-dendritic transport,P
20224,137,1990000,amyloid fibril formation,P
20223,137,8344,adult locomotory behavior,P
20222,137,7219,Notch signaling pathway,P
20221,137,46914,transition metal ion binding,F
20220,137,4867,serine-type endopeptidase inhibitor activity,F
20219,137,5102,receptor binding,F
20218,137,5515,protein binding,F
20217,137,16504,peptidase activator activity,F
20216,137,42802,identical protein binding,F
20215,137,8201,heparin binding,F
20214,137,70851,growth factor receptor binding,F
20213,137,19899,enzyme binding,F
20212,137,51425,PTB domain binding,F
20211,137,3677,DNA binding,F
20093,138,17127,cholesterol transporter activity,F
20092,138,15485,cholesterol binding,F
20091,138,1540,beta-amyloid binding,F
20090,138,16209,antioxidant activity,F
20156,138,10873,positive regulation of cholesterol esterification,P
20155,138,10875,positive regulation of cholesterol efflux,P
20154,138,10875,positive regulation of cholesterol efflux,P
20153,138,30828,positive regulation of cGMP biosynthetic process,P
20151,138,33700,phospholipid efflux,P
20152,138,44794,positive regulation by host of viral process,P
20150,138,7263,nitric oxide mediated signal transduction,P
20149,138,31102,neuron projection regeneration,P
20148,138,90209,negative regulation of triglyceride metabolic process,P
20147,138,1901630,negative regulation of presynaptic membrane organization,P
20146,138,10544,negative regulation of platelet activation,P
20145,138,1901215,negative regulation of neuron death,P
20144,138,43524,negative regulation of neuron apoptotic process,P
20143,138,50728,negative regulation of inflammatory response,P
20142,138,1937,negative regulation of endothelial cell proliferation,P
20141,138,45541,negative regulation of cholesterol biosynthetic process,P
20140,138,90090,negative regulation of canonical Wnt signaling pathway,P
20139,138,43537,negative regulation of blood vessel endothelial cell migration,P
20138,138,30195,negative regulation of blood coagulation,P
20137,138,1902430,negative regulation of beta-amyloid formation,P
20136,138,43407,negative regulation of MAP kinase activity,P
20135,138,51651,maintenance of location in cell,P
20134,138,34374,low-density lipoprotein particle remodeling,P
20133,138,15909,long-chain fatty acid transport,P
20132,138,42157,lipoprotein metabolic process,P
20131,138,42159,lipoprotein catabolic process,P
20130,138,42159,lipoprotein catabolic process,P
20129,138,42158,lipoprotein biosynthetic process,P
20128,138,10877,lipid transport involved in lipid storage,P
20127,138,46907,intracellular transport,P
20126,138,34375,high-density lipoprotein particle remodeling,P
20125,138,34384,high-density lipoprotein particle clearance,P
20124,138,34380,high-density lipoprotein particle assembly,P
20123,138,55089,fatty acid homeostasis,P
20122,138,7010,cytoskeleton organization,P
20121,138,34382,chylomicron remnant clearance,P
20119,138,8203,cholesterol metabolic process,P
20120,138,8203,cholesterol metabolic process,P
20118,138,42632,cholesterol homeostasis,P
20117,138,33344,cholesterol efflux,P
20116,138,6707,cholesterol catabolic process,P
20115,138,98869,cellular oxidant detoxification,P
20114,138,6874,cellular calcium ion homeostasis,P
20113,138,19934,cGMP-mediated signaling,P
20112,138,48844,artery morphogenesis,P
20111,138,97114,NMDA glutamate receptor clustering,P
20110,138,7186,G-protein coupled receptor signaling pathway,P
20109,138,97113,AMPA glutamate receptor clustering,P
20108,138,70326,very-low-density lipoprotein particle receptor binding,F
20107,138,70326,very-low-density lipoprotein particle receptor binding,F
20106,138,48156,tau protein binding,F
20105,138,42803,protein homodimerization activity,F
20104,138,5515,protein binding,F
20103,138,5543,phospholipid binding,F
20102,138,60228,phosphatidylcholine-sterol O-acyltransferase activator activity,F
20101,138,46911,metal chelating activity,F
20100,138,50750,low-density lipoprotein particle receptor binding,F
20099,138,50750,low-density lipoprotein particle receptor binding,F
20098,138,71813,lipoprotein particle binding,F
20097,138,5319,lipid transporter activity,F
20096,138,8289,lipid binding,F
20095,138,42802,identical protein binding,F
20094,138,8201,heparin binding,F
20079,139,10951,negative regulation of endopeptidase activity,P
20078,139,1869,"negative regulation of complement activation, lectin pathway",P
20077,139,22617,extracellular matrix disassembly,P
20076,139,7597,"blood coagulation, intrinsic pathway",P
20075,139,43120,tumor necrosis factor binding,F
20074,139,4867,serine-type endopeptidase inhibitor activity,F
20073,139,5102,receptor binding,F
20072,139,5515,protein binding,F
20071,139,2020,protease binding,F
20070,139,19959,interleukin-8 binding,F
20069,139,19966,interleukin-1 binding,F
20068,139,19838,growth factor binding,F
20067,139,19899,enzyme binding,F
20066,139,48306,calcium-dependent protein binding,F
20065,139,5096,GTPase activator activity,F
20033,141,42267,natural killer cell mediated cytotoxicity,P
20032,141,42744,hydrogen peroxide catabolic process,P
20031,141,34101,erythrocyte homeostasis,P
20030,141,98609,cell-cell adhesion,P
20029,141,45454,cell redox homeostasis,P
20028,141,8283,cell proliferation,P
20027,141,8379,thioredoxin peroxidase activity,F
20026,141,8379,thioredoxin peroxidase activity,F
20025,141,5515,protein binding,F
20024,141,44822,poly(A) RNA binding,F
20023,141,4601,peroxidase activity,F
20022,141,42802,identical protein binding,F
20021,141,98641,cadherin binding involved in cell-cell adhesion,F
20006,142,10875,positive regulation of cholesterol efflux,P
20005,142,51099,positive regulation of binding,P
20004,142,46470,phosphatidylcholine metabolic process,P
20003,142,46434,organophosphate catabolic process,P
20002,142,34445,negative regulation of plasma lipoprotein particle oxidation,P
20001,142,16311,dephosphorylation,P
20000,142,8203,cholesterol metabolic process,P
19999,142,46395,carboxylic acid catabolic process,P
19998,142,19439,aromatic compound catabolic process,P
19997,142,42803,protein homodimerization activity,F
19996,142,5543,phospholipid binding,F
19995,142,5509,calcium ion binding,F
19994,142,4064,arylesterase activity,F
19993,142,4064,arylesterase activity,F
19992,142,4063,aryldialkylphosphatase activity,F
19991,142,102007,acyl-L-homoserine-lactone lactonohydrolase activity,F
19773,144,5125,cytokine activity,F
19772,144,5125,cytokine activity,F
19844,144,43065,positive regulation of apoptotic process,P
19843,144,2675,positive regulation of acute inflammatory response,P
19842,144,45630,positive regulation of T-helper 2 cell differentiation,P
19841,144,2000553,positive regulation of T-helper 2 cell cytokine production,P
19840,144,42102,positive regulation of T cell proliferation,P
19839,144,2000366,positive regulation of STAT protein import into nucleus,P
19838,144,51092,positive regulation of NF-kappaB transcription factor activity,P
19837,144,43410,positive regulation of MAPK cascade,P
19836,144,46427,positive regulation of JAK-STAT cascade,P
19835,144,70374,positive regulation of ERK1 and ERK2 cascade,P
19834,144,45740,positive regulation of DNA replication,P
19833,144,50871,positive regulation of B cell activation,P
19832,144,30168,platelet activation,P
19831,144,2446,neutrophil mediated immunity,P
19830,144,1781,neutrophil apoptotic process,P
19829,144,31175,neuron projection development,P
19828,144,6469,negative regulation of protein kinase activity,P
19827,144,1901215,negative regulation of neuron death,P
19826,144,48635,negative regulation of muscle organ development,P
19825,144,45837,negative regulation of membrane potential,P
19824,144,10888,negative regulation of lipid storage,P
19823,144,2000660,negative regulation of interleukin-1-mediated signaling pathway,P
19822,144,46888,negative regulation of hormone secretion,P
19821,144,45721,negative regulation of gluconeogenesis,P
19820,144,45599,negative regulation of fat cell differentiation,P
19819,144,50710,negative regulation of cytokine secretion,P
19818,144,43154,negative regulation of cysteine-type endopeptidase activity involved in apoptotic process,P
19817,144,32966,negative regulation of collagen biosynthetic process,P
19816,144,45079,negative regulation of chemokine biosynthetic process,P
19815,144,8285,negative regulation of cell proliferation,P
19814,144,45779,negative regulation of bone resorption,P
19813,144,43066,negative regulation of apoptotic process,P
19812,144,46716,muscle cell cellular homeostasis,P
19811,144,2548,monocyte chemotaxis,P
19810,144,31294,lymphocyte costimulation,P
19809,144,70102,interleukin-6-mediated signaling pathway,P
19808,144,6954,inflammatory response,P
19807,144,6959,humoral immune response,P
19806,144,2384,hepatic immune response,P
19805,144,2384,hepatic immune response,P
19804,144,42593,glucose homeostasis,P
19803,144,70091,glucagon secretion,P
19802,144,60664,epithelial cell proliferation involved in salivary gland morphogenesis,P
19801,144,31018,endocrine pancreas development,P
19800,144,51607,defense response to virus,P
19799,144,42832,defense response to protozoan,P
19798,144,50830,defense response to Gram-positive bacterium,P
19797,144,50829,defense response to Gram-negative bacterium,P
19796,144,19221,cytokine-mediated signaling pathway,P
19795,144,71356,cellular response to tumor necrosis factor,P
19794,144,1990646,cellular response to prolactin,P
19793,144,31669,cellular response to nutrient levels,P
19792,144,71222,cellular response to lipopolysaccharide,P
19791,144,71347,cellular response to interleukin-1,P
19790,144,70301,cellular response to hydrogen peroxide,P
19789,144,35729,cellular response to hepatocyte growth factor stimulus,P
19788,144,71392,cellular response to estradiol stimulus,P
19787,144,71549,cellular response to dexamethasone stimulus,P
19786,144,45454,cell redox homeostasis,P
19785,144,16049,cell growth,P
19784,144,60445,branching involved in salivary gland morphogenesis,P
19783,144,46849,bone remodeling,P
19782,144,7568,aging,P
19781,144,6953,acute-phase response,P
19780,144,72540,T-helper 17 cell lineage commitment,P
19779,144,5515,protein binding,F
19778,144,5138,interleukin-6 receptor binding,F
19777,144,5138,interleukin-6 receptor binding,F
19776,144,5138,interleukin-6 receptor binding,F
19775,144,8083,growth factor activity,F
19774,144,5125,cytokine activity,F
19737,145,6874,cellular calcium ion homeostasis,P
19736,145,7568,aging,P
19735,145,19853,L-ascorbic acid biosynthetic process,P
19734,145,8270,zinc ion binding,F
19733,145,4341,gluconolactonase activity,F
19732,145,30234,enzyme regulator activity,F
19731,145,5509,calcium ion binding,F
19730,145,5509,calcium ion binding,F
19723,146,31012,extracellular matrix,C
19721,146,15992,proton transport,P
19722,146,70062,extracellular exosome,C
19720,146,42776,mitochondrial ATP synthesis coupled proton transport,P
19719,146,42776,mitochondrial ATP synthesis coupled proton transport,P
19718,146,6754,ATP biosynthetic process,P
19717,146,6754,ATP biosynthetic process,P
19716,146,5215,transporter activity,F
19715,146,22857,transmembrane transporter activity,F
19714,146,46933,"proton-transporting ATP synthase activity, rotational mechanism",F
19713,146,5515,protein binding,F
19712,146,8144,drug binding,F
19711,146,16887,ATPase activity,F
19703,147,6974,cellular response to DNA damage stimulus,P
19702,147,6310,DNA recombination,P
19701,147,730,DNA recombinase assembly,P
19700,147,10792,DNA double-strand break processing involved in repair via single-strand annealing,P
19699,147,5515,protein binding,F
19698,147,42802,identical protein binding,F
19697,147,3677,DNA binding,F
19690,148,5515,protein binding,F
19689,148,44822,poly(A) RNA binding,F
19688,148,3917,DNA topoisomerase type I activity,F
19687,148,3916,DNA topoisomerase activity,F
19686,148,3677,DNA binding,F
19661,149,6295,"nucleotide-excision repair, DNA incision, 3'-to lesion",P
19660,149,6295,"nucleotide-excision repair, DNA incision, 3'-to lesion",P
19659,149,33683,"nucleotide-excision repair, DNA incision",P
19658,149,6289,nucleotide-excision repair,P
19657,149,6289,nucleotide-excision repair,P
19656,149,32205,negative regulation of telomere maintenance,P
19655,149,35264,multicellular organism growth,P
19654,149,10259,multicellular organism aging,P
19653,149,6312,mitotic recombination,P
19652,149,710,meiotic mismatch repair,P
19651,149,8584,male gonad development,P
19650,149,45190,isotype switching,P
19649,149,36297,interstrand cross-link repair,P
19648,149,70911,global genome nucleotide-excision repair,P
19647,149,48568,embryonic organ development,P
19646,149,6302,double-strand break repair,P
19645,149,8283,cell proliferation,P
19644,149,70914,UV-damage excision repair,P
19643,149,9650,UV protection,P
19642,149,6281,DNA repair,P
19641,149,6310,DNA recombination,P
19640,149,43566,structure-specific DNA binding,F
19639,149,14,single-stranded DNA endodeoxyribonuclease activity,F
19638,149,3697,single-stranded DNA binding,F
19637,149,19904,protein domain specific binding,F
19636,149,5515,protein binding,F
19635,149,8022,protein C-terminus binding,F
19634,149,3684,damaged DNA binding,F
19633,149,1094,TFIID-class transcription factor binding,F
19455,150,5515,protein binding,F
19454,150,8022,protein C-terminus binding,F
19453,150,2039,p53 binding,F
19452,150,35257,nuclear hormone receptor binding,F
19451,150,51019,mitogen-activated protein kinase binding,F
19450,150,46872,metal ion binding,F
19449,150,1990254,keratin filament binding,F
19448,150,42802,identical protein binding,F
19447,150,4407,histone deacetylase activity,F
19446,150,4407,histone deacetylase activity,F
19445,150,42393,histone binding,F
19444,150,19899,enzyme binding,F
19443,150,19213,deacetylase activity,F
19442,150,1046,core promoter sequence-specific DNA binding,F
19441,150,43425,bHLH transcription factor binding,F
19440,150,34979,NAD-dependent protein deacetylase activity,F
19439,150,34979,NAD-dependent protein deacetylase activity,F
19438,150,34979,NAD-dependent protein deacetylase activity,F
19433,150,43398,HLH domain binding,F
19434,150,3950,NAD+ ADP-ribosyltransferase activity,F
19435,150,70403,NAD+ binding,F
19436,150,17136,NAD-dependent histone deacetylase activity,F
19437,150,46969,NAD-dependent histone deacetylase activity (H3-K9 specific),F
19524,150,1902166,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator,P
19523,150,2000619,negative regulation of histone H4-K16 acetylation,P
19522,150,1900113,negative regulation of histone H3-K9 trimethylation,P
19520,150,51097,negative regulation of helicase activity,P
19521,150,71441,negative regulation of histone H3-K14 acetylation,P
19519,150,60125,negative regulation of growth hormone secretion,P
19518,150,10629,negative regulation of gene expression,P
19517,150,2000270,negative regulation of fibroblast apoptotic process,P
19516,150,45599,negative regulation of fat cell differentiation,P
19515,150,2000773,negative regulation of cellular senescence,P
19514,150,2000655,negative regulation of cellular response to testosterone stimulus,P
19513,150,30308,negative regulation of cell growth,P
19512,150,10667,negative regulation of cardiac muscle cell apoptotic process,P
19511,150,2000480,negative regulation of cAMP-dependent protein kinase activity,P
19510,150,43066,negative regulation of apoptotic process,P
19509,150,60766,negative regulation of androgen receptor signaling pathway,P
19508,150,32007,negative regulation of TOR signaling,P
19507,150,32088,negative regulation of NF-kappaB transcription factor activity,P
19506,150,43124,negative regulation of I-kappaB kinase/NF-kappaB signaling,P
19505,150,43518,"negative regulation of DNA damage response, signal transduction by p53 class mediator",P
19503,150,7517,muscle organ development,P
19504,150,43392,negative regulation of DNA binding,P
19502,150,6346,methylation-dependent chromatin silencing,P
19501,150,6344,maintenance of chromatin silencing,P
19500,150,30225,macrophage differentiation,P
19498,150,33210,leptin-mediated signaling pathway,P
19499,150,10934,macrophage cytokine production,P
19497,150,42771,intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator,P
19496,150,16575,histone deacetylation,P
19495,150,61647,histone H3-K9 modification,P
19494,150,1990619,histone H3-K9 deacetylation,P
19493,150,70932,histone H3 deacetylation,P
19492,150,70932,histone H3 deacetylation,P
19491,150,55089,fatty acid homeostasis,P
19490,150,6343,establishment of chromatin silencing,P
19489,150,32922,circadian regulation of gene expression,P
19488,150,32922,circadian regulation of gene expression,P
19487,150,183,chromatin silencing at rDNA,P
19485,150,6342,chromatin silencing,P
19486,150,183,chromatin silencing at rDNA,P
19484,150,6325,chromatin organization,P
19483,150,42632,cholesterol homeostasis,P
19482,150,35356,cellular triglyceride homeostasis,P
19481,150,71303,cellular response to vitamin B3,P
19480,150,71356,cellular response to tumor necrosis factor,P
19479,150,9267,cellular response to starvation,P
19478,150,1904648,cellular response to rotenone,P
19477,150,71479,cellular response to ionizing radiation,P
19476,150,71456,cellular response to hypoxia,P
19475,150,70301,cellular response to hydrogen peroxide,P
19474,150,1904644,cellular response to curcumin,P
19473,150,1904646,cellular response to beta-amyloid,P
19472,150,71236,cellular response to antibiotic,P
19471,150,6974,cellular response to DNA damage stimulus,P
19469,150,7569,cell aging,P
19470,150,1678,cellular glucose homeostasis,P
19468,150,42595,behavioral response to starvation,P
19467,150,1525,angiogenesis,P
19466,150,70914,UV-damage excision repair,P
19465,150,731,DNA synthesis involved in DNA repair,P
19464,150,6260,DNA replication,P
19463,150,6281,DNA repair,P
19462,150,1077,"transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding",F
19461,150,8134,transcription factor binding,F
19460,150,3714,transcription corepressor activity,F
19459,150,3714,transcription corepressor activity,F
19458,150,43422,protein kinase B binding,F
19457,150,33558,protein deacetylase activity,F
19456,150,33558,protein deacetylase activity,F
19401,151,43922,negative regulation by host of viral transcription,P
19400,151,6346,methylation-dependent chromatin silencing,P
19399,151,16575,histone deacetylation,P
19398,151,70933,histone H4 deacetylation,P
19397,151,70932,histone H3 deacetylation,P
19396,151,60789,hair follicle placode formation,P
19395,151,61198,fungiform papilla formation,P
19394,151,61029,eyelid development in camera-type eye,P
19393,151,9913,epidermal cell differentiation,P
19392,151,42733,embryonic digit morphogenesis,P
19391,151,32922,circadian regulation of gene expression,P
19390,151,6338,chromatin remodeling,P
19389,151,6325,chromatin organization,P
19388,151,7596,blood coagulation,P
19387,151,1904837,beta-catenin-TCF complex assembly,P
19386,151,43044,ATP-dependent chromatin remodeling,P
19385,151,976,transcription regulatory region sequence-specific DNA binding,F
19384,151,44212,transcription regulatory region DNA binding,F
19383,151,8134,transcription factor binding,F
19382,151,8134,transcription factor binding,F
19381,151,3700,"transcription factor activity, sequence-specific DNA binding",F
19380,151,70491,repressing transcription factor binding,F
19379,151,33558,protein deacetylase activity,F
19378,151,33558,protein deacetylase activity,F
19377,151,5515,protein binding,F
19376,151,47485,protein N-terminus binding,F
19375,151,31492,nucleosomal DNA binding,F
19374,151,42826,histone deacetylase binding,F
19373,151,4407,histone deacetylase activity,F
19372,151,4407,histone deacetylase activity,F
19371,151,4407,histone deacetylase activity,F
19370,151,19899,enzyme binding,F
19369,151,19213,deacetylase activity,F
19368,151,1047,core promoter binding,F
19367,151,33613,activating transcription factor binding,F
19366,151,1085,RNA polymerase II transcription factor binding,F
19365,151,1106,RNA polymerase II transcription corepressor activity,F
19364,151,1103,RNA polymerase II repressing transcription factor binding,F
19363,151,980,RNA polymerase II distal enhancer sequence-specific DNA binding,F
19362,151,978,RNA polymerase II core promoter proximal region sequence-specific DNA binding,F
19361,151,51059,NF-kappaB binding,F
19360,151,32041,NAD-dependent histone deacetylase activity (H3-K14 specific),F
19319,153,43523,regulation of neuron apoptotic process,P
19318,153,33599,regulation of mammary gland epithelial cell proliferation,P
19317,153,40029,"regulation of gene expression, epigenetic",P
19316,153,6195,purine nucleotide catabolic process,P
19315,153,18158,protein oxidation,P
19314,153,1902905,positive regulation of supramolecular fiber organization,P
19313,153,51897,positive regulation of protein kinase B signaling,P
19312,153,90201,negative regulation of release of cytochrome c from mitochondria,P
19311,153,1902176,negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway,P
19310,153,2862,negative regulation of inflammatory response to antigenic stimulus,P
19309,153,1902042,negative regulation of extrinsic apoptotic signaling pathway via death domain receptors,P
19308,153,43154,negative regulation of cysteine-type endopeptidase activity involved in apoptotic process,P
19307,153,51450,myoblast proliferation,P
19306,153,19372,lipoxygenase pathway,P
19305,153,8631,intrinsic apoptotic signaling pathway in response to oxidative stress,P
19304,153,51702,interaction with symbiont,P
19303,153,42744,hydrogen peroxide catabolic process,P
19302,153,60047,heart contraction,P
19301,153,6749,glutathione metabolic process,P
19300,153,45444,fat cell differentiation,P
19299,153,1885,endothelial cell development,P
19298,153,34599,cellular response to oxidative stress,P
19297,153,98869,cellular oxidant detoxification,P
19296,153,45454,cell redox homeostasis,P
19295,153,43534,blood vessel endothelial cell migration,P
19294,153,60055,angiogenesis involved in wound healing,P
19293,153,9650,UV protection,P
19292,153,4602,glutathione peroxidase activity,F
19291,153,4602,glutathione peroxidase activity,F
19290,153,17124,SH3 domain binding,F
19283,154,15949,nucleobase-containing small molecule interconversion,P
19282,154,6749,glutathione metabolic process,P
19281,154,98869,cellular oxidant detoxification,P
19280,154,45454,cell redox homeostasis,P
19279,154,4362,glutathione-disulfide reductase activity,F
19278,154,50660,flavin adenine dinucleotide binding,F
19277,154,9055,electron carrier activity,F
19276,154,50661,NADP binding,F
19268,155,46686,response to cadmium ion,P
19267,155,43200,response to amino acid,P
19266,155,7399,nervous system development,P
19265,155,6750,glutathione biosynthetic process,P
19264,155,6750,glutathione biosynthetic process,P
19263,155,6520,cellular amino acid metabolic process,P
19262,155,7568,aging,P
19261,155,42803,protein homodimerization activity,F
19260,155,5515,protein binding,F
19259,155,287,magnesium ion binding,F
19258,155,42802,identical protein binding,F
19257,155,16594,glycine binding,F
19256,155,4363,glutathione synthase activity,F
19255,155,43295,glutathione binding,F
19254,155,5524,ATP binding,F
19250,156,1901687,glutathione derivative biosynthetic process,P
19249,156,42803,protein homodimerization activity,F
19248,156,5515,protein binding,F
19247,156,42802,identical protein binding,F
19246,156,4364,glutathione transferase activity,F
19245,156,4364,glutathione transferase activity,F
19212,157,32691,negative regulation of interleukin-1 beta production,P
19211,157,48147,negative regulation of fibroblast proliferation,P
19210,157,2001237,negative regulation of extrinsic apoptotic signaling pathway,P
19209,157,9890,negative regulation of biosynthetic process,P
19208,157,43066,negative regulation of apoptotic process,P
19207,157,2674,negative regulation of acute inflammatory response,P
19206,157,43409,negative regulation of MAPK cascade,P
19205,157,43407,negative regulation of MAP kinase activity,P
19204,157,43508,negative regulation of JUN kinase activity,P
19203,157,43124,negative regulation of I-kappaB kinase/NF-kappaB signaling,P
19202,157,70373,negative regulation of ERK1 and ERK2 cascade,P
19201,157,43651,linoleic acid metabolic process,P
19200,157,6749,glutathione metabolic process,P
19199,157,1901687,glutathione derivative biosynthetic process,P
19198,157,35726,common myeloid progenitor cell proliferation,P
19197,157,7417,central nervous system development,P
19196,157,71222,cellular response to lipopolysaccharide,P
19195,157,32869,cellular response to insulin stimulus,P
19194,157,71385,cellular response to glucocorticoid stimulus,P
19193,157,71364,cellular response to epidermal growth factor stimulus,P
19192,157,71460,cellular response to cell-matrix adhesion,P
19191,157,98869,cellular oxidant detoxification,P
19189,157,5515,protein binding,F
19190,157,31100,animal organ regeneration,P
19188,157,70026,nitric oxide binding,F
19187,157,19207,kinase regulator activity,F
19186,157,4364,glutathione transferase activity,F
19185,157,4364,glutathione transferase activity,F
19184,157,4602,glutathione peroxidase activity,F
19183,157,43295,glutathione binding,F
19182,157,8144,drug binding,F
19181,157,35731,dinitrosyl-iron complex binding,F
19180,157,35730,S-nitrosoglutathione binding,F
19179,157,8432,JUN kinase binding,F
19147,159,32729,positive regulation of interferon-gamma production,P
19146,159,32729,positive regulation of interferon-gamma production,P
19145,159,32727,positive regulation of interferon-alpha production,P
19144,159,43065,positive regulation of apoptotic process,P
19143,159,2842,positive regulation of T cell mediated immune response to tumor cell,P
19142,159,50870,positive regulation of T cell activation,P
19141,159,50870,positive regulation of T cell activation,P
19140,159,43066,negative regulation of apoptotic process,P
19138,159,61077,chaperone-mediated protein folding,P
19139,159,48291,isotype switching to IgG isotypes,P
19137,159,51131,chaperone-mediated protein complex assembly,P
19136,159,8637,apoptotic mitochondrial changes,P
19135,159,6919,activation of cysteine-type endopeptidase activity involved in apoptotic process,P
19134,159,42110,T cell activation,P
19133,159,2755,MyD88-dependent toll-like receptor signaling pathway,P
19132,159,42100,B cell proliferation,P
19131,159,2368,B cell cytokine production,P
19130,159,42113,B cell activation,P
19129,159,6458,'de novo' protein folding,P
19128,159,6458,'de novo' protein folding,P
19127,159,51082,unfolded protein binding,F
19126,159,51082,unfolded protein binding,F
19125,159,51082,unfolded protein binding,F
19124,159,31625,ubiquitin protein ligase binding,F
19123,159,3697,single-stranded DNA binding,F
19122,159,44183,protein binding involved in protein folding,F
19121,159,5515,protein binding,F
19120,159,44822,poly(A) RNA binding,F
19119,159,2039,p53 binding,F
19118,159,1530,lipopolysaccharide binding,F
19117,159,3725,double-stranded RNA binding,F
19116,159,51087,chaperone binding,F
19115,159,3688,DNA replication origin binding,F
19114,159,16887,ATPase activity,F
19113,159,5524,ATP binding,F
19031,161,60548,negative regulation of cell death,P
19030,161,60548,negative regulation of cell death,P
19029,161,34599,cellular response to oxidative stress,P
19028,161,34605,cellular response to heat,P
19027,161,70370,cellular heat acclimation,P
19026,161,46034,ATP metabolic process,P
19025,161,1618,virus receptor activity,F
19024,161,51082,unfolded protein binding,F
19023,161,51082,unfolded protein binding,F
19022,161,31625,ubiquitin protein ligase binding,F
19021,161,5102,receptor binding,F
19020,161,44183,protein binding involved in protein folding,F
19019,161,5515,protein binding,F
19018,161,42826,histone deacetylase binding,F
19017,161,31072,heat shock protein binding,F
19016,161,19899,enzyme binding,F
19015,161,1664,G-protein coupled receptor binding,F
19014,161,55131,C3HC4-type RING finger domain binding,F
19013,161,42623,"ATPase activity, coupled",F
19012,161,16887,ATPase activity,F
19011,161,5524,ATP binding,F
19000,162,4719,protein-L-isoaspartate (D-aspartate) O-methyltransferase activity,F
18999,162,5515,protein binding,F
18998,162,98641,cadherin binding involved in cell-cell adhesion,F
18996,163,5654,nucleoplasm,C
18995,163,5739,mitochondrion,C
18994,163,5829,cytosol,C
18993,163,48511,rhythmic process,P
18992,163,6950,response to stress,P
18991,163,9411,response to UV,P
18990,163,51090,regulation of sequence-specific DNA binding transcription factor activity,P
18989,163,32880,regulation of protein localization,P
18988,163,16241,regulation of macroautophagy,P
18987,163,31063,regulation of histone deacetylation,P
18986,163,42752,regulation of circadian rhythm,P
18985,163,6468,protein phosphorylation,P
18984,163,51247,positive regulation of protein metabolic process,P
18983,163,1900740,positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway,P
18982,163,10628,positive regulation of gene expression,P
18981,163,90045,positive regulation of deacetylase activity,P
18980,163,31281,positive regulation of cyclase activity,P
18979,163,43065,positive regulation of apoptotic process,P
18978,163,18107,peptidyl-threonine phosphorylation,P
18977,163,18107,peptidyl-threonine phosphorylation,P
18976,163,18105,peptidyl-serine phosphorylation,P
18975,163,32091,negative regulation of protein binding,P
18974,163,43066,negative regulation of apoptotic process,P
18973,163,71260,cellular response to mechanical stimulus,P
18972,163,71222,cellular response to lipopolysaccharide,P
18971,163,7258,JUN phosphorylation,P
18970,163,7254,JNK cascade,P
18969,163,7254,JNK cascade,P
18968,163,38095,Fc-epsilon receptor signaling pathway,P
18967,163,4674,protein serine/threonine kinase activity,F
18966,163,5515,protein binding,F
18965,163,16301,kinase activity,F
18964,163,35033,histone deacetylase regulator activity,F
18963,163,42826,histone deacetylase binding,F
18962,163,19899,enzyme binding,F
18961,163,4705,JUN kinase activity,F
18960,163,4705,JUN kinase activity,F
18959,163,5524,ATP binding,F
18945,164,43488,regulation of mRNA stability,P
18944,164,1900740,positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway,P
18943,164,30168,platelet activation,P
18942,164,43066,negative regulation of apoptotic process,P
18941,164,61024,membrane organization,P
18940,164,51683,establishment of Golgi localization,P
18939,164,98609,cell-cell adhesion,P
18938,164,90168,Golgi reassembly,P
18936,164,8134,transcription factor binding,F
18937,164,31625,ubiquitin protein ligase binding,F
18935,164,19901,protein kinase binding,F
18934,164,19904,protein domain specific binding,F
18933,164,5515,protein binding,F
18932,164,44822,poly(A) RNA binding,F
18931,164,42802,identical protein binding,F
18930,164,98641,cadherin binding involved in cell-cell adhesion,F
18870,165,43552,positive regulation of phosphatidylinositol 3-kinase activity,P
18869,165,50731,positive regulation of peptidyl-tyrosine phosphorylation,P
18868,165,51000,positive regulation of nitric-oxide synthase activity,P
18867,165,45429,positive regulation of nitric oxide biosynthetic process,P
18866,165,10976,positive regulation of neuron projection development,P
18865,165,2000463,positive regulation of excitatory postsynaptic potential,P
18864,165,10595,positive regulation of endothelial cell migration,P
18863,165,7204,positive regulation of cytosolic calcium ion concentration,P
18862,165,1954,positive regulation of cell-matrix adhesion,P
18861,165,8284,positive regulation of cell proliferation,P
18860,165,30335,positive regulation of cell migration,P
18859,165,30307,positive regulation of cell growth,P
18858,165,45766,positive regulation of angiogenesis,P
18857,165,30838,positive regulation of actin filament polymerization,P
18856,165,43507,positive regulation of JUN kinase activity,P
18855,165,46330,positive regulation of JNK cascade,P
18854,165,70374,positive regulation of ERK1 and ERK2 cascade,P
18853,165,2000573,positive regulation of DNA biosynthetic process,P
18852,165,2000538,positive regulation of B cell chemotaxis,P
18851,165,18108,peptidyl-tyrosine phosphorylation,P
18850,165,38083,peptidyl-tyrosine autophosphorylation,P
18849,165,38083,peptidyl-tyrosine autophosphorylation,P
18848,165,1556,oocyte maturation,P
18847,165,31175,neuron projection development,P
18846,165,43267,negative regulation of potassium ion transport,P
18845,165,43524,negative regulation of neuron apoptotic process,P
18844,165,45638,negative regulation of myeloid cell differentiation,P
18843,165,10656,negative regulation of muscle cell apoptotic process,P
18842,165,8285,negative regulation of cell proliferation,P
18840,165,43066,negative regulation of apoptotic process,P
18841,165,30502,negative regulation of bone mineralization,P
18839,165,2315,marginal zone B cell differentiation,P
18838,165,60291,long-term synaptic potentiation,P
18837,165,60292,long term synaptic depression,P
18836,165,35235,ionotropic glutamate receptor signaling pathway,P
18835,165,7229,integrin-mediated signaling pathway,P
18834,165,45087,innate immune response,P
18833,165,14009,glial cell proliferation,P
18832,165,48041,focal adhesion assembly,P
18831,165,7173,epidermal growth factor receptor signaling pathway,P
18830,165,70098,chemokine-mediated signaling pathway,P
18829,165,71300,cellular response to retinoic acid,P
18828,165,71498,cellular response to fluid shear stress,P
18827,165,6968,cellular defense response,P
18825,165,45453,bone resorption,P
18826,165,7166,cell surface receptor signaling pathway,P
18824,165,43534,blood vessel endothelial cell migration,P
18823,165,6915,apoptotic process,P
18822,165,1525,angiogenesis,P
18821,165,2250,adaptive immune response,P
18820,165,42976,activation of Janus kinase activity,P
18819,165,90630,activation of GTPase activity,P
18818,165,165,MAPK cascade,P
18817,165,4871,signal transducer activity,F
18816,165,5102,receptor binding,F
18815,165,4713,protein tyrosine kinase activity,F
18814,165,32403,protein complex binding,F
18813,165,5515,protein binding,F
18812,165,4715,non-membrane spanning protein tyrosine kinase activity,F
18811,165,4683,calmodulin-dependent protein kinase activity,F
18810,165,4972,NMDA glutamate receptor activity,F
18809,165,5524,ATP binding,F
18808,165,43423,3-phosphoinositide-dependent protein kinase binding,F
18781,166,42127,regulation of cell proliferation,P
18780,166,33628,regulation of cell adhesion mediated by integrin,P
18779,166,43087,regulation of GTPase activity,P
18778,166,46777,protein autophosphorylation,P
18777,166,2000060,positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process,P
18776,166,1934,positive regulation of protein phosphorylation,P
18775,166,45860,positive regulation of protein kinase activity,P
18774,166,51897,positive regulation of protein kinase B signaling,P
18773,166,14068,positive regulation of phosphatidylinositol 3-kinase signaling,P
18772,166,43552,positive regulation of phosphatidylinositol 3-kinase activity,P
18771,166,8284,positive regulation of cell proliferation,P
18770,166,30335,positive regulation of cell migration,P
18769,166,43547,positive regulation of GTPase activity,P
18768,166,1890,placenta development,P
18767,166,18108,peptidyl-tyrosine phosphorylation,P
18766,166,38083,peptidyl-tyrosine autophosphorylation,P
18765,166,1764,neuron migration,P
18764,166,38007,netrin-activated signaling pathway,P
18763,166,51964,negative regulation of synapse assembly,P
18762,166,46621,negative regulation of organ growth,P
18761,166,22408,negative regulation of cell-cell adhesion,P
18760,166,50771,negative regulation of axonogenesis,P
18759,166,43066,negative regulation of apoptotic process,P
18758,166,2000811,negative regulation of anoikis,P
18757,166,226,microtubule cytoskeleton organization,P
18756,166,7229,integrin-mediated signaling pathway,P
18755,166,7229,integrin-mediated signaling pathway,P
18754,166,7229,integrin-mediated signaling pathway,P
18753,166,45087,innate immune response,P
18752,166,3007,heart morphogenesis,P
18751,166,60396,growth hormone receptor signaling pathway,P
18750,166,30198,extracellular matrix organization,P
18749,166,40023,establishment of nucleus localization,P
18748,166,30010,establishment of cell polarity,P
18746,166,48013,ephrin receptor signaling pathway,P
18747,166,7173,epidermal growth factor receptor signaling pathway,P
18745,166,48013,ephrin receptor signaling pathway,P
18744,166,43542,endothelial cell migration,P
18743,166,9790,embryo development,P
18742,166,21955,central nervous system neuron axonogenesis,P
18741,166,6921,cellular component disassembly involved in execution phase of apoptosis,P
18740,166,48870,cell motility,P
18739,166,7411,axon guidance,P
18738,166,1525,angiogenesis,P
18737,166,165,MAPK cascade,P
18736,166,38096,Fc-gamma receptor signaling pathway involved in phagocytosis,P
18735,166,4871,signal transducer activity,F
18734,166,5102,receptor binding,F
18733,166,4713,protein tyrosine kinase activity,F
18732,166,19901,protein kinase binding,F
18731,166,4672,protein kinase activity,F
18730,166,5515,protein binding,F
18729,166,4715,non-membrane spanning protein tyrosine kinase activity,F
18728,166,3779,actin binding,F
18727,166,42169,SH2 domain binding,F
18726,166,5088,Ras guanyl-nucleotide exchange factor activity,F
18725,166,8432,JUN kinase binding,F
18724,166,5524,ATP binding,F
18715,167,30890,positive regulation of B cell proliferation,P
18714,167,2001240,negative regulation of extrinsic apoptotic signaling pathway in absence of ligand,P
18713,167,43086,negative regulation of catalytic activity,P
18712,167,43066,negative regulation of apoptotic process,P
18711,167,6959,humoral immune response,P
18710,167,48873,homeostasis of number of cells within a tissue,P
18709,167,7267,cell-cell signaling,P
18708,167,45453,bone resorption,P
18707,167,9887,animal organ morphogenesis,P
18706,167,2360,T cell lineage commitment,P
18705,167,5515,protein binding,F
18704,167,5139,interleukin-7 receptor binding,F
18703,167,8083,growth factor activity,F
18702,167,5125,cytokine activity,F
18677,168,45944,positive regulation of transcription from RNA polymerase II promoter,P
18676,168,2000379,positive regulation of reactive oxygen species metabolic process,P
18675,168,42307,positive regulation of protein import into nucleus,P
18674,168,10831,positive regulation of myotube differentiation,P
18673,168,1901741,positive regulation of myoblast fusion,P
18672,168,45663,positive regulation of myoblast differentiation,P
18671,168,51149,positive regulation of muscle cell differentiation,P
18670,168,2001184,positive regulation of interleukin-12 secretion,P
18669,168,46326,positive regulation of glucose import,P
18668,168,10628,positive regulation of gene expression,P
18667,168,45648,positive regulation of erythrocyte differentiation,P
18666,168,31281,positive regulation of cyclase activity,P
18665,168,60045,positive regulation of cardiac muscle cell proliferation,P
18664,168,90336,positive regulation of brown fat cell differentiation,P
18663,168,43536,positive regulation of blood vessel endothelial cell migration,P
18662,168,1890,placenta development,P
18661,168,18105,peptidyl-serine phosphorylation,P
18660,168,38066,p38MAPK cascade,P
18659,168,30316,osteoclast differentiation,P
18658,168,90090,negative regulation of canonical Wnt signaling pathway,P
18657,168,14835,myoblast differentiation involved in skeletal muscle regeneration,P
18656,168,6928,movement of cell or subcellular component,P
18655,168,31663,lipopolysaccharide-mediated signaling pathway,P
18654,168,35556,intracellular signal transduction,P
18652,168,19395,fatty acid oxidation,P
18653,168,6006,glucose metabolic process,P
18650,168,6935,chemotaxis,P
18651,168,2062,chondrocyte differentiation,P
18649,168,98586,cellular response to virus,P
18648,168,35924,cellular response to vascular endothelial growth factor stimulus,P
18647,168,71222,cellular response to lipopolysaccharide,P
18646,168,71479,cellular response to ionizing radiation,P
18645,168,7166,cell surface receptor signaling pathway,P
18644,168,902,cell morphogenesis,P
18643,168,1502,cartilage condensation,P
18642,168,6915,apoptotic process,P
18641,168,1525,angiogenesis,P
18640,168,187,activation of MAPK activity,P
18639,168,7265,Ras protein signal transduction,P
18638,168,77,DNA damage checkpoint,P
18637,168,70935,3'-UTR-mediated mRNA stabilization,P
18636,168,4674,protein serine/threonine kinase activity,F
18635,168,19903,protein phosphatase binding,F
18634,168,5515,protein binding,F
18633,168,19899,enzyme binding,F
18632,168,51525,NFAT protein binding,F
18631,168,4708,MAP kinase kinase activity,F
18630,168,4707,MAP kinase activity,F
18629,168,5524,ATP binding,F
18594,169,8284,positive regulation of cell proliferation,P
18593,169,8284,positive regulation of cell proliferation,P
18592,169,60045,positive regulation of cardiac muscle cell proliferation,P
18591,169,90080,positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway,P
18590,169,43410,positive regulation of MAPK cascade,P
18589,169,43406,positive regulation of MAP kinase activity,P
18588,169,43547,positive regulation of GTPase activity,P
18587,169,48015,phosphatidylinositol-mediated signaling,P
18586,169,36092,phosphatidylinositol-3-phosphate biosynthetic process,P
18585,169,46854,phosphatidylinositol phosphorylation,P
18584,169,18108,peptidyl-tyrosine phosphorylation,P
18583,169,48339,paraxial mesoderm development,P
18582,169,42473,outer ear morphogenesis,P
18581,169,1759,organ induction,P
18580,169,1764,neuron migration,P
18579,169,122,negative regulation of transcription from RNA polymerase II promoter,P
18578,169,90272,negative regulation of fibroblast growth factor production,P
18577,169,42474,middle ear morphogenesis,P
18576,169,30901,midbrain development,P
18575,169,48762,mesenchymal cell differentiation,P
18574,169,60484,lung-associated mesenchyme development,P
18573,169,42472,inner ear morphogenesis,P
18572,169,1701,in utero embryonic development,P
18571,169,35607,fibroblast growth factor receptor signaling pathway involved in orbitofrontal cortex development,P
18570,169,8543,fibroblast growth factor receptor signaling pathway,P
18569,169,8543,fibroblast growth factor receptor signaling pathway,P
18568,169,8543,fibroblast growth factor receptor signaling pathway,P
18567,169,8543,fibroblast growth factor receptor signaling pathway,P
18566,169,30326,embryonic limb morphogenesis,P
18565,169,43009,chordate embryonic development,P
18564,169,2062,chondrocyte differentiation,P
18563,169,16477,cell migration,P
18562,169,48469,cell maturation,P
18561,169,60445,branching involved in salivary gland morphogenesis,P
18559,169,1525,angiogenesis,P
18560,169,60117,auditory receptor cell development,P
18558,169,165,MAPK cascade,P
18557,169,90722,receptor-receptor interaction,F
18556,169,4713,protein tyrosine kinase activity,F
18554,169,42803,protein homodimerization activity,F
18555,169,4713,protein tyrosine kinase activity,F
18553,169,5515,protein binding,F
18552,169,46934,"phosphatidylinositol-4,5-bisphosphate 3-kinase activity",F
18551,169,42802,identical protein binding,F
18550,169,8201,heparin binding,F
18549,169,5007,fibroblast growth factor-activated receptor activity,F
18548,169,5007,fibroblast growth factor-activated receptor activity,F
18547,169,17134,fibroblast growth factor binding,F
18546,169,5088,Ras guanyl-nucleotide exchange factor activity,F
18545,169,5524,ATP binding,F
18544,169,16303,1-phosphatidylinositol-3-kinase activity,F
18532,170,45893,"positive regulation of transcription, DNA-templated",P
18531,170,45944,positive regulation of transcription from RNA polymerase II promoter,P
18530,170,45944,positive regulation of transcription from RNA polymerase II promoter,P
18529,170,45944,positive regulation of transcription from RNA polymerase II promoter,P
18528,170,45944,positive regulation of transcription from RNA polymerase II promoter,P
18527,170,1904828,positive regulation of hydrogen sulfide biosynthetic process,P
18526,170,43923,positive regulation by host of viral transcription,P
18525,170,32869,cellular response to insulin stimulus,P
18524,170,44212,transcription regulatory region DNA binding,F
18523,170,8134,transcription factor binding,F
18522,170,3700,"transcription factor activity, sequence-specific DNA binding",F
18521,170,982,"transcription factor activity, RNA polymerase II core promoter proximal region sequence-specific binding",F
18520,170,43565,sequence-specific DNA binding,F
18519,170,42803,protein homodimerization activity,F
18518,170,5515,protein binding,F
18517,170,8022,protein C-terminus binding,F
18516,170,46872,metal ion binding,F
18515,170,42826,histone deacetylase binding,F
18514,170,35035,histone acetyltransferase binding,F
18513,170,3690,double-stranded DNA binding,F
18512,170,1046,core promoter sequence-specific DNA binding,F
18511,170,43425,bHLH transcription factor binding,F
18510,170,1103,RNA polymerase II repressing transcription factor binding,F
18509,170,977,RNA polymerase II regulatory region sequence-specific DNA binding,F
18508,170,978,RNA polymerase II core promoter proximal region sequence-specific DNA binding,F
18507,170,978,RNA polymerase II core promoter proximal region sequence-specific DNA binding,F
18506,170,71837,HMG box domain binding,F
18505,170,3677,DNA binding,F
18495,171,48010,vascular endothelial growth factor receptor signaling pathway,P
18494,171,48010,vascular endothelial growth factor receptor signaling pathway,P
18493,171,7169,transmembrane receptor protein tyrosine kinase signaling pathway,P
18492,171,46777,protein autophosphorylation,P
18491,171,30949,positive regulation of vascular endothelial growth factor receptor signaling pathway,P
18490,171,10863,positive regulation of phospholipase C activity,P
18489,171,14068,positive regulation of phosphatidylinositol 3-kinase signaling,P
18488,171,43552,positive regulation of phosphatidylinositol 3-kinase activity,P
18487,171,8284,positive regulation of cell proliferation,P
18486,171,30335,positive regulation of cell migration,P
18485,171,45766,positive regulation of angiogenesis,P
18484,171,43410,positive regulation of MAPK cascade,P
18483,171,43406,positive regulation of MAP kinase activity,P
18482,171,18108,peptidyl-tyrosine phosphorylation,P
18481,171,2548,monocyte chemotaxis,P
18480,171,48598,embryonic morphogenesis,P
18479,171,35924,cellular response to vascular endothelial growth factor stimulus,P
18477,171,30154,cell differentiation,P
18478,171,16477,cell migration,P
18476,171,48514,blood vessel morphogenesis,P
18475,171,1525,angiogenesis,P
18474,171,5021,vascular endothelial growth factor-activated receptor activity,F
18473,171,5021,vascular endothelial growth factor-activated receptor activity,F
18471,171,5515,protein binding,F
18472,171,4714,transmembrane receptor protein tyrosine kinase activity,F
18470,171,36332,placental growth factor-activated receptor activity,F
18469,171,19838,growth factor binding,F
18468,171,36327,VEGF-B-activated receptor activity,F
18467,171,36326,VEGF-A-activated receptor activity,F
18466,171,5524,ATP binding,F
18429,172,70374,positive regulation of ERK1 and ERK2 cascade,P
18428,172,2000144,"positive regulation of DNA-templated transcription, initiation",P
18426,172,43923,positive regulation by host of viral transcription,P
18427,172,45740,positive regulation of DNA replication,P
18425,172,3151,outflow tract morphogenesis,P
18424,172,45892,"negative regulation of transcription, DNA-templated",P
18422,172,31953,negative regulation of protein autophosphorylation,P
18423,172,1990441,negative regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress,P
18421,172,43524,negative regulation of neuron apoptotic process,P
18420,172,8285,negative regulation of cell proliferation,P
18419,172,43392,negative regulation of DNA binding,P
18418,172,43922,negative regulation by host of viral transcription,P
18417,172,30224,monocyte differentiation,P
18416,172,1774,microglial cell activation,P
18415,172,51899,membrane depolarization,P
18414,172,1889,liver development,P
18413,172,7612,learning,P
18412,172,35026,leading edge cell differentiation,P
18411,172,61029,eyelid development in camera-type eye,P
18410,172,7623,circadian rhythm,P
18409,172,51365,cellular response to potassium ion starvation,P
18408,172,32870,cellular response to hormone stimulus,P
18407,172,71277,cellular response to calcium ion,P
18406,172,31103,axon regeneration,P
18405,172,1525,angiogenesis,P
18404,172,7568,aging,P
18403,172,60395,SMAD protein signal transduction,P
18402,172,7184,SMAD protein import into nucleus,P
18401,172,7265,Ras protein signal transduction,P
18400,172,38095,Fc-epsilon receptor signaling pathway,P
18399,172,1190,"transcriptional activator activity, RNA polymerase II transcription factor binding",F
18398,172,1077,"transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding",F
18397,172,44212,transcription regulatory region DNA binding,F
18396,172,8134,transcription factor binding,F
18395,172,3700,"transcription factor activity, sequence-specific DNA binding",F
18394,172,3705,"transcription factor activity, RNA polymerase II distal enhancer sequence-specific binding",F
18393,172,3705,"transcription factor activity, RNA polymerase II distal enhancer sequence-specific binding",F
18392,172,982,"transcription factor activity, RNA polymerase II core promoter proximal region sequence-specific binding",F
18391,172,3713,transcription coactivator activity,F
18390,172,42803,protein homodimerization activity,F
18389,172,46982,protein heterodimerization activity,F
18388,172,5515,protein binding,F
18387,172,44822,poly(A) RNA binding,F
18386,172,42802,identical protein binding,F
18385,172,19899,enzyme binding,F
18384,172,3682,chromatin binding,F
18383,172,35497,cAMP response element binding,F
18382,172,981,"RNA polymerase II transcription factor activity, sequence-specific DNA binding",F
18381,172,980,RNA polymerase II distal enhancer sequence-specific DNA binding,F
18380,172,978,RNA polymerase II core promoter proximal region sequence-specific DNA binding,F
18379,172,1102,RNA polymerase II activating transcription factor binding,F
18378,172,70412,R-SMAD binding,F
18377,172,71837,HMG box domain binding,F
18376,172,5096,GTPase activator activity,F
18375,172,3677,DNA binding,F
18339,173,35357,peroxisome proliferator activated receptor signaling pathway,P
18338,173,122,negative regulation of transcription from RNA polymerase II promoter,P
18337,173,45665,negative regulation of neuron differentiation,P
18336,173,10839,negative regulation of keratinocyte proliferation,P
18335,173,43066,negative regulation of apoptotic process,P
18334,173,30224,monocyte differentiation,P
18333,173,35855,megakaryocyte development,P
18332,173,60744,mammary gland branching involved in thelarche,P
18331,173,60745,mammary gland branching involved in pregnancy,P
18330,173,42789,mRNA transcription from RNA polymerase II promoter,P
18329,173,1889,liver development,P
18328,173,2088,lens development in camera-type eye,P
18327,173,7595,lactation,P
18326,173,30216,keratinocyte differentiation,P
18325,173,30518,intracellular steroid hormone receptor signaling pathway,P
18324,173,45444,fat cell differentiation,P
18323,173,48821,erythrocyte development,P
18322,173,60750,epithelial cell proliferation involved in mammary gland duct elongation,P
18321,173,48822,enucleate erythrocyte development,P
18320,173,1892,embryonic placenta development,P
18319,173,35116,embryonic hindlimb morphogenesis,P
18318,173,35162,embryonic hemopoiesis,P
18317,173,35050,embryonic heart tube development,P
18316,173,97067,cellular response to thyroid hormone stimulus,P
18315,173,71383,cellular response to steroid hormone stimulus,P
18314,173,35729,cellular response to hepatocyte growth factor stimulus,P
18313,173,71364,cellular response to epidermal growth factor stimulus,P
18312,173,44255,cellular lipid metabolic process,P
18311,173,902,cell morphogenesis,P
18310,173,7420,brain development,P
18309,173,31100,animal organ regeneration,P
18308,173,1525,angiogenesis,P
18307,173,30521,androgen receptor signaling pathway,P
18306,173,6702,androgen biosynthetic process,P
18305,173,70371,ERK1 and ERK2 cascade,P
18304,173,42809,vitamin D receptor binding,F
18303,173,42809,vitamin D receptor binding,F
18302,173,42809,vitamin D receptor binding,F
18301,173,61630,ubiquitin protein ligase activity,F
18300,173,8134,transcription factor binding,F
18299,173,3712,transcription cofactor activity,F
18298,173,3713,transcription coactivator activity,F
18297,173,3713,transcription coactivator activity,F
18296,173,30375,thyroid hormone receptor coactivator activity,F
18295,173,46966,thyroid hormone receptor binding,F
18294,173,46966,thyroid hormone receptor binding,F
18292,173,4872,receptor activity,F
18293,173,42974,retinoic acid receptor binding,F
18291,173,5515,protein binding,F
18290,173,42975,peroxisome proliferator activated receptor binding,F
18289,173,35257,nuclear hormone receptor binding,F
18288,173,36033,mediator complex binding,F
18287,173,30374,ligand-dependent nuclear receptor transcription coactivator activity,F
18286,173,30374,ligand-dependent nuclear receptor transcription coactivator activity,F
18285,173,16922,ligand-dependent nuclear receptor binding,F
18284,173,16922,ligand-dependent nuclear receptor binding,F
18283,173,30331,estrogen receptor binding,F
18282,173,1047,core promoter binding,F
18281,173,3682,chromatin binding,F
18280,173,31490,chromatin DNA binding,F
18279,173,981,"RNA polymerase II transcription factor activity, sequence-specific DNA binding",F
18278,173,1104,RNA polymerase II transcription cofactor activity,F
18277,173,978,RNA polymerase II core promoter proximal region sequence-specific DNA binding,F
18276,173,50693,LBD domain binding,F
18356,173,51726,regulation of cell cycle,P
18357,173,6356,regulation of transcription from RNA polymerase I promoter,P
18355,173,2001141,regulation of RNA biosynthetic process,P
18354,173,16567,protein ubiquitination,P
18353,173,45893,"positive regulation of transcription, DNA-templated",P
18352,173,45944,positive regulation of transcription from RNA polymerase II promoter,P
18351,173,45944,positive regulation of transcription from RNA polymerase II promoter,P
18350,173,2000273,positive regulation of receptor activity,P
18349,173,33160,"positive regulation of protein import into nucleus, translocation",P
18348,173,33601,positive regulation of mammary gland epithelial cell proliferation,P
18347,173,45618,positive regulation of keratinocyte differentiation,P
18346,173,33148,positive regulation of intracellular estrogen receptor signaling pathway,P
18345,173,60335,positive regulation of interferon-gamma-mediated signaling pathway,P
18344,173,2000347,positive regulation of hepatocyte proliferation,P
18343,173,10628,positive regulation of gene expression,P
18342,173,10628,positive regulation of gene expression,P
18341,173,45648,positive regulation of erythrocyte differentiation,P
18340,173,70318,positive regulation of G0 to G1 transition,P
18275,174,5654,nucleoplasm,C
18273,174,5829,cytosol,C
18274,174,5739,mitochondrion,C
18272,174,48511,rhythmic process,P
18271,174,6950,response to stress,P
18270,174,46686,response to cadmium ion,P
18269,174,51090,regulation of sequence-specific DNA binding transcription factor activity,P
18268,174,42752,regulation of circadian rhythm,P
18267,174,6468,protein phosphorylation,P
18266,174,71803,positive regulation of podosome assembly,P
18265,174,10744,positive regulation of macrophage derived foam cell differentiation,P
18264,174,10628,positive regulation of gene expression,P
18263,174,2001235,positive regulation of apoptotic signaling pathway,P
18262,174,7258,JUN phosphorylation,P
18261,174,7254,JNK cascade,P
18260,174,7254,JNK cascade,P
18259,174,38095,Fc-epsilon receptor signaling pathway,P
18258,174,8134,transcription factor binding,F
18257,174,5515,protein binding,F
18256,174,4705,JUN kinase activity,F
18255,174,5524,ATP binding,F
18225,175,2000641,regulation of early endosome to late endosome transport,P
18224,175,51493,regulation of cytoskeleton organization,P
18223,175,1900034,regulation of cellular response to heat,P
18222,175,90170,regulation of Golgi inheritance,P
18221,175,6468,protein phosphorylation,P
18220,175,6461,protein complex assembly,P
18219,175,1904417,positive regulation of xenophagy,P
18218,175,45727,positive regulation of translation,P
18217,175,45944,positive regulation of transcription from RNA polymerase II promoter,P
18216,175,32212,positive regulation of telomere maintenance via telomerase,P
18215,175,1904355,positive regulation of telomere capping,P
18214,175,51973,positive regulation of telomerase activity,P
18213,175,1934,positive regulation of protein phosphorylation,P
18212,175,33129,positive regulation of histone phosphorylation,P
18211,175,35066,positive regulation of histone acetylation,P
18210,175,31281,positive regulation of cyclase activity,P
18209,175,70374,positive regulation of ERK1 and ERK2 cascade,P
18208,175,30168,platelet activation,P
18207,175,16310,phosphorylation,P
18206,175,38083,peptidyl-tyrosine autophosphorylation,P
18205,175,18105,peptidyl-serine phosphorylation,P
18204,175,42473,outer ear morphogenesis,P
18203,175,2000657,negative regulation of apolipoprotein binding,P
18202,175,60425,lung morphogenesis,P
18201,175,31663,lipopolysaccharide-mediated signaling pathway,P
18200,175,70498,interleukin-1-mediated signaling pathway,P
18199,175,8543,fibroblast growth factor receptor signaling pathway,P
18198,175,60324,face development,P
18197,175,71260,cellular response to mechanical stimulus,P
18196,175,7049,cell cycle,P
18195,175,72584,caveolin-mediated endocytosis,P
18194,175,51216,cartilage development,P
18192,175,7411,axon guidance,P
18193,175,61308,cardiac neural crest cell development involved in heart development,P
18191,175,19369,arachidonic acid metabolic process,P
18190,175,6915,apoptotic process,P
18189,175,187,activation of MAPK activity,P
18188,175,189,MAPK import into nucleus,P
18187,175,165,MAPK cascade,P
18186,175,165,MAPK cascade,P
18185,175,60397,JAK-STAT cascade involved in growth hormone signaling pathway,P
18184,175,38096,Fc-gamma receptor signaling pathway involved in phagocytosis,P
18183,175,38095,Fc-epsilon receptor signaling pathway,P
18182,175,70371,ERK1 and ERK2 cascade,P
18181,175,6975,DNA damage induced protein phosphorylation,P
18180,175,60020,Bergmann glial cell differentiation,P
18179,175,30509,BMP signaling pathway,P
18178,175,97110,scaffold protein binding,F
18177,175,4674,protein serine/threonine kinase activity,F
18176,175,5515,protein binding,F
18175,175,1784,phosphotyrosine binding,F
18174,175,19902,phosphatase binding,F
18173,175,16301,kinase activity,F
18172,175,4707,MAP kinase activity,F
18171,175,4707,MAP kinase activity,F
18170,175,4707,MAP kinase activity,F
18169,175,5524,ATP binding,F
18124,176,2437,inflammatory response to antigenic stimulus,P
18123,176,6954,inflammatory response,P
18122,176,2407,dendritic cell chemotaxis,P
18121,176,6914,autophagy,P
18120,176,43277,apoptotic cell clearance,P
18119,176,6309,apoptotic DNA fragmentation,P
18118,176,2218,activation of innate immune response,P
18117,176,33151,V(D)J recombination,P
18116,176,45063,T-helper 1 cell differentiation,P
18115,176,35711,T-helper 1 cell activation,P
18114,176,6265,DNA topological change,P
18113,176,6310,DNA recombination,P
18111,176,32392,DNA geometric change,P
18112,176,51103,DNA ligation involved in DNA repair,P
18110,176,8134,transcription factor binding,F
18109,176,3700,"transcription factor activity, sequence-specific DNA binding",F
18107,176,3697,single-stranded DNA binding,F
18108,176,97100,supercoiled DNA binding,F
18106,176,70491,repressing transcription factor binding,F
18104,176,44822,poly(A) RNA binding,F
18105,176,5515,protein binding,F
18103,176,1786,phosphatidylserine binding,F
18102,176,16829,lyase activity,F
18101,176,1530,lipopolysaccharide binding,F
18100,176,400,four-way junction DNA binding,F
18098,176,3684,damaged DNA binding,F
18099,176,3690,double-stranded DNA binding,F
18096,176,5125,cytokine activity,F
18097,176,3684,damaged DNA binding,F
18095,176,42056,chemoattractant activity,F
18094,176,405,bubble DNA binding,F
18093,176,50786,RAGE receptor binding,F
18092,176,70182,DNA polymerase binding,F
18091,176,8301,"DNA binding, bending",F
18090,176,8301,"DNA binding, bending",F
18089,176,19958,C-X-C chemokine binding,F
18066,177,71456,cellular response to hypoxia,P
18065,177,71392,cellular response to estradiol stimulus,P
18064,177,71314,cellular response to cocaine,P
18063,177,51301,cell division,P
18062,177,31100,animal organ regeneration,P
18061,177,7265,Ras protein signal transduction,P
18060,177,86,G2/M transition of mitotic cell cycle,P
18059,177,19901,protein kinase binding,F
18058,177,19901,protein kinase binding,F
18057,177,5515,protein binding,F
18026,178,1902042,negative regulation of extrinsic apoptotic signaling pathway via death domain receptors,P
18025,178,8584,male gonad development,P
18024,178,45087,innate immune response,P
18023,178,2437,inflammatory response to antigenic stimulus,P
18022,178,50830,defense response to Gram-positive bacterium,P
18021,178,50829,defense response to Gram-negative bacterium,P
18020,178,6325,chromatin organization,P
18019,178,71222,cellular response to lipopolysaccharide,P
18018,178,60326,cell chemotaxis,P
18017,178,6309,apoptotic DNA fragmentation,P
18015,178,6265,DNA topological change,P
18016,178,33151,V(D)J recombination,P
18014,178,51103,DNA ligation involved in DNA repair,P
18013,178,32392,DNA geometric change,P
18012,178,44212,transcription regulatory region DNA binding,F
18011,178,8134,transcription factor binding,F
18010,178,3700,"transcription factor activity, sequence-specific DNA binding",F
18009,178,97100,supercoiled DNA binding,F
18008,178,3697,single-stranded DNA binding,F
18007,178,19904,protein domain specific binding,F
18006,178,5515,protein binding,F
18005,178,44822,poly(A) RNA binding,F
18004,178,44378,"non-sequence-specific DNA binding, bending",F
18003,178,400,four-way junction DNA binding,F
18002,178,1158,enhancer sequence-specific DNA binding,F
18001,178,8144,drug binding,F
18000,178,3690,double-stranded DNA binding,F
17999,178,3684,damaged DNA binding,F
17998,178,42056,chemoattractant activity,F
17997,178,50786,RAGE receptor binding,F
17996,178,8301,"DNA binding, bending",F
17995,178,3677,DNA binding,F
17971,179,45087,innate immune response,P
17970,179,72577,endothelial cell apoptotic process,P
17969,179,71356,cellular response to tumor necrosis factor,P
17968,179,1902170,cellular response to reactive nitrogen species,P
17967,179,70301,cellular response to hydrogen peroxide,P
17966,179,97190,apoptotic signaling pathway,P
17965,179,186,activation of MAPKK activity,P
17964,179,7257,activation of JUN kinase activity,P
17963,179,165,MAPK cascade,P
17962,179,7254,JNK cascade,P
17961,179,4674,protein serine/threonine kinase activity,F
17960,179,19903,protein phosphatase binding,F
17958,179,4672,protein kinase activity,F
17959,179,19901,protein kinase binding,F
17957,179,42803,protein homodimerization activity,F
17956,179,5515,protein binding,F
17954,179,4709,MAP kinase kinase kinase activity,F
17955,179,287,magnesium ion binding,F
17953,179,5524,ATP binding,F
21289,115,1902042,negative regulation of extrinsic apoptotic signaling pathway via death domain receptors,P
21288,115,43066,negative regulation of apoptotic process,P
21286,115,97527,necroptotic signaling pathway,P
21287,115,50869,negative regulation of B cell activation,P
21285,115,97049,motor neuron apoptotic process,P
21284,115,6954,inflammatory response,P
21283,115,6925,inflammatory cell apoptotic process,P
21282,115,2377,immunoglobulin production,P
21281,115,6955,immune response,P
21280,115,97284,hepatocyte apoptotic process,P
21279,115,10467,gene expression,P
21278,115,8625,extrinsic apoptotic signaling pathway via death domain receptors,P
21277,115,97192,extrinsic apoptotic signaling pathway in absence of ligand,P
21276,115,97191,extrinsic apoptotic signaling pathway,P
21275,115,7623,circadian rhythm,P
21274,115,71260,cellular response to mechanical stimulus,P
21273,115,71285,cellular response to lithium ion,P
21272,115,71455,cellular response to hyperoxia,P
21271,115,7420,brain development,P
21269,115,6915,apoptotic process,P
21270,115,97190,apoptotic signaling pathway,P
21268,115,6924,activation-induced cell death of T cells,P
21267,115,97296,activation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway,P
21266,115,6919,activation of cysteine-type endopeptidase activity involved in apoptotic process,P
21265,115,19724,B cell mediated immunity,P
21264,115,5031,tumor necrosis factor-activated receptor activity,F
21263,115,4871,signal transducer activity,F
21262,115,4872,receptor activity,F
21261,115,5515,protein binding,F
21260,115,19900,kinase binding,F
21259,115,42802,identical protein binding,F
17880,181,5637,nuclear inner membrane,C
17879,181,5635,nuclear envelope,C
17878,181,16020,membrane,C
17877,181,5638,lamin filament,C
17876,181,5198,structural molecule activity,F
17875,181,5515,protein binding,F
17874,181,43274,phospholipase binding,F
17869,182,5743,mitochondrial inner membrane,C
17868,182,5743,mitochondrial inner membrane,C
17867,182,16021,integral component of membrane,C
17866,182,6099,tricarboxylic acid cycle,P
17865,182,6099,tricarboxylic acid cycle,P
17864,182,55114,oxidation-reduction process,P
17863,182,6121,"mitochondrial electron transport, succinate to ubiquinone",P
17862,182,9060,aerobic respiration,P
17861,182,104,succinate dehydrogenase activity,F
17860,182,46872,metal ion binding,F
17859,182,20037,heme binding,F
17858,182,9055,electron carrier activity,F
17844,183,14911,positive regulation of smooth muscle cell migration,P
17843,183,71158,positive regulation of cell cycle arrest,P
17842,183,51151,negative regulation of smooth muscle cell differentiation,P
17841,183,8285,negative regulation of cell proliferation,P
17840,183,16525,negative regulation of angiogenesis,P
17839,183,70317,negative regulation of G0 to G1 transition,P
17838,183,7517,muscle organ development,P
17837,183,7095,mitotic G2 DNA damage checkpoint,P
17836,183,8286,insulin receptor signaling pathway,P
17835,183,7050,cell cycle arrest,P
17834,183,7568,aging,P
17833,183,8134,transcription factor binding,F
17832,183,3700,"transcription factor activity, sequence-specific DNA binding",F
17831,183,43565,sequence-specific DNA binding,F
17830,183,5515,protein binding,F
17829,183,1990841,promoter-specific chromatin binding,F
17828,183,42802,identical protein binding,F
17827,183,19899,enzyme binding,F
17826,183,8013,beta-catenin binding,F
17825,183,981,"RNA polymerase II transcription factor activity, sequence-specific DNA binding",F
17824,183,3677,DNA binding,F
17819,184,45892,"negative regulation of transcription, DNA-templated",P
17818,184,48853,forebrain morphogenesis,P
17817,184,7420,brain development,P
17816,184,43565,sequence-specific DNA binding,F
17815,184,5515,protein binding,F
17814,184,47485,protein N-terminus binding,F
17813,184,8022,protein C-terminus binding,F
17812,184,3682,chromatin binding,F
17811,184,3677,DNA binding,F
17765,185,50900,leukocyte migration,P
17764,185,8630,intrinsic apoptotic signaling pathway in response to DNA damage,P
17763,185,48009,insulin-like growth factor receptor signaling pathway,P
17762,185,48009,insulin-like growth factor receptor signaling pathway,P
17761,185,8286,insulin receptor signaling pathway,P
17760,185,60396,growth hormone receptor signaling pathway,P
17759,185,8625,extrinsic apoptotic signaling pathway via death domain receptors,P
17758,185,7173,epidermal growth factor receptor signaling pathway,P
17757,185,32869,cellular response to insulin stimulus,P
17756,185,34644,cellular response to UV,P
17755,185,1678,cellular glucose homeostasis,P
17754,185,50852,T cell receptor signaling pathway,P
17753,185,31295,T cell costimulation,P
17752,185,51531,NFAT protein import into nucleus,P
17751,185,38096,Fc-gamma receptor signaling pathway involved in phagocytosis,P
17750,185,38095,Fc-epsilon receptor signaling pathway,P
17749,185,38128,ERBB2 signaling pathway,P
17748,185,30183,B cell differentiation,P
17747,185,5068,transmembrane receptor protein tyrosine kinase adaptor activity,F
17746,185,8134,transcription factor binding,F
17745,185,19903,protein phosphatase binding,F
17744,185,46982,protein heterodimerization activity,F
17743,185,5515,protein binding,F
17742,185,46934,"phosphatidylinositol-4,5-bisphosphate 3-kinase activity",F
17741,185,36312,phosphatidylinositol 3-kinase regulatory subunit binding,F
17740,185,35014,phosphatidylinositol 3-kinase regulator activity,F
17739,185,43548,phosphatidylinositol 3-kinase binding,F
17738,185,5168,neurotrophin TRKA receptor binding,F
17737,185,5159,insulin-like growth factor receptor binding,F
17736,185,43560,insulin receptor substrate binding,F
17735,185,5158,insulin receptor binding,F
17734,185,43559,insulin binding,F
17733,185,43125,ErbB-3 class receptor binding,F
17732,185,46935,1-phosphatidylinositol-3-kinase regulator activity,F
17731,185,16303,1-phosphatidylinositol-3-kinase activity,F
17728,186,19915,lipid storage,P
17727,186,34389,lipid particle organization,P
17726,186,16042,lipid catabolic process,P
17725,186,45444,fat cell differentiation,P
17724,186,5515,protein binding,F
17723,186,3674,molecular_function,F
17718,187,42493,response to drug,P
17717,187,1961,positive regulation of cytokine-mediated signaling pathway,P
17716,187,1819,positive regulation of cytokine production,P
17715,187,6644,phospholipid metabolic process,P
17714,187,6654,phosphatidic acid biosynthetic process,P
17713,187,6654,phosphatidic acid biosynthetic process,P
17712,187,8544,epidermis development,P
17711,187,16024,CDP-diacylglycerol biosynthetic process,P
17710,187,3841,1-acylglycerol-3-phosphate O-acyltransferase activity,F
17709,187,3841,1-acylglycerol-3-phosphate O-acyltransferase activity,F
17708,187,3841,1-acylglycerol-3-phosphate O-acyltransferase activity,F
17697,188,51443,positive regulation of ubiquitin-protein transferase activity,P
17696,188,48146,positive regulation of fibroblast proliferation,P
17695,188,122,negative regulation of transcription from RNA polymerase II promoter,P
17694,188,45814,"negative regulation of gene expression, epigenetic",P
17693,188,30097,hemopoiesis,P
17692,188,16569,covalent chromatin modification,P
17691,188,8270,zinc ion binding,F
17690,188,5515,protein binding,F
17689,188,1990841,promoter-specific chromatin binding,F
17688,188,71535,RING-like zinc finger domain binding,F
17670,189,6355,"regulation of transcription, DNA-templated",P
17669,189,1904714,regulation of chaperone-mediated autophagy,P
17668,189,71364,cellular response to epidermal growth factor stimulus,P
17667,189,3746,translation elongation factor activity,F
17666,189,49,tRNA binding,F
17665,189,19901,protein kinase binding,F
17664,189,5515,protein binding,F
17663,189,44822,poly(A) RNA binding,F
17662,189,3924,GTPase activity,F
17661,189,5525,GTP binding,F
17659,190,5634,nucleus,C
17660,190,5634,nucleus,C
17657,190,43231,intracellular membrane-bounded organelle,C
17658,190,5654,nucleoplasm,C
17654,190,5794,Golgi apparatus,C
17655,190,5813,centrosome,C
17656,190,5737,cytoplasm,C
17651,190,7605,sensory perception of sound,P
17652,190,6366,transcription from RNA polymerase II promoter,P
17653,190,21559,trigeminal nerve development,P
17650,190,10842,retina layer formation,P
17649,190,45595,regulation of cell differentiation,P
17648,190,45893,"positive regulation of transcription, DNA-templated",P
17647,190,45893,"positive regulation of transcription, DNA-templated",P
17646,190,45944,positive regulation of transcription from RNA polymerase II promoter,P
17645,190,70172,positive regulation of tooth mineralization,P
17644,190,43525,positive regulation of neuron apoptotic process,P
17643,190,10628,positive regulation of gene expression,P
17642,190,30501,positive regulation of bone mineralization,P
17641,190,60021,palate development,P
17640,190,3404,optic vesicle morphogenesis,P
17639,190,3409,optic cup structural organization,P
17638,190,21623,oculomotor nerve formation,P
17637,190,45892,"negative regulation of transcription, DNA-templated",P
17636,190,122,negative regulation of transcription from RNA polymerase II promoter,P
17635,190,10944,negative regulation of transcription by competitive promoter binding,P
17634,190,2000378,negative regulation of reactive oxygen species metabolic process,P
17633,190,8285,negative regulation of cell proliferation,P
17632,190,43066,negative regulation of apoptotic process,P
17631,190,1822,kidney development,P
17630,190,42472,inner ear morphogenesis,P
17629,190,61029,eyelid development in camera-type eye,P
17628,190,35115,embryonic forelimb morphogenesis,P
17627,190,48701,embryonic cranial skeleton morphogenesis,P
17625,190,60349,bone morphogenesis,P
17626,190,71281,cellular response to iron ion,P
17624,190,1078,"transcriptional repressor activity, RNA polymerase II core promoter proximal region sequence-specific binding",F
17623,190,1077,"transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding",F
17622,190,976,transcription regulatory region sequence-specific DNA binding,F
17621,190,44212,transcription regulatory region DNA binding,F
17620,190,982,"transcription factor activity, RNA polymerase II core promoter proximal region sequence-specific binding",F
17619,190,3713,transcription coactivator activity,F
17618,190,43565,sequence-specific DNA binding,F
17617,190,42803,protein homodimerization activity,F
17616,190,46983,protein dimerization activity,F
17615,190,5515,protein binding,F
17614,190,987,core promoter proximal region sequence-specific DNA binding,F
17613,190,3682,chromatin binding,F
17612,190,981,"RNA polymerase II transcription factor activity, sequence-specific DNA binding",F
17611,190,979,RNA polymerase II core promoter sequence-specific DNA binding,F
17610,190,978,RNA polymerase II core promoter proximal region sequence-specific DNA binding,F
17677,189,98574,cytoplasmic side of lysosomal membrane,C
17676,189,5737,cytoplasm,C
17675,189,5737,cytoplasm,C
17674,189,5737,cytoplasm,C
17673,189,30864,cortical actin cytoskeleton,C
17672,189,6414,translational elongation,P
17671,189,6351,"transcription, DNA-templated",P
17609,191,48471,perinuclear region of cytoplasm,C
17608,191,5576,extracellular region,C
17607,191,5737,cytoplasm,C
17606,191,7416,synapse assembly,P
17605,191,2000008,regulation of protein localization to cell surface,P
17604,191,51965,positive regulation of synapse assembly,P
17603,191,1900122,positive regulation of receptor binding,P
17602,191,48672,positive regulation of collateral sprouting,P
17601,191,31550,positive regulation of brain-derived neurotrophic factor receptor signaling pathway,P
17600,191,7399,nervous system development,P
17599,191,43524,negative regulation of neuron apoptotic process,P
17598,191,10832,negative regulation of myotube differentiation,P
17597,191,48668,collateral sprouting,P
17596,191,7267,cell-cell signaling,P
17595,191,31547,brain-derived neurotrophic factor receptor signaling pathway,P
17594,191,7411,axon guidance,P
17593,191,5169,neurotrophin TRKB receptor binding,F
17592,191,8083,growth factor activity,F
17557,192,45600,positive regulation of fat cell differentiation,P
17555,192,43065,positive regulation of apoptotic process,P
17556,192,55025,positive regulation of cardiac muscle tissue development,P
17554,192,45899,positive regulation of RNA polymerase II transcriptional preinitiation complex assembly,P
17553,192,21983,pituitary gland development,P
17552,192,10944,negative regulation of transcription by competitive promoter binding,P
17550,192,7613,memory,P
17551,192,1901215,negative regulation of neuron death,P
17549,192,60430,lung saccule development,P
17548,192,7595,lactation,P
17547,192,7623,circadian rhythm,P
17546,192,34670,chemotaxis to arachidonic acid,P
17545,192,71294,cellular response to zinc ion,P
17544,192,36120,cellular response to platelet-derived growth factor stimulus,P
17543,192,1990090,cellular response to nerve growth factor stimulus,P
17542,192,1990314,cellular response to insulin-like growth factor stimulus,P
17541,192,35729,cellular response to hepatocyte growth factor stimulus,P
17540,192,71398,cellular response to fatty acid,P
17539,192,7411,axon guidance,P
17538,192,7568,aging,P
17537,192,60509,Type I pneumocyte differentiation,P
17536,192,1190,"transcriptional activator activity, RNA polymerase II transcription factor binding",F
17535,192,1077,"transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding",F
17534,192,3700,"transcription factor activity, sequence-specific DNA binding",F
17533,192,3705,"transcription factor activity, RNA polymerase II distal enhancer sequence-specific binding",F
17532,192,3712,transcription cofactor activity,F
17531,192,5515,protein binding,F
17530,192,42802,identical protein binding,F
17529,192,35035,histone acetyltransferase binding,F
17528,192,19899,enzyme binding,F
17527,192,35497,cAMP response element binding,F
17526,192,1990763,arrestin family protein binding,F
17525,192,980,RNA polymerase II distal enhancer sequence-specific DNA binding,F
17524,192,978,RNA polymerase II core promoter proximal region sequence-specific DNA binding,F
17523,192,1102,RNA polymerase II activating transcription factor binding,F
17522,192,30544,Hsp70 protein binding,F
17508,193,45944,positive regulation of transcription from RNA polymerase II promoter,P
17506,193,43525,positive regulation of neuron apoptotic process,P
17507,193,51091,positive regulation of sequence-specific DNA binding transcription factor activity,P
17504,193,3151,outflow tract morphogenesis,P
17505,193,1902110,positive regulation of mitochondrial membrane permeability involved in apoptotic process,P
17503,193,122,negative regulation of transcription from RNA polymerase II promoter,P
17502,193,50680,negative regulation of epithelial cell proliferation,P
17501,193,31573,intra-S DNA damage checkpoint,P
17500,193,16573,histone acetylation,P
17499,193,45444,fat cell differentiation,P
17498,193,6974,cellular response to DNA damage stimulus,P
17497,193,6974,cellular response to DNA damage stimulus,P
17496,193,97186,amelogenesis,P
17495,193,60612,adipose tissue development,P
17494,193,1228,"transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding",F
17493,193,1077,"transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding",F
17492,193,3700,"transcription factor activity, sequence-specific DNA binding",F
17491,193,1076,"transcription factor activity, RNA polymerase II transcription factor binding",F
17490,193,3705,"transcription factor activity, RNA polymerase II distal enhancer sequence-specific binding",F
17489,193,3713,transcription coactivator activity,F
17488,193,19901,protein kinase binding,F
17487,193,46982,protein heterodimerization activity,F
17486,193,5515,protein binding,F
17485,193,46872,metal ion binding,F
17484,193,4402,histone acetyltransferase activity,F
17483,193,4402,histone acetyltransferase activity,F
17482,193,1158,enhancer sequence-specific DNA binding,F
17481,193,3682,chromatin binding,F
17480,193,8140,cAMP response element binding protein binding,F
17479,193,35497,cAMP response element binding,F
17478,193,977,RNA polymerase II regulatory region sequence-specific DNA binding,F
17477,193,980,RNA polymerase II distal enhancer sequence-specific DNA binding,F
17476,193,1102,RNA polymerase II activating transcription factor binding,F
17451,194,42795,snRNA transcription from RNA polymerase II promoter,P
17450,194,6359,regulation of transcription from RNA polymerase III promoter,P
17449,194,1901796,regulation of signal transduction by p53 class mediator,P
17448,194,45893,"positive regulation of transcription, DNA-templated",P
17447,194,45815,"positive regulation of gene expression, epigenetic",P
17446,194,44212,transcription regulatory region DNA binding,F
17445,194,8134,transcription factor binding,F
17444,194,70491,repressing transcription factor binding,F
17443,194,5515,protein binding,F
17442,194,19899,enzyme binding,F
17441,194,1034,"RNA polymerase III transcription factor activity, sequence-specific DNA binding",F
17440,194,1103,RNA polymerase II repressing transcription factor binding,F
17439,194,979,RNA polymerase II core promoter sequence-specific DNA binding,F
17438,194,978,RNA polymerase II core promoter proximal region sequence-specific DNA binding,F
17406,195,90502,"RNA phosphodiester bond hydrolysis, endonucleolytic",P
17405,195,6281,DNA repair,P
17404,195,6310,DNA recombination,P
17403,195,80111,DNA demethylation,P
17402,195,4844,uracil DNA N-glycosylase activity,F
17401,195,3714,transcription corepressor activity,F
17400,195,3713,transcription coactivator activity,F
17399,195,16890,"site-specific endodeoxyribonuclease activity, specific for altered base",F
17398,195,32403,protein complex binding,F
17397,195,5515,protein binding,F
17396,195,44822,poly(A) RNA binding,F
17395,195,8081,phosphoric diester hydrolase activity,F
17394,195,4528,phosphodiesterase I activity,F
17393,195,16491,oxidoreductase activity,F
17392,195,46872,metal ion binding,F
17391,195,4519,endonuclease activity,F
17390,195,4520,endodeoxyribonuclease activity,F
17389,195,3691,double-stranded telomeric DNA binding,F
17388,195,8309,double-stranded DNA exodeoxyribonuclease activity,F
17387,195,8311,double-stranded DNA 3'-5' exodeoxyribonuclease activity,F
17386,195,3684,damaged DNA binding,F
17385,195,31490,chromatin DNA binding,F
17384,195,4523,RNA-DNA hybrid ribonuclease activity,F
17383,195,51059,NF-kappaB binding,F
17382,195,3906,DNA-(apurinic or apyrimidinic site) lyase activity,F
17381,195,3906,DNA-(apurinic or apyrimidinic site) lyase activity,F
17380,195,3677,DNA binding,F
17379,195,8408,3'-5' exonuclease activity,F
17378,195,8408,3'-5' exonuclease activity,F
17375,196,6355,"regulation of transcription, DNA-templated",P
17374,196,7050,cell cycle arrest,P
17373,196,16055,Wnt signaling pathway,P
17372,196,5515,protein binding,F
17371,196,3723,RNA binding,F
17370,196,3677,DNA binding,F
16371,215,33130,acetylcholine receptor binding,F
16370,215,42169,SH2 domain binding,F
16369,215,5088,Ras guanyl-nucleotide exchange factor activity,F
16368,215,5524,ATP binding,F
16442,215,10811,positive regulation of cell-substrate adhesion,P
16441,215,30335,positive regulation of cell migration,P
16440,215,45597,positive regulation of cell differentiation,P
16439,215,50867,positive regulation of cell activation,P
16438,215,43547,positive regulation of GTPase activity,P
16437,215,43388,positive regulation of DNA binding,P
16436,215,48008,platelet-derived growth factor receptor signaling pathway,P
16435,215,18108,peptidyl-tyrosine phosphorylation,P
16434,215,38083,peptidyl-tyrosine autophosphorylation,P
16433,215,43524,negative regulation of neuron apoptotic process,P
16432,215,45822,negative regulation of heart contraction,P
16431,215,22408,negative regulation of cell-cell adhesion,P
16430,215,8285,negative regulation of cell proliferation,P
16429,215,10667,negative regulation of cardiac muscle cell apoptotic process,P
16428,215,43392,negative regulation of DNA binding,P
16427,215,6928,movement of cell or subcellular component,P
16426,215,31959,mineralocorticoid receptor signaling pathway,P
16425,215,7498,mesoderm development,P
16424,215,61180,mammary gland epithelium development,P
16423,215,8631,intrinsic apoptotic signaling pathway in response to oxidative stress,P
16422,215,35556,intracellular signal transduction,P
16421,215,35722,interleukin-12-mediated signaling pathway,P
16420,215,60333,interferon-gamma-mediated signaling pathway,P
16419,215,45087,innate immune response,P
16418,215,35409,histone H3-Y41 phosphorylation,P
16417,215,60396,growth hormone receptor signaling pathway,P
16416,215,97191,extrinsic apoptotic signaling pathway,P
16415,215,30218,erythrocyte differentiation,P
16414,215,30218,erythrocyte differentiation,P
16413,215,7167,enzyme linked receptor protein signaling pathway,P
16412,215,19221,cytokine-mediated signaling pathway,P
16411,215,19221,cytokine-mediated signaling pathway,P
16410,215,16477,cell migration,P
16409,215,30154,cell differentiation,P
16408,215,7596,blood coagulation,P
16407,215,31103,axon regeneration,P
16406,215,6915,apoptotic process,P
16405,215,2250,adaptive immune response,P
16404,215,97296,activation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway,P
16403,215,6919,activation of cysteine-type endopeptidase activity involved in apoptotic process,P
16402,215,186,activation of MAPKK activity,P
16401,215,42977,activation of JAK2 kinase activity,P
16400,215,30041,actin filament polymerization,P
16399,215,7262,STAT protein import into nucleus,P
16398,215,165,MAPK cascade,P
16397,215,60397,JAK-STAT cascade involved in growth hormone signaling pathway,P
16395,215,7259,JAK-STAT cascade,P
16396,215,60397,JAK-STAT cascade involved in growth hormone signaling pathway,P
16394,215,7186,G-protein coupled receptor signaling pathway,P
16393,215,31702,type 1 angiotensin receptor binding,F
16392,215,5102,receptor binding,F
16391,215,4713,protein tyrosine kinase activity,F
16389,215,4713,protein tyrosine kinase activity,F
16390,215,4713,protein tyrosine kinase activity,F
16388,215,4713,protein tyrosine kinase activity,F
16387,215,19901,protein kinase binding,F
16386,215,4672,protein kinase activity,F
16385,215,5515,protein binding,F
16384,215,8022,protein C-terminus binding,F
16383,215,43548,phosphatidylinositol 3-kinase binding,F
16382,215,51428,peptide hormone receptor binding,F
16381,215,4715,non-membrane spanning protein tyrosine kinase activity,F
16380,215,4715,non-membrane spanning protein tyrosine kinase activity,F
16379,215,46872,metal ion binding,F
16378,215,5143,interleukin-12 receptor binding,F
16377,215,43560,insulin receptor substrate binding,F
16376,215,35401,histone kinase activity (H3-Y41 specific),F
16375,215,42393,histone binding,F
16374,215,20037,heme binding,F
16373,215,5131,growth hormone receptor binding,F
16372,215,5131,growth hormone receptor binding,F
17303,198,31394,positive regulation of prostaglandin biosynthetic process,P
17302,198,90362,positive regulation of platelet-derived growth factor production,P
17301,198,45429,positive regulation of nitric oxide biosynthetic process,P
17300,198,90271,positive regulation of fibroblast growth factor production,P
17299,198,31622,positive regulation of fever generation,P
17298,198,90050,positive regulation of cell migration involved in sprouting angiogenesis,P
17297,198,90336,positive regulation of brown fat cell differentiation,P
17296,198,43065,positive regulation of apoptotic process,P
17295,198,42346,positive regulation of NF-kappaB import into nucleus,P
17294,198,55114,oxidation-reduction process,P
17293,198,30728,ovulation,P
17292,198,6769,nicotinamide metabolic process,P
17291,198,32227,"negative regulation of synaptic transmission, dopaminergic",P
17290,198,45986,negative regulation of smooth muscle contraction,P
17289,198,8285,negative regulation of cell proliferation,P
17288,198,45786,negative regulation of cell cycle,P
17287,198,51926,negative regulation of calcium ion transport,P
17286,198,6928,movement of cell or subcellular component,P
17285,198,7613,memory,P
17284,198,35633,maintenance of permeability of blood-brain barrier,P
17283,198,19372,lipoxygenase pathway,P
17282,198,7612,learning,P
17280,198,42633,hair cycle,P
17281,198,6954,inflammatory response,P
17279,198,7566,embryo implantation,P
17278,198,46697,decidualization,P
17277,198,19371,cyclooxygenase pathway,P
17276,198,19371,cyclooxygenase pathway,P
17275,198,71260,cellular response to mechanical stimulus,P
17274,198,71456,cellular response to hypoxia,P
17273,198,71498,cellular response to fluid shear stress,P
17272,198,34644,cellular response to UV,P
17271,198,71318,cellular response to ATP,P
17270,198,98869,cellular oxidant detoxification,P
17269,198,50873,brown fat cell differentiation,P
17268,198,30282,bone mineralization,P
17267,198,1525,angiogenesis,P
17266,198,42803,protein homodimerization activity,F
17265,198,5515,protein binding,F
17264,198,4666,prostaglandin-endoperoxide synthase activity,F
17263,198,4666,prostaglandin-endoperoxide synthase activity,F
17262,198,4601,peroxidase activity,F
17261,198,4601,peroxidase activity,F
17260,198,46872,metal ion binding,F
17259,198,8289,lipid binding,F
17258,198,20037,heme binding,F
17257,198,19899,enzyme binding,F
17256,198,50473,arachidonate 15-lipoxygenase activity,F
19347,152,45647,negative regulation of erythrocyte differentiation,P
19346,152,43066,negative regulation of apoptotic process,P
19345,152,30218,erythrocyte differentiation,P
19344,152,51082,unfolded protein binding,F
19343,152,31625,ubiquitin protein ligase binding,F
19342,152,5515,protein binding,F
19341,152,44822,poly(A) RNA binding,F
19340,152,5524,ATP binding,F
17162,200,45892,"negative regulation of transcription, DNA-templated",P
17161,200,2000678,negative regulation of transcription regulatory region DNA binding,P
17160,200,122,negative regulation of transcription from RNA polymerase II promoter,P
17159,200,1900181,negative regulation of protein localization to nucleus,P
17158,200,1901675,negative regulation of histone H3-K27 acetylation,P
17157,200,42754,negative regulation of circadian rhythm,P
17156,200,43066,negative regulation of apoptotic process,P
17155,200,1701,in utero embryonic development,P
17154,200,16575,histone deacetylation,P
17153,200,2244,hematopoietic progenitor cell differentiation,P
17152,200,71333,cellular response to glucose stimulus,P
17151,200,1903351,cellular response to dopamine,P
17150,200,34613,cellular protein localization,P
17148,200,7568,aging,P
17149,200,44255,cellular lipid metabolic process,P
17147,200,2218,activation of innate immune response,P
17146,200,6260,DNA replication,P
17145,200,976,transcription regulatory region sequence-specific DNA binding,F
17144,200,3700,"transcription factor activity, sequence-specific DNA binding",F
17143,200,33558,protein deacetylase activity,F
17142,200,32403,protein complex binding,F
17140,200,4407,histone deacetylase activity,F
17141,200,5515,protein binding,F
17139,200,3682,chromatin binding,F
17138,200,1106,RNA polymerase II transcription corepressor activity,F
17137,200,1103,RNA polymerase II repressing transcription factor binding,F
17136,200,1102,RNA polymerase II activating transcription factor binding,F
17135,200,3723,RNA binding,F
17111,201,83,regulation of transcription involved in G1/S transition of mitotic cell cycle,P
17110,201,45995,regulation of embryonic development,P
17109,201,14038,regulation of Schwann cell differentiation,P
17108,201,42787,protein ubiquitination involved in ubiquitin-dependent protein catabolic process,P
17107,201,34501,protein localization to kinetochore,P
17106,201,6461,protein complex assembly,P
17105,201,43161,proteasome-mediated ubiquitin-dependent protein catabolic process,P
17104,201,7344,pronuclear fusion,P
17103,201,51437,positive regulation of ubiquitin-protein ligase activity involved in regulation of mitotic cell cycle transition,P
17102,201,1900182,positive regulation of protein localization to nucleus,P
17100,201,45931,positive regulation of mitotic cell cycle,P
17101,201,33160,"positive regulation of protein import into nucleus, translocation",P
17099,201,10628,positive regulation of gene expression,P
17098,201,60045,positive regulation of cardiac muscle cell proliferation,P
17097,201,45740,positive regulation of DNA replication,P
17096,201,18107,peptidyl-threonine phosphorylation,P
17095,201,18105,peptidyl-serine phosphorylation,P
17094,201,51436,negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle,P
17093,201,43066,negative regulation of apoptotic process,P
17092,201,7077,mitotic nuclear envelope disassembly,P
17091,201,7067,mitotic nuclear division,P
17090,201,7095,mitotic G2 DNA damage checkpoint,P
17089,201,226,microtubule cytoskeleton organization,P
17088,201,16572,histone phosphorylation,P
17087,201,30855,epithelial cell differentiation,P
17085,201,7098,centrosome cycle,P
17086,201,30261,chromosome condensation,P
17083,201,8283,cell proliferation,P
17084,201,70301,cellular response to hydrogen peroxide,P
17082,201,16477,cell migration,P
17081,201,51301,cell division,P
17080,201,7569,cell aging,P
17079,201,6915,apoptotic process,P
17078,201,31100,animal organ regeneration,P
17077,201,31145,anaphase-promoting complex-dependent catabolic process,P
17075,201,90166,Golgi disassembly,P
17076,201,187,activation of MAPK activity,P
17074,201,86,G2/M transition of mitotic cell cycle,P
17073,201,82,G1/S transition of mitotic cell cycle,P
17072,201,6260,DNA replication,P
17071,201,6281,DNA repair,P
17070,201,6977,"DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest",P
17069,201,4674,protein serine/threonine kinase activity,F
17068,201,4674,protein serine/threonine kinase activity,F
17067,201,4672,protein kinase activity,F
17066,201,5515,protein binding,F
17065,201,35173,histone kinase activity,F
17064,201,4693,cyclin-dependent protein serine/threonine kinase activity,F
17063,201,4693,cyclin-dependent protein serine/threonine kinase activity,F
17062,201,30332,cyclin binding,F
17061,201,30332,cyclin binding,F
17060,201,3682,chromatin binding,F
17059,201,8353,RNA polymerase II carboxy-terminal domain kinase activity,F
17058,201,30544,Hsp70 protein binding,F
17057,201,5524,ATP binding,F
17048,202,70345,negative regulation of fat cell proliferation,P
17047,202,8283,cell proliferation,P
17046,202,6977,"DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest",P
17045,202,8134,transcription factor binding,F
17044,202,3700,"transcription factor activity, sequence-specific DNA binding",F
17043,202,3713,transcription coactivator activity,F
17042,202,19904,protein domain specific binding,F
17041,202,5515,protein binding,F
17040,202,981,"RNA polymerase II transcription factor activity, sequence-specific DNA binding",F
17039,202,3677,DNA binding,F
27006,18,45599,negative regulation of fat cell differentiation,P
27005,18,43392,negative regulation of DNA binding,P
27004,18,48255,mRNA stabilization,P
27003,18,1990086,lens fiber cell apoptotic process,P
27002,18,8630,intrinsic apoptotic signaling pathway in response to DNA damage,P
27001,18,72332,intrinsic apoptotic signaling pathway by p53 class mediator,P
27000,18,30900,forebrain development,P
26999,18,71466,cellular response to xenobiotic stimulus,P
26998,18,1990090,cellular response to nerve growth factor stimulus,P
26997,18,71456,cellular response to hypoxia,P
26996,18,71398,cellular response to fatty acid,P
26995,18,43276,anoikis,P
26993,18,77,DNA damage checkpoint,P
26994,18,6977,"DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest",P
26992,18,8134,transcription factor binding,F
26991,18,3700,"transcription factor activity, sequence-specific DNA binding",F
26990,18,3700,"transcription factor activity, sequence-specific DNA binding",F
26989,18,43565,sequence-specific DNA binding,F
26988,18,19901,protein kinase binding,F
26987,18,46983,protein dimerization activity,F
26986,18,5515,protein binding,F
26985,18,1047,core promoter binding,F
26984,18,3677,DNA binding,F
26983,18,3677,DNA binding,F
16840,206,32330,regulation of chondrocyte differentiation,P
16839,206,1558,regulation of cell growth,P
16838,206,72593,reactive oxygen species metabolic process,P
16837,206,51496,positive regulation of stress fiber assembly,P
16836,206,10628,positive regulation of gene expression,P
16835,206,43280,positive regulation of cysteine-type endopeptidase activity involved in apoptotic process,P
16834,206,32967,positive regulation of collagen biosynthetic process,P
16833,206,8284,positive regulation of cell proliferation,P
16832,206,45597,positive regulation of cell differentiation,P
16831,206,50867,positive regulation of cell activation,P
16830,206,60452,positive regulation of cardiac muscle contraction,P
16829,206,46330,positive regulation of JNK cascade,P
16828,206,70318,positive regulation of G0 to G1 transition,P
16827,206,70374,positive regulation of ERK1 and ERK2 cascade,P
16826,206,1503,ossification,P
16825,206,10629,negative regulation of gene expression,P
16824,206,60548,negative regulation of cell death,P
16823,206,30324,lung development,P
16822,206,35556,intracellular signal transduction,P
16821,206,7229,integrin-mediated signaling pathway,P
16820,206,8543,fibroblast growth factor receptor signaling pathway,P
16819,206,70278,extracellular matrix constituent secretion,P
16818,206,8544,epidermis development,P
16817,206,60401,cytosolic calcium ion transport,P
16816,206,35988,chondrocyte proliferation,P
16815,206,7160,cell-matrix adhesion,P
16814,206,7267,cell-cell signaling,P
16813,206,16477,cell migration,P
16812,206,30154,cell differentiation,P
16811,206,7155,cell adhesion,P
16810,206,1502,cartilage condensation,P
16809,206,1525,angiogenesis,P
16808,206,7568,aging,P
16807,206,71897,DNA biosynthetic process,P
16806,206,5515,protein binding,F
16805,206,8022,protein C-terminus binding,F
16804,206,5178,integrin binding,F
16803,206,5520,insulin-like growth factor binding,F
16802,206,8201,heparin binding,F
16801,206,8083,growth factor activity,F
16800,206,1968,fibronectin binding,F
16765,207,2000757,negative regulation of peptidyl-lysine acetylation,P
16764,207,10977,negative regulation of neuron projection development,P
16763,207,61000,negative regulation of dendritic spine development,P
16762,207,43066,negative regulation of apoptotic process,P
16761,207,45347,negative regulation of MHC class II biosynthetic process,P
16760,207,43392,negative regulation of DNA binding,P
16759,207,6344,maintenance of chromatin silencing,P
16758,207,16575,histone deacetylation,P
16757,207,70933,histone H4 deacetylation,P
16756,207,70932,histone H3 deacetylation,P
16755,207,60789,hair follicle placode formation,P
16754,207,61198,fungiform papilla formation,P
16753,207,61029,eyelid development in camera-type eye,P
16752,207,9913,epidermal cell differentiation,P
16751,207,42733,embryonic digit morphogenesis,P
16750,207,16358,dendrite development,P
16749,207,32922,circadian regulation of gene expression,P
16748,207,6338,chromatin remodeling,P
16747,207,71560,cellular response to transforming growth factor beta stimulus,P
16746,207,71300,cellular response to retinoic acid,P
16745,207,70301,cellular response to hydrogen peroxide,P
16744,207,34605,cellular response to heat,P
16743,207,1903351,cellular response to dopamine,P
16742,207,3300,cardiac muscle hypertrophy,P
16740,207,48149,behavioral response to ethanol,P
16741,207,7596,blood coagulation,P
16739,207,43044,ATP-dependent chromatin remodeling,P
16738,207,8134,transcription factor binding,F
16737,207,43565,sequence-specific DNA binding,F
16736,207,33558,protein deacetylase activity,F
16735,207,5515,protein binding,F
16734,207,44822,poly(A) RNA binding,F
16733,207,31492,nucleosomal DNA binding,F
16732,207,4407,histone deacetylase activity,F
16731,207,4407,histone deacetylase activity,F
16730,207,31072,heat shock protein binding,F
16728,207,19213,deacetylase activity,F
16729,207,19899,enzyme binding,F
16726,207,3682,chromatin binding,F
16727,207,1047,core promoter binding,F
16725,207,1103,RNA polymerase II repressing transcription factor binding,F
16724,207,980,RNA polymerase II distal enhancer sequence-specific DNA binding,F
16723,207,978,RNA polymerase II core promoter proximal region sequence-specific DNA binding,F
16722,207,51059,NF-kappaB binding,F
16721,207,32041,NAD-dependent histone deacetylase activity (H3-K14 specific),F
16707,208,10629,negative regulation of gene expression,P
16706,208,9267,cellular response to starvation,P
16705,208,71375,cellular response to peptide hormone stimulus,P
16704,208,3700,"transcription factor activity, sequence-specific DNA binding",F
16703,208,983,"transcription factor activity, RNA polymerase II core promoter sequence-specific",F
16702,208,3712,transcription cofactor activity,F
16701,208,3713,transcription coactivator activity,F
16700,208,42803,protein homodimerization activity,F
16699,208,46982,protein heterodimerization activity,F
16698,208,32403,protein complex binding,F
16697,208,5515,protein binding,F
16696,208,978,RNA polymerase II core promoter proximal region sequence-specific DNA binding,F
16688,209,3700,"transcription factor activity, sequence-specific DNA binding",F
16687,209,3714,transcription corepressor activity,F
16686,209,3712,transcription cofactor activity,F
16685,209,46983,protein dimerization activity,F
16684,209,5515,protein binding,F
16683,209,978,RNA polymerase II core promoter proximal region sequence-specific DNA binding,F
16636,210,18205,peptidyl-lysine modification,P
16635,210,45892,"negative regulation of transcription, DNA-templated",P
16634,210,122,negative regulation of transcription from RNA polymerase II promoter,P
16632,210,10955,negative regulation of protein processing,P
16633,210,1901797,negative regulation of signal transduction by p53 class mediator,P
16631,210,10977,negative regulation of neuron projection development,P
16630,210,43154,negative regulation of cysteine-type endopeptidase activity involved in apoptotic process,P
16629,210,71157,negative regulation of cell cycle arrest,P
16628,210,43518,"negative regulation of DNA damage response, signal transduction by p53 class mediator",P
16627,210,45184,establishment of protein localization,P
16626,210,3203,endocardial cushion morphogenesis,P
16625,210,71301,cellular response to vitamin B1,P
16624,210,71375,cellular response to peptide hormone stimulus,P
16623,210,71456,cellular response to hypoxia,P
16622,210,70301,cellular response to hydrogen peroxide,P
16621,210,71363,cellular response to growth factor stimulus,P
16619,210,71236,cellular response to antibiotic,P
16620,210,71391,cellular response to estrogen stimulus,P
16618,210,71312,cellular response to alkaloid,P
16617,210,71494,cellular response to UV-C,P
16616,210,60411,cardiac septum morphogenesis,P
16615,210,1974,blood vessel remodeling,P
16614,210,1568,blood vessel development,P
16613,210,3181,atrioventricular valve morphogenesis,P
16612,210,3283,atrial septum development,P
16611,210,6977,"DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest",P
16610,210,6977,"DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest",P
16609,210,8270,zinc ion binding,F
16608,210,4842,ubiquitin-protein transferase activity,F
16607,210,4842,ubiquitin-protein transferase activity,F
16606,210,4842,ubiquitin-protein transferase activity,F
16605,210,31625,ubiquitin protein ligase binding,F
16604,210,61630,ubiquitin protein ligase activity,F
16603,210,61630,ubiquitin protein ligase activity,F
16602,210,97110,scaffold protein binding,F
16601,210,5515,protein binding,F
16600,210,42975,peroxisome proliferator activated receptor binding,F
16599,210,2039,p53 binding,F
16598,210,16874,ligase activity,F
16597,210,42802,identical protein binding,F
16596,210,19899,enzyme binding,F
16595,210,19789,SUMO transferase activity,F
17906,180,51123,RNA polymerase II transcriptional preinitiation complex assembly,P
17905,180,6352,"DNA-templated transcription, initiation",P
17904,180,61631,ubiquitin conjugating enzyme activity,F
17903,180,44212,transcription regulatory region DNA binding,F
17902,180,8134,transcription factor binding,F
17901,180,1075,"transcription factor activity, RNA polymerase II core promoter sequence-specific binding involved in preinitiation complex assembly",F
17900,180,3713,transcription coactivator activity,F
17899,180,43565,sequence-specific DNA binding,F
17898,180,43565,sequence-specific DNA binding,F
17897,180,4674,protein serine/threonine kinase activity,F
17895,180,46982,protein heterodimerization activity,F
17896,180,4674,protein serine/threonine kinase activity,F
17893,180,2039,p53 binding,F
17894,180,5515,protein binding,F
17892,180,70577,lysine-acetylated histone binding,F
17890,180,4402,histone acetyltransferase activity,F
17891,180,16301,kinase activity,F
17889,180,4402,histone acetyltransferase activity,F
17888,180,1905502,acetyl-CoA binding,F
17887,180,17025,TBP-class protein binding,F
17886,180,1129,"RNA polymerase II transcription factor activity, TBP-class protein binding, involved in preinitiation complex assembly",F
17885,180,979,RNA polymerase II core promoter sequence-specific DNA binding,F
17884,180,5524,ATP binding,F
16957,204,5658,alpha DNA polymerase:primase complex,C
16956,204,16032,viral process,P
16955,204,722,telomere maintenance via recombination,P
16954,204,83,regulation of transcription involved in G1/S transition of mitotic cell cycle,P
16953,204,90305,nucleic acid phosphodiester bond hydrolysis,P
16952,204,6272,leading strand elongation,P
16951,204,6273,lagging strand elongation,P
16950,204,6303,double-strand break repair via nonhomologous end joining,P
16949,204,8283,cell proliferation,P
16948,204,82,G1/S transition of mitotic cell cycle,P
16947,204,731,DNA synthesis involved in DNA repair,P
16946,204,6271,DNA strand elongation involved in DNA replication,P
16945,204,6271,DNA strand elongation involved in DNA replication,P
16944,204,6269,"DNA replication, synthesis of RNA primer",P
16943,204,6270,DNA replication initiation,P
16942,204,6270,DNA replication initiation,P
16941,204,6260,DNA replication,P
16940,204,6281,DNA repair,P
16939,204,19901,protein kinase binding,F
16937,204,5515,protein binding,F
16938,204,46982,protein heterodimerization activity,F
16936,204,166,nucleotide binding,F
16935,204,1882,nucleoside binding,F
16934,204,46872,metal ion binding,F
16933,204,3682,chromatin binding,F
16932,204,3887,DNA-directed DNA polymerase activity,F
16931,204,3887,DNA-directed DNA polymerase activity,F
16930,204,3896,DNA primase activity,F
16929,204,3677,DNA binding,F
16928,204,3677,DNA binding,F
16927,204,51539,"4 iron, 4 sulfur cluster binding",F
16926,204,8408,3'-5' exonuclease activity,F
16994,203,70059,intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress,P
16993,203,70059,intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress,P
16992,203,72655,establishment of protein localization to mitochondrion,P
16990,203,45454,cell redox homeostasis,P
16991,203,6974,cellular response to DNA damage stimulus,P
16989,203,7050,cell cycle arrest,P
16988,203,1955,blood vessel maturation,P
16987,203,16055,Wnt signaling pathway,P
16986,203,36499,PERK-mediated unfolded protein response,P
16985,203,6983,ER overload response,P
16984,203,36500,ATF6-mediated unfolded protein response,P
16983,203,1077,"transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding",F
16982,203,976,transcription regulatory region sequence-specific DNA binding,F
16981,203,44212,transcription regulatory region DNA binding,F
16980,203,44212,transcription regulatory region DNA binding,F
16979,203,8134,transcription factor binding,F
16978,203,3700,"transcription factor activity, sequence-specific DNA binding",F
16977,203,3700,"transcription factor activity, sequence-specific DNA binding",F
16976,203,3714,transcription corepressor activity,F
16975,203,42803,protein homodimerization activity,F
16974,203,46982,protein heterodimerization activity,F
16973,203,46982,protein heterodimerization activity,F
16971,203,5515,protein binding,F
16972,203,46982,protein heterodimerization activity,F
16970,203,43522,leucine zipper domain binding,F
16969,203,8140,cAMP response element binding protein binding,F
16968,203,978,RNA polymerase II core promoter proximal region sequence-specific DNA binding,F
16967,203,3677,DNA binding,F
19945,143,1901223,negative regulation of NIK/NF-kappaB signaling,P
19946,143,43066,negative regulation of apoptotic process,P
19944,143,31293,membrane protein intracellular domain proteolysis,P
19943,143,1889,liver development,P
19942,143,6954,inflammatory response,P
19941,143,1942,hair follicle development,P
19940,143,51607,defense response to virus,P
19939,143,19221,cytokine-mediated signaling pathway,P
19938,143,71356,cellular response to tumor necrosis factor,P
19937,143,71375,cellular response to peptide hormone stimulus,P
19936,143,71316,cellular response to nicotine,P
19935,143,71222,cellular response to lipopolysaccharide,P
19934,143,71354,cellular response to interleukin-6,P
19933,143,71347,cellular response to interleukin-1,P
19932,143,70301,cellular response to hydrogen peroxide,P
19931,143,35729,cellular response to hepatocyte growth factor stimulus,P
19930,143,6968,cellular defense response,P
19929,143,9887,animal organ morphogenesis,P
19928,143,7568,aging,P
19927,143,6117,acetaldehyde metabolic process,P
19926,143,50852,T cell receptor signaling pathway,P
19925,143,38095,Fc-epsilon receptor signaling pathway,P
19924,143,31625,ubiquitin protein ligase binding,F
19923,143,1078,"transcriptional repressor activity, RNA polymerase II core promoter proximal region sequence-specific binding",F
19922,143,1205,"transcriptional activator activity, RNA polymerase II distal enhancer sequence-specific binding",F
19921,143,1077,"transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding",F
19919,143,8134,transcription factor binding,F
19920,143,44212,transcription regulatory region DNA binding,F
19918,143,3700,"transcription factor activity, sequence-specific DNA binding",F
19917,143,3705,"transcription factor activity, RNA polymerase II distal enhancer sequence-specific binding",F
19916,143,983,"transcription factor activity, RNA polymerase II core promoter sequence-specific",F
19915,143,70491,repressing transcription factor binding,F
19914,143,19901,protein kinase binding,F
19913,143,42803,protein homodimerization activity,F
19912,143,46982,protein heterodimerization activity,F
19911,143,32403,protein complex binding,F
19910,143,5515,protein binding,F
19909,143,47485,protein N-terminus binding,F
19908,143,42301,phosphate ion binding,F
19907,143,42802,identical protein binding,F
19906,143,42802,identical protein binding,F
19905,143,42826,histone deacetylase binding,F
19904,143,1046,core promoter sequence-specific DNA binding,F
19903,143,3682,chromatin binding,F
19902,143,31490,chromatin DNA binding,F
19901,143,71532,ankyrin repeat binding,F
19900,143,33613,activating transcription factor binding,F
19899,143,42805,actinin binding,F
19898,143,977,RNA polymerase II regulatory region sequence-specific DNA binding,F
19897,143,980,RNA polymerase II distal enhancer sequence-specific DNA binding,F
19896,143,978,RNA polymerase II core promoter proximal region sequence-specific DNA binding,F
19895,143,51059,NF-kappaB binding,F
19894,143,3677,DNA binding,F
19893,143,3677,DNA binding,F
23763,71,6734,NADH metabolic process,P
23762,71,36503,ERAD pathway,P
23761,71,36503,ERAD pathway,P
23760,71,30433,ER-associated ubiquitin-dependent protein catabolic process,P
23759,71,30433,ER-associated ubiquitin-dependent protein catabolic process,P
23758,71,30433,ER-associated ubiquitin-dependent protein catabolic process,P
23757,71,71712,ER-associated misfolded protein catabolic process,P
23756,71,6888,ER to Golgi vesicle-mediated transport,P
23755,71,6281,DNA repair,P
23754,71,46034,ATP metabolic process,P
23753,71,1990381,ubiquitin-specific protease binding,F
23751,71,31625,ubiquitin protein ligase binding,F
23752,71,44389,ubiquitin-like protein ligase binding,F
23750,71,19903,protein phosphatase binding,F
23748,71,5515,protein binding,F
23749,71,19904,protein domain specific binding,F
23747,71,31593,polyubiquitin binding,F
23746,71,44822,poly(A) RNA binding,F
23745,71,8289,lipid binding,F
23744,71,42802,identical protein binding,F
23743,71,35800,deubiquitinase activator activity,F
23742,71,42288,MHC class I protein binding,F
23741,71,36435,K48-linked polyubiquitin binding,F
23740,71,1904288,BAT3 complex binding,F
23739,71,16887,ATPase activity,F
23738,71,16887,ATPase activity,F
23737,71,5524,ATP binding,F
23736,71,43531,ADP binding,F
24132,66,90263,positive regulation of canonical Wnt signaling pathway,P
24131,66,43065,positive regulation of apoptotic process,P
24130,66,51092,positive regulation of NF-kappaB transcription factor activity,P
24129,66,43123,positive regulation of I-kappaB kinase/NF-kappaB signaling,P
24128,66,6294,"nucleotide-excision repair, preincision complex assembly",P
24127,66,6296,"nucleotide-excision repair, DNA incision, 5'-to lesion",P
24126,66,33683,"nucleotide-excision repair, DNA incision",P
24125,66,6297,"nucleotide-excision repair, DNA gap filling",P
24124,66,717,"nucleotide-excision repair, DNA duplex unwinding",P
24123,66,715,"nucleotide-excision repair, DNA damage recognition",P
24121,66,48812,neuron projection morphogenesis,P
24122,66,70423,nucleotide-binding oligomerization domain containing signaling pathway,P
24120,66,51436,negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle,P
24119,66,32480,negative regulation of type I interferon production,P
24118,66,30512,negative regulation of transforming growth factor beta receptor signaling pathway,P
24117,66,122,negative regulation of transcription from RNA polymerase II promoter,P
24116,66,42059,negative regulation of epidermal growth factor receptor signaling pathway,P
24115,66,90090,negative regulation of canonical Wnt signaling pathway,P
24114,66,43066,negative regulation of apoptotic process,P
24113,66,47497,mitochondrion transport along microtubule,P
24111,66,34220,ion transmembrane transport,P
24112,66,16236,macroautophagy,P
24110,66,75733,intracellular transport of virus,P
24108,66,45087,innate immune response,P
24109,66,36297,interstrand cross-link repair,P
24106,66,70911,global genome nucleotide-excision repair,P
24107,66,5978,glycogen biosynthetic process,P
24105,66,8543,fibroblast growth factor receptor signaling pathway,P
24104,66,42276,error-prone translesion synthesis,P
24103,66,70987,error-free translesion synthesis,P
24102,66,16197,endosomal transport,P
24101,66,44267,cellular protein metabolic process,P
24099,66,187,activation of MAPK activity,P
24100,66,31145,anaphase-promoting complex-dependent catabolic process,P
24098,66,60071,"Wnt signaling pathway, planar cell polarity pathway",P
24097,66,16055,Wnt signaling pathway,P
24096,66,35666,TRIF-dependent toll-like receptor signaling pathway,P
24095,66,50852,T cell receptor signaling pathway,P
24094,66,7219,Notch signaling pathway,P
24093,66,38061,NIK/NF-kappaB signaling,P
24092,66,2756,MyD88-independent toll-like receptor signaling pathway,P
24091,66,2755,MyD88-dependent toll-like receptor signaling pathway,P
24090,66,165,MAPK cascade,P
24089,66,7254,JNK cascade,P
24088,66,7249,I-kappaB kinase/NF-kappaB signaling,P
24087,66,86,G2/M transition of mitotic cell cycle,P
24086,66,38095,Fc-epsilon receptor signaling pathway,P
24085,66,38128,ERBB2 signaling pathway,P
24084,66,6977,"DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest",P
24083,66,42769,"DNA damage response, detection of DNA damage",P
24082,66,5515,protein binding,F
24708,59,45893,"positive regulation of transcription, DNA-templated",P
24707,59,45944,positive regulation of transcription from RNA polymerase II promoter,P
24706,59,45944,positive regulation of transcription from RNA polymerase II promoter,P
24705,59,51091,positive regulation of sequence-specific DNA binding transcription factor activity,P
24704,59,45666,positive regulation of neuron differentiation,P
24703,59,45666,positive regulation of neuron differentiation,P
24702,59,51149,positive regulation of muscle cell differentiation,P
24701,59,122,negative regulation of transcription from RNA polymerase II promoter,P
24700,59,33152,immunoglobulin V(D)J recombination,P
24699,59,2326,B cell lineage commitment,P
24698,59,30183,B cell differentiation,P
24697,59,70644,vitamin D response element binding,F
24696,59,1078,"transcriptional repressor activity, RNA polymerase II core promoter proximal region sequence-specific binding",F
24695,59,8134,transcription factor binding,F
24694,59,3700,"transcription factor activity, sequence-specific DNA binding",F
24693,59,3700,"transcription factor activity, sequence-specific DNA binding",F
24692,59,3713,transcription coactivator activity,F
24691,59,70491,repressing transcription factor binding,F
24689,59,46982,protein heterodimerization activity,F
24690,59,42803,protein homodimerization activity,F
24688,59,46982,protein heterodimerization activity,F
24687,59,46982,protein heterodimerization activity,F
24686,59,5515,protein binding,F
24685,59,31435,mitogen-activated protein kinase kinase kinase binding,F
24684,59,35326,enhancer binding,F
24683,59,43425,bHLH transcription factor binding,F
24682,59,978,RNA polymerase II core promoter proximal region sequence-specific DNA binding,F
24681,59,70888,E-box binding,F
24680,59,70888,E-box binding,F
24679,59,70888,E-box binding,F
24678,59,3677,DNA binding,F
24677,59,3677,DNA binding,F
25379,45,122,negative regulation of transcription from RNA polymerase II promoter,P
25378,45,7623,circadian rhythm,P
25377,45,32870,cellular response to hormone stimulus,P
25376,45,71277,cellular response to calcium ion,P
25375,45,7568,aging,P
25374,45,44212,transcription regulatory region DNA binding,F
25373,45,8134,transcription factor binding,F
25372,45,3713,transcription coactivator activity,F
25371,45,5515,protein binding,F
25370,45,16922,ligand-dependent nuclear receptor binding,F
25369,45,19899,enzyme binding,F
25368,45,981,"RNA polymerase II transcription factor activity, sequence-specific DNA binding",F
25367,45,978,RNA polymerase II core promoter proximal region sequence-specific DNA binding,F
22657,90,8285,negative regulation of cell proliferation,P
22656,90,42994,cytoplasmic sequestering of transcription factor,P
22655,90,3714,transcription corepressor activity,F
22653,90,5515,protein binding,F
22654,90,46983,protein dimerization activity,F
22652,90,3677,DNA binding,F
25420,44,6303,double-strand break repair via nonhomologous end joining,P
25419,44,724,double-strand break repair via homologous recombination,P
25418,44,724,double-strand break repair via homologous recombination,P
25417,44,6302,double-strand break repair,P
25416,44,8283,cell proliferation,P
25415,44,7050,cell cycle arrest,P
25414,44,1832,blastocyst growth,P
25413,44,731,DNA synthesis involved in DNA repair,P
25412,44,6260,DNA replication,P
25411,44,32508,DNA duplex unwinding,P
25410,44,729,DNA double-strand break processing,P
25409,44,30330,"DNA damage response, signal transduction by p53 class mediator",P
25408,44,77,DNA damage checkpoint,P
25407,44,8134,transcription factor binding,F
25406,44,5515,protein binding,F
25405,44,47485,protein N-terminus binding,F
25404,44,3684,damaged DNA binding,F
25403,44,3684,damaged DNA binding,F
25402,44,4003,ATP-dependent DNA helicase activity,F
16563,211,45892,"negative regulation of transcription, DNA-templated",P
16562,211,43433,negative regulation of sequence-specific DNA binding transcription factor activity,P
16561,211,1902260,negative regulation of delayed rectifier potassium channel activity,P
16560,211,45759,negative regulation of action potential,P
16559,211,43392,negative regulation of DNA binding,P
16558,211,70911,global genome nucleotide-excision repair,P
16557,211,6303,double-strand break repair via nonhomologous end joining,P
16555,211,71276,cellular response to cadmium ion,P
16556,211,34605,cellular response to heat,P
16554,211,30578,PML body organization,P
16553,211,6281,DNA repair,P
16552,211,31625,ubiquitin protein ligase binding,F
16551,211,8134,transcription factor binding,F
16550,211,31386,protein tag,F
16549,211,5515,protein binding,F
16548,211,15459,potassium channel regulator activity,F
16547,211,44822,poly(A) RNA binding,F
16546,211,44325,ion channel binding,F
16527,212,6303,double-strand break repair via nonhomologous end joining,P
16526,212,724,double-strand break repair via homologous recombination,P
16525,212,6302,double-strand break repair,P
16524,212,6342,chromatin silencing,P
16523,212,21987,cerebral cortex development,P
16522,212,90398,cellular senescence,P
16521,212,71480,cellular response to gamma radiation,P
16520,212,6974,cellular response to DNA damage stimulus,P
16519,212,77,DNA damage checkpoint,P
16518,212,46982,protein heterodimerization activity,F
16517,212,5515,protein binding,F
16516,212,42393,histone binding,F
16515,212,19899,enzyme binding,F
16514,212,3684,damaged DNA binding,F
16513,212,3677,DNA binding,F
16512,212,3677,DNA binding,F
16506,213,90190,positive regulation of branching involved in ureteric bud morphogenesis,P
16505,213,30099,myeloid cell differentiation,P
16504,213,7275,multicellular organism development,P
16503,213,48704,embryonic skeletal system morphogenesis,P
16502,213,9952,anterior/posterior pattern specification,P
16501,213,3700,"transcription factor activity, sequence-specific DNA binding",F
16500,213,43565,sequence-specific DNA binding,F
16499,213,5515,protein binding,F
23602,75,71383,cellular response to steroid hormone stimulus,P
23601,75,51301,cell division,P
23600,75,6915,apoptotic process,P
23599,75,8270,zinc ion binding,F
23598,75,1077,"transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding",F
23597,75,3700,"transcription factor activity, sequence-specific DNA binding",F
23596,75,1990239,steroid hormone binding,F
23595,75,5496,steroid binding,F
23594,75,5515,protein binding,F
23593,75,38051,glucocorticoid-activated RNA polymerase II transcription factor binding transcription factor activity,F
23592,75,4883,glucocorticoid receptor activity,F
23591,75,978,RNA polymerase II core promoter proximal region sequence-specific DNA binding,F
23590,75,3723,RNA binding,F
16495,214,48562,embryonic organ morphogenesis,P
16494,214,51216,cartilage development,P
16493,214,9952,anterior/posterior pattern specification,P
16492,214,3700,"transcription factor activity, sequence-specific DNA binding",F
16491,214,43565,sequence-specific DNA binding,F
16490,214,5515,protein binding,F
16489,214,71837,HMG box domain binding,F
21934,101,775,"chromosome, centromeric region",C
21933,101,6351,"transcription, DNA-templated",P
21932,101,31508,pericentric heterochromatin assembly,P
21931,101,7275,multicellular organism development,P
21930,101,7067,mitotic nuclear division,P
21929,101,6346,methylation-dependent chromatin silencing,P
21928,101,10216,maintenance of DNA methylation,P
21927,101,46651,lymphocyte proliferation,P
21926,101,51301,cell division,P
21925,101,5515,protein binding,F
21924,101,4386,helicase activity,F
21923,101,5524,ATP binding,F
23722,72,7568,aging,P
23721,72,6261,DNA-dependent DNA replication,P
23720,72,6259,DNA metabolic process,P
23719,72,71897,DNA biosynthetic process,P
23718,72,5515,protein binding,F
23717,72,2020,protease binding,F
23716,72,3682,chromatin binding,F
23715,72,3887,DNA-directed DNA polymerase activity,F
23714,72,3677,DNA binding,F
23713,72,8408,3'-5' exonuclease activity,F
17356,197,7062,sister chromatid cohesion,P
17355,197,42787,protein ubiquitination involved in ubiquitin-dependent protein catabolic process,P
17354,197,6468,protein phosphorylation,P
17353,197,34501,protein localization to kinetochore,P
17352,197,43161,proteasome-mediated ubiquitin-dependent protein catabolic process,P
17351,197,51437,positive regulation of ubiquitin-protein ligase activity involved in regulation of mitotic cell cycle transition,P
17350,197,51436,negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle,P
17349,197,7094,mitotic spindle assembly checkpoint,P
17348,197,7067,mitotic nuclear division,P
17347,197,7093,mitotic cell cycle checkpoint,P
17346,197,7091,metaphase/anaphase transition of mitotic cell cycle,P
17345,197,8283,cell proliferation,P
17344,197,51301,cell division,P
17343,197,6915,apoptotic process,P
17342,197,31145,anaphase-promoting complex-dependent catabolic process,P
17341,197,4674,protein serine/threonine kinase activity,F
17340,197,4672,protein kinase activity,F
17339,197,5515,protein binding,F
17338,197,5524,ATP binding,F
20061,140,5815,microtubule organizing center,C
20060,140,70062,extracellular exosome,C
20059,140,5737,cytoplasm,C
20058,140,30424,axon,C
20057,140,50808,synapse organization,P
20056,140,46928,regulation of neurotransmitter secretion,P
20055,140,14059,regulation of dopamine secretion,P
20054,140,9306,protein secretion,P
20053,140,7268,chemical synaptic transmission,P
20052,140,8344,adult locomotory behavior,P
20051,140,5515,protein binding,F
22236,95,31647,regulation of protein stability,P
22235,95,90305,nucleic acid phosphodiester bond hydrolysis,P
22234,95,16311,dephosphorylation,P
22233,95,6974,cellular response to DNA damage stimulus,P
22232,95,6266,DNA ligation,P
22231,95,5515,protein binding,F
22230,95,47485,protein N-terminus binding,F
22229,95,51219,phosphoprotein binding,F
22228,95,8967,phosphoglycolate phosphatase activity,F
22227,95,46872,metal ion binding,F
22226,95,3725,double-stranded RNA binding,F
22225,95,3690,double-stranded DNA binding,F
22224,95,3684,damaged DNA binding,F
22223,95,3682,chromatin binding,F
22222,95,33699,DNA 5'-adenosine monophosphate hydrolase activity,F
22748,88,1889,liver development,P
22747,88,55088,lipid homeostasis,P
22746,88,48839,inner ear development,P
22745,88,30851,granulocyte differentiation,P
22744,88,42593,glucose homeostasis,P
22743,88,6091,generation of precursor metabolites and energy,P
22742,88,45444,fat cell differentiation,P
22741,88,1892,embryonic placenta development,P
22740,88,19221,cytokine-mediated signaling pathway,P
22739,88,8203,cholesterol metabolic process,P
22738,88,71356,cellular response to tumor necrosis factor,P
22737,88,71407,cellular response to organic cyclic compound,P
22736,88,71285,cellular response to lithium ion,P
22735,88,48469,cell maturation,P
22734,88,50873,brown fat cell differentiation,P
22733,88,7219,Notch signaling pathway,P
22732,88,1228,"transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding",F
22731,88,1077,"transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding",F
22730,88,44212,transcription regulatory region DNA binding,F
22729,88,8134,transcription factor binding,F
22728,88,3700,"transcription factor activity, sequence-specific DNA binding",F
22727,88,3705,"transcription factor activity, RNA polymerase II distal enhancer sequence-specific binding",F
22726,88,3713,transcription coactivator activity,F
22725,88,42803,protein homodimerization activity,F
22724,88,5515,protein binding,F
22723,88,19900,kinase binding,F
22722,88,978,RNA polymerase II core promoter proximal region sequence-specific DNA binding,F
22721,88,3677,DNA binding,F
22684,89,71347,cellular response to interleukin-1,P
22681,89,6953,acute-phase response,P
22682,89,50873,brown fat cell differentiation,P
22683,89,71230,cellular response to amino acid stimulus,P
22680,89,44389,ubiquitin-like protein ligase binding,F
22679,89,1077,"transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding",F
22678,89,8134,transcription factor binding,F
22677,89,3700,"transcription factor activity, sequence-specific DNA binding",F
22676,89,3705,"transcription factor activity, RNA polymerase II distal enhancer sequence-specific binding",F
22675,89,42803,protein homodimerization activity,F
22674,89,46982,protein heterodimerization activity,F
22673,89,5515,protein binding,F
22672,89,19900,kinase binding,F
22671,89,42826,histone deacetylase binding,F
22670,89,35035,histone acetyltransferase binding,F
22669,89,35259,glucocorticoid receptor binding,F
22668,89,3682,chromatin binding,F
22667,89,977,RNA polymerase II regulatory region sequence-specific DNA binding,F
22666,89,979,RNA polymerase II core promoter sequence-specific DNA binding,F
22665,89,978,RNA polymerase II core promoter proximal region sequence-specific DNA binding,F
22664,89,3677,DNA binding,F
16334,216,43433,negative regulation of sequence-specific DNA binding transcription factor activity,P
16333,216,1903799,negative regulation of production of miRNAs involved in gene silencing by miRNA,P
16332,216,10629,negative regulation of gene expression,P
16331,216,43124,negative regulation of I-kappaB kinase/NF-kappaB signaling,P
16330,216,60745,mammary gland branching involved in pregnancy,P
16329,216,60749,mammary gland alveolus development,P
16328,216,8584,male gonad development,P
16327,216,30518,intracellular steroid hormone receptor signaling pathway,P
16326,216,30520,intracellular estrogen receptor signaling pathway,P
16325,216,60750,epithelial cell proliferation involved in mammary gland duct elongation,P
16324,216,2064,epithelial cell development,P
16323,216,6338,chromatin remodeling,P
16322,216,71391,cellular response to estrogen stimulus,P
16321,216,71392,cellular response to estradiol stimulus,P
16320,216,71392,cellular response to estradiol stimulus,P
16319,216,1547,antral ovarian follicle growth,P
16318,216,8209,androgen metabolic process,P
16317,216,8270,zinc ion binding,F
16316,216,1077,"transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding",F
16315,216,8134,transcription factor binding,F
16314,216,3700,"transcription factor activity, sequence-specific DNA binding",F
16313,216,3707,steroid hormone receptor activity,F
16312,216,5496,steroid binding,F
16311,216,5515,protein binding,F
16309,216,42802,identical protein binding,F
16310,216,30235,nitric-oxide synthase regulator activity,F
16308,216,34056,estrogen response element binding,F
16306,216,19899,enzyme binding,F
16307,216,30284,estrogen receptor activity,F
16305,216,1046,core promoter sequence-specific DNA binding,F
16303,216,8013,beta-catenin binding,F
16304,216,3682,chromatin binding,F
16302,216,38052,"RNA polymerase II transcription factor activity, estrogen-activated sequence-specific DNA binding",F
16301,216,38052,"RNA polymerase II transcription factor activity, estrogen-activated sequence-specific DNA binding",F
16300,216,978,RNA polymerase II core promoter proximal region sequence-specific DNA binding,F
16299,216,51117,ATPase binding,F
16242,217,10888,negative regulation of lipid storage,P
16241,217,2000486,negative regulation of glutamine transport,P
16240,217,46325,negative regulation of glucose import,P
16239,217,70093,negative regulation of glucagon secretion,P
16238,217,61037,negative regulation of cartilage development,P
16237,217,10507,negative regulation of autophagy,P
16236,217,38108,negative regulation of appetite by leptin-mediated signaling pathway,P
16235,217,38108,negative regulation of appetite by leptin-mediated signaling pathway,P
16234,217,32099,negative regulation of appetite,P
16233,217,43066,negative regulation of apoptotic process,P
16232,217,6629,lipid metabolic process,P
16231,217,50901,leukocyte tethering or rolling,P
16230,217,33210,leptin-mediated signaling pathway,P
16229,217,50892,intestinal absorption,P
16228,217,72606,interleukin-8 secretion,P
16227,217,72604,interleukin-6 secretion,P
16225,217,30073,insulin secretion,P
16226,217,32615,interleukin-12 production,P
16224,217,42445,hormone metabolic process,P
16223,217,6114,glycerol biosynthetic process,P
16222,217,6006,glucose metabolic process,P
16221,217,42593,glucose homeostasis,P
16220,217,7565,female pregnancy,P
16219,217,6635,fatty acid beta-oxidation,P
16218,217,6112,energy reserve metabolic process,P
16216,217,7623,circadian rhythm,P
16217,217,42755,eating behavior,P
16215,217,8203,cholesterol metabolic process,P
16214,217,21954,central nervous system neuron development,P
16213,217,71300,cellular response to retinoic acid,P
16212,217,44320,cellular response to leptin stimulus,P
16211,217,71298,cellular response to L-ascorbic acid,P
16210,217,3300,cardiac muscle hypertrophy,P
16209,217,35630,bone mineralization involved in bone maturation,P
16208,217,98868,bone growth,P
16207,217,8206,bile acid metabolic process,P
16206,217,1525,angiogenesis,P
16205,217,8343,adult feeding behavior,P
16204,217,60612,adipose tissue development,P
16203,217,1990051,activation of protein kinase C activity,P
16202,217,30217,T cell differentiation,P
16201,217,51428,peptide hormone receptor binding,F
16200,217,5179,hormone activity,F
16199,217,8083,growth factor activity,F
16181,218,6112,energy reserve metabolic process,P
16180,218,97009,energy homeostasis,P
16179,218,8203,cholesterol metabolic process,P
16178,218,7166,cell surface receptor signaling pathway,P
16177,218,98868,bone growth,P
16176,218,1525,angiogenesis,P
16175,218,30217,T cell differentiation,P
16174,218,4888,transmembrane signaling receptor activity,F
16173,218,5515,protein binding,F
16172,218,38021,leptin receptor activity,F
16163,219,35994,response to muscle stretch,P
16162,219,32495,response to muramyl dipeptide,P
16161,219,43330,response to exogenous dsRNA,P
16160,219,42127,regulation of cell proliferation,P
16159,219,42345,regulation of NF-kappaB import into nucleus,P
16158,219,60,"protein import into nucleus, translocation",P
16157,219,45944,positive regulation of transcription from RNA polymerase II promoter,P
16156,219,45944,positive regulation of transcription from RNA polymerase II promoter,P
16155,219,10875,positive regulation of cholesterol efflux,P
16154,219,32270,positive regulation of cellular protein metabolic process,P
16153,219,51092,positive regulation of NF-kappaB transcription factor activity,P
16152,219,70431,nucleotide-binding oligomerization domain containing 2 signaling pathway,P
16151,219,70427,nucleotide-binding oligomerization domain containing 1 signaling pathway,P
16150,219,45638,negative regulation of myeloid cell differentiation,P
16149,219,10745,negative regulation of macrophage derived foam cell differentiation,P
16148,219,10888,negative regulation of lipid storage,P
16147,219,43066,negative regulation of apoptotic process,P
16146,219,45746,negative regulation of Notch signaling pathway,P
16145,219,32088,negative regulation of NF-kappaB transcription factor activity,P
16144,219,43392,negative regulation of DNA binding,P
16143,219,97421,liver regeneration,P
16142,219,31663,lipopolysaccharide-mediated signaling pathway,P
16141,219,42994,cytoplasmic sequestering of transcription factor,P
16140,219,7253,cytoplasmic sequestering of NF-kappaB,P
16139,219,71407,cellular response to organic cyclic compound,P
16138,219,71345,cellular response to cytokine stimulus,P
16137,219,70417,cellular response to cold,P
16136,219,6915,apoptotic process,P
16135,219,50852,T cell receptor signaling pathway,P
16134,219,38095,Fc-epsilon receptor signaling pathway,P
16133,219,31625,ubiquitin protein ligase binding,F
16132,219,8134,transcription factor binding,F
16131,219,32403,protein complex binding,F
16130,219,5515,protein binding,F
16129,219,8139,nuclear localization sequence binding,F
16128,219,42802,identical protein binding,F
16127,219,31072,heat shock protein binding,F
16126,219,19899,enzyme binding,F
16125,219,51059,NF-kappaB binding,F
16124,219,51059,NF-kappaB binding,F
16087,220,1901216,positive regulation of neuron death,P
16086,220,1901216,positive regulation of neuron death,P
16085,220,1902998,positive regulation of neurofibrillary tangle assembly,P
16084,220,1902004,positive regulation of beta-amyloid formation,P
16083,220,51092,positive regulation of NF-kappaB transcription factor activity,P
16082,220,2576,platelet degranulation,P
16081,220,32463,negative regulation of protein homooligomerization,P
16080,220,1902230,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage,P
16079,220,1902430,negative regulation of beta-amyloid formation,P
16078,220,61518,microglial cell proliferation,P
16076,220,6629,lipid metabolic process,P
16077,220,1774,microglial cell activation,P
16074,220,6958,"complement activation, classical pathway",P
16075,220,45087,innate immune response,P
16073,220,6956,complement activation,P
16072,220,61077,chaperone-mediated protein folding,P
16071,220,51131,chaperone-mediated protein complex assembly,P
16070,220,32286,central nervous system myelin maintenance,P
16069,220,902,cell morphogenesis,P
16068,220,31625,ubiquitin protein ligase binding,F
16067,220,5515,protein binding,F
16066,220,51787,misfolded protein binding,F
16065,220,51787,misfolded protein binding,F
16064,220,51087,chaperone binding,F
16063,220,16887,ATPase activity,F
15989,221,30838,positive regulation of actin filament polymerization,P
15988,221,16310,phosphorylation,P
15987,221,48015,phosphatidylinositol-mediated signaling,P
15986,221,18107,peptidyl-threonine phosphorylation,P
15985,221,18105,peptidyl-serine phosphorylation,P
15984,221,31397,negative regulation of protein ubiquitination,P
15983,221,1933,negative regulation of protein phosphorylation,P
15982,221,14736,negative regulation of muscle atrophy,P
15981,221,16242,negative regulation of macroautophagy,P
15980,221,1904213,negative regulation of iodide transmembrane transport,P
15979,221,1904193,negative regulation of cholangiocyte apoptotic process,P
15978,221,45792,negative regulation of cell size,P
15977,221,10507,negative regulation of autophagy,P
15976,221,51534,negative regulation of NFAT protein import into nucleus,P
15975,221,35264,multicellular organism growth,P
15974,221,60135,maternal process involved in female pregnancy,P
15973,221,16236,macroautophagy,P
15972,221,48255,mRNA stabilization,P
15971,221,7616,long-term memory,P
15970,221,3179,heart valve morphogenesis,P
15969,221,3007,heart morphogenesis,P
15968,221,40007,growth,P
15967,221,7281,germ cell development,P
15966,221,6112,energy reserve metabolic process,P
15965,221,31669,cellular response to nutrient levels,P
15964,221,71456,cellular response to hypoxia,P
15963,221,16049,cell growth,P
15962,221,16049,cell growth,P
15960,221,7569,cell aging,P
15961,221,7050,cell cycle arrest,P
15959,221,60048,cardiac muscle contraction,P
15958,221,55013,cardiac muscle cell development,P
15957,221,7420,brain development,P
15955,221,38202,TORC1 signaling,P
15956,221,6914,autophagy,P
15954,221,31929,TOR signaling,P
15953,221,31295,T cell costimulation,P
15952,221,6281,DNA repair,P
15951,221,6207,'de novo' pyrimidine nucleobase biosynthetic process,P
15950,221,43022,ribosome binding,F
15949,221,4674,protein serine/threonine kinase activity,F
15948,221,4674,protein serine/threonine kinase activity,F
15947,221,4674,protein serine/threonine kinase activity,F
15946,221,19901,protein kinase binding,F
15945,221,4672,protein kinase activity,F
15944,221,19904,protein domain specific binding,F
15943,221,5515,protein binding,F
15942,221,51219,phosphoprotein binding,F
15941,221,16301,kinase activity,F
15940,221,16301,kinase activity,F
15939,221,1156,TFIIIC-class transcription factor binding,F
15938,221,1032,RNA polymerase III type 3 promoter DNA binding,F
15937,221,1031,RNA polymerase III type 2 promoter DNA binding,F
15936,221,1030,RNA polymerase III type 1 promoter DNA binding,F
15935,221,5524,ATP binding,F
15917,222,40018,positive regulation of multicellular organism growth,P
15916,222,43568,positive regulation of insulin-like growth factor receptor signaling pathway,P
15915,222,60124,positive regulation of growth hormone secretion,P
15914,222,46010,"positive regulation of circadian sleep/wake cycle, non-REM sleep",P
15913,222,8284,positive regulation of cell proliferation,P
15912,222,30819,positive regulation of cAMP biosynthetic process,P
15911,222,48609,multicellular organismal reproductive process,P
15910,222,7595,lactation,P
15909,222,42445,hormone metabolic process,P
15908,222,30252,growth hormone secretion,P
15907,222,8340,determination of adult lifespan,P
15906,222,32869,cellular response to insulin stimulus,P
15905,222,71333,cellular response to glucose stimulus,P
15903,222,48469,cell maturation,P
15904,222,7166,cell surface receptor signaling pathway,P
15902,222,19933,cAMP-mediated signaling,P
15901,222,7189,adenylate cyclase-activating G-protein coupled receptor signaling pathway,P
15900,222,7190,activation of adenylate cyclase activity,P
15899,222,5515,protein binding,F
15898,222,17046,peptide hormone binding,F
15897,222,16520,growth hormone-releasing hormone receptor activity,F
15896,222,19838,growth factor binding,F
15895,222,4930,G-protein coupled receptor activity,F
15745,223,1990791,dorsal root ganglion development,P
15744,223,1904888,cranial skeletal system development,P
15743,223,61550,cranial ganglion development,P
15742,223,48096,chromatin-mediated maintenance of transcription,P
15741,223,7268,chemical synaptic transmission,P
15740,223,22009,central nervous system vasculogenesis,P
15739,223,71681,cellular response to indole-3-methanol,P
15738,223,71363,cellular response to growth factor stimulus,P
15737,223,7160,cell-matrix adhesion,P
15736,223,904,cell morphogenesis involved in differentiation,P
15735,223,48469,cell maturation,P
15734,223,1708,cell fate specification,P
15733,223,7155,cell adhesion,P
15732,223,35411,catenin import into nucleus,P
15731,223,44334,canonical Wnt signaling pathway involved in positive regulation of epithelial to mesenchymal transition,P
15730,223,61324,canonical Wnt signaling pathway involved in positive regulation of cardiac outflow tract cell proliferation,P
15729,223,44336,canonical Wnt signaling pathway involved in negative regulation of apoptotic process,P
15728,223,1904954,canonical Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation,P
15727,223,60070,canonical Wnt signaling pathway,P
15725,223,1569,branching involved in blood vessel morphogenesis,P
15726,223,1658,branching involved in ureteric bud morphogenesis,P
15723,223,1904837,beta-catenin-TCF complex assembly,P
15724,223,45453,bone resorption,P
15722,223,1904886,beta-catenin destruction complex disassembly,P
15721,223,9948,anterior/posterior axis specification,P
15720,223,30521,androgen receptor signaling pathway,P
15719,223,34333,adherens junction assembly,P
15718,223,7223,"Wnt signaling pathway, calcium modulating pathway",P
15717,223,16055,Wnt signaling pathway,P
15716,223,16055,Wnt signaling pathway,P
15715,223,33077,T cell differentiation in thymus,P
15714,223,44212,transcription regulatory region DNA binding,F
15713,223,44212,transcription regulatory region DNA binding,F
15712,223,8134,transcription factor binding,F
15711,223,8134,transcription factor binding,F
15710,223,3700,"transcription factor activity, sequence-specific DNA binding",F
15709,223,3713,transcription coactivator activity,F
15708,223,3713,transcription coactivator activity,F
15707,223,4871,signal transducer activity,F
15706,223,70491,repressing transcription factor binding,F
15705,223,19903,protein phosphatase binding,F
15704,223,19901,protein kinase binding,F
15703,223,46982,protein heterodimerization activity,F
15702,223,5515,protein binding,F
15701,223,8022,protein C-terminus binding,F
15700,223,35257,nuclear hormone receptor binding,F
15699,223,35257,nuclear hormone receptor binding,F
15698,223,19900,kinase binding,F
15697,223,44325,ion channel binding,F
15696,223,30331,estrogen receptor binding,F
15695,223,19899,enzyme binding,F
15694,223,3690,double-stranded DNA binding,F
15693,223,3682,chromatin binding,F
15692,223,98641,cadherin binding involved in cell-cell adhesion,F
15691,223,45296,cadherin binding,F
15690,223,50681,androgen receptor binding,F
15689,223,45294,alpha-catenin binding,F
15688,223,46332,SMAD binding,F
15687,223,1085,RNA polymerase II transcription factor binding,F
15685,223,70411,I-SMAD binding,F
15686,223,1102,RNA polymerase II activating transcription factor binding,F
15806,223,60769,positive regulation of epithelial cell proliferation involved in prostate gland development,P
15805,223,45603,positive regulation of endothelial cell differentiation,P
15804,223,2000017,positive regulation of determination of dorsal identity,P
15803,223,1904798,positive regulation of core promoter binding,P
15802,223,1904501,positive regulation of chromatin-mediated maintenance of transcription,P
15801,223,43065,positive regulation of apoptotic process,P
15800,223,43410,positive regulation of MAPK cascade,P
15799,223,43123,positive regulation of I-kappaB kinase/NF-kappaB signaling,P
15798,223,2000144,"positive regulation of DNA-templated transcription, initiation",P
15797,223,31016,pancreas development,P
15796,223,60066,oviduct development,P
15795,223,30316,osteoclast differentiation,P
15794,223,48599,oocyte development,P
15793,223,42475,odontogenesis of dentin-containing tooth,P
15792,223,1764,neuron migration,P
15791,223,1840,neural plate development,P
15790,223,72079,nephron tubule formation,P
15789,223,45892,"negative regulation of transcription, DNA-templated",P
15788,223,122,negative regulation of transcription from RNA polymerase II promoter,P
15787,223,33234,negative regulation of protein sumoylation,P
15786,223,1903204,negative regulation of oxidative stress-induced neuron death,P
15785,223,45671,negative regulation of osteoclast differentiation,P
15784,223,48715,negative regulation of oligodendrocyte differentiation,P
15783,223,45976,"negative regulation of mitotic cell cycle, embryonic",P
15782,223,3340,negative regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis,P
15781,223,32331,negative regulation of chondrocyte differentiation,P
15780,223,8285,negative regulation of cell proliferation,P
15779,223,2001234,negative regulation of apoptotic signaling pathway,P
15778,223,1904948,midbrain dopaminergic neuron differentiation,P
15777,223,3338,metanephros morphogenesis,P
15776,223,60916,mesenchymal cell proliferation involved in lung development,P
15775,223,30539,male genitalia development,P
15774,223,60484,lung-associated mesenchyme development,P
15773,223,60492,lung induction,P
15772,223,60479,lung cell differentiation,P
15771,223,2089,lens morphogenesis in camera-type eye,P
15770,223,21819,layer formation in cerebral cortex,P
15769,223,1701,in utero embryonic development,P
15768,223,30902,hindbrain development,P
15767,223,60789,hair follicle placode formation,P
15766,223,31069,hair follicle morphogenesis,P
15765,223,35315,hair cell differentiation,P
15764,223,7403,glial cell fate determination,P
15763,223,35112,genitalia morphogenesis,P
15762,223,1702,gastrulation with mouth forming second,P
15761,223,61198,fungiform papilla formation,P
15760,223,60441,epithelial tube branching involved in lung morphogenesis,P
15759,223,1837,epithelial to mesenchymal transition,P
15758,223,60742,epithelial cell differentiation involved in prostate gland development,P
15757,223,61154,endothelial tube morphogenesis,P
15756,223,1711,endodermal cell fate commitment,P
15755,223,36023,embryonic skeletal limb joint morphogenesis,P
15754,223,35116,embryonic hindlimb morphogenesis,P
15753,223,35050,embryonic heart tube development,P
15752,223,35115,embryonic forelimb morphogenesis,P
15751,223,48617,embryonic foregut morphogenesis,P
15750,223,42733,embryonic digit morphogenesis,P
15749,223,1990403,embryonic brain development,P
15748,223,578,embryonic axis specification,P
15747,223,7398,ectoderm development,P
15746,223,9950,dorsal/ventral axis specification,P
15582,224,8013,beta-catenin binding,F
15581,224,4190,aspartic-type endopeptidase activity,F
15580,224,30165,PDZ domain binding,F
15642,224,43393,regulation of protein binding,P
15641,224,42325,regulation of phosphorylation,P
15640,224,15031,protein transport,P
15639,224,16485,protein processing,P
15638,224,6486,protein glycosylation,P
15637,224,9791,post-embryonic development,P
15636,224,45893,"positive regulation of transcription, DNA-templated",P
15635,224,1921,positive regulation of receptor recycling,P
15634,224,32436,positive regulation of proteasomal ubiquitin-dependent protein catabolic process,P
15633,224,60999,positive regulation of dendritic spine development,P
15632,224,50820,positive regulation of coagulation,P
15631,224,43085,positive regulation of catalytic activity,P
15630,224,43065,positive regulation of apoptotic process,P
15629,224,43406,positive regulation of MAP kinase activity,P
15628,224,1764,neuron migration,P
15627,224,48666,neuron development,P
15626,224,51402,neuron apoptotic process,P
15625,224,3407,neural retina development,P
15624,224,51444,negative regulation of ubiquitin-protein transferase activity,P
15623,224,122,negative regulation of transcription from RNA polymerase II promoter,P
15622,224,2000059,negative regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process,P
15621,224,43524,negative regulation of neuron apoptotic process,P
15620,224,7175,negative regulation of epidermal growth factor-activated receptor activity,P
15619,224,50771,negative regulation of axonogenesis,P
15618,224,2001234,negative regulation of apoptotic signaling pathway,P
15617,224,43066,negative regulation of apoptotic process,P
15616,224,43011,myeloid dendritic cell differentiation,P
15615,224,6839,mitochondrial transport,P
15614,224,7613,memory,P
15613,224,6509,membrane protein ectodomain proteolysis,P
15612,224,35556,intracellular signal transduction,P
15610,224,1947,heart looping,P
15611,224,2244,hematopoietic progenitor cell differentiation,P
15609,224,50673,epithelial cell proliferation,P
15608,224,32469,endoplasmic reticulum calcium ion homeostasis,P
15607,224,32469,endoplasmic reticulum calcium ion homeostasis,P
15606,224,30326,embryonic limb morphogenesis,P
15605,224,21904,dorsal/ventral neural tube patterning,P
15604,224,15871,choline transport,P
15603,224,21795,cerebral cortex cell migration,P
15602,224,6974,cellular response to DNA damage stimulus,P
15601,224,1708,cell fate specification,P
15600,224,60070,canonical Wnt signaling pathway,P
15599,224,70588,calcium ion transmembrane transport,P
15598,224,48854,brain morphogenesis,P
15597,224,1568,blood vessel development,P
15596,224,34205,beta-amyloid formation,P
15595,224,45,autophagosome assembly,P
15594,224,42987,amyloid precursor protein catabolic process,P
15593,224,186,activation of MAPKK activity,P
15592,224,50852,T cell receptor signaling pathway,P
15591,224,2286,T cell activation involved in immune response,P
15590,224,7219,Notch signaling pathway,P
15589,224,7220,Notch receptor processing,P
15588,224,15813,L-glutamate transport,P
15587,224,21870,Cajal-Retzius cell differentiation,P
15586,224,5515,protein binding,F
15585,224,4175,endopeptidase activity,F
15584,224,5262,calcium channel activity,F
15583,224,45296,cadherin binding,F
15576,225,48339,paraxial mesoderm development,P
15575,225,50768,negative regulation of neurogenesis,P
15574,225,7386,compartment pattern specification,P
15573,225,7219,Notch signaling pathway,P
15572,225,5509,calcium ion binding,F
15571,225,5112,Notch binding,F
15652,224,16080,synaptic vesicle targeting,P
15651,224,1756,somitogenesis,P
15650,224,51563,smooth endoplasmic reticulum calcium ion homeostasis,P
15649,224,43589,skin morphogenesis,P
15648,224,48705,skeletal system morphogenesis,P
15647,224,16337,single organismal cell-cell adhesion,P
15646,224,6979,response to oxidative stress,P
15644,224,48167,regulation of synaptic plasticity,P
15645,224,51966,"regulation of synaptic transmission, glutamatergic",P
15643,224,60075,regulation of resting membrane potential,P
15579,225,16021,integral component of membrane,C
15578,225,1756,somitogenesis,P
15577,225,1501,skeletal system development,P
15570,226,35985,senescence-associated heterochromatin focus,C
15569,226,5634,nucleus,C
15568,226,5829,cytosol,C
15567,226,5737,cytoplasm,C
15565,226,90399,replicative senescence,P
15566,226,35986,senescence-associated heterochromatin focus assembly,P
15564,226,34393,positive regulation of smooth muscle cell apoptotic process,P
15563,226,2000111,positive regulation of macrophage apoptotic process,P
15562,226,2000774,positive regulation of cellular senescence,P
15560,226,42326,negative regulation of phosphorylation,P
15561,226,45892,"negative regulation of transcription, DNA-templated",P
15559,226,45736,negative regulation of cyclin-dependent protein serine/threonine kinase activity,P
15558,226,1953,negative regulation of cell-matrix adhesion,P
15557,226,8285,negative regulation of cell proliferation,P
15556,226,8285,negative regulation of cell proliferation,P
15555,226,30308,negative regulation of cell growth,P
15554,226,32088,negative regulation of NF-kappaB transcription factor activity,P
15553,226,90398,cellular senescence,P
15552,226,7050,cell cycle arrest,P
15551,226,7050,cell cycle arrest,P
15550,226,7265,Ras protein signal transduction,P
15549,226,82,G1/S transition of mitotic cell cycle,P
15548,226,19901,protein kinase binding,F
15547,226,5515,protein binding,F
15546,226,44822,poly(A) RNA binding,F
15545,226,4861,cyclin-dependent protein serine/threonine kinase inhibitor activity,F
15544,226,51059,NF-kappaB binding,F
15490,228,61351,neural precursor cell proliferation,P
15489,228,32507,maintenance of protein location in cell,P
15488,228,98609,cell-cell adhesion,P
15487,228,10644,cell communication by electrical coupling,P
15486,228,10643,cell communication by chemical coupling,P
15485,228,7015,actin filament organization,P
15484,228,5515,protein binding,F
15483,228,5522,profilin binding,F
15482,228,98641,cadherin binding involved in cell-cell adhesion,F
15481,228,3779,actin binding,F
15454,229,60394,negative regulation of pathway-restricted SMAD protein phosphorylation,P
15453,229,60394,negative regulation of pathway-restricted SMAD protein phosphorylation,P
15452,229,45668,negative regulation of osteoblast differentiation,P
15451,229,1905006,negative regulation of epithelial to mesenchymal transition involved in endocardial cushion formation,P
15450,229,60302,negative regulation of cytokine activity,P
15449,229,30336,negative regulation of cell migration,P
15448,229,61037,negative regulation of cartilage development,P
15447,229,60044,negative regulation of cardiac muscle cell proliferation,P
15446,229,90090,negative regulation of canonical Wnt signaling pathway,P
15445,229,48712,negative regulation of astrocyte differentiation,P
15444,229,2001234,negative regulation of apoptotic signaling pathway,P
15443,229,30514,negative regulation of BMP signaling pathway,P
15442,229,30514,negative regulation of BMP signaling pathway,P
15441,229,8045,motor neuron axon guidance,P
15439,229,1707,mesoderm formation,P
15440,229,42474,middle ear morphogenesis,P
15438,229,3149,membranous septum morphogenesis,P
15437,229,60425,lung morphogenesis,P
15436,229,60173,limb development,P
15435,229,1701,in utero embryonic development,P
15434,229,61384,heart trabecula morphogenesis,P
15433,229,60825,fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation,P
15432,229,60325,face morphogenesis,P
15431,229,1837,epithelial to mesenchymal transition,P
15430,229,1706,endoderm formation,P
15429,229,3203,endocardial cushion morphogenesis,P
15428,229,48706,embryonic skeletal system development,P
15427,229,60272,embryonic skeletal joint morphogenesis,P
15426,229,42733,embryonic digit morphogenesis,P
15425,229,9953,dorsal/ventral pattern formation,P
15424,229,21533,cell differentiation in hindbrain,P
15422,229,48318,axial mesoderm development,P
15423,229,51216,cartilage development,P
15421,229,55009,atrial cardiac muscle tissue morphogenesis,P
15420,229,61312,BMP signaling pathway involved in heart development,P
15419,229,30509,BMP signaling pathway,P
15418,229,42803,protein homodimerization activity,F
15416,229,19955,cytokine binding,F
15417,229,5515,protein binding,F
15415,230,5578,proteinaceous extracellular matrix,C
15414,230,5576,extracellular region,C
15413,230,71953,elastic fiber,C
15412,230,7585,respiratory gaseous exchange,P
15411,230,30198,extracellular matrix organization,P
15410,230,22617,extracellular matrix disassembly,P
15409,230,8283,cell proliferation,P
15408,230,8015,blood circulation,P
15407,230,9887,animal organ morphogenesis,P
15406,230,5515,protein binding,F
15405,230,5201,extracellular matrix structural constituent,F
15518,227,5977,glycogen metabolic process,P
15517,227,43153,entrainment of circadian clock by photoperiod,P
15516,227,16311,dephosphorylation,P
15515,227,32922,circadian regulation of gene expression,P
15514,227,51301,cell division,P
15513,227,7049,cell cycle,P
15512,227,48754,branching morphogenesis of an epithelial tube,P
15511,227,1904886,beta-catenin destruction complex disassembly,P
15510,227,43021,ribonucleoprotein complex binding,F
15509,227,4722,protein serine/threonine phosphatase activity,F
15508,227,8157,protein phosphatase 1 binding,F
15507,227,32403,protein complex binding,F
15506,227,5515,protein binding,F
15505,227,4721,phosphoprotein phosphatase activity,F
15504,227,16791,phosphatase activity,F
15503,227,46872,metal ion binding,F
16882,205,48312,intracellular distribution of mitochondria,P
16881,205,48699,generation of neurons,P
16880,205,31122,cytoplasmic microtubule organization,P
16879,205,34605,cellular response to heat,P
16878,205,19896,axonal transport of mitochondrion,P
16877,205,98930,axonal transport,P
16876,205,48143,astrocyte activation,P
16875,205,6919,activation of cysteine-type endopeptidase activity involved in apoptotic process,P
16874,205,48018,receptor agonist activity,F
16873,205,48018,receptor agonist activity,F
16872,205,51721,protein phosphatase 2A binding,F
16871,205,5515,protein binding,F
16870,205,8017,microtubule binding,F
16869,205,8017,microtubule binding,F
16868,205,71813,lipoprotein particle binding,F
16867,205,19899,enzyme binding,F
16866,205,34452,dynactin binding,F
16865,205,34185,apolipoprotein binding,F
16864,205,3779,actin binding,F
16863,205,17124,SH3 domain binding,F
16862,205,51879,Hsp90 protein binding,F
16861,205,3677,DNA binding,F
15364,232,7584,response to nutrient,P
15363,232,32868,response to insulin,P
15362,232,1666,response to hypoxia,P
15361,232,51384,response to glucocorticoid,P
15360,232,9409,response to cold,P
15359,232,14823,response to activity,P
15358,232,7585,respiratory gaseous exchange,P
15357,232,15992,proton transport,P
15356,232,6839,mitochondrial transport,P
15355,232,6629,lipid metabolic process,P
15354,232,6631,fatty acid metabolic process,P
15353,232,32870,cellular response to hormone stimulus,P
15352,232,7568,aging,P
15351,232,5215,transporter activity,F
15350,232,5515,protein binding,F
15349,232,17077,oxidative phosphorylation uncoupler activity,F
15344,233,6508,proteolysis,P
15343,233,30327,prenylated protein catabolic process,P
15342,233,6998,nuclear envelope organization,P
15341,233,71586,CAAX-box protein processing,P
15340,233,8235,metalloexopeptidase activity,F
15339,233,4222,metalloendopeptidase activity,F
15338,233,46872,metal ion binding,F
15301,234,2053,positive regulation of mesenchymal cell proliferation,P
15302,234,45669,positive regulation of osteoblast differentiation,P
15300,234,10838,positive regulation of keratinocyte proliferation,P
15299,234,2000271,positive regulation of fibroblast apoptotic process,P
15298,234,45747,positive regulation of Notch signaling pathway,P
15297,234,30859,polarized epithelial cell differentiation,P
15296,234,42475,odontogenesis of dentin-containing tooth,P
15295,234,51402,neuron apoptotic process,P
15294,234,45892,"negative regulation of transcription, DNA-templated",P
15293,234,122,negative regulation of transcription from RNA polymerase II promoter,P
15292,234,2000381,negative regulation of mesoderm development,P
15291,234,45617,negative regulation of keratinocyte differentiation,P
15290,234,43066,negative regulation of apoptotic process,P
15289,234,10259,multicellular organism aging,P
15288,234,31571,mitotic G1 DNA damage checkpoint,P
15287,234,43616,keratinocyte proliferation,P
15286,234,30216,keratinocyte differentiation,P
15285,234,42771,intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator,P
15284,234,31069,hair follicle morphogenesis,P
15283,234,48807,female genitalia morphogenesis,P
15282,234,61436,establishment of skin barrier,P
15281,234,1736,establishment of planar polarity,P
15280,234,2064,epithelial cell development,P
15279,234,10481,epidermal cell division,P
15278,234,30326,embryonic limb morphogenesis,P
15277,234,7499,ectoderm and mesoderm interaction,P
15276,234,60197,cloacal septation,P
15275,234,6338,chromatin remodeling,P
15274,234,34644,cellular response to UV,P
15273,234,6915,apoptotic process,P
15272,234,7219,Notch signaling pathway,P
15271,234,6978,"DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator",P
15270,234,1077,"transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding",F
15269,234,44212,transcription regulatory region DNA binding,F
15268,234,989,"transcription factor activity, transcription factor binding",F
15267,234,3700,"transcription factor activity, sequence-specific DNA binding",F
15266,234,43565,sequence-specific DNA binding,F
15264,234,2039,p53 binding,F
15265,234,5515,protein binding,F
15263,234,46872,metal ion binding,F
15262,234,42802,identical protein binding,F
15261,234,3690,double-stranded DNA binding,F
15260,234,3684,damaged DNA binding,F
15259,234,3682,chromatin binding,F
15258,234,50699,WW domain binding,F
15257,234,3677,DNA binding,F
15246,235,43066,negative regulation of apoptotic process,P
15245,235,6839,mitochondrial transport,P
15244,235,97421,liver regeneration,P
15243,235,7565,female pregnancy,P
15242,235,32869,cellular response to insulin stimulus,P
15241,235,71333,cellular response to glucose stimulus,P
15240,235,34198,cellular response to amino acid starvation,P
15239,235,7568,aging,P
15238,235,5515,protein binding,F
15214,236,6288,"base-excision repair, DNA ligation",P
15213,236,6284,base-excision repair,P
15212,236,6284,base-excision repair,P
15211,236,7568,aging,P
15210,236,6261,DNA-dependent DNA replication,P
15209,236,6281,DNA repair,P
15208,236,71897,DNA biosynthetic process,P
15207,236,5515,protein binding,F
15206,236,8017,microtubule binding,F
15205,236,46872,metal ion binding,F
15204,236,16829,lyase activity,F
15203,236,19899,enzyme binding,F
15202,236,3684,damaged DNA binding,F
15201,236,3887,DNA-directed DNA polymerase activity,F
15200,236,3887,DNA-directed DNA polymerase activity,F
15199,236,3906,DNA-(apurinic or apyrimidinic site) lyase activity,F
15175,237,6750,glutathione biosynthetic process,P
15174,237,6750,glutathione biosynthetic process,P
15173,237,6750,glutathione biosynthetic process,P
15172,237,6750,glutathione biosynthetic process,P
15171,237,6536,glutamate metabolic process,P
15170,237,6534,cysteine metabolic process,P
15169,237,97069,cellular response to thyroxine stimulus,P
15168,237,71260,cellular response to mechanical stimulus,P
15167,237,32869,cellular response to insulin stimulus,P
15166,237,35729,cellular response to hepatocyte growth factor stimulus,P
15165,237,71333,cellular response to glucose stimulus,P
15164,237,71372,cellular response to follicle-stimulating hormone stimulus,P
15163,237,44344,cellular response to fibroblast growth factor stimulus,P
15161,237,8637,apoptotic mitochondrial changes,P
15162,237,45454,cell redox homeostasis,P
15160,237,7568,aging,P
15159,237,19852,L-ascorbic acid metabolic process,P
15158,237,46982,protein heterodimerization activity,F
15157,237,287,magnesium ion binding,F
15156,237,4357,glutamate-cysteine ligase activity,F
15155,237,4357,glutamate-cysteine ligase activity,F
15154,237,16595,glutamate binding,F
15153,237,50662,coenzyme binding,F
15152,237,5524,ATP binding,F
15151,237,43531,ADP binding,F
15133,238,6750,glutathione biosynthetic process,P
15132,238,6750,glutathione biosynthetic process,P
15131,238,6750,glutathione biosynthetic process,P
15130,238,6536,glutamate metabolic process,P
15129,238,6534,cysteine metabolic process,P
15128,238,97069,cellular response to thyroxine stimulus,P
15127,238,35729,cellular response to hepatocyte growth factor stimulus,P
15126,238,71333,cellular response to glucose stimulus,P
15125,238,71372,cellular response to follicle-stimulating hormone stimulus,P
15124,238,44344,cellular response to fibroblast growth factor stimulus,P
15123,238,8637,apoptotic mitochondrial changes,P
15122,238,7568,aging,P
15121,238,46982,protein heterodimerization activity,F
15120,238,35226,glutamate-cysteine ligase catalytic subunit binding,F
15119,238,4357,glutamate-cysteine ligase activity,F
15118,238,4357,glutamate-cysteine ligase activity,F
15117,238,30234,enzyme regulator activity,F
15085,239,5515,protein binding,F
15084,239,3682,chromatin binding,F
15083,239,34979,NAD-dependent protein deacetylase activity,F
15082,239,46969,NAD-dependent histone deacetylase activity (H3-K9 specific),F
15081,239,17136,NAD-dependent histone deacetylase activity,F
15080,239,70403,NAD+ binding,F
15079,239,3950,NAD+ ADP-ribosyltransferase activity,F
15078,239,3956,NAD(P)+-protein-arginine ADP-ribosyltransferase activity,F
15068,240,43161,proteasome-mediated ubiquitin-dependent protein catabolic process,P
15067,240,51437,positive regulation of ubiquitin-protein ligase activity involved in regulation of mitotic cell cycle transition,P
15066,240,51436,negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle,P
15065,240,7094,mitotic spindle assembly checkpoint,P
15063,240,51321,meiotic cell cycle,P
15064,240,70,mitotic sister chromatid segregation,P
15062,240,51301,cell division,P
15061,240,8608,attachment of spindle microtubules to kinetochore,P
15060,240,31145,anaphase-promoting complex-dependent catabolic process,P
15059,240,43130,ubiquitin binding,F
15058,240,5515,protein binding,F
15048,241,6409,tRNA export from nucleus,P
15047,241,10827,regulation of glucose transport,P
15046,241,1900034,regulation of cellular response to heat,P
15045,241,16925,protein sumoylation,P
15044,241,6606,protein import into nucleus,P
15043,241,7077,mitotic nuclear envelope disassembly,P
15042,241,6406,mRNA export from nucleus,P
15041,241,75733,intracellular transport of virus,P
15040,241,31047,gene silencing by RNA,P
15039,241,71407,cellular response to organic cyclic compound,P
15038,241,43130,ubiquitin binding,F
15037,241,8017,microtubule binding,F
15036,241,3723,RNA binding,F
15032,242,7283,spermatogenesis,P
15031,242,7218,neuropeptide signaling pathway,P
15030,242,7275,multicellular organism development,P
15029,242,7631,feeding behavior,P
15028,242,7268,chemical synaptic transmission,P
15027,242,30154,cell differentiation,P
15026,242,30354,melanin-concentrating hormone activity,F
22805,87,34122,negative regulation of toll-like receptor signaling pathway,P
22804,87,6469,negative regulation of protein kinase activity,P
22803,87,43524,negative regulation of neuron apoptotic process,P
22802,87,10667,negative regulation of cardiac muscle cell apoptotic process,P
22801,87,35556,intracellular signal transduction,P
22800,87,35556,intracellular signal transduction,P
22799,87,6972,hyperosmotic response,P
22798,87,48041,focal adhesion assembly,P
22797,87,97191,extrinsic apoptotic signaling pathway,P
22796,87,7173,epidermal growth factor receptor signaling pathway,P
22795,87,32869,cellular response to insulin stimulus,P
22794,87,71364,cellular response to epidermal growth factor stimulus,P
22792,87,16477,cell migration,P
22793,87,1990416,cellular response to brain-derived neurotrophic factor stimulus,P
22791,87,19722,calcium-mediated signaling,P
22789,87,30036,actin cytoskeleton organization,P
22790,87,32148,activation of protein kinase B activity,P
22788,87,50852,T cell receptor signaling pathway,P
22787,87,31295,T cell costimulation,P
22786,87,38095,Fc-epsilon receptor signaling pathway,P
22785,87,4674,protein serine/threonine kinase activity,F
22784,87,4674,protein serine/threonine kinase activity,F
22783,87,4674,protein serine/threonine kinase activity,F
22782,87,4674,protein serine/threonine kinase activity,F
22781,87,19901,protein kinase binding,F
22780,87,5515,protein binding,F
22779,87,43274,phospholipase binding,F
22778,87,16004,phospholipase activator activity,F
22777,87,16301,kinase activity,F
22776,87,5158,insulin receptor binding,F
22775,87,5524,ATP binding,F
22774,87,4676,3-phosphoinositide-dependent protein kinase activity,F
15385,231,97695,establishment of macromolecular complex localization to telomere,P
15384,231,97694,establishment of RNA localization to telomere,P
15383,231,71480,cellular response to gamma radiation,P
15382,231,34644,cellular response to UV,P
15381,231,6974,cellular response to DNA damage stimulus,P
15380,231,7049,cell cycle,P
15379,231,6260,DNA replication,P
15378,231,6281,DNA repair,P
15377,231,77,DNA damage checkpoint,P
15376,231,4674,protein serine/threonine kinase activity,F
15374,231,4672,protein kinase activity,F
15375,231,4674,protein serine/threonine kinase activity,F
15373,231,5515,protein binding,F
15372,231,32407,MutSalpha complex binding,F
15371,231,32405,MutLalpha complex binding,F
15370,231,3677,DNA binding,F
15369,231,5524,ATP binding,F
15012,243,289,nuclear-transcribed mRNA poly(A) tail shortening,P
15011,243,45950,negative regulation of mitotic recombination,P
15010,243,6298,mismatch repair,P
15009,243,6298,mismatch repair,P
15008,243,45141,meiotic telomere clustering,P
15007,243,51257,meiotic spindle midzone assembly,P
15006,243,43060,meiotic metaphase I plate congression,P
15005,243,7060,male meiosis chromosome segregation,P
15004,243,45190,isotype switching,P
15003,243,8630,intrinsic apoptotic signaling pathway in response to DNA damage,P
15002,243,16321,female meiosis chromosome segregation,P
15001,243,6303,double-strand break repair via nonhomologous end joining,P
15000,243,3697,single-stranded DNA binding,F
14999,243,5515,protein binding,F
14998,243,5515,protein binding,F
14997,243,32137,guanine/thymine mispair binding,F
14996,243,3682,chromatin binding,F
14995,243,32407,MutSalpha complex binding,F
14994,243,16887,ATPase activity,F
14993,243,5524,ATP binding,F
21913,102,6641,triglyceride metabolic process,P
21912,102,70328,triglyceride homeostasis,P
21911,102,19433,triglyceride catabolic process,P
21910,102,43691,reverse cholesterol transport,P
21909,102,1523,retinoid metabolic process,P
21908,102,32489,regulation of Cdc42 protein signal transduction,P
21907,102,33700,phospholipid efflux,P
21906,102,10903,negative regulation of very-low-density lipoprotein particle remodeling,P
21905,102,10903,negative regulation of very-low-density lipoprotein particle remodeling,P
21904,102,10916,negative regulation of very-low-density lipoprotein particle clearance,P
21903,102,10897,negative regulation of triglyceride catabolic process,P
21902,102,48261,negative regulation of receptor-mediated endocytosis,P
21901,102,10989,negative regulation of low-density lipoprotein particle clearance,P
21900,102,51005,negative regulation of lipoprotein lipase activity,P
21899,102,45833,negative regulation of lipid metabolic process,P
21898,102,50995,negative regulation of lipid catabolic process,P
21897,102,10987,negative regulation of high-density lipoprotein particle clearance,P
21896,102,45717,negative regulation of fatty acid biosynthetic process,P
21895,102,60621,negative regulation of cholesterol import,P
21894,102,42157,lipoprotein metabolic process,P
21893,102,34375,high-density lipoprotein particle remodeling,P
21892,102,34382,chylomicron remnant clearance,P
21891,102,42632,cholesterol homeostasis,P
21890,102,33344,cholesterol efflux,P
21889,102,7186,G-protein coupled receptor signaling pathway,P
21888,102,5543,phospholipid binding,F
21887,102,55102,lipase inhibitor activity,F
21886,102,70653,high-density lipoprotein particle receptor binding,F
21885,102,30234,enzyme regulator activity,F
21884,102,15485,cholesterol binding,F
14966,244,1990090,cellular response to nerve growth factor stimulus,P
14965,244,34613,cellular protein localization,P
14964,244,16055,Wnt signaling pathway,P
14963,244,86,G2/M transition of mitotic cell cycle,P
14962,244,6281,DNA repair,P
14961,244,4674,protein serine/threonine kinase activity,F
14959,244,4672,protein kinase activity,F
14960,244,4674,protein serine/threonine kinase activity,F
14958,244,4672,protein kinase activity,F
14957,244,5515,protein binding,F
14956,244,44822,poly(A) RNA binding,F
14955,244,5524,ATP binding,F
14922,245,30968,endoplasmic reticulum unfolded protein response,P
14921,245,71218,cellular response to misfolded protein,P
14920,245,38128,ERBB2 signaling pathway,P
14919,245,36503,ERAD pathway,P
14918,245,6281,DNA repair,P
14917,245,34450,ubiquitin-ubiquitin ligase activity,F
14916,245,4842,ubiquitin-protein transferase activity,F
14915,245,4842,ubiquitin-protein transferase activity,F
14914,245,4842,ubiquitin-protein transferase activity,F
14913,245,31625,ubiquitin protein ligase binding,F
14912,245,1904264,ubiquitin protein ligase activity involved in ERAD pathway,F
14911,245,61630,ubiquitin protein ligase activity,F
14909,245,42803,protein homodimerization activity,F
14910,245,61630,ubiquitin protein ligase activity,F
14908,245,42803,protein homodimerization activity,F
14907,245,30674,"protein binding, bridging",F
14906,245,5515,protein binding,F
14905,245,51787,misfolded protein binding,F
14904,245,16874,ligase activity,F
14903,245,19900,kinase binding,F
14902,245,19899,enzyme binding,F
14900,245,46332,SMAD binding,F
14901,245,30911,TPR domain binding,F
14899,245,46332,SMAD binding,F
14898,245,51879,Hsp90 protein binding,F
14897,245,30544,Hsp70 protein binding,F
14896,245,30544,Hsp70 protein binding,F
14895,245,1664,G-protein coupled receptor binding,F
14888,246,9267,cellular response to starvation,P
14887,246,86,G2/M transition of mitotic cell cycle,P
14886,246,4722,protein serine/threonine phosphatase activity,F
14885,246,5515,protein binding,F
14884,246,51019,mitogen-activated protein kinase binding,F
14883,246,46872,metal ion binding,F
14854,247,8630,intrinsic apoptotic signaling pathway in response to DNA damage,P
14853,247,6302,double-strand break repair,P
14852,247,71480,cellular response to gamma radiation,P
14851,247,35690,cellular response to drug,P
14850,247,1903926,cellular response to bisphenol A,P
14849,247,6974,cellular response to DNA damage stimulus,P
14848,247,6974,cellular response to DNA damage stimulus,P
14847,247,6974,cellular response to DNA damage stimulus,P
14846,247,44257,cellular protein catabolic process,P
14845,247,51301,cell division,P
14844,247,86,G2/M transition of mitotic cell cycle,P
14843,247,6978,"DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator",P
14842,247,6977,"DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest",P
14841,247,6975,DNA damage induced protein phosphorylation,P
14840,247,77,DNA damage checkpoint,P
14839,247,31625,ubiquitin protein ligase binding,F
14838,247,4674,protein serine/threonine kinase activity,F
14837,247,4674,protein serine/threonine kinase activity,F
14836,247,19901,protein kinase binding,F
14835,247,42803,protein homodimerization activity,F
14834,247,5515,protein binding,F
14833,247,46872,metal ion binding,F
14832,247,42802,identical protein binding,F
14831,247,5524,ATP binding,F
14810,248,71347,cellular response to interleukin-1,P
14809,248,32869,cellular response to insulin stimulus,P
14808,248,71456,cellular response to hypoxia,P
14807,248,71377,cellular response to glucagon stimulus,P
14806,248,71332,cellular response to fructose stimulus,P
14805,248,71320,cellular response to cAMP,P
14804,248,7568,aging,P
14803,248,4613,phosphoenolpyruvate carboxykinase (GTP) activity,F
14802,248,4613,phosphoenolpyruvate carboxykinase (GTP) activity,F
14801,248,30145,manganese ion binding,F
14800,248,287,magnesium ion binding,F
14799,248,31406,carboxylic acid binding,F
14798,248,5525,GTP binding,F
14797,248,19003,GDP binding,F
14787,249,43547,positive regulation of GTPase activity,P
14786,249,98609,cell-cell adhesion,P
14785,249,7266,Rho protein signal transduction,P
14784,249,5515,protein binding,F
14783,249,98641,cadherin binding involved in cell-cell adhesion,F
14782,249,5070,SH3/SH2 adaptor activity,F
14781,249,17124,SH3 domain binding,F
14780,249,5096,GTPase activator activity,F
14779,249,5096,GTPase activator activity,F
14736,250,33138,positive regulation of peptidyl-serine phosphorylation,P
14735,250,43525,positive regulation of neuron apoptotic process,P
14734,250,51149,positive regulation of muscle cell differentiation,P
14733,250,90316,positive regulation of intracellular protein transport,P
14732,250,71338,positive regulation of hair follicle cell proliferation,P
14731,250,10628,positive regulation of gene expression,P
14730,250,60501,positive regulation of epithelial cell proliferation involved in lung morphogenesis,P
14729,250,32467,positive regulation of cytokinesis,P
14728,250,30307,positive regulation of cell growth,P
14727,250,46330,positive regulation of JNK cascade,P
14726,250,45740,positive regulation of DNA replication,P
14725,250,72384,organelle transport along microtubule,P
14724,250,7097,nuclear migration,P
14723,250,48664,neuron fate determination,P
14722,250,31333,negative regulation of protein complex assembly,P
14721,250,10629,negative regulation of gene expression,P
14720,250,42059,negative regulation of epidermal growth factor receptor signaling pathway,P
14719,250,35264,multicellular organism growth,P
14718,250,30225,macrophage differentiation,P
14717,250,3334,keratinocyte development,P
14716,250,31424,keratinization,P
14715,250,60047,heart contraction,P
14713,250,31069,hair follicle morphogenesis,P
14714,250,60789,hair follicle placode formation,P
14712,250,46847,filopodium assembly,P
14711,250,7163,establishment or maintenance of cell polarity,P
14710,250,35088,establishment or maintenance of apical/basal cell polarity,P
14709,250,51683,establishment of Golgi localization,P
14708,250,60684,epithelial-mesenchymal cell signaling,P
14707,250,90136,epithelial cell-cell adhesion,P
14706,250,48013,ephrin receptor signaling pathway,P
14705,250,36336,dendritic cell migration,P
14704,250,34613,cellular protein localization,P
14703,250,3161,cardiac conduction system development,P
14702,250,60070,canonical Wnt signaling pathway,P
14701,250,7596,blood coagulation,P
14700,250,34332,adherens junction organization,P
14699,250,51017,actin filament bundle assembly,P
14698,250,90135,actin filament branching,P
14697,250,30036,actin cytoskeleton organization,P
14696,250,60071,"Wnt signaling pathway, planar cell polarity pathway",P
14695,250,31295,T cell costimulation,P
14694,250,7030,Golgi organization,P
14693,250,38096,Fc-gamma receptor signaling pathway involved in phagocytosis,P
14692,250,61630,ubiquitin protein ligase activity,F
14691,250,31996,thioesterase binding,F
14690,250,19901,protein kinase binding,F
14689,250,19901,protein kinase binding,F
14688,250,5515,protein binding,F
14687,250,31435,mitogen-activated protein kinase kinase kinase binding,F
14686,250,42802,identical protein binding,F
14685,250,34191,apolipoprotein A-I receptor binding,F
14684,250,51022,Rho GDP-dissociation inhibitor binding,F
14683,250,3924,GTPase activity,F
14682,250,30742,GTP-dependent protein binding,F
14681,250,5525,GTP binding,F
14644,251,1190,"transcriptional activator activity, RNA polymerase II transcription factor binding",F
14643,251,976,transcription regulatory region sequence-specific DNA binding,F
14641,251,43565,sequence-specific DNA binding,F
14642,251,982,"transcription factor activity, RNA polymerase II core promoter proximal region sequence-specific binding",F
14640,251,70491,repressing transcription factor binding,F
14639,251,46982,protein heterodimerization activity,F
14638,251,5515,protein binding,F
14636,251,1047,core promoter binding,F
14637,251,1046,core promoter sequence-specific DNA binding,F
14635,251,43425,bHLH transcription factor binding,F
14634,251,17162,aryl hydrocarbon receptor binding,F
14633,251,51879,Hsp90 protein binding,F
14632,251,70888,E-box binding,F
14631,251,3677,DNA binding,F
14630,251,3677,DNA binding,F
14598,252,77,DNA damage checkpoint,P
14599,252,71479,cellular response to ionizing radiation,P
14597,252,1190,"transcriptional activator activity, RNA polymerase II transcription factor binding",F
14596,252,3700,"transcription factor activity, sequence-specific DNA binding",F
14595,252,982,"transcription factor activity, RNA polymerase II core promoter proximal region sequence-specific binding",F
14594,252,43565,sequence-specific DNA binding,F
14593,252,46983,protein dimerization activity,F
14592,252,5515,protein binding,F
14591,252,4402,histone acetyltransferase activity,F
14590,252,1046,core promoter sequence-specific DNA binding,F
14589,252,1047,core promoter binding,F
14588,252,31490,chromatin DNA binding,F
14587,252,978,RNA polymerase II core promoter proximal region sequence-specific DNA binding,F
14586,252,70888,E-box binding,F
14585,252,3677,DNA binding,F
14579,253,43517,"positive regulation of DNA damage response, signal transduction by p53 class mediator",P
14578,253,122,negative regulation of transcription from RNA polymerase II promoter,P
14577,253,122,negative regulation of transcription from RNA polymerase II promoter,P
14576,253,30178,negative regulation of Wnt signaling pathway,P
14575,253,7275,multicellular organism development,P
14573,253,16055,Wnt signaling pathway,P
14574,253,8630,intrinsic apoptotic signaling pathway in response to DNA damage,P
14572,253,3700,"transcription factor activity, sequence-specific DNA binding",F
14571,253,3700,"transcription factor activity, sequence-specific DNA binding",F
14570,253,43565,sequence-specific DNA binding,F
14569,253,5515,protein binding,F
14568,253,46872,metal ion binding,F
14567,253,42826,histone deacetylase binding,F
14562,254,51384,response to glucocorticoid,P
14561,254,32354,response to follicle-stimulating hormone,P
14560,254,6508,proteolysis,P
14559,254,7565,female pregnancy,P
14558,254,44267,cellular protein metabolic process,P
14557,254,8270,zinc ion binding,F
14556,254,8237,metallopeptidase activity,F
14555,254,8237,metallopeptidase activity,F
14554,254,4222,metalloendopeptidase activity,F
14553,254,4222,metalloendopeptidase activity,F
14540,255,1904322,cellular response to forskolin,P
14539,255,19933,cAMP-mediated signaling,P
14538,255,6171,cAMP biosynthetic process,P
14537,255,6171,cAMP biosynthetic process,P
14536,255,7195,adenylate cyclase-inhibiting dopamine receptor signaling pathway,P
14535,255,7193,adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway,P
14534,255,7193,adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway,P
14533,255,7191,adenylate cyclase-activating dopamine receptor signaling pathway,P
14532,255,7189,adenylate cyclase-activating G-protein coupled receptor signaling pathway,P
14531,255,7189,adenylate cyclase-activating G-protein coupled receptor signaling pathway,P
14530,255,1973,adenosine receptor signaling pathway,P
14529,255,34199,activation of protein kinase A activity,P
14528,255,7190,activation of adenylate cyclase activity,P
14527,255,97110,scaffold protein binding,F
14526,255,46982,protein heterodimerization activity,F
14525,255,46872,metal ion binding,F
14524,255,8179,adenylate cyclase binding,F
14523,255,4016,adenylate cyclase activity,F
14522,255,4016,adenylate cyclase activity,F
14521,255,5524,ATP binding,F
14442,256,35865,cellular response to potassium ion,P
14441,256,34599,cellular response to oxidative stress,P
14440,256,71250,cellular response to nitrite,P
14439,256,71222,cellular response to lipopolysaccharide,P
14438,256,1904637,cellular response to ionomycin,P
14437,256,71354,cellular response to interleukin-6,P
14436,256,71456,cellular response to hypoxia,P
14435,256,71333,cellular response to glucose stimulus,P
14434,256,71332,cellular response to fructose stimulus,P
14433,256,71372,cellular response to follicle-stimulating hormone stimulus,P
14432,256,71392,cellular response to estradiol stimulus,P
14431,256,71313,cellular response to caffeine,P
14430,256,45333,cellular respiration,P
14429,256,1678,cellular glucose homeostasis,P
14428,256,50873,brown fat cell differentiation,P
14427,256,30521,androgen receptor signaling pathway,P
14426,256,8209,androgen metabolic process,P
14425,256,7568,aging,P
14424,256,60612,adipose tissue development,P
14422,256,8380,RNA splicing,P
14423,256,1990845,adaptive thermogenesis,P
14421,256,31625,ubiquitin protein ligase binding,F
14420,256,8134,transcription factor binding,F
14419,256,3713,transcription coactivator activity,F
14417,256,5515,protein binding,F
14418,256,43565,sequence-specific DNA binding,F
14416,256,1990841,promoter-specific chromatin binding,F
14415,256,42975,peroxisome proliferator activated receptor binding,F
14414,256,166,nucleotide binding,F
14413,256,30374,ligand-dependent nuclear receptor transcription coactivator activity,F
14412,256,16922,ligand-dependent nuclear receptor binding,F
14411,256,30331,estrogen receptor binding,F
14410,256,31490,chromatin DNA binding,F
14409,256,50681,androgen receptor binding,F
14408,256,43014,alpha-tubulin binding,F
14407,256,1104,RNA polymerase II transcription cofactor activity,F
14406,256,3723,RNA binding,F
14405,256,3677,DNA binding,F
14404,256,3677,DNA binding,F
14398,257,6644,phospholipid metabolic process,P
14397,257,55114,oxidation-reduction process,P
14396,257,7275,multicellular organism development,P
14395,257,19372,lipoxygenase pathway,P
14394,257,98869,cellular oxidant detoxification,P
14393,257,47066,phospholipid-hydroperoxide glutathione peroxidase activity,F
14392,257,4602,glutathione peroxidase activity,F
14376,258,50873,brown fat cell differentiation,P
14375,258,1990845,adaptive thermogenesis,P
14374,258,22857,transmembrane transporter activity,F
14373,258,32555,purine ribonucleotide binding,F
14372,258,17077,oxidative phosphorylation uncoupler activity,F
14371,258,36041,long-chain fatty acid binding,F
14370,258,1901612,cardiolipin binding,F
27856,259,8543,fibroblast growth factor receptor signaling pathway,P
27857,259,30502,negative regulation of bone mineralization,P
27858,259,46888,negative regulation of hormone secretion,P
27859,259,45668,negative regulation of osteoblast differentiation,P
27860,259,18108,peptidyl-tyrosine phosphorylation,P
27861,259,55062,phosphate ion homeostasis,P
27862,259,46854,phosphatidylinositol phosphorylation,P
27863,259,36092,phosphatidylinositol-3-phosphate biosynthetic process,P
27864,259,48015,phosphatidylinositol-mediated signaling,P
27865,259,70374,positive regulation of ERK1 and ERK2 cascade,P
27866,259,43547,positive regulation of GTPase activity,P
27867,259,90080,positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway,P
27868,259,45893,"positive regulation of transcription, DNA-templated",P
27869,259,10980,positive regulation of vitamin D 24-hydroxylase activity,P
27870,259,10966,regulation of phosphate transport,P
27871,259,14066,regulation of phosphatidylinositol 3-kinase signaling,P
27872,259,32026,response to magnesium ion,P
27873,259,1904383,response to sodium phosphate,P
27874,259,42369,vitamin D catabolic process,P
27831,260,48048,embryonic eye morphogenesis,P
27832,260,7173,epidermal growth factor receptor signaling pathway,P
27833,260,32331,negative regulation of chondrocyte differentiation,P
27834,260,18108,peptidyl-tyrosine phosphorylation,P
27835,260,48050,post-embryonic eye morphogenesis,P
27836,260,6355,"regulation of transcription, DNA-templated",P
27837,260,7601,visual perception,P
27838,260,70062,extracellular exosome,C
27839,260,31012,extracellular matrix,C
27840,260,5576,extracellular region,C
27841,260,5615,extracellular space,C
27789,261,6281,DNA repair,P
27790,261,9650,UV protection,P
27791,261,34644,cellular response to UV,P
27792,261,724,double-strand break repair via homologous recombination,P
27793,261,6303,double-strand break repair via nonhomologous end joining,P
27794,261,70911,global genome nucleotide-excision repair,P
27795,261,36297,interstrand cross-link repair,P
27796,261,1905768,negative regulation of double-stranded telomeric DNA binding,P
27797,261,1905765,negative regulation of protection from non-homologous end joining at telomere,P
27798,261,51974,negative regulation of telomerase activity,P
27799,261,32205,negative regulation of telomere maintenance,P
27800,261,1904357,negative regulation of telomere maintenance via telomere lengthening,P
27801,261,6289,nucleotide-excision repair,P
27802,261,6289,nucleotide-excision repair,P
27803,261,1901255,nucleotide-excision repair involved in interstrand cross-link repair,P
27804,261,33683,"nucleotide-excision repair, DNA incision",P
27805,261,33683,"nucleotide-excision repair, DNA incision",P
27806,261,6295,"nucleotide-excision repair, DNA incision, 3'-to lesion",P
27807,261,6295,"nucleotide-excision repair, DNA incision, 3'-to lesion",P
27808,261,6296,"nucleotide-excision repair, DNA incision, 5'-to lesion",P
27809,261,6296,"nucleotide-excision repair, DNA incision, 5'-to lesion",P
27810,261,6293,"nucleotide-excision repair, preincision complex stabilization",P
14260,262,55091,phospholipid homeostasis,P
14259,262,46470,phosphatidylcholine metabolic process,P
14258,262,10745,negative regulation of macrophage derived foam cell differentiation,P
14257,262,34374,low-density lipoprotein particle remodeling,P
14256,262,42157,lipoprotein metabolic process,P
14255,262,6869,lipid transport,P
14254,262,55088,lipid homeostasis,P
14253,262,34375,high-density lipoprotein particle remodeling,P
14252,262,34375,high-density lipoprotein particle remodeling,P
14251,262,30301,cholesterol transport,P
14250,262,8203,cholesterol metabolic process,P
14249,262,8203,cholesterol metabolic process,P
14248,262,42632,cholesterol homeostasis,P
14247,262,17129,triglyceride binding,F
14246,262,5548,phospholipid transporter activity,F
14245,262,31210,phosphatidylcholine binding,F
14244,262,5319,lipid transporter activity,F
14243,262,8289,lipid binding,F
14242,262,17127,cholesterol transporter activity,F
14241,262,15485,cholesterol binding,F
14194,263,10871,negative regulation of receptor biosynthetic process,P
14193,263,2000230,negative regulation of pancreatic stellate cell proliferation,P
14192,263,10745,negative regulation of macrophage derived foam cell differentiation,P
14191,263,10745,negative regulation of macrophage derived foam cell differentiation,P
14190,263,60336,negative regulation of interferon-gamma-mediated signaling pathway,P
14189,263,32966,negative regulation of collagen biosynthetic process,P
14188,263,10887,negative regulation of cholesterol storage,P
14187,263,30308,negative regulation of cell growth,P
14186,263,2674,negative regulation of acute inflammatory response,P
14185,263,30224,monocyte differentiation,P
14184,263,10742,macrophage derived foam cell differentiation,P
14183,263,45713,low-density lipoprotein particle receptor biosynthetic process,P
14182,263,15909,long-chain fatty acid transport,P
14181,263,42953,lipoprotein transport,P
14180,263,6629,lipid metabolic process,P
14179,263,55088,lipid homeostasis,P
14178,263,45087,innate immune response,P
14177,263,7507,heart development,P
14176,263,42593,glucose homeostasis,P
14175,263,19395,fatty acid oxidation,P
14174,263,30855,epithelial cell differentiation,P
14173,263,71306,cellular response to vitamin E,P
14172,263,71300,cellular response to retinoic acid,P
14171,263,71380,cellular response to prostaglandin E stimulus,P
14170,263,32869,cellular response to insulin stimulus,P
14169,263,71455,cellular response to hyperoxia,P
14167,263,45165,cell fate commitment,P
14168,263,48469,cell maturation,P
14166,263,31100,animal organ regeneration,P
14165,263,6919,activation of cysteine-type endopeptidase activity involved in apoptotic process,P
14164,263,7186,G-protein coupled receptor signaling pathway,P
14163,263,8270,zinc ion binding,F
14162,263,44212,transcription regulatory region DNA binding,F
14161,263,44212,transcription regulatory region DNA binding,F
14160,263,8134,transcription factor binding,F
14159,263,3700,"transcription factor activity, sequence-specific DNA binding",F
14158,263,3700,"transcription factor activity, sequence-specific DNA binding",F
14157,263,3707,steroid hormone receptor activity,F
14156,263,43565,sequence-specific DNA binding,F
14155,263,46965,retinoid X receptor binding,F
14153,263,5515,protein binding,F
14154,263,19903,protein phosphatase binding,F
14152,263,4955,prostaglandin receptor activity,F
14151,263,30374,ligand-dependent nuclear receptor transcription coactivator activity,F
14150,263,42802,identical protein binding,F
14149,263,30331,estrogen receptor binding,F
14148,263,19899,enzyme binding,F
14147,263,8144,drug binding,F
14146,263,1046,core promoter sequence-specific DNA binding,F
14145,263,3682,chromatin binding,F
14144,263,50544,arachidonic acid binding,F
14143,263,51393,alpha-actinin binding,F
14142,263,33613,activating transcription factor binding,F
14141,263,4879,"RNA polymerase II transcription factor activity, ligand-activated sequence-specific DNA binding",F
14140,263,3677,DNA binding,F
14139,263,3677,DNA binding,F
14128,264,3081,regulation of systemic arterial blood pressure by renin-angiotensin,P
14127,264,35813,regulation of renal sodium excretion,P
14126,264,50727,regulation of inflammatory response,P
14125,264,42127,regulation of cell proliferation,P
14124,264,1558,regulation of cell growth,P
14123,264,2034,regulation of blood vessel diameter by renin-angiotensin,P
14122,264,2000379,positive regulation of reactive oxygen species metabolic process,P
14121,264,32430,positive regulation of phospholipase A2 activity,P
14120,264,10744,positive regulation of macrophage derived foam cell differentiation,P
14119,264,50729,positive regulation of inflammatory response,P
14118,264,51482,positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G-protein coupled signaling pathway,P
14117,264,7204,positive regulation of cytosolic calcium ion concentration,P
14116,264,10873,positive regulation of cholesterol esterification,P
14115,264,32270,positive regulation of cellular protein metabolic process,P
14114,264,33864,positive regulation of NAD(P)H oxidase activity,P
14113,264,86097,phospholipase C-activating angiotensin-activated signaling pathway,P
14112,264,7200,phospholipase C-activating G-protein coupled receptor signaling pathway,P
14111,264,34374,low-density lipoprotein particle remodeling,P
14109,264,60326,cell chemotaxis,P
14110,264,1822,kidney development,P
14108,264,19722,calcium-mediated signaling,P
14107,264,38166,angiotensin-activated signaling pathway,P
14106,264,7266,Rho protein signal transduction,P
14105,264,7186,G-protein coupled receptor signaling pathway,P
14104,264,46982,protein heterodimerization activity,F
14103,264,5515,protein binding,F
14102,264,31711,bradykinin receptor binding,F
14101,264,4945,angiotensin type II receptor activity,F
14100,264,1596,angiotensin type I receptor activity,F
14099,264,1596,angiotensin type I receptor activity,F
14093,265,5783,endoplasmic reticulum,C
14092,265,10506,regulation of autophagy,P
14091,265,10259,multicellular organism aging,P
14090,265,422,mitophagy,P
14089,265,42803,protein homodimerization activity,F
14088,265,5515,protein binding,F
14087,265,44822,poly(A) RNA binding,F
14086,265,46872,metal ion binding,F
14085,265,51537,"2 iron, 2 sulfur cluster binding",F
14074,266,43517,"positive regulation of DNA damage response, signal transduction by p53 class mediator",P
14073,266,8285,negative regulation of cell proliferation,P
14072,266,6749,glutathione metabolic process,P
14071,266,3746,translation elongation factor activity,F
14070,266,5515,protein binding,F
14069,266,4364,glutathione transferase activity,F
14055,267,9967,positive regulation of signal transduction,P
14054,267,10458,exit from mitosis,P
14053,267,7173,epidermal growth factor receptor signaling pathway,P
14052,267,36336,dendritic cell migration,P
14051,267,8283,cell proliferation,P
14050,267,48149,behavioral response to ethanol,P
14049,267,51016,barbed-end actin filament capping,P
14048,267,8344,adult locomotory behavior,P
14047,267,70358,actin polymerization-dependent cell motility,P
14046,267,51017,actin filament bundle assembly,P
14045,267,31532,actin cytoskeleton reorganization,P
14044,267,51764,actin crosslink formation,P
14043,267,16601,Rac protein signal transduction,P
14042,267,5515,protein binding,F
14041,267,3779,actin binding,F
14040,267,5070,SH3/SH2 adaptor activity,F
14039,267,48365,Rac GTPase binding,F
14032,268,6813,potassium ion transport,P
14031,268,71805,potassium ion transmembrane transport,P
14030,268,5244,voltage-gated ion channel activity,F
14029,268,15271,outward rectifier potassium channel activity,F
14028,268,5251,delayed rectifier potassium channel activity,F
14022,269,122,negative regulation of transcription from RNA polymerase II promoter,P
14021,269,70933,histone H4 deacetylation,P
14020,269,70932,histone H3 deacetylation,P
14019,269,5515,protein binding,F
14017,269,3682,chromatin binding,F
14018,269,46872,metal ion binding,F
14016,269,97372,NAD-dependent histone deacetylase activity (H3-K18 specific),F
14015,269,70403,NAD+ binding,F
14010,270,35725,sodium ion transmembrane transport,P
14009,270,15382,sodium:sulfate symporter activity,F
14008,270,15382,sodium:sulfate symporter activity,F
13997,271,43066,negative regulation of apoptotic process,P
13996,271,46426,negative regulation of JAK-STAT cascade,P
13995,271,60396,growth hormone receptor signaling pathway,P
13994,271,19221,cytokine-mediated signaling pathway,P
13993,271,32870,cellular response to hormone stimulus,P
13992,271,7259,JAK-STAT cascade,P
13991,271,4860,protein kinase inhibitor activity,F
13990,271,5515,protein binding,F
13989,271,5159,insulin-like growth factor receptor binding,F
13988,271,5131,growth hormone receptor binding,F
13987,271,5070,SH3/SH2 adaptor activity,F
13986,271,8269,JAK pathway signal transduction adaptor activity,F
13980,273,8240,tripeptidyl-peptidase activity,F
13979,273,4252,serine-type endopeptidase activity,F
13977,273,42277,peptide binding,F
13978,273,5515,protein binding,F
13976,273,4175,endopeptidase activity,F
13975,273,4177,aminopeptidase activity,F
13966,274,45944,positive regulation of transcription from RNA polymerase II promoter,P
13965,274,51091,positive regulation of sequence-specific DNA binding transcription factor activity,P
13964,274,6303,double-strand break repair via nonhomologous end joining,P
13963,274,71481,cellular response to X-ray,P
13962,274,6974,cellular response to DNA damage stimulus,P
13961,274,77,DNA damage checkpoint,P
13959,274,2039,p53 binding,F
13960,274,5515,protein binding,F
13958,274,35064,methylated histone binding,F
13957,274,1104,RNA polymerase II transcription cofactor activity,F
13956,274,1102,RNA polymerase II activating transcription factor binding,F
13955,274,3677,DNA binding,F
13946,275,7005,mitochondrion organization,P
13945,275,7568,aging,P
13944,275,9060,aerobic respiration,P
13943,275,8270,zinc ion binding,F
13942,275,5515,protein binding,F
13941,275,16787,hydrolase activity,F
13940,275,19899,enzyme binding,F
13939,275,70403,NAD+ binding,F
13938,275,3950,NAD+ ADP-ribosyltransferase activity,F
13926,276,72365,regulation of cellular ketone metabolic process by negative regulation of transcription from RNA polymerase II promoter,P
13925,276,122,negative regulation of transcription from RNA polymerase II promoter,P
13924,276,122,negative regulation of transcription from RNA polymerase II promoter,P
13923,276,1903799,negative regulation of production of miRNAs involved in gene silencing by miRNA,P
13922,276,44255,cellular lipid metabolic process,P
13920,276,3714,transcription corepressor activity,F
13921,276,8134,transcription factor binding,F
13919,276,3714,transcription corepressor activity,F
13918,276,5515,protein binding,F
13917,276,47485,protein N-terminus binding,F
13916,276,16922,ligand-dependent nuclear receptor binding,F
13915,276,42826,histone deacetylase binding,F
13914,276,5112,Notch binding,F
13913,276,3677,DNA binding,F
13903,277,21817,nucleokinesis involved in cell motility in cerebral cortex radial glia guided migration,P
13902,277,90292,nuclear matrix anchoring at nuclear membrane,P
13901,277,6998,nuclear envelope organization,P
13900,277,70197,meiotic attachment of telomere to nuclear envelope,P
13899,277,90286,cytoskeletal anchoring at nuclear membrane,P
13898,277,51642,centrosome localization,P
13897,277,5515,protein binding,F
13896,277,5521,lamin binding,F
13862,278,33137,negative regulation of peptidyl-serine phosphorylation,P
13861,278,10629,negative regulation of gene expression,P
13860,278,32471,negative regulation of endoplasmic reticulum calcium ion concentration,P
13859,278,8285,negative regulation of cell proliferation,P
13858,278,2262,myeloid cell homeostasis,P
13857,278,8053,mitochondrial fusion,P
13856,278,35108,limb morphogenesis,P
13855,278,70059,intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress,P
13854,278,8630,intrinsic apoptotic signaling pathway in response to DNA damage,P
13853,278,44346,fibroblast apoptotic process,P
13852,278,97192,extrinsic apoptotic signaling pathway in absence of ligand,P
13851,278,10248,establishment or maintenance of transmembrane electrochemical gradient,P
13850,278,32469,endoplasmic reticulum calcium ion homeostasis,P
13849,278,31018,endocrine pancreas development,P
13848,278,19835,cytolysis,P
13847,278,71260,cellular response to mechanical stimulus,P
13846,278,34644,cellular response to UV,P
13845,278,34644,cellular response to UV,P
13844,278,8283,cell proliferation,P
13843,278,7420,brain development,P
13842,278,1974,blood vessel remodeling,P
13841,278,97190,apoptotic signaling pathway,P
13840,278,1902262,apoptotic process involved in blood vessel morphogenesis,P
13839,278,31100,animal organ regeneration,P
13838,278,7568,aging,P
13837,278,6987,activation of signaling protein activity involved in unfolded protein response,P
13836,278,8635,activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c,P
13835,278,97202,activation of cysteine-type endopeptidase activity,P
13834,278,2352,B cell negative selection,P
13833,278,1782,B cell homeostasis,P
13832,278,1783,B cell apoptotic process,P
13831,278,42803,protein homodimerization activity,F
13830,278,46982,protein heterodimerization activity,F
13829,278,5515,protein binding,F
13828,278,46872,metal ion binding,F
13827,278,44325,ion channel binding,F
13826,278,42802,identical protein binding,F
13825,278,31072,heat shock protein binding,F
13824,278,51087,chaperone binding,F
13823,278,51400,BH domain binding,F
13807,279,43567,regulation of insulin-like growth factor receptor signaling pathway,P
13806,279,43567,regulation of insulin-like growth factor receptor signaling pathway,P
13805,279,43567,regulation of insulin-like growth factor receptor signaling pathway,P
13804,279,1558,regulation of cell growth,P
13803,279,42104,positive regulation of activated T cell proliferation,P
13802,279,90090,negative regulation of canonical Wnt signaling pathway,P
13801,279,7565,female pregnancy,P
13800,279,32870,cellular response to hormone stimulus,P
13799,279,44267,cellular protein metabolic process,P
13798,279,7568,aging,P
13797,279,5102,receptor binding,F
13796,279,5515,protein binding,F
13795,279,31995,insulin-like growth factor II binding,F
13794,279,31995,insulin-like growth factor II binding,F
13793,279,31994,insulin-like growth factor I binding,F
13787,280,1903206,negative regulation of hydrogen peroxide-induced cell death,P
13786,280,34599,cellular response to oxidative stress,P
13785,280,8652,cellular amino acid biosynthetic process,P
13784,280,55129,L-proline biosynthetic process,P
13783,280,4735,pyrroline-5-carboxylate reductase activity,F
13782,280,4735,pyrroline-5-carboxylate reductase activity,F
13781,280,5515,protein binding,F
13780,280,42802,identical protein binding,F
13753,281,122,negative regulation of transcription from RNA polymerase II promoter,P
13752,281,45665,negative regulation of neuron differentiation,P
13751,281,43524,negative regulation of neuron apoptotic process,P
13750,281,60044,negative regulation of cardiac muscle cell proliferation,P
13749,281,43508,negative regulation of JUN kinase activity,P
13746,281,1822,kidney development,P
13747,281,6298,mismatch repair,P
13748,281,31571,mitotic G1 DNA damage checkpoint,P
13745,281,42771,intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator,P
13744,281,8630,intrinsic apoptotic signaling pathway in response to DNA damage,P
13743,281,34644,cellular response to UV,P
13742,281,6974,cellular response to DNA damage stimulus,P
13740,281,187,activation of MAPK activity,P
13741,281,7050,cell cycle arrest,P
13739,281,6978,"DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator",P
13738,281,1077,"transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding",F
13737,281,44212,transcription regulatory region DNA binding,F
13736,281,8134,transcription factor binding,F
13735,281,3700,"transcription factor activity, sequence-specific DNA binding",F
13734,281,19901,protein kinase binding,F
13732,281,2039,p53 binding,F
13733,281,5515,protein binding,F
13731,281,46872,metal ion binding,F
13730,281,42802,identical protein binding,F
13729,281,3684,damaged DNA binding,F
13728,281,3682,chromatin binding,F
13727,281,981,"RNA polymerase II transcription factor activity, sequence-specific DNA binding",F
13726,281,978,RNA polymerase II core promoter proximal region sequence-specific DNA binding,F
13708,282,50796,regulation of insulin secretion,P
13707,282,60259,regulation of feeding behavior,P
13706,282,10976,positive regulation of neuron projection development,P
13705,282,31622,positive regulation of fever generation,P
13704,282,45777,positive regulation of blood pressure,P
13703,282,43065,positive regulation of apoptotic process,P
13702,282,2866,positive regulation of acute inflammatory response to antigenic stimulus,P
13701,282,51001,negative regulation of nitric-oxide synthase activity,P
13700,282,33004,negative regulation of mast cell activation,P
13699,282,31999,negative regulation of fatty acid beta-oxidation,P
13698,282,33602,negative regulation of dopamine secretion,P
13697,282,45776,negative regulation of blood pressure,P
13695,282,7613,memory,P
13696,282,45759,negative regulation of action potential,P
13694,282,60135,maternal process involved in female pregnancy,P
13693,282,42593,glucose homeostasis,P
13692,282,38171,cannabinoid signaling pathway,P
13691,282,7413,axonal fasciculation,P
13690,282,7568,aging,P
13689,282,7188,adenylate cyclase-modulating G-protein coupled receptor signaling pathway,P
13688,282,7187,"G-protein coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger",P
13687,282,8144,drug binding,F
13686,282,4949,cannabinoid receptor activity,F
13648,283,34599,cellular response to oxidative stress,P
13647,283,71499,cellular response to laminar fluid shear stress,P
13646,283,71456,cellular response to hypoxia,P
13645,283,70301,cellular response to hydrogen peroxide,P
13644,283,42149,cellular response to glucose starvation,P
13643,283,71498,cellular response to fluid shear stress,P
13642,283,35690,cellular response to drug,P
13641,283,45454,cell redox homeostasis,P
13640,283,7568,aging,P
13638,283,36499,PERK-mediated unfolded protein response,P
13639,283,36499,PERK-mediated unfolded protein response,P
13637,283,1205,"transcriptional activator activity, RNA polymerase II distal enhancer sequence-specific binding",F
13635,283,44212,transcription regulatory region DNA binding,F
13636,283,976,transcription regulatory region sequence-specific DNA binding,F
13634,283,3700,"transcription factor activity, sequence-specific DNA binding",F
13633,283,1221,transcription cofactor binding,F
13632,283,19904,protein domain specific binding,F
13631,283,5515,protein binding,F
13630,283,980,RNA polymerase II distal enhancer sequence-specific DNA binding,F
13629,283,1102,RNA polymerase II activating transcription factor binding,F
13628,283,3677,DNA binding,F
13599,284,42326,negative regulation of phosphorylation,P
13598,284,10629,negative regulation of gene expression,P
13597,284,45736,negative regulation of cyclin-dependent protein serine/threonine kinase activity,P
13595,284,8285,negative regulation of cell proliferation,P
13596,284,8285,negative regulation of cell proliferation,P
13594,284,30308,negative regulation of cell growth,P
13593,284,43066,negative regulation of apoptotic process,P
13592,284,2000134,negative regulation of G1/S transition of mitotic cell cycle,P
13591,284,71850,mitotic cell cycle arrest,P
13590,284,42771,intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator,P
13589,284,97193,intrinsic apoptotic signaling pathway,P
13588,284,60574,intestinal epithelial cell maturation,P
13587,284,90398,cellular senescence,P
13586,284,71479,cellular response to ionizing radiation,P
13585,284,34605,cellular response to heat,P
13584,284,71480,cellular response to gamma radiation,P
13583,284,31668,cellular response to extracellular stimulus,P
13582,284,34198,cellular response to amino acid starvation,P
13581,284,71493,cellular response to UV-B,P
13580,284,6974,cellular response to DNA damage stimulus,P
13579,284,7050,cell cycle arrest,P
13577,284,31100,animal organ regeneration,P
13578,284,7050,cell cycle arrest,P
13576,284,7265,Ras protein signal transduction,P
13575,284,86,G2/M transition of mitotic cell cycle,P
13574,284,82,G1/S transition of mitotic cell cycle,P
13573,284,82,G1/S transition of mitotic cell cycle,P
13572,284,6978,"DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator",P
13571,284,6977,"DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest",P
13570,284,6977,"DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest",P
13569,284,31625,ubiquitin protein ligase binding,F
13568,284,32403,protein complex binding,F
13567,284,5515,protein binding,F
13566,284,46872,metal ion binding,F
13565,284,4861,cyclin-dependent protein serine/threonine kinase inhibitor activity,F
13564,284,19912,cyclin-dependent protein kinase activating kinase activity,F
13563,284,30332,cyclin binding,F
13536,285,30335,positive regulation of cell migration,P
13535,285,43547,positive regulation of GTPase activity,P
13534,285,70374,positive regulation of ERK1 and ERK2 cascade,P
13533,285,45740,positive regulation of DNA replication,P
13532,285,35790,platelet-derived growth factor receptor-alpha signaling pathway,P
13531,285,48008,platelet-derived growth factor receptor signaling pathway,P
13530,285,70527,platelet aggregation,P
13529,285,48015,phosphatidylinositol-mediated signaling,P
13528,285,48015,phosphatidylinositol-mediated signaling,P
13527,285,46854,phosphatidylinositol phosphorylation,P
13526,285,18108,peptidyl-tyrosine phosphorylation,P
13525,285,60021,palate development,P
13524,285,42475,odontogenesis of dentin-containing tooth,P
13523,285,10544,negative regulation of platelet activation,P
13522,285,72277,metanephric glomerular capillary formation,P
13521,285,30539,male genitalia development,P
13520,285,1553,luteinization,P
13519,285,30324,lung development,P
13518,285,1701,in utero embryonic development,P
13517,285,2244,hematopoietic progenitor cell differentiation,P
13516,285,60325,face morphogenesis,P
13515,285,30198,extracellular matrix organization,P
13514,285,8210,estrogen metabolic process,P
13513,285,48704,embryonic skeletal system morphogenesis,P
13512,285,48557,embryonic digestive tract morphogenesis,P
13511,285,48701,embryonic cranial skeleton morphogenesis,P
13510,285,34614,cellular response to reactive oxygen species,P
13509,285,71230,cellular response to amino acid stimulus,P
13508,285,60326,cell chemotaxis,P
13507,285,1775,cell activation,P
13506,285,55003,cardiac myofibril assembly,P
13505,285,30325,adrenal gland development,P
13504,285,165,MAPK cascade,P
13503,285,33327,Leydig cell differentiation,P
13502,285,5021,vascular endothelial growth factor-activated receptor activity,F
13501,285,38085,vascular endothelial growth factor binding,F
13500,285,4714,transmembrane receptor protein tyrosine kinase activity,F
13499,285,4672,protein kinase activity,F
13498,285,42803,protein homodimerization activity,F
13496,285,5515,protein binding,F
13497,285,32403,protein complex binding,F
13495,285,5161,platelet-derived growth factor receptor binding,F
13494,285,48407,platelet-derived growth factor binding,F
13493,285,48407,platelet-derived growth factor binding,F
13492,285,5018,platelet-derived growth factor alpha-receptor activity,F
13491,285,5018,platelet-derived growth factor alpha-receptor activity,F
13490,285,46934,"phosphatidylinositol-4,5-bisphosphate 3-kinase activity",F
13489,285,5088,Ras guanyl-nucleotide exchange factor activity,F
13488,285,5524,ATP binding,F
13461,286,38028,insulin receptor signaling pathway via phosphatidylinositol 3-kinase,P
13460,286,44029,hypomethylation of CpG island,P
13459,286,6006,glucose metabolic process,P
13458,286,7173,epidermal growth factor receptor signaling pathway,P
13457,286,97009,energy homeostasis,P
13456,286,43542,endothelial cell migration,P
13455,286,71333,cellular response to glucose stimulus,P
13454,286,60048,cardiac muscle contraction,P
13453,286,1525,angiogenesis,P
13452,286,60612,adipose tissue development,P
13451,286,32147,activation of protein kinase activity,P
13450,286,50852,T cell receptor signaling pathway,P
13449,286,31295,T cell costimulation,P
13448,286,38096,Fc-gamma receptor signaling pathway involved in phagocytosis,P
13447,286,38095,Fc-epsilon receptor signaling pathway,P
13446,286,38128,ERBB2 signaling pathway,P
13445,286,4674,protein serine/threonine kinase activity,F
13444,286,30295,protein kinase activator activity,F
13443,286,5515,protein binding,F
13442,286,46934,"phosphatidylinositol-4,5-bisphosphate 3-kinase activity",F
13441,286,46934,"phosphatidylinositol-4,5-bisphosphate 3-kinase activity",F
13440,286,35004,phosphatidylinositol 3-kinase activity,F
13439,286,35004,phosphatidylinositol 3-kinase activity,F
13438,286,16301,kinase activity,F
13437,286,16301,kinase activity,F
13436,286,43560,insulin receptor substrate binding,F
13435,286,5524,ATP binding,F
13434,286,35005,1-phosphatidylinositol-4-phosphate 3-kinase activity,F
13433,286,16303,1-phosphatidylinositol-3-kinase activity,F
13432,286,16303,1-phosphatidylinositol-3-kinase activity,F
13425,287,45087,innate immune response,P
13424,287,6958,"complement activation, classical pathway",P
13423,287,6956,complement activation,P
13422,287,7267,cell-cell signaling,P
13421,287,4252,serine-type endopeptidase activity,F
13420,287,5515,protein binding,F
13414,288,79,regulation of cyclin-dependent protein serine/threonine kinase activity,P
13413,288,30511,positive regulation of transforming growth factor beta receptor signaling pathway,P
13412,288,45944,positive regulation of transcription from RNA polymerase II promoter,P
13411,288,71901,negative regulation of protein serine/threonine kinase activity,P
13410,288,42326,negative regulation of phosphorylation,P
13409,288,50680,negative regulation of epithelial cell proliferation,P
13408,288,8285,negative regulation of cell proliferation,P
13407,288,2000134,negative regulation of G1/S transition of mitotic cell cycle,P
13406,288,7093,mitotic cell cycle checkpoint,P
13405,288,30219,megakaryocyte differentiation,P
13404,288,31670,cellular response to nutrient,P
13403,288,31668,cellular response to extracellular stimulus,P
13402,288,7050,cell cycle arrest,P
13401,288,86,G2/M transition of mitotic cell cycle,P
13400,288,19901,protein kinase binding,F
13399,288,5515,protein binding,F
13398,288,4861,cyclin-dependent protein serine/threonine kinase inhibitor activity,F
13397,288,4861,cyclin-dependent protein serine/threonine kinase inhibitor activity,F
13390,289,15031,protein transport,P
13389,289,45905,positive regulation of translational termination,P
13388,289,45901,positive regulation of translational elongation,P
13387,289,8284,positive regulation of cell proliferation,P
13386,289,10509,polyamine homeostasis,P
13385,289,8612,peptidyl-lysine modification to peptidyl-hypusine,P
13384,289,51028,mRNA transport,P
13383,289,3746,translation elongation factor activity,F
13382,289,43022,ribosome binding,F
13381,289,5515,protein binding,F
13360,290,50715,positive regulation of cytokine secretion,P
13359,290,2000343,positive regulation of chemokine (C-X-C motif) ligand 2 production,P
13358,290,90238,positive regulation of arachidonic acid secretion,P
13357,290,43406,positive regulation of MAP kinase activity,P
13356,290,70374,positive regulation of ERK1 and ERK2 cascade,P
13355,290,30890,positive regulation of B cell proliferation,P
13354,290,50918,positive chemotaxis,P
13353,290,33033,negative regulation of myeloid cell apoptotic process,P
13352,290,2906,negative regulation of mature B cell apoptotic process,P
13351,290,1902166,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator,P
13350,290,10629,negative regulation of gene expression,P
13349,290,32269,negative regulation of cellular protein metabolic process,P
13348,290,71157,negative regulation of cell cycle arrest,P
13347,290,90344,negative regulation of cell aging,P
13346,290,43066,negative regulation of apoptotic process,P
13344,290,50900,leukocyte migration,P
13345,290,43518,"negative regulation of DNA damage response, signal transduction by p53 class mediator",P
13343,290,45087,innate immune response,P
13342,290,6954,inflammatory response,P
13341,290,7166,cell surface receptor signaling pathway,P
13339,290,7569,cell aging,P
13340,290,8283,cell proliferation,P
13338,290,19752,carboxylic acid metabolic process,P
13337,290,30330,"DNA damage response, signal transduction by p53 class mediator",P
13335,290,5515,protein binding,F
13336,290,5102,receptor binding,F
13334,290,50178,phenylpyruvate tautomerase activity,F
13333,290,4167,dopachrome isomerase activity,F
13332,290,5126,cytokine receptor binding,F
13331,290,5125,cytokine activity,F
13330,290,42056,chemoattractant activity,F
13323,291,19432,triglyceride biosynthetic process,P
13322,291,42572,retinol metabolic process,P
13321,291,35336,long-chain fatty-acyl-CoA metabolic process,P
13320,291,19915,lipid storage,P
13319,291,55089,fatty acid homeostasis,P
13318,291,46339,diacylglycerol metabolic process,P
13317,291,36155,acylglycerol acyl-chain remodeling,P
13316,291,16746,"transferase activity, transferring acyl groups",F
13315,291,50252,retinol O-fatty-acyltransferase activity,F
13314,291,5515,protein binding,F
13313,291,4144,diacylglycerol O-acyltransferase activity,F
13312,291,4144,diacylglycerol O-acyltransferase activity,F
13311,291,4144,diacylglycerol O-acyltransferase activity,F
13310,291,3846,2-acylglycerol O-acyltransferase activity,F
13309,292,48471,perinuclear region of cytoplasm,C
13308,292,5634,nucleus,C
13307,292,5737,cytoplasm,C
13306,292,45926,negative regulation of growth,P
13305,292,71294,cellular response to zinc ion,P
13304,292,71276,cellular response to cadmium ion,P
13303,292,8270,zinc ion binding,F
13286,293,72577,endothelial cell apoptotic process,P
13285,293,30968,endoplasmic reticulum unfolded protein response,P
13283,293,71333,cellular response to glucose stimulus,P
13284,293,71404,cellular response to low-density lipoprotein particle stimulus,P
13282,293,71377,cellular response to glucagon stimulus,P
13281,293,35690,cellular response to drug,P
13279,293,5515,protein binding,F
13280,293,7267,cell-cell signaling,P
13278,293,8083,growth factor activity,F
13277,293,5104,fibroblast growth factor receptor binding,F
13243,294,1904924,negative regulation of mitophagy in response to mitochondrial depolarization,P
13242,294,45786,negative regulation of cell cycle,P
13241,294,7005,mitochondrion organization,P
13240,294,8630,intrinsic apoptotic signaling pathway in response to DNA damage,P
13238,294,97194,execution phase of apoptosis,P
13239,294,30900,forebrain development,P
13237,294,6672,ceramide metabolic process,P
13236,294,71300,cellular response to retinoic acid,P
13235,294,34599,cellular response to oxidative stress,P
13234,294,34599,cellular response to oxidative stress,P
13233,294,35458,cellular response to interferon-beta,P
13232,294,34605,cellular response to heat,P
13230,294,44257,cellular protein catabolic process,P
13231,294,71363,cellular response to growth factor stimulus,P
13229,294,7568,aging,P
13228,294,7628,adult walking behavior,P
13227,294,51082,unfolded protein binding,F
13226,294,8236,serine-type peptidase activity,F
13225,294,8236,serine-type peptidase activity,F
13224,294,4252,serine-type endopeptidase activity,F
13223,294,4252,serine-type endopeptidase activity,F
13222,294,5515,protein binding,F
13221,294,8233,peptidase activity,F
13220,294,8233,peptidase activity,F
13208,295,1901030,positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway,P
13207,295,45823,positive regulation of heart contraction,P
13206,295,2000467,positive regulation of glycogen (starch) synthase activity,P
13205,295,30819,positive regulation of cAMP biosynthetic process,P
13204,295,71879,positive regulation of adrenergic receptor signaling pathway,P
13203,295,7399,nervous system development,P
13202,295,2000077,negative regulation of type B pancreatic cell development,P
13201,295,46627,negative regulation of insulin receptor signaling pathway,P
13200,295,1904227,"negative regulation of glycogen synthase activity, transferring glucose-1-phosphate",P
13199,295,45719,negative regulation of glycogen biosynthetic process,P
13198,295,2000466,negative regulation of glycogen (starch) synthase activity,P
13197,295,46325,negative regulation of glucose import,P
13196,295,61052,negative regulation of cell growth involved in cardiac muscle cell development,P
13195,295,90090,negative regulation of canonical Wnt signaling pathway,P
13194,295,10905,negative regulation of UDP-glucose catabolic process,P
13193,295,32007,negative regulation of TOR signaling,P
13192,295,8286,insulin receptor signaling pathway,P
13191,295,5977,glycogen metabolic process,P
13190,295,97192,extrinsic apoptotic signaling pathway in absence of ligand,P
13189,295,7212,dopamine receptor signaling pathway,P
13188,295,99565,"chemical synaptic transmission, postsynaptic",P
13187,295,36016,cellular response to interleukin-3,P
13186,295,32869,cellular response to insulin stimulus,P
13185,295,3214,cardiac left ventricle morphogenesis,P
13184,295,16055,Wnt signaling pathway,P
13183,295,36498,IRE1-mediated unfolded protein response,P
13182,295,50321,tau-protein kinase activity,F
13181,295,4674,protein serine/threonine kinase activity,F
13180,295,34236,protein kinase A catalytic subunit binding,F
13179,295,5515,protein binding,F
13178,295,5524,ATP binding,F
13156,296,5515,protein binding,F
13157,296,30515,snoRNA binding,F
13155,296,46872,metal ion binding,F
13154,296,50072,m7G(5')pppN diphosphatase activity,F
13153,296,3924,GTPase activity,F
13152,296,36219,GTP diphosphatase activity,F
13151,296,47693,ATP diphosphatase activity,F
13150,296,8413,"8-oxo-7,8-dihydroguanosine triphosphate pyrophosphatase activity",F
13149,296,35539,"8-oxo-7,8-dihydrodeoxyguanosine triphosphate pyrophosphatase activity",F
13148,296,35539,"8-oxo-7,8-dihydrodeoxyguanosine triphosphate pyrophosphatase activity",F
13147,296,44713,2-hydroxy-adenosine triphosphate pyrophosphatase activity,F
13146,296,44714,2-hydroxy-(deoxy)adenosine-triphosphate pyrophosphatase activity,F
13130,297,6468,protein phosphorylation,P
13129,297,6468,protein phosphorylation,P
13128,297,45893,"positive regulation of transcription, DNA-templated",P
13127,297,45944,positive regulation of transcription from RNA polymerase II promoter,P
13126,297,51092,positive regulation of NF-kappaB transcription factor activity,P
13125,297,51092,positive regulation of NF-kappaB transcription factor activity,P
13124,297,43123,positive regulation of I-kappaB kinase/NF-kappaB signaling,P
13123,297,70423,nucleotide-binding oligomerization domain containing signaling pathway,P
13122,297,35509,negative regulation of myosin-light-chain-phosphatase activity,P
13121,297,1903347,negative regulation of bicellular tight junction assembly,P
13120,297,43066,negative regulation of apoptotic process,P
13119,297,70498,interleukin-1-mediated signaling pathway,P
13117,297,6954,inflammatory response,P
13118,297,45087,innate immune response,P
13116,297,90002,establishment of protein localization to plasma membrane,P
13115,297,30866,cortical actin cytoskeleton organization,P
13114,297,71356,cellular response to tumor necrosis factor,P
13113,297,9653,anatomical structure morphogenesis,P
13112,297,35666,TRIF-dependent toll-like receptor signaling pathway,P
13111,297,50852,T cell receptor signaling pathway,P
13110,297,7252,I-kappaB phosphorylation,P
13109,297,7249,I-kappaB kinase/NF-kappaB signaling,P
13108,297,7249,I-kappaB kinase/NF-kappaB signaling,P
13107,297,38095,Fc-epsilon receptor signaling pathway,P
13106,297,97110,scaffold protein binding,F
13105,297,4674,protein serine/threonine kinase activity,F
13104,297,4674,protein serine/threonine kinase activity,F
13103,297,19901,protein kinase binding,F
13102,297,4672,protein kinase activity,F
13101,297,42803,protein homodimerization activity,F
13100,297,46982,protein heterodimerization activity,F
13099,297,5515,protein binding,F
13098,297,8384,IkappaB kinase activity,F
13097,297,5524,ATP binding,F
13067,298,44130,negative regulation of growth of symbiont in host,P
13066,298,43066,negative regulation of apoptotic process,P
13065,298,98779,mitophagy in response to mitochondrial depolarization,P
13064,298,98779,mitophagy in response to mitochondrial depolarization,P
13063,298,422,mitophagy,P
13062,298,16236,macroautophagy,P
13061,298,16236,macroautophagy,P
13060,298,35556,intracellular signal transduction,P
13059,298,2376,immune system process,P
13058,298,16197,endosomal transport,P
13057,298,30154,cell differentiation,P
13056,298,6914,autophagy,P
13055,298,6914,autophagy,P
13054,298,6915,apoptotic process,P
13053,298,8270,zinc ion binding,F
13052,298,31625,ubiquitin protein ligase binding,F
13051,298,43130,ubiquitin binding,F
13050,298,43130,ubiquitin binding,F
13049,298,30971,receptor tyrosine kinase binding,F
13048,298,4674,protein serine/threonine kinase activity,F
13047,298,19901,protein kinase binding,F
13046,298,5080,protein kinase C binding,F
13045,298,42803,protein homodimerization activity,F
13044,298,5515,protein binding,F
13043,298,42802,identical protein binding,F
13042,298,42169,SH2 domain binding,F
13041,298,70530,K63-linked polyubiquitin binding,F
13028,299,6362,transcription elongation from RNA polymerase I promoter,P
13027,299,6363,termination of RNA polymerase I transcription,P
13026,299,42795,snRNA transcription from RNA polymerase II promoter,P
13025,299,79,regulation of cyclin-dependent protein serine/threonine kinase activity,P
13024,299,6468,protein phosphorylation,P
13023,299,45893,"positive regulation of transcription, DNA-templated",P
13022,299,45944,positive regulation of transcription from RNA polymerase II promoter,P
13021,299,6294,"nucleotide-excision repair, preincision complex assembly",P
13020,299,8283,cell proliferation,P
13019,299,51301,cell division,P
13018,299,7050,cell cycle arrest,P
13017,299,30521,androgen receptor signaling pathway,P
13016,299,86,G2/M transition of mitotic cell cycle,P
13015,299,82,G1/S transition of mitotic cell cycle,P
13014,299,6370,7-methylguanosine mRNA capping,P
13013,299,3713,transcription coactivator activity,F
13012,299,4674,protein serine/threonine kinase activity,F
13011,299,4672,protein kinase activity,F
13010,299,5515,protein binding,F
13009,299,8022,protein C-terminus binding,F
13008,299,16301,kinase activity,F
13007,299,4693,cyclin-dependent protein serine/threonine kinase activity,F
13006,299,50681,androgen receptor binding,F
13005,299,8353,RNA polymerase II carboxy-terminal domain kinase activity,F
13004,299,8094,DNA-dependent ATPase activity,F
13003,299,5524,ATP binding,F
13002,300,43231,intracellular membrane-bounded organelle,C
13001,300,5615,extracellular space,C
13000,300,70062,extracellular exosome,C
12999,300,7165,signal transduction,P
12998,300,5515,protein binding,F
12997,300,44822,poly(A) RNA binding,F
12996,300,8083,growth factor activity,F
12995,300,5125,cytokine activity,F
12895,304,5125,cytokine activity,F
12896,304,5146,leukemia inhibitory factor receptor binding,F
12930,303,10468,regulation of gene expression,P
12852,306,43065,positive regulation of apoptotic process,P
12851,306,2790,peptide secretion,P
12850,306,122,negative regulation of transcription from RNA polymerase II promoter,P
12849,306,90212,negative regulation of establishment of blood-brain barrier,P
12847,306,6629,lipid metabolic process,P
12846,306,14047,glutamate secretion,P
12845,306,1660,fever generation,P
12844,306,2024,diet induced thermogenesis,P
12843,306,50960,detection of temperature stimulus involved in thermoception,P
12841,306,50968,detection of chemical stimulus involved in sensory perception of pain,P
12840,306,7635,chemosensory behavior,P
12795,307,3700,"transcription factor activity, sequence-specific DNA binding",F
12794,307,3712,transcription cofactor activity,F
12793,307,5515,protein binding,F
12792,307,980,RNA polymerase II distal enhancer sequence-specific DNA binding,F
12876,305,44822,poly(A) RNA binding,F
12875,305,5524,ATP binding,F
12929,303,2000114,regulation of establishment of cell polarity,P
12928,303,32956,regulation of actin cytoskeleton organization,P
12927,303,43087,regulation of GTPase activity,P
12926,303,51897,positive regulation of protein kinase B signaling,P
12925,303,50731,positive regulation of peptidyl-tyrosine phosphorylation,P
12924,303,1938,positive regulation of endothelial cell proliferation,P
12923,303,43085,positive regulation of catalytic activity,P
12922,303,30838,positive regulation of actin filament polymerization,P
12921,303,32008,positive regulation of TOR signaling,P
12920,303,48015,phosphatidylinositol-mediated signaling,P
12919,303,18105,peptidyl-serine phosphorylation,P
12918,303,30950,establishment or maintenance of actin cytoskeleton polarity,P
12917,303,30010,establishment of cell polarity,P
12916,303,9790,embryo development,P
12915,303,31532,actin cytoskeleton reorganization,P
12914,303,31929,TOR signaling,P
12913,303,31295,T cell costimulation,P
12912,303,43022,ribosome binding,F
12910,303,5515,protein binding,F
12911,303,19901,protein kinase binding,F
12909,303,8047,enzyme activator activity,F
12777,308,45071,negative regulation of viral genome replication,P
12776,308,2000552,negative regulation of T-helper 2 cell cytokine production,P
12775,308,45581,negative regulation of T cell differentiation,P
12774,308,2323,natural killer cell activation involved in immune response,P
12773,308,30101,natural killer cell activation,P
12772,308,6959,humoral immune response,P
12771,308,51607,defense response to virus,P
12770,308,42742,defense response to bacterium,P
12769,308,98586,cellular response to virus,P
12768,308,35458,cellular response to interferon-beta,P
12767,308,71360,cellular response to exogenous dsRNA,P
12766,308,71549,cellular response to dexamethasone stimulus,P
12764,308,7596,blood coagulation,P
12765,308,7166,cell surface receptor signaling pathway,P
12763,308,42100,B cell proliferation,P
12762,308,30183,B cell differentiation,P
12760,308,2250,adaptive immune response,P
12761,308,2312,B cell activation involved in immune response,P
12759,308,5132,type I interferon receptor binding,F
12758,308,5125,cytokine activity,F
12757,308,8811,chloramphenicol O-acetyltransferase activity,F
12756,308,5615,extracellular space,C
12755,308,5576,extracellular region,C
12738,309,31016,pancreas development,P
12737,309,60021,palate development,P
12736,309,8285,negative regulation of cell proliferation,P
12735,309,45596,negative regulation of cell differentiation,P
12734,309,1656,metanephros development,P
12733,309,48469,cell maturation,P
12732,309,48593,camera-type eye morphogenesis,P
12731,309,5654,nucleoplasm,C
12730,309,43231,intracellular membrane-bounded organelle,C
12729,309,5615,extracellular space,C
12848,306,1774,microglial cell activation,P
12842,306,50965,detection of temperature stimulus involved in sensory perception of pain,P
12839,306,71356,cellular response to tumor necrosis factor,P
12838,306,71502,cellular response to temperature stimulus,P
12837,306,1990090,cellular response to nerve growth factor stimulus,P
12836,306,34605,cellular response to heat,P
12835,306,71312,cellular response to alkaloid,P
12834,306,71468,cellular response to acidic pH,P
12833,306,71318,cellular response to ATP,P
12832,306,7166,cell surface receptor signaling pathway,P
12831,306,70588,calcium ion transmembrane transport,P
12830,306,70588,calcium ion transmembrane transport,P
12829,306,1990035,calcium ion import into cell,P
12828,306,48266,behavioral response to pain,P
12827,306,4888,transmembrane signaling receptor activity,F
12826,306,97603,temperature-gated ion channel activity,F
12825,306,51219,phosphoprotein binding,F
12824,306,35091,phosphatidylinositol binding,F
12823,306,46872,metal ion binding,F
12822,306,42802,identical protein binding,F
12821,306,5230,extracellular ligand-gated ion channel activity,F
12820,306,5231,excitatory extracellular ligand-gated ion channel activity,F
12819,306,17081,chloride channel regulator activity,F
12818,306,5516,calmodulin binding,F
12817,306,15278,calcium-release channel activity,F
12816,306,5262,calcium channel activity,F
12815,306,5262,calcium channel activity,F
12814,306,5524,ATP binding,F
12778,308,2001235,positive regulation of apoptotic signaling pathway,P
12779,308,45089,positive regulation of innate immune response,P
12780,308,33141,positive regulation of peptidyl-serine phosphorylation of STAT protein,P
12781,308,45944,positive regulation of transcription from RNA polymerase II promoter,P
12782,308,45343,regulation of MHC class I biosynthetic process,P
12783,308,60338,regulation of type I interferon-mediated signaling pathway,P
12784,308,43330,response to exogenous dsRNA,P
12785,308,9615,response to virus,P
12786,308,2286,T cell activation involved in immune response,P
12787,308,60337,type I interferon signaling pathway,P
12788,308,60337,type I interferon signaling pathway,P
12739,309,1501,skeletal system development,P
12740,309,21512,spinal cord anterior/posterior patterning,P
12741,309,1657,ureteric bud development,P
12742,309,1657,ureteric bud development,P
12743,309,31016,pancreas development,P
12744,309,10862,positive regulation of pathway-restricted SMAD protein phosphorylation,P
12745,309,43408,regulation of MAPK cascade,P
12746,309,42981,regulation of apoptotic process,P
12747,309,1501,skeletal system development,P
12748,309,21512,spinal cord anterior/posterior patterning,P
12749,309,1657,ureteric bud development,P
12750,309,5575,cellular_component,C
12751,309,5615,extracellular space,C
12752,309,43231,intracellular membrane-bounded organelle,C
12753,309,5654,nucleoplasm,C
12754,309,43234,protein complex,C
12789,308,5576,extracellular region,C
12790,308,5576,extracellular region,C
12791,308,5615,extracellular space,C
12796,307,976,transcription regulatory region sequence-specific DNA binding,F
12797,307,1205,"transcriptional activator activity, RNA polymerase II distal enhancer sequence-specific binding",F
12798,307,1190,"transcriptional activator activity, RNA polymerase II transcription factor binding",F
12799,307,9653,anatomical structure morphogenesis,P
12800,307,34599,cellular response to oxidative stress,P
12801,307,30218,erythrocyte differentiation,P
12802,307,6783,heme biosynthetic process,P
12803,307,6954,inflammatory response,P
12804,307,45944,positive regulation of transcription from RNA polymerase II promoter,P
12805,307,45893,"positive regulation of transcription, DNA-templated",P
12806,307,6357,regulation of transcription from RNA polymerase II promoter,P
12807,307,6366,transcription from RNA polymerase II promoter,P
12808,307,5737,cytoplasm,C
12809,307,5737,cytoplasm,C
12810,307,5789,endoplasmic reticulum membrane,C
12811,307,16021,integral component of membrane,C
12812,307,5634,nucleus,C
12813,307,5634,nucleus,C
12853,306,60454,positive regulation of gastric acid secretion,P
12854,306,45429,positive regulation of nitric oxide biosynthetic process,P
12855,306,51289,protein homotetramerization,P
12856,306,51209,release of sequestered calcium ion into cytosol,P
12857,306,1901594,response to capsazepine,P
12858,306,1901594,response to capsazepine,P
12859,306,43434,response to peptide hormone,P
12860,306,50954,sensory perception of mechanical stimulus,P
12861,306,60083,smooth muscle contraction involved in micturition,P
12862,306,50955,thermoception,P
12863,306,6810,transport,P
12864,306,30054,cell junction,C
12865,306,5829,cytosol,C
12866,306,30425,dendrite,C
12867,306,32591,dendritic spine membrane,C
12868,306,9897,external side of plasma membrane,C
12869,306,16021,integral component of membrane,C
12870,306,5887,integral component of plasma membrane,C
12871,306,31226,intrinsic component of plasma membrane,C
12872,306,43025,neuronal cell body,C
12873,306,5886,plasma membrane,C
12874,306,45211,postsynaptic membrane,C
12877,305,5515,protein binding,F
12878,305,19901,protein kinase binding,F
12879,305,5164,tumor necrosis factor receptor binding,F
12880,305,51082,unfolded protein binding,F
12881,305,61077,chaperone-mediated protein folding,P
12882,305,1901856,negative regulation of cellular respiration,P
12883,305,1903751,negative regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide,P
12884,305,1903427,negative regulation of reactive oxygen species biosynthetic process,P
12885,305,6950,response to stress,P
12886,305,9386,translational attenuation,P
12887,305,70062,extracellular exosome,C
12888,305,5811,lipid particle,C
12889,305,16020,membrane,C
12890,305,5743,mitochondrial inner membrane,C
12891,305,5758,mitochondrial intermembrane space,C
12892,305,5759,mitochondrial matrix,C
12893,305,5739,mitochondrion,C
12894,305,5654,nucleoplasm,C
12904,304,48666,neuron development,P
12905,304,8284,positive regulation of cell proliferation,P
12906,304,42517,positive regulation of tyrosine phosphorylation of Stat3 protein,P
12907,304,5576,extracellular region,C
12908,304,5615,extracellular space,C
12931,303,50727,regulation of inflammatory response,P
12932,303,33135,regulation of peptidyl-serine phosphorylation,P
12933,303,42325,regulation of phosphorylation,P
12934,303,51896,regulation of protein kinase B signaling,P
12935,303,31932,TORC2 complex,C
12936,303,5829,cytosol,C
12938,302,70530,K63-linked polyubiquitin binding,F
12939,302,46872,metal ion binding,F
12940,302,5515,protein binding,F
12941,302,43130,ubiquitin binding,F
12942,302,6974,cellular response to DNA damage stimulus,P
12943,302,70987,error-free translesion synthesis,P
12944,302,31398,positive regulation of protein ubiquitination,P
12945,302,9411,response to UV,P
12946,302,19985,translesion synthesis,P
12947,302,19985,translesion synthesis,P
12948,302,5694,chromosome,C
12949,302,16607,nuclear speck,C
12950,302,5654,nucleoplasm,C
12951,302,5654,nucleoplasm,C
12952,302,5634,nucleus,C
12954,301,5515,protein binding,F
12955,301,5102,receptor binding,F
12956,301,4867,serine-type endopeptidase inhibitor activity,F
12957,301,4867,serine-type endopeptidase inhibitor activity,F
12958,301,1525,angiogenesis,P
12959,301,71222,cellular response to lipopolysaccharide,P
12960,301,1300,chronological cell aging,P
12961,301,7623,circadian rhythm,P
12962,301,50829,defense response to Gram-negative bacterium,P
12963,301,30198,extracellular matrix organization,P
12964,301,42730,fibrinolysis,P
12965,301,30195,negative regulation of blood coagulation,P
12966,301,33629,negative regulation of cell adhesion mediated by integrin,P
12967,301,30336,negative regulation of cell migration,P
12968,301,10951,negative regulation of endopeptidase activity,P
12969,301,2000352,negative regulation of endothelial cell apoptotic process,P
12970,301,1902042,negative regulation of extrinsic apoptotic signaling pathway via death domain receptors,P
12971,301,51918,negative regulation of fibrinolysis,P
12972,301,10757,negative regulation of plasminogen activation,P
12973,301,10757,negative regulation of plasminogen activation,P
12974,301,14912,negative regulation of smooth muscle cell migration,P
12975,301,2000098,negative regulation of smooth muscle cell-matrix adhesion,P
12976,301,61044,negative regulation of vascular wound healing,P
12977,301,61045,negative regulation of wound healing,P
12978,301,2576,platelet degranulation,P
12979,301,45766,positive regulation of angiogenesis,P
12980,301,30194,positive regulation of blood coagulation,P
12981,301,50729,positive regulation of inflammatory response,P
12982,301,32757,positive regulation of interleukin-8 production,P
12983,301,35491,positive regulation of leukotriene production involved in inflammatory response,P
12984,301,90026,positive regulation of monocyte chemotaxis,P
12985,301,48260,positive regulation of receptor-mediated endocytosis,P
12986,301,45944,positive regulation of transcription from RNA polymerase II promoter,P
12987,301,10469,regulation of receptor activity,P
12988,301,70062,extracellular exosome,C
12989,301,31012,extracellular matrix,C
12990,301,5576,extracellular region,C
12991,301,5576,extracellular region,C
12992,301,5615,extracellular space,C
12993,301,5886,plasma membrane,C
12994,301,31093,platelet alpha granule lumen,C
13029,299,6368,transcription elongation from RNA polymerase II promoter,P
13030,299,6366,transcription from RNA polymerase II promoter,P
13031,299,6366,transcription from RNA polymerase II promoter,P
13032,299,6361,transcription initiation from RNA polymerase I promoter,P
13033,299,6367,transcription initiation from RNA polymerase II promoter,P
13034,299,6283,transcription-coupled nucleotide-excision repair,P
13035,299,5737,cytoplasm,C
13036,299,5675,holo TFIIH complex,C
13037,299,5739,mitochondrion,C
13038,299,5654,nucleoplasm,C
13039,299,5634,nucleus,C
13040,299,48471,perinuclear region of cytoplasm,C
13068,298,122,negative regulation of transcription from RNA polymerase II promoter,P
13069,298,43065,positive regulation of apoptotic process,P
13070,298,16239,positive regulation of macroautophagy,P
13071,298,1934,positive regulation of protein phosphorylation,P
13072,298,45944,positive regulation of transcription from RNA polymerase II promoter,P
13073,298,51291,protein heterooligomerization,P
13074,298,8104,protein localization,P
13075,298,6468,protein phosphorylation,P
13076,298,43122,regulation of I-kappaB kinase/NF-kappaB signaling,P
13077,298,46578,regulation of Ras protein signal transduction,P
13078,298,10821,regulation of mitochondrion organization,P
13079,298,61635,regulation of protein complex stability,P
13080,298,6950,response to stress,P
13081,298,6511,ubiquitin-dependent protein catabolic process,P
13082,298,932,P-body,C
13083,298,16605,PML body,C
13084,298,16235,aggresome,C
13085,298,44753,amphisome,C
13086,298,44754,autolysosome,C
13087,298,5776,autophagosome,C
13088,298,5737,cytoplasm,C
13089,298,5829,cytosol,C
13090,298,5783,endoplasmic reticulum,C
13091,298,70062,extracellular exosome,C
13092,298,16234,inclusion body,C
13093,298,5770,late endosome,C
13094,298,5654,nucleoplasm,C
13095,298,407,pre-autophagosomal structure,C
13096,298,97225,sperm midpiece,C
13131,297,1903140,regulation of establishment of endothelial barrier,P
13132,297,42325,regulation of phosphorylation,P
13133,297,10803,regulation of tumor necrosis factor-mediated signaling pathway,P
13134,297,9615,response to virus,P
13135,297,42501,serine phosphorylation of STAT protein,P
13136,297,2223,stimulatory C-type lectin receptor signaling pathway,P
13137,297,51403,stress-activated MAPK cascade,P
13138,297,33209,tumor necrosis factor-mediated signaling pathway,P
13139,297,35631,CD40 receptor complex,C
13140,297,8385,IkappaB kinase complex,C
13141,297,5737,cytoplasm,C
13142,297,9898,cytoplasmic side of plasma membrane,C
13143,297,5829,cytosol,C
13144,297,45121,membrane raft,C
13145,297,5634,nucleus,C
13158,296,42262,DNA protection,P
13159,296,6281,DNA repair,P
13160,296,7568,aging,P
13161,296,46061,dATP catabolic process,P
13162,296,6203,dGTP catabolic process,P
13163,296,8584,male gonad development,P
13164,296,34656,nucleobase-containing small molecule catabolic process,P
13165,296,6195,purine nucleotide catabolic process,P
13166,296,46686,response to cadmium ion,P
13167,296,6979,response to oxidative stress,P
13168,296,1669,acrosomal vesicle,C
13169,296,5737,cytoplasm,C
13170,296,5829,cytosol,C
13171,296,70062,extracellular exosome,C
13172,296,5615,extracellular space,C
13173,296,5759,mitochondrial matrix,C
13174,296,5739,mitochondrion,C
13175,296,31965,nuclear membrane,C
13176,296,5634,nucleus,C
13177,296,5886,plasma membrane,C
13209,295,45732,positive regulation of protein catabolic process,P
13210,295,1903955,positive regulation of protein targeting to mitochondrion,P
13211,295,43161,proteasome-mediated ubiquitin-dependent protein catabolic process,P
13212,295,6468,protein phosphorylation,P
13213,295,1903146,regulation of mitophagy,P
13214,295,3073,regulation of systemic arterial blood pressure,P
13215,295,30877,beta-catenin destruction complex,C
13216,295,30877,beta-catenin destruction complex,C
13217,295,5829,cytosol,C
13218,295,5739,mitochondrion,C
13219,295,98794,postsynapse,C
13244,294,1901215,negative regulation of neuron death,P
13245,294,1902176,negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway,P
13246,294,48666,neuron development,P
13247,294,19742,pentacyclic triterpenoid metabolic process,P
13248,294,43065,positive regulation of apoptotic process,P
13249,294,43065,positive regulation of apoptotic process,P
13250,294,10942,positive regulation of cell death,P
13251,294,43280,positive regulation of cysteine-type endopeptidase activity involved in apoptotic process,P
13252,294,2001269,positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway,P
13253,294,2001241,positive regulation of extrinsic apoptotic signaling pathway in absence of ligand,P
13254,294,10822,positive regulation of mitochondrion organization,P
13255,294,1903955,positive regulation of protein targeting to mitochondrion,P
13256,294,16540,protein autoprocessing,P
13257,294,6508,proteolysis,P
13258,294,6508,proteolysis,P
13259,294,6508,proteolysis,P
13260,294,1903146,regulation of mitophagy,P
13261,294,40014,regulation of multicellular organism growth,P
13262,294,9635,response to herbicide,P
13263,294,35631,CD40 receptor complex,C
13264,294,785,chromatin,C
13265,294,9898,cytoplasmic side of plasma membrane,C
13266,294,5856,cytoskeleton,C
13267,294,5829,cytosol,C
13268,294,5783,endoplasmic reticulum,C
13269,294,5789,endoplasmic reticulum membrane,C
13270,294,16020,membrane,C
13271,294,5758,mitochondrial intermembrane space,C
13272,294,31966,mitochondrial membrane,C
13273,294,5739,mitochondrion,C
13274,294,5739,mitochondrion,C
13275,294,5739,mitochondrion,C
13276,294,5634,nucleus,C
13287,293,2000352,negative regulation of endothelial cell apoptotic process,P
13288,293,1901215,negative regulation of neuron death,P
13289,293,70374,positive regulation of ERK1 and ERK2 cascade,P
13290,293,90080,positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway,P
13291,293,8284,positive regulation of cell proliferation,P
13292,293,46326,positive regulation of glucose import,P
13293,293,45716,positive regulation of low-density lipoprotein particle receptor biosynthetic process,P
13294,293,10898,positive regulation of triglyceride catabolic process,P
13295,293,10988,regulation of low-density lipoprotein particle clearance,P
13296,293,14823,response to activity,P
13297,293,1904640,response to methionine,P
13298,293,31667,response to nutrient levels,P
13299,293,7165,signal transduction,P
13300,293,5623,cell,C
13301,293,5576,extracellular region,C
13302,293,5615,extracellular space,C
13324,291,19432,triglyceride biosynthetic process,P
13325,291,6641,triglyceride metabolic process,P
13326,291,34379,very-low-density lipoprotein particle assembly,P
13327,291,5789,endoplasmic reticulum membrane,C
13328,291,5789,endoplasmic reticulum membrane,C
13329,291,16021,integral component of membrane,C
13361,290,48146,positive regulation of fibroblast proliferation,P
13362,290,31666,positive regulation of lipopolysaccharide-mediated signaling pathway,P
13363,290,61081,positive regulation of myeloid leukocyte cytokine production involved in immune response,P
13364,290,33138,positive regulation of peptidyl-serine phosphorylation,P
13365,290,50731,positive regulation of peptidyl-tyrosine phosphorylation,P
13366,290,42327,positive regulation of phosphorylation,P
13367,290,61078,positive regulation of prostaglandin secretion involved in immune response,P
13368,290,10739,positive regulation of protein kinase A signaling,P
13369,290,1516,prostaglandin biosynthetic process,P
13370,290,70207,protein homotrimerization,P
13371,290,43030,regulation of macrophage activation,P
13372,290,9986,cell surface,C
13373,290,5737,cytoplasm,C
13374,290,70062,extracellular exosome,C
13375,290,5576,extracellular region,C
13376,290,5576,extracellular region,C
13377,290,5615,extracellular space,C
13378,290,43209,myelin sheath,C
13379,290,5654,nucleoplasm,C
13380,290,31982,vesicle,C
13391,289,7283,spermatogenesis,P
13392,289,6452,translational frameshifting,P
13393,289,5829,cytosol,C
13394,289,5789,endoplasmic reticulum membrane,C
13395,289,43231,intracellular membrane-bounded organelle,C
13396,289,5643,nuclear pore,C
13415,288,48536,spleen development,P
13416,288,5737,cytoplasm,C
13417,288,5829,cytosol,C
13418,288,5654,nucleoplasm,C
13419,288,5634,nucleus,C
13426,287,6508,proteolysis,P
13427,287,10039,response to iron ion,P
13428,287,5581,collagen trimer,C
13429,287,5602,complement component C1 complex,C
13430,287,70062,extracellular exosome,C
13431,287,5576,extracellular region,C
13462,286,50900,leukocyte migration,P
13463,286,1889,liver development,P
13464,286,2000811,negative regulation of anoikis,P
13465,286,2000270,negative regulation of fibroblast apoptotic process,P
13466,286,43524,negative regulation of neuron apoptotic process,P
13467,286,6661,phosphatidylinositol biosynthetic process,P
13468,286,46854,phosphatidylinositol phosphorylation,P
13469,286,36092,phosphatidylinositol-3-phosphate biosynthetic process,P
13470,286,48015,phosphatidylinositol-mediated signaling,P
13471,286,16310,phosphorylation,P
13472,286,30168,platelet activation,P
13473,286,33138,positive regulation of peptidyl-serine phosphorylation,P
13474,286,43491,protein kinase B signaling,P
13475,286,6468,protein phosphorylation,P
13476,286,43457,regulation of cellular respiration,P
13477,286,10468,regulation of gene expression,P
13478,286,2000653,regulation of genetic imprinting,P
13479,286,40014,regulation of multicellular organism growth,P
13480,286,14066,regulation of phosphatidylinositol 3-kinase signaling,P
13481,286,48010,vascular endothelial growth factor receptor signaling pathway,P
13482,286,1944,vasculature development,P
13483,286,5829,cytosol,C
13484,286,30027,lamellipodium,C
13485,286,5942,phosphatidylinositol 3-kinase complex,C
13486,286,5943,"phosphatidylinositol 3-kinase complex, class IA",C
13487,286,5886,plasma membrane,C
13537,285,30335,positive regulation of cell migration,P
13538,285,8284,positive regulation of cell proliferation,P
13539,285,38091,positive regulation of cell proliferation by VEGF-activated platelet derived growth factor receptor signaling pathway,P
13540,285,7204,positive regulation of cytosolic calcium ion concentration,P
13541,285,48146,positive regulation of fibroblast proliferation,P
13542,285,43552,positive regulation of phosphatidylinositol 3-kinase activity,P
13543,285,14068,positive regulation of phosphatidylinositol 3-kinase signaling,P
13544,285,10863,positive regulation of phospholipase C activity,P
13545,285,46777,protein autophosphorylation,P
13546,285,2000249,regulation of actin cytoskeleton reorganization,P
13547,285,50920,regulation of chemotaxis,P
13548,285,2000739,regulation of mesenchymal stem cell differentiation,P
13549,285,14066,regulation of phosphatidylinositol 3-kinase signaling,P
13550,285,61298,retina vasculature development in camera-type eye,P
13551,285,23019,signal transduction involved in regulation of gene expression,P
13552,285,16032,viral process,P
13553,285,42060,wound healing,P
13554,285,5737,cytoplasm,C
13555,285,9897,external side of plasma membrane,C
13556,285,5887,integral component of plasma membrane,C
13557,285,31226,intrinsic component of plasma membrane,C
13558,285,16020,membrane,C
13559,285,5902,microvillus,C
13560,285,5634,nucleus,C
13561,285,5886,plasma membrane,C
13562,285,43234,protein complex,C
13600,284,30890,positive regulation of B cell proliferation,P
13601,284,1904031,positive regulation of cyclin-dependent protein kinase activity,P
13602,284,48146,positive regulation of fibroblast proliferation,P
13603,284,43068,positive regulation of programmed cell death,P
13604,284,45860,positive regulation of protein kinase activity,P
13605,284,2000379,positive regulation of reactive oxygen species metabolic process,P
13606,284,50821,protein stabilization,P
13607,284,2000278,regulation of DNA biosynthetic process,P
13608,284,79,regulation of cyclin-dependent protein serine/threonine kinase activity,P
13609,284,33158,"regulation of protein import into nucleus, translocation",P
13610,284,90399,replicative senescence,P
13611,284,10165,response to X-ray,P
13612,284,46685,response to arsenic-containing substance,P
13613,284,51412,response to corticosterone,P
13614,284,42493,response to drug,P
13615,284,55093,response to hyperoxia,P
13616,284,10243,response to organonitrogen compound,P
13617,284,9636,response to toxic substance,P
13618,284,90400,stress-induced premature senescence,P
13619,284,70557,PCNA-p21 complex,C
13620,284,307,cyclin-dependent protein kinase holoenzyme complex,C
13621,284,5829,cytosol,C
13622,284,5730,nucleolus,C
13623,284,5654,nucleoplasm,C
13624,284,5654,nucleoplasm,C
13625,284,5634,nucleus,C
13626,284,48471,perinuclear region of cytoplasm,C
13627,284,43234,protein complex,C
13649,283,34599,cellular response to oxidative stress,P
13650,283,71356,cellular response to tumor necrosis factor,P
13651,283,30968,endoplasmic reticulum unfolded protein response,P
13652,283,6954,inflammatory response,P
13653,283,10667,negative regulation of cardiac muscle cell apoptotic process,P
13654,283,2000352,negative regulation of endothelial cell apoptotic process,P
13655,283,1902037,negative regulation of hematopoietic stem cell differentiation,P
13656,283,1903206,negative regulation of hydrogen peroxide-induced cell death,P
13657,283,1902176,negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway,P
13658,283,1904753,negative regulation of vascular associated smooth muscle cell migration,P
13659,283,1903071,positive regulation of ER-associated ubiquitin-dependent protein catabolic process,P
13660,283,45766,positive regulation of angiogenesis,P
13661,283,30194,positive regulation of blood coagulation,P
13662,283,43536,positive regulation of blood vessel endothelial cell migration,P
13663,283,10628,positive regulation of gene expression,P
13664,283,46326,positive regulation of glucose import,P
13665,283,1903788,positive regulation of glutathione biosynthetic process,P
13666,283,10976,positive regulation of neuron projection development,P
13667,283,2000379,positive regulation of reactive oxygen species metabolic process,P
13668,283,45944,positive regulation of transcription from RNA polymerase II promoter,P
13669,283,45944,positive regulation of transcription from RNA polymerase II promoter,P
13670,283,45944,positive regulation of transcription from RNA polymerase II promoter,P
13671,283,36091,positive regulation of transcription from RNA polymerase II promoter in response to oxidative stress,P
13672,283,36003,positive regulation of transcription from RNA polymerase II promoter in response to stress,P
13673,283,10499,proteasomal ubiquitin-independent protein catabolic process,P
13674,283,43161,proteasome-mediated ubiquitin-dependent protein catabolic process,P
13675,283,16567,protein ubiquitination,P
13676,283,45995,regulation of embryonic development,P
13677,283,2000121,regulation of removal of superoxide radicals,P
13678,283,6366,transcription from RNA polymerase II promoter,P
13679,283,5813,centrosome,C
13680,283,785,chromatin,C
13681,283,5737,cytoplasm,C
13682,283,5829,cytosol,C
13683,283,5634,nucleus,C
13684,283,5886,plasma membrane,C
13685,283,32993,protein-DNA complex,C
13709,282,60405,regulation of penile erection,P
13710,282,32228,"regulation of synaptic transmission, GABAergic",P
13711,282,51966,"regulation of synaptic transmission, glutamatergic",P
13712,282,42220,response to cocaine,P
13713,282,45471,response to ethanol,P
13714,282,32496,response to lipopolysaccharide,P
13715,282,43278,response to morphine,P
13716,282,35094,response to nicotine,P
13717,282,7584,response to nutrient,P
13718,282,19233,sensory perception of pain,P
13719,282,7283,spermatogenesis,P
13720,282,30424,axon,C
13721,282,30426,growth cone,C
13722,282,5887,integral component of plasma membrane,C
13723,282,43231,intracellular membrane-bounded organelle,C
13724,282,45121,membrane raft,C
13725,282,5886,plasma membrane,C
13754,281,71158,positive regulation of cell cycle arrest,P
13755,281,48714,positive regulation of oligodendrocyte differentiation,P
13756,281,1900740,positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway,P
13757,281,45944,positive regulation of transcription from RNA polymerase II promoter,P
13758,281,45893,"positive regulation of transcription, DNA-templated",P
13759,281,51262,protein tetramerization,P
13760,281,42981,regulation of apoptotic process,P
13761,281,10468,regulation of gene expression,P
13762,281,7346,regulation of mitotic cell cycle,P
13763,281,1901796,regulation of signal transduction by p53 class mediator,P
13764,281,10165,response to X-ray,P
13765,281,42493,response to drug,P
13766,281,10332,response to gamma radiation,P
13767,281,10243,response to organonitrogen compound,P
13768,281,6366,transcription from RNA polymerase II promoter,P
13769,281,16032,viral process,P
13770,281,5794,Golgi apparatus,C
13771,281,30054,cell junction,C
13772,281,785,chromatin,C
13773,281,5829,cytosol,C
13774,281,43231,intracellular membrane-bounded organelle,C
13775,281,5739,mitochondrion,C
13776,281,5654,nucleoplasm,C
13777,281,5654,nucleoplasm,C
13778,281,5634,nucleus,C
13779,281,5667,transcription factor complex,C
13788,280,55114,oxidation-reduction process,P
13789,280,6561,proline biosynthetic process,P
13790,280,51881,regulation of mitochondrial membrane potential,P
13791,280,5759,mitochondrial matrix,C
13792,280,5739,mitochondrion,C
13808,279,42493,response to drug,P
13809,279,32355,response to estradiol,P
13810,279,43627,response to estrogen,P
13811,279,51384,response to glucocorticoid,P
13812,279,10226,response to lithium ion,P
13813,279,9612,response to mechanical stimulus,P
13814,279,7584,response to nutrient,P
13815,279,32526,response to retinoic acid,P
13816,279,7165,signal transduction,P
13817,279,16324,apical plasma membrane,C
13818,279,31410,cytoplasmic vesicle,C
13819,279,70062,extracellular exosome,C
13820,279,5576,extracellular region,C
13821,279,5576,extracellular region,C
13822,279,5615,extracellular space,C
13863,278,1903896,positive regulation of IRE1-mediated unfolded protein response,P
13864,278,43065,positive regulation of apoptotic process,P
13865,278,43065,positive regulation of apoptotic process,P
13866,278,10524,positive regulation of calcium ion transport into cytosol,P
13867,278,1900103,positive regulation of endoplasmic reticulum unfolded protein response,P
13868,278,1901030,positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway,P
13869,278,45862,positive regulation of proteolysis,P
13870,278,90200,positive regulation of release of cytochrome c from mitochondria,P
13871,278,48597,post-embryonic camera-type eye morphogenesis,P
13872,278,51726,regulation of cell cycle,P
13873,278,46902,regulation of mitochondrial membrane permeability,P
13874,278,51881,regulation of mitochondrial membrane potential,P
13875,278,43497,regulation of protein heterodimerization activity,P
13876,278,43496,regulation of protein homodimerization activity,P
13877,278,1836,release of cytochrome c from mitochondria,P
13878,278,1836,release of cytochrome c from mitochondria,P
13879,278,10225,response to UV-C,P
13880,278,42493,response to drug,P
13881,278,45471,response to ethanol,P
13882,278,9620,response to fungus,P
13883,278,10332,response to gamma radiation,P
13884,278,42542,response to hydrogen peroxide,P
13885,278,10046,response to mycotoxin,P
13886,278,14070,response to organic cyclic compound,P
13887,278,70242,thymocyte apoptotic process,P
13888,278,60068,vagina development,P
13889,278,5829,cytosol,C
13890,278,5783,endoplasmic reticulum,C
13891,278,31307,integral component of mitochondrial outer membrane,C
13892,278,5741,mitochondrial outer membrane,C
13893,278,5741,mitochondrial outer membrane,C
13894,278,5739,mitochondrion,C
13895,278,46930,pore complex,C
13904,277,1503,ossification,P
13905,277,9612,response to mechanical stimulus,P
13906,277,7129,synapsis,P
13907,277,34993,LINC complex,C
13908,277,2080,acrosomal membrane,C
13909,277,5639,integral component of nuclear inner membrane,C
13910,277,43231,intracellular membrane-bounded organelle,C
13911,277,5635,nuclear envelope,C
13912,277,31965,nuclear membrane,C
13927,276,6351,"transcription, DNA-templated",P
13928,276,118,histone deacetylase complex,C
13929,276,16020,membrane,C
13930,276,16604,nuclear body,C
13931,276,790,nuclear chromatin,C
13932,276,16363,nuclear matrix,C
13933,276,5654,nucleoplasm,C
13934,276,5654,nucleoplasm,C
13935,276,5634,nucleus,C
13936,276,5634,nucleus,C
13937,276,17053,transcriptional repressor complex,C
13947,275,70373,negative regulation of ERK1 and ERK2 cascade,P
13948,275,2000378,negative regulation of reactive oxygen species metabolic process,P
13949,275,34983,peptidyl-lysine deacetylation,P
13950,275,32024,positive regulation of insulin secretion,P
13951,275,6471,protein ADP-ribosylation,P
13952,275,6476,protein deacetylation,P
13953,275,5759,mitochondrial matrix,C
13954,275,5739,mitochondrion,C
13967,274,45893,"positive regulation of transcription, DNA-templated",P
13968,274,16925,protein sumoylation,P
13969,274,6351,"transcription, DNA-templated",P
13970,274,781,"chromosome, telomeric region",C
13971,274,777,condensed chromosome kinetochore,C
13972,274,5737,cytoplasm,C
13973,274,5654,nucleoplasm,C
13974,274,5634,nucleus,C
13981,273,209,protein polyubiquitination,P
13982,273,6508,proteolysis,P
13983,273,5737,cytoplasm,C
13984,273,5829,cytosol,C
13985,273,5634,nucleus,C
13998,271,46627,negative regulation of insulin receptor signaling pathway,P
13999,271,6469,negative regulation of protein kinase activity,P
14000,271,9967,positive regulation of signal transduction,P
14001,271,16567,protein ubiquitination,P
14002,271,1558,regulation of cell growth,P
14003,271,9966,regulation of signal transduction,P
14004,271,32355,response to estradiol,P
14005,271,5737,cytoplasm,C
14006,271,5737,cytoplasm,C
14007,271,5829,cytosol,C
14011,270,1902358,sulfate transmembrane transport,P
14012,270,8272,sulfate transport,P
14013,270,5887,integral component of plasma membrane,C
14014,270,5886,plasma membrane,C
14023,269,7072,positive regulation of transcription involved in exit from mitosis,P
14024,269,9303,rRNA transcription,P
14025,269,5737,cytoplasm,C
14026,269,5730,nucleolus,C
14027,269,5731,nucleolus organizer region,C
14033,268,51260,protein homooligomerization,P
14034,268,34765,regulation of ion transmembrane transport,P
14035,268,30424,axon,C
14036,268,45121,membrane raft,C
14037,268,5886,plasma membrane,C
14038,268,8076,voltage-gated potassium channel complex,C
14056,267,30832,regulation of actin filament length,P
14057,267,8360,regulation of cell shape,P
14058,267,7165,signal transduction,P
14059,267,17146,NMDA selective glutamate receptor complex,C
14060,267,5903,brush border,C
14061,267,5938,cell cortex,C
14062,267,30054,cell junction,C
14063,267,70062,extracellular exosome,C
14064,267,30426,growth cone,C
14065,267,14069,postsynaptic density,C
14066,267,32587,ruffle membrane,C
14067,267,32420,stereocilium,C
14068,267,31982,vesicle,C
14075,266,43065,positive regulation of apoptotic process,P
14076,266,2000774,positive regulation of cellular senescence,P
14077,266,6418,tRNA aminoacylation for protein translation,P
14078,266,6414,translational elongation,P
14079,266,5737,cytoplasm,C
14080,266,5737,cytoplasm,C
14081,266,5829,cytosol,C
14082,266,70062,extracellular exosome,C
14083,266,5634,nucleus,C
14084,266,5634,nucleus,C
14094,265,5789,endoplasmic reticulum membrane,C
14095,265,16021,integral component of membrane,C
14096,265,16020,membrane,C
14097,265,5741,mitochondrial outer membrane,C
14098,265,43234,protein complex,C
14129,264,19229,regulation of vasoconstriction,P
14130,264,19229,regulation of vasoconstriction,P
14131,264,19229,regulation of vasoconstriction,P
14132,264,42312,regulation of vasodilation,P
14133,264,2018,renin-angiotensin regulation of aldosterone production,P
14134,264,16021,integral component of membrane,C
14135,264,5887,integral component of plasma membrane,C
14136,264,5622,intracellular,C
14137,264,5886,plasma membrane,C
14138,264,5886,plasma membrane,C
14195,263,10891,negative regulation of sequestering of triglyceride,P
14196,263,48662,negative regulation of smooth muscle cell proliferation,P
14197,263,51974,negative regulation of telomerase activity,P
14198,263,122,negative regulation of transcription from RNA polymerase II promoter,P
14199,263,122,negative regulation of transcription from RNA polymerase II promoter,P
14200,263,45892,"negative regulation of transcription, DNA-templated",P
14201,263,35357,peroxisome proliferator activated receptor signaling pathway,P
14202,263,1890,placenta development,P
14203,263,45600,positive regulation of fat cell differentiation,P
14204,263,46321,positive regulation of fatty acid oxidation,P
14205,263,48714,positive regulation of oligodendrocyte differentiation,P
14206,263,60100,"positive regulation of phagocytosis, engulfment",P
14207,263,51091,positive regulation of sequence-specific DNA binding transcription factor activity,P
14208,263,45944,positive regulation of transcription from RNA polymerase II promoter,P
14209,263,45944,positive regulation of transcription from RNA polymerase II promoter,P
14210,263,45893,"positive regulation of transcription, DNA-templated",P
14211,263,8217,regulation of blood pressure,P
14212,263,60694,regulation of cholesterol transporter activity,P
14213,263,42752,regulation of circadian rhythm,P
14214,263,60850,regulation of transcription involved in cell fate commitment,P
14215,263,31000,response to caffeine,P
14216,263,9409,response to cold,P
14217,263,42493,response to drug,P
14218,263,43627,response to estrogen,P
14219,263,35902,response to immobilization stress,P
14220,263,33993,response to lipid,P
14221,263,55098,response to low-density lipoprotein particle,P
14222,263,9612,response to mechanical stimulus,P
14223,263,1901558,response to metformin,P
14224,263,7584,response to nutrient,P
14225,263,32526,response to retinoic acid,P
14226,263,42594,response to starvation,P
14227,263,33189,response to vitamin A,P
14228,263,48511,rhythmic process,P
14229,263,7165,signal transduction,P
14230,263,43401,steroid hormone mediated signaling pathway,P
14231,263,6367,transcription initiation from RNA polymerase II promoter,P
14232,263,50872,white fat cell differentiation,P
14233,263,50872,white fat cell differentiation,P
14234,263,5794,Golgi apparatus,C
14235,263,90575,RNA polymerase II transcription factor complex,C
14236,263,5829,cytosol,C
14237,263,43231,intracellular membrane-bounded organelle,C
14238,263,5654,nucleoplasm,C
14239,263,5634,nucleus,C
14240,263,48471,perinuclear region of cytoplasm,C
14261,262,15914,phospholipid transport,P
14262,262,6898,receptor-mediated endocytosis,P
14263,262,10874,regulation of cholesterol efflux,P
14264,262,43691,reverse cholesterol transport,P
14265,262,70328,triglyceride homeostasis,P
14266,262,6641,triglyceride metabolic process,P
14267,262,34197,triglyceride transport,P
14268,262,34372,very-low-density lipoprotein particle remodeling,P
14269,262,70062,extracellular exosome,C
14270,262,5576,extracellular region,C
14271,262,5615,extracellular space,C
14272,262,34364,high-density lipoprotein particle,C
14273,262,31982,vesicle,C
27788,261,6281,DNA repair,P
27787,261,10521,telomerase inhibitor activity,F
27786,261,14,single-stranded DNA endodeoxyribonuclease activity,F
27785,261,3697,single-stranded DNA binding,F
27784,261,5515,protein binding,F
27783,261,47485,protein N-terminus binding,F
27782,261,8022,protein C-terminus binding,F
27781,261,4520,endodeoxyribonuclease activity,F
27780,261,4520,endodeoxyribonuclease activity,F
27779,261,4520,endodeoxyribonuclease activity,F
27778,261,3684,damaged DNA binding,F
27777,261,1094,TFIID-class transcription factor binding,F
27776,261,1990599,3' overhang single-stranded DNA endodeoxyribonuclease activity,F
27830,260,43010,camera-type eye development,P
27829,260,5515,protein binding,F
27828,260,8083,growth factor activity,F
27827,260,5006,epidermal growth factor-activated receptor activity,F
27826,260,5154,epidermal growth factor receptor binding,F
27825,260,5509,calcium ion binding,F
27855,259,71305,cellular response to vitamin D,P
27854,259,71374,cellular response to parathyroid hormone stimulus,P
27853,259,44320,cellular response to leptin stimulus,P
27852,259,71354,cellular response to interleukin-6,P
27850,259,30154,cell differentiation,P
27851,259,30643,cellular phosphate ion homeostasis,P
27849,259,165,MAPK cascade,P
27848,259,5105,type 1 fibroblast growth factor receptor binding,F
27847,259,4713,protein tyrosine kinase activity,F
27846,259,46934,"phosphatidylinositol-4,5-bisphosphate 3-kinase activity",F
27845,259,8083,growth factor activity,F
27844,259,5088,Ras guanyl-nucleotide exchange factor activity,F
27843,259,16303,1-phosphatidylinositol-3-kinase activity,F
14377,258,71398,cellular response to fatty acid,P
14378,258,32870,cellular response to hormone stimulus,P
14379,258,34614,cellular response to reactive oxygen species,P
14380,258,2024,diet induced thermogenesis,P
14381,258,1990542,mitochondrial transmembrane transport,P
14382,258,15992,proton transport,P
14383,258,15992,proton transport,P
14384,258,1903426,regulation of reactive oxygen species biosynthetic process,P
14385,258,6357,regulation of transcription from RNA polymerase II promoter,P
14386,258,31667,response to nutrient levels,P
14387,258,9266,response to temperature stimulus,P
14388,258,16021,integral component of membrane,C
14389,258,5743,mitochondrial inner membrane,C
14390,258,5743,mitochondrial inner membrane,C
14391,258,5739,mitochondrion,C
14399,257,6979,response to oxidative stress,P
14400,257,5829,cytosol,C
14401,257,70062,extracellular exosome,C
14402,257,5739,mitochondrion,C
14403,257,5634,nucleus,C
14443,256,1904639,cellular response to resveratrol,P
14444,256,97067,cellular response to thyroid hormone stimulus,P
14445,256,71560,cellular response to transforming growth factor beta stimulus,P
14446,256,71356,cellular response to tumor necrosis factor,P
14447,256,21549,cerebellum development,P
14448,256,32922,circadian regulation of gene expression,P
14449,256,7623,circadian rhythm,P
14450,256,7586,digestion,P
14451,256,19395,fatty acid oxidation,P
14452,256,51552,flavone metabolic process,P
14453,256,30900,forebrain development,P
14454,256,6012,galactose metabolic process,P
14455,256,6094,gluconeogenesis,P
14456,256,6397,mRNA processing,P
14457,256,7005,mitochondrion organization,P
14458,256,7005,mitochondrion organization,P
14459,256,422,mitophagy,P
14460,256,45820,negative regulation of glycolytic process,P
14461,256,90258,negative regulation of mitochondrial fission,P
14462,256,43524,negative regulation of neuron apoptotic process,P
14463,256,1901215,negative regulation of neuron death,P
14464,256,1933,negative regulation of protein phosphorylation,P
14465,256,2000272,negative regulation of receptor activity,P
14466,256,14912,negative regulation of smooth muscle cell migration,P
14467,256,48662,negative regulation of smooth muscle cell proliferation,P
14468,256,2001171,positive regulation of ATP biosynthetic process,P
14469,256,1901857,positive regulation of cellular respiration,P
14470,256,2000507,positive regulation of energy homeostasis,P
14471,256,46321,positive regulation of fatty acid oxidation,P
14472,256,1904635,positive regulation of glomerular visceral epithelial cell apoptotic process,P
14473,256,45722,positive regulation of gluconeogenesis,P
14474,256,35066,positive regulation of histone acetylation,P
14475,256,1901860,positive regulation of mitochondrial DNA metabolic process,P
14476,256,10822,positive regulation of mitochondrion organization,P
14477,256,10822,positive regulation of mitochondrion organization,P
14478,256,10822,positive regulation of mitochondrion organization,P
14479,256,1901863,positive regulation of muscle tissue development,P
14480,256,2000184,positive regulation of progesterone biosynthetic process,P
14481,256,51091,positive regulation of sequence-specific DNA binding transcription factor activity,P
14482,256,48661,positive regulation of smooth muscle cell proliferation,P
14483,256,45944,positive regulation of transcription from RNA polymerase II promoter,P
14484,256,45944,positive regulation of transcription from RNA polymerase II promoter,P
14485,256,45893,"positive regulation of transcription, DNA-templated",P
14486,256,45893,"positive regulation of transcription, DNA-templated",P
14487,256,6461,protein complex assembly,P
14488,256,50821,protein stabilization,P
14489,256,2000310,regulation of N-methyl-D-aspartate selective glutamate receptor activity,P
14490,256,42752,regulation of circadian rhythm,P
14491,256,6355,"regulation of transcription, DNA-templated",P
14492,256,22904,respiratory electron transport chain,P
14493,256,9409,response to cold,P
14494,256,2021,response to dietary excess,P
14495,256,42493,response to drug,P
14496,256,14878,response to electrical stimulus involved in regulation of muscle adaptation,P
14497,256,71871,response to epinephrine,P
14498,256,2931,response to ischemia,P
14499,256,43201,response to leucine,P
14500,256,1901558,response to metformin,P
14501,256,1904640,response to methionine,P
14502,256,14850,response to muscle activity,P
14503,256,71873,response to norepinephrine,P
14504,256,302,response to reactive oxygen species,P
14505,256,42594,response to starvation,P
14506,256,14732,skeletal muscle atrophy,P
14507,256,1659,temperature homeostasis,P
14508,256,6367,transcription initiation from RNA polymerase II promoter,P
14509,256,5665,"DNA-directed RNA polymerase II, core complex",C
14510,256,16605,PML body,C
14511,256,97440,apical dendrite,C
14512,256,22626,cytosolic ribosome,C
14513,256,1990844,interfibrillar mitochondrion,C
14514,256,43025,neuronal cell body,C
14515,256,5719,nuclear euchromatin,C
14516,256,5654,nucleoplasm,C
14517,256,5634,nucleus,C
14518,256,5634,nucleus,C
14519,256,5634,nucleus,C
14520,256,1990843,subsarcolemmal mitochondrion,C
14541,255,71377,cellular response to glucagon stimulus,P
14542,255,7626,locomotory behavior,P
14543,255,50885,neuromuscular process controlling balance,P
14544,255,7204,positive regulation of cytosolic calcium ion concentration,P
14545,255,61178,regulation of insulin secretion involved in cellular response to glucose stimulus,P
14546,255,3091,renal water homeostasis,P
14547,255,5929,cilium,C
14548,255,16021,integral component of membrane,C
14549,255,5622,intracellular,C
14550,255,5886,plasma membrane,C
14551,255,5886,plasma membrane,C
14552,255,5886,plasma membrane,C
14563,254,5576,extracellular region,C
14564,254,5576,extracellular region,C
14565,254,5576,extracellular region,C
14566,254,5615,extracellular space,C
14580,253,6355,"regulation of transcription, DNA-templated",P
14581,253,6351,"transcription, DNA-templated",P
14582,253,785,chromatin,C
14583,253,5737,cytoplasm,C
14584,253,5654,nucleoplasm,C
14600,252,32922,circadian regulation of gene expression,P
14601,252,32922,circadian regulation of gene expression,P
14602,252,32922,circadian regulation of gene expression,P
14603,252,7623,circadian rhythm,P
14604,252,16573,histone acetylation,P
14605,252,2000323,negative regulation of glucocorticoid receptor signaling pathway,P
14606,252,45892,"negative regulation of transcription, DNA-templated",P
14607,252,9648,photoperiodism,P
14608,252,51092,positive regulation of NF-kappaB transcription factor activity,P
14609,252,50729,positive regulation of inflammatory response,P
14610,252,45944,positive regulation of transcription from RNA polymerase II promoter,P
14611,252,45893,"positive regulation of transcription, DNA-templated",P
14612,252,45893,"positive regulation of transcription, DNA-templated",P
14613,252,43161,proteasome-mediated ubiquitin-dependent protein catabolic process,P
14614,252,42634,regulation of hair cycle,P
14615,252,50796,regulation of insulin secretion,P
14616,252,6357,regulation of transcription from RNA polymerase II promoter,P
14617,252,6355,"regulation of transcription, DNA-templated",P
14618,252,2000074,regulation of type B pancreatic cell development,P
14619,252,51775,response to redox state,P
14620,252,7165,signal transduction,P
14621,252,7283,spermatogenesis,P
14622,252,6366,transcription from RNA polymerase II promoter,P
14623,252,33391,chromatoid body,C
14624,252,5694,chromosome,C
14625,252,43231,intracellular membrane-bounded organelle,C
14626,252,5654,nucleoplasm,C
14627,252,5654,nucleoplasm,C
14628,252,5634,nucleus,C
14629,252,5667,transcription factor complex,C
14645,251,32922,circadian regulation of gene expression,P
14646,251,32922,circadian regulation of gene expression,P
14647,251,7623,circadian rhythm,P
14648,251,60137,maternal process involved in parturition,P
14649,251,32007,negative regulation of TOR signaling,P
14650,251,45599,negative regulation of fat cell differentiation,P
14651,251,2000323,negative regulation of glucocorticoid receptor signaling pathway,P
14652,251,45892,"negative regulation of transcription, DNA-templated",P
14653,251,90403,oxidative stress-induced premature senescence,P
14654,251,90263,positive regulation of canonical Wnt signaling pathway,P
14655,251,42753,positive regulation of circadian rhythm,P
14656,251,2001016,positive regulation of skeletal muscle cell differentiation,P
14657,251,45944,positive regulation of transcription from RNA polymerase II promoter,P
14658,251,45944,positive regulation of transcription from RNA polymerase II promoter,P
14659,251,45893,"positive regulation of transcription, DNA-templated",P
14660,251,45893,"positive regulation of transcription, DNA-templated",P
14661,251,43161,proteasome-mediated ubiquitin-dependent protein catabolic process,P
14662,251,60,"protein import into nucleus, translocation",P
14663,251,51726,regulation of cell cycle,P
14664,251,2000772,regulation of cellular senescence,P
14665,251,42634,regulation of hair cycle,P
14666,251,50796,regulation of insulin secretion,P
14667,251,50767,regulation of neurogenesis,P
14668,251,42176,regulation of protein catabolic process,P
14669,251,6355,"regulation of transcription, DNA-templated",P
14670,251,2000074,regulation of type B pancreatic cell development,P
14671,251,51775,response to redox state,P
14672,251,7283,spermatogenesis,P
14673,251,6366,transcription from RNA polymerase II promoter,P
14674,251,16605,PML body,C
14675,251,33391,chromatoid body,C
14676,251,43231,intracellular membrane-bounded organelle,C
14677,251,5654,nucleoplasm,C
14678,251,5654,nucleoplasm,C
14679,251,5634,nucleus,C
14680,251,5667,transcription factor complex,C
14737,250,43552,positive regulation of phosphatidylinositol 3-kinase activity,P
14738,250,31274,positive regulation of pseudopodium assembly,P
14739,250,1900026,positive regulation of substrate adhesion-dependent cell spreading,P
14740,250,51835,positive regulation of synapse structural plasticity,P
14741,250,16567,protein ubiquitination,P
14742,250,51988,regulation of attachment of spindle microtubules to kinetochore,P
14743,250,51489,regulation of filopodium assembly,P
14744,250,7088,regulation of mitotic nuclear division,P
14745,250,42176,regulation of protein catabolic process,P
14746,250,43497,regulation of protein heterodimerization activity,P
14747,250,45859,regulation of protein kinase activity,P
14748,250,31647,regulation of protein stability,P
14749,250,51056,regulation of small GTPase mediated signal transduction,P
14750,250,7264,small GTPase mediated signal transduction,P
14751,250,2040,sprouting angiogenesis,P
14752,250,60661,submandibular salivary gland formation,P
14753,250,21762,substantia nigra development,P
14754,250,48010,vascular endothelial growth factor receptor signaling pathway,P
14755,250,39694,viral RNA genome replication,P
14756,250,139,Golgi membrane,C
14757,250,45177,apical part of cell,C
14758,250,5911,cell-cell junction,C
14759,250,5737,cytoplasm,C
14760,250,36464,cytoplasmic ribonucleoprotein granule,C
14761,250,5829,cytosol,C
14762,250,5789,endoplasmic reticulum membrane,C
14763,250,70062,extracellular exosome,C
14764,250,30175,filopodium,C
14765,250,5925,focal adhesion,C
14766,250,31256,leading edge membrane,C
14767,250,16020,membrane,C
14768,250,5815,microtubule organizing center,C
14769,250,30496,midbody,C
14770,250,72686,mitotic spindle,C
14771,250,43209,myelin sheath,C
14772,250,43005,neuron projection,C
14773,250,43025,neuronal cell body,C
14774,250,5886,plasma membrane,C
14775,250,5886,plasma membrane,C
14776,250,30141,secretory granule,C
14777,250,51233,spindle midzone,C
14778,250,322,storage vacuole,C
14788,249,9967,positive regulation of signal transduction,P
14789,249,51056,regulation of small GTPase mediated signal transduction,P
14790,249,7264,small GTPase mediated signal transduction,P
14791,249,5913,cell-cell adherens junction,C
14792,249,5737,cytoplasm,C
14793,249,5737,cytoplasm,C
14794,249,5829,cytosol,C
14795,249,70062,extracellular exosome,C
14796,249,48471,perinuclear region of cytoplasm,C
14811,248,51365,cellular response to potassium ion starvation,P
14812,248,71300,cellular response to retinoic acid,P
14813,248,71356,cellular response to tumor necrosis factor,P
14814,248,6094,gluconeogenesis,P
14815,248,6094,gluconeogenesis,P
14816,248,6094,gluconeogenesis,P
14817,248,42593,glucose homeostasis,P
14818,248,6006,glucose metabolic process,P
14819,248,46327,glycerol biosynthetic process from pyruvate,P
14820,248,6475,internal protein amino acid acetylation,P
14821,248,6107,oxaloacetate metabolic process,P
14822,248,61402,positive regulation of transcription from RNA polymerase II promoter in response to acidic pH,P
14823,248,14823,response to activity,P
14824,248,32868,response to insulin,P
14825,248,70741,response to interleukin-6,P
14826,248,32496,response to lipopolysaccharide,P
14827,248,1904640,response to methionine,P
14828,248,5737,cytoplasm,C
14829,248,5829,cytosol,C
14830,248,70062,extracellular exosome,C
14855,247,8630,intrinsic apoptotic signaling pathway in response to DNA damage,P
14856,247,42771,intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator,P
14857,247,90307,mitotic spindle assembly,P
14858,247,2000002,negative regulation of DNA damage checkpoint,P
14859,247,71157,negative regulation of cell cycle arrest,P
14860,247,18105,peptidyl-serine phosphorylation,P
14861,247,18107,peptidyl-threonine phosphorylation,P
14862,247,2000210,positive regulation of anoikis,P
14863,247,1934,positive regulation of protein phosphorylation,P
14864,247,45893,"positive regulation of transcription, DNA-templated",P
14865,247,46777,protein autophosphorylation,P
14866,247,6468,protein phosphorylation,P
14867,247,50821,protein stabilization,P
14868,247,42981,regulation of apoptotic process,P
14869,247,42176,regulation of protein catabolic process,P
14870,247,1901796,regulation of signal transduction by p53 class mediator,P
14871,247,6355,"regulation of transcription, DNA-templated",P
14872,247,1302,replicative cell aging,P
14873,247,90399,replicative senescence,P
14874,247,1903416,response to glycoside,P
14875,247,42770,signal transduction in response to DNA damage,P
14876,247,72428,signal transduction involved in intra-S DNA damage checkpoint,P
14877,247,6351,"transcription, DNA-templated",P
14878,247,5794,Golgi apparatus,C
14879,247,16605,PML body,C
14880,247,781,"chromosome, telomeric region",C
14881,247,5654,nucleoplasm,C
14882,247,5654,nucleoplasm,C
14889,246,8285,negative regulation of cell proliferation,P
14890,246,35970,peptidyl-threonine dephosphorylation,P
14891,246,6470,protein dephosphorylation,P
14892,246,9617,response to bacterium,P
14893,246,9314,response to radiation,P
14894,246,5634,nucleus,C
14923,245,6515,misfolded or incompletely synthesized protein catabolic process,P
14924,245,32091,negative regulation of protein binding,P
14925,245,30512,negative regulation of transforming growth factor beta receptor signaling pathway,P
14926,245,30512,negative regulation of transforming growth factor beta receptor signaling pathway,P
14927,245,90035,positive regulation of chaperone-mediated protein complex assembly,P
14928,245,32436,positive regulation of proteasomal ubiquitin-dependent protein catabolic process,P
14929,245,31398,positive regulation of protein ubiquitination,P
14930,245,51443,positive regulation of ubiquitin-protein transferase activity,P
14931,245,43161,proteasome-mediated ubiquitin-dependent protein catabolic process,P
14932,245,70534,protein K63-linked ubiquitination,P
14933,245,51865,protein autoubiquitination,P
14934,245,51604,protein maturation,P
14935,245,209,protein polyubiquitination,P
14936,245,209,protein polyubiquitination,P
14937,245,16567,protein ubiquitination,P
14938,245,16567,protein ubiquitination,P
14939,245,42787,protein ubiquitination involved in ubiquitin-dependent protein catabolic process,P
14940,245,31943,regulation of glucocorticoid metabolic process,P
14941,245,31647,regulation of protein stability,P
14942,245,30579,ubiquitin-dependent SMAD protein catabolic process,P
14943,245,6511,ubiquitin-dependent protein catabolic process,P
14944,245,30018,Z disc,C
14945,245,5737,cytoplasm,C
14946,245,5829,cytosol,C
14947,245,5783,endoplasmic reticulum,C
14948,245,70062,extracellular exosome,C
14949,245,45111,intermediate filament cytoskeleton,C
14950,245,42405,nuclear inclusion body,C
14951,245,5654,nucleoplasm,C
14952,245,5886,plasma membrane,C
14953,245,31371,ubiquitin conjugating enzyme complex,C
14954,245,151,ubiquitin ligase complex,C
14967,244,48512,circadian behavior,P
14968,244,32922,circadian regulation of gene expression,P
14969,244,6897,endocytosis,P
14970,244,30178,negative regulation of Wnt signaling pathway,P
14971,244,32091,negative regulation of protein binding,P
14972,244,18105,peptidyl-serine phosphorylation,P
14973,244,1905426,positive regulation of Wnt-mediated midbrain dopaminergic neuron differentiation,P
14974,244,1902004,positive regulation of beta-amyloid formation,P
14975,244,90263,positive regulation of canonical Wnt signaling pathway,P
14976,244,2000052,positive regulation of non-canonical Wnt signaling pathway,P
14977,244,32436,positive regulation of proteasomal ubiquitin-dependent protein catabolic process,P
14978,244,6468,protein phosphorylation,P
14979,244,6468,protein phosphorylation,P
14980,244,6364,rRNA processing,P
14981,244,8360,regulation of cell shape,P
14982,244,1903827,regulation of cellular protein localization,P
14983,244,42752,regulation of circadian rhythm,P
14984,244,7165,signal transduction,P
14985,244,5737,cytoplasm,C
14986,244,5829,cytosol,C
14987,244,30426,growth cone,C
14988,244,30529,intracellular ribonucleoprotein complex,C
14989,244,43025,neuronal cell body,C
14990,244,5654,nucleoplasm,C
14991,244,5634,nucleus,C
14992,244,5634,nucleus,C
15013,243,48477,oogenesis,P
15014,243,712,resolution of meiotic recombination intermediates,P
15015,243,16446,somatic hypermutation of immunoglobulin genes,P
15016,243,7283,spermatogenesis,P
15017,243,7129,synapsis,P
15018,243,32389,MutLalpha complex,C
15019,243,5712,chiasma,C
15020,243,1673,male germ cell nucleus,C
15021,243,16020,membrane,C
15022,243,5654,nucleoplasm,C
15023,243,5654,nucleoplasm,C
15024,243,5634,nucleus,C
15025,243,795,synaptonemal complex,C
15033,242,5576,extracellular region,C
15034,242,5576,extracellular region,C
15035,242,5634,nucleus,C
15049,241,972,transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery,P
15050,241,16032,viral process,P
15051,241,19083,viral transcription,P
15052,241,5737,cytoplasm,C
15053,241,5635,nuclear envelope,C
15054,241,5635,nuclear envelope,C
15055,241,5643,nuclear pore,C
15056,241,5730,nucleolus,C
15057,241,5634,nucleus,C
15069,240,42787,protein ubiquitination involved in ubiquitin-dependent protein catabolic process,P
15070,240,7062,sister chromatid cohesion,P
15071,240,71173,spindle assembly checkpoint,P
15072,240,1990298,bub1-bub3 complex,C
15073,240,777,condensed chromosome kinetochore,C
15074,240,5829,cytosol,C
15075,240,776,kinetochore,C
15076,240,33597,mitotic checkpoint complex,C
15077,240,5654,nucleoplasm,C
15086,239,3714,transcription corepressor activity,F
15087,239,8270,zinc ion binding,F
15088,239,6284,base-excision repair,P
15089,239,42593,glucose homeostasis,P
15090,239,1990619,histone H3-K9 deacetylation,P
15091,239,61647,histone H3-K9 modification,P
15092,239,8285,negative regulation of cell proliferation,P
15093,239,46325,negative regulation of glucose import,P
15094,239,45820,negative regulation of glycolytic process,P
15095,239,45892,"negative regulation of transcription, DNA-templated",P
15096,239,1905555,positive regulation blood vessel branching,P
15097,239,1902732,positive regulation of chondrocyte proliferation,P
15098,239,31940,positive regulation of chromatin silencing at telomere,P
15099,239,48146,positive regulation of fibroblast proliferation,P
15100,239,2000648,positive regulation of stem cell proliferation,P
15101,239,32206,positive regulation of telomere maintenance,P
15102,239,1905549,positive regulation of telomeric heterochromatin assembly,P
15103,239,1905564,positive regulation of vascular endothelial cell proliferation,P
15104,239,3247,post-embryonic cardiac muscle cell growth involved in heart morphogenesis,P
15105,239,6471,protein ADP-ribosylation,P
15106,239,6471,protein ADP-ribosylation,P
15107,239,31648,protein destabilization,P
15108,239,10569,regulation of double-strand break repair via homologous recombination,P
15109,239,31667,response to nutrient levels,P
15110,239,5737,cytoplasm,C
15111,239,5724,nuclear telomeric heterochromatin,C
15112,239,5730,nucleolus,C
15113,239,5654,nucleoplasm,C
15114,239,5654,nucleoplasm,C
15115,239,5634,nucleus,C
15116,239,5634,nucleus,C
15134,238,6750,glutathione biosynthetic process,P
15135,238,35733,hepatic stellate cell activation,P
15136,238,2001237,negative regulation of extrinsic apoptotic signaling pathway,P
15137,238,43524,negative regulation of neuron apoptotic process,P
15138,238,35229,positive regulation of glutamate-cysteine ligase activity,P
15139,238,50880,regulation of blood vessel size,P
15140,238,51900,regulation of mitochondrial depolarization,P
15141,238,14823,response to activity,P
15142,238,42493,response to drug,P
15143,238,44752,response to human chorionic gonadotropin,P
15144,238,51409,response to nitrosative stress,P
15145,238,7584,response to nutrient,P
15146,238,6979,response to oxidative stress,P
15147,238,96,sulfur amino acid metabolic process,P
15148,238,5829,cytosol,C
15149,238,5829,cytosol,C
15150,238,17109,glutamate-cysteine ligase complex,C
15176,237,43066,negative regulation of apoptotic process,P
15177,237,2001237,negative regulation of extrinsic apoptotic signaling pathway,P
15178,237,2000490,negative regulation of hepatic stellate cell activation,P
15179,237,43524,negative regulation of neuron apoptotic process,P
15180,237,31397,negative regulation of protein ubiquitination,P
15181,237,45892,"negative regulation of transcription, DNA-templated",P
15182,237,32436,positive regulation of proteasomal ubiquitin-dependent protein catabolic process,P
15183,237,50880,regulation of blood vessel size,P
15184,237,51900,regulation of mitochondrial depolarization,P
15185,237,14823,response to activity,P
15186,237,46685,response to arsenic-containing substance,P
15187,237,46686,response to cadmium ion,P
15188,237,9408,response to heat,P
15189,237,9725,response to hormone,P
15190,237,44752,response to human chorionic gonadotropin,P
15191,237,70555,response to interleukin-1,P
15192,237,51409,response to nitrosative stress,P
15193,237,7584,response to nutrient,P
15194,237,6979,response to oxidative stress,P
15195,237,9410,response to xenobiotic stimulus,P
15196,237,96,sulfur amino acid metabolic process,P
15197,237,5829,cytosol,C
15198,237,17109,glutamate-cysteine ligase complex,C
15215,236,6286,"base-excision repair, base-free sugar-phosphate removal",P
15216,236,6287,"base-excision repair, gap-filling",P
15217,236,6974,cellular response to DNA damage stimulus,P
15218,236,48872,homeostasis of number of cells,P
15219,236,71707,immunoglobulin heavy chain V-D-J recombination,P
15220,236,6954,inflammatory response,P
15221,236,8630,intrinsic apoptotic signaling pathway in response to DNA damage,P
15222,236,48535,lymph node development,P
15223,236,51402,neuron apoptotic process,P
15224,236,6297,"nucleotide-excision repair, DNA gap filling",P
15225,236,6290,pyrimidine dimer repair,P
15226,236,45471,response to ethanol,P
15227,236,10332,response to gamma radiation,P
15228,236,55093,response to hyperoxia,P
15229,236,7435,salivary gland morphogenesis,P
15230,236,16446,somatic hypermutation of immunoglobulin genes,P
15231,236,48536,spleen development,P
15232,236,5737,cytoplasm,C
15233,236,5874,microtubule,C
15234,236,5654,nucleoplasm,C
15235,236,5634,nucleus,C
15236,236,43234,protein complex,C
15237,236,5876,spindle microtubule,C
15247,235,61179,negative regulation of insulin secretion involved in cellular response to glucose stimulus,P
15248,235,10942,positive regulation of cell death,P
15249,235,15992,proton transport,P
15250,235,51881,regulation of mitochondrial membrane potential,P
15251,235,70542,response to fatty acid,P
15252,235,1666,response to hypoxia,P
15253,235,303,response to superoxide,P
15254,235,6810,transport,P
15255,235,16021,integral component of membrane,C
15256,235,5743,mitochondrial inner membrane,C
15303,234,1900740,positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway,P
15304,234,45944,positive regulation of transcription from RNA polymerase II promoter,P
15305,234,45893,"positive regulation of transcription, DNA-templated",P
15306,234,45893,"positive regulation of transcription, DNA-templated",P
15307,234,36342,post-anal tail morphogenesis,P
15308,234,60513,prostatic bud formation,P
15309,234,51289,protein homotetramerization,P
15310,234,9954,proximal/distal pattern formation,P
15311,234,42981,regulation of apoptotic process,P
15312,234,43281,regulation of cysteine-type endopeptidase activity involved in apoptotic process,P
15313,234,10482,regulation of epidermal cell division,P
15314,234,43523,regulation of neuron apoptotic process,P
15315,234,1901796,regulation of signal transduction by p53 class mediator,P
15316,234,1302,replicative cell aging,P
15317,234,10165,response to X-ray,P
15318,234,10332,response to gamma radiation,P
15319,234,1501,skeletal system development,P
15320,234,43589,skin morphogenesis,P
15321,234,48745,smooth muscle tissue development,P
15322,234,7283,spermatogenesis,P
15323,234,60529,squamous basal epithelial stem cell differentiation involved in prostate gland acinus development,P
15324,234,48485,sympathetic nervous system development,P
15325,234,6366,transcription from RNA polymerase II promoter,P
15326,234,60157,urinary bladder development,P
15327,234,5737,cytoplasm,C
15328,234,5829,cytosol,C
15329,234,30425,dendrite,C
15330,234,5739,mitochondrion,C
15331,234,790,nuclear chromatin,C
15332,234,5654,nucleoplasm,C
15333,234,5654,nucleoplasm,C
15334,234,5634,nucleus,C
15335,234,5634,nucleus,C
15336,234,5791,rough endoplasmic reticulum,C
15337,234,5667,transcription factor complex,C
15345,233,70062,extracellular exosome,C
15346,233,30176,integral component of endoplasmic reticulum membrane,C
15347,233,16020,membrane,C
15348,233,5637,nuclear inner membrane,C
15365,232,303,response to superoxide,P
15366,232,16021,integral component of membrane,C
15367,232,5743,mitochondrial inner membrane,C
15368,232,5739,mitochondrion,C
15386,231,36297,interstrand cross-link repair,P
15387,231,7275,multicellular organism development,P
15388,231,8156,negative regulation of DNA replication,P
15389,231,18105,peptidyl-serine phosphorylation,P
15390,231,43517,"positive regulation of DNA damage response, signal transduction by p53 class mediator",P
15391,231,1904884,positive regulation of telomerase catalytic core complex assembly,P
15392,231,32212,positive regulation of telomere maintenance via telomerase,P
15393,231,46777,protein autophosphorylation,P
15394,231,70198,"protein localization to chromosome, telomeric region",P
15395,231,1900034,regulation of cellular response to heat,P
15396,231,1901796,regulation of signal transduction by p53 class mediator,P
15397,231,90399,replicative senescence,P
15398,231,42493,response to drug,P
15399,231,5794,Golgi apparatus,C
15400,231,16605,PML body,C
15401,231,5694,chromosome,C
15402,231,784,"nuclear chromosome, telomeric region",C
15403,231,5654,nucleoplasm,C
15404,231,5654,nucleoplasm,C
15455,229,122,negative regulation of transcription from RNA polymerase II promoter,P
15456,229,7399,nervous system development,P
15457,229,1839,neural plate morphogenesis,P
15458,229,1843,neural tube closure,P
15459,229,48570,notochord morphogenesis,P
15460,229,1649,osteoblast differentiation,P
15461,229,3151,outflow tract morphogenesis,P
15462,229,61626,pharyngeal arch artery morphogenesis,P
15463,229,21983,pituitary gland development,P
15464,229,90190,positive regulation of branching involved in ureteric bud morphogenesis,P
15465,229,50679,positive regulation of epithelial cell proliferation,P
15466,229,10628,positive regulation of gene expression,P
15467,229,90193,positive regulation of glomerulus development,P
15468,229,45944,positive regulation of transcription from RNA polymerase II promoter,P
15469,229,60513,prostatic bud formation,P
15470,229,2000313,regulation of fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation,P
15471,229,1501,skeletal system development,P
15472,229,35019,somatic stem cell population maintenance,P
15473,229,61053,somite development,P
15474,229,21510,spinal cord development,P
15475,229,60676,ureteric bud formation,P
15476,229,3223,ventricular compact myocardium morphogenesis,P
15477,229,60412,ventricular septum morphogenesis,P
15478,229,42060,wound healing,P
15479,229,5576,extracellular region,C
15480,229,5615,extracellular space,C
15491,228,50773,regulation of dendrite development,P
15492,228,48168,regulation of neuronal synaptic plasticity,P
15493,228,15629,actin cytoskeleton,C
15494,228,15629,actin cytoskeleton,C
15495,228,42641,actomyosin,C
15496,228,5938,cell cortex,C
15497,228,5913,cell-cell adherens junction,C
15498,228,5737,cytoplasm,C
15499,228,30425,dendrite,C
15500,228,5921,gap junction,C
15501,228,30426,growth cone,C
15502,228,5886,plasma membrane,C
15519,227,30324,lung development,P
15520,227,32091,negative regulation of protein binding,P
15521,227,2001241,positive regulation of extrinsic apoptotic signaling pathway in absence of ligand,P
15522,227,6470,protein dephosphorylation,P
15523,227,6470,protein dephosphorylation,P
15524,227,60828,regulation of canonical Wnt signaling pathway,P
15525,227,42752,regulation of circadian rhythm,P
15526,227,5979,regulation of glycogen biosynthetic process,P
15527,227,5981,regulation of glycogen catabolic process,P
15528,227,36496,regulation of translational initiation by eIF2 alpha dephosphorylation,P
15529,227,70688,MLL5-L complex,C
15530,227,72357,PTW/PP1 phosphatase complex,C
15531,227,5911,cell-cell junction,C
15532,227,5737,cytoplasm,C
15533,227,5829,cytosol,C
15534,227,43197,dendritic spine,C
15535,227,70062,extracellular exosome,C
15536,227,42587,glycogen granule,C
15537,227,784,"nuclear chromosome, telomeric region",C
15538,227,5730,nucleolus,C
15539,227,5654,nucleoplasm,C
15540,227,5634,nucleus,C
15541,227,43204,perikaryon,C
15542,227,5886,plasma membrane,C
15543,227,164,protein phosphatase type 1 complex,C
15653,224,48538,thymus development,P
15654,224,5794,Golgi apparatus,C
15655,224,139,Golgi membrane,C
15656,224,16235,aggresome,C
15657,224,30424,axon,C
15658,224,30054,cell junction,C
15659,224,9986,cell surface,C
15660,224,5813,centrosome,C
15661,224,35253,ciliary rootlet,C
15662,224,31410,cytoplasmic vesicle,C
15663,224,43198,dendritic shaft,C
15664,224,5783,endoplasmic reticulum,C
15665,224,5789,endoplasmic reticulum membrane,C
15666,224,70765,gamma-secretase complex,C
15667,224,30426,growth cone,C
15668,224,16021,integral component of membrane,C
15669,224,5887,integral component of plasma membrane,C
15670,224,776,kinetochore,C
15671,224,5765,lysosomal membrane,C
15672,224,16020,membrane,C
15673,224,45121,membrane raft,C
15674,224,5743,mitochondrial inner membrane,C
15675,224,5739,mitochondrion,C
15676,224,31594,neuromuscular junction,C
15677,224,43025,neuronal cell body,C
15678,224,31965,nuclear membrane,C
15679,224,5640,nuclear outer membrane,C
15680,224,5634,nucleus,C
15681,224,5886,plasma membrane,C
15682,224,98793,presynapse,C
15683,224,5791,rough endoplasmic reticulum,C
15684,224,5790,smooth endoplasmic reticulum,C
15807,223,10718,positive regulation of epithelial to mesenchymal transition,P
15808,223,45743,positive regulation of fibroblast growth factor receptor signaling pathway,P
15809,223,10909,positive regulation of heparan sulfate proteoglycan biosynthetic process,P
15810,223,51571,positive regulation of histone H3-K4 methylation,P
15811,223,2053,positive regulation of mesenchymal cell proliferation,P
15812,223,51149,positive regulation of muscle cell differentiation,P
15813,223,2052,positive regulation of neuroblast proliferation,P
15814,223,43525,positive regulation of neuron apoptotic process,P
15815,223,45669,positive regulation of osteoblast differentiation,P
15816,223,51091,positive regulation of sequence-specific DNA binding transcription factor activity,P
15817,223,48643,positive regulation of skeletal muscle tissue development,P
15818,223,51973,positive regulation of telomerase activity,P
15819,223,32212,positive regulation of telomere maintenance via telomerase,P
15820,223,45944,positive regulation of transcription from RNA polymerase II promoter,P
15821,223,45944,positive regulation of transcription from RNA polymerase II promoter,P
15822,223,45944,positive regulation of transcription from RNA polymerase II promoter,P
15823,223,45944,positive regulation of transcription from RNA polymerase II promoter,P
15824,223,45893,"positive regulation of transcription, DNA-templated",P
15825,223,45893,"positive regulation of transcription, DNA-templated",P
15826,223,32481,positive regulation of type I interferon production,P
15827,223,43161,proteasome-mediated ubiquitin-dependent protein catabolic process,P
15828,223,34394,protein localization to cell surface,P
15829,223,9954,proximal/distal pattern formation,P
15830,223,42129,regulation of T cell proliferation,P
15831,223,45765,regulation of angiogenesis,P
15832,223,90279,regulation of calcium ion import,P
15833,223,30997,regulation of centriole-centriole cohesion,P
15834,223,70602,regulation of centromeric sister chromatid cohesion,P
15835,223,1904793,regulation of euchromatin binding,P
15836,223,48145,regulation of fibroblast proliferation,P
15837,223,31641,regulation of myelination,P
15838,223,72182,regulation of nephron tubule epithelial cell differentiation,P
15839,223,50767,regulation of neurogenesis,P
15840,223,2000008,regulation of protein localization to cell surface,P
15841,223,3266,regulation of secondary heart field cardioblast proliferation,P
15842,223,48660,regulation of smooth muscle cell proliferation,P
15843,223,72053,renal inner medulla development,P
15844,223,72054,renal outer medulla development,P
15845,223,72033,renal vesicle formation,P
15846,223,42493,response to drug,P
15847,223,32355,response to estradiol,P
15848,223,16337,single organismal cell-cell adhesion,P
15849,223,51145,smooth muscle cell differentiation,P
15850,223,19827,stem cell population maintenance,P
15851,223,61549,sympathetic ganglion development,P
15852,223,50808,synapse organization,P
15853,223,48489,synaptic vesicle transport,P
15854,223,48538,thymus development,P
15855,223,60440,trachea formation,P
15856,223,6351,"transcription, DNA-templated",P
15857,223,34750,Scrib-APC-beta-catenin complex,C
15858,223,1990909,Wnt signalosome,C
15859,223,30018,Z disc,C
15860,223,5912,adherens junction,C
15861,223,45177,apical part of cell,C
15862,223,16323,basolateral plasma membrane,C
15863,223,30877,beta-catenin destruction complex,C
15864,223,1990907,beta-catenin-TCF complex,C
15865,223,70369,beta-catenin-TCF7L2 complex,C
15866,223,5923,bicellular tight junction,C
15867,223,16342,catenin complex,C
15868,223,5938,cell cortex,C
15869,223,30054,cell junction,C
15870,223,30054,cell junction,C
15871,223,71944,cell periphery,C
15872,223,5913,cell-cell adherens junction,C
15873,223,5911,cell-cell junction,C
15874,223,5813,centrosome,C
15875,223,5737,cytoplasm,C
15876,223,5829,cytosol,C
15877,223,5829,cytosol,C
15878,223,70062,extracellular exosome,C
15879,223,5916,fascia adherens,C
15880,223,16600,flotillin complex,C
15881,223,5925,focal adhesion,C
15882,223,30027,lamellipodium,C
15883,223,16328,lateral plasma membrane,C
15884,223,16020,membrane,C
15885,223,31528,microvillus membrane,C
15886,223,5719,nuclear euchromatin,C
15887,223,5654,nucleoplasm,C
15888,223,5634,nucleus,C
15889,223,48471,perinuclear region of cytoplasm,C
15890,223,5886,plasma membrane,C
15891,223,43234,protein complex,C
15892,223,32993,protein-DNA complex,C
15893,223,922,spindle pole,C
15894,223,5667,transcription factor complex,C
15918,222,33143,regulation of intracellular steroid hormone receptor signaling pathway,P
15919,222,51246,regulation of protein metabolic process,P
15920,222,43627,response to estrogen,P
15921,222,51384,response to glucocorticoid,P
15922,222,32868,response to insulin,P
15923,222,60133,somatotropin secreting cell development,P
15924,222,30104,water homeostasis,P
15925,222,9986,cell surface,C
15926,222,5737,cytoplasm,C
15927,222,16021,integral component of membrane,C
15928,222,5637,nuclear inner membrane,C
15929,222,16363,nuclear matrix,C
15930,222,5640,nuclear outer membrane,C
15931,222,5886,plasma membrane,C
15932,222,5886,plasma membrane,C
15933,222,42383,sarcolemma,C
15934,222,30141,secretory granule,C
15990,221,61051,positive regulation of cell growth involved in cardiac muscle cell development,P
15991,221,1904056,positive regulation of cholangiocyte proliferation,P
15992,221,60999,positive regulation of dendritic spine development,P
15993,221,1904000,positive regulation of eating behavior,P
15994,221,1938,positive regulation of endothelial cell proliferation,P
15995,221,10628,positive regulation of gene expression,P
15996,221,60252,positive regulation of glial cell proliferation,P
15997,221,1904197,positive regulation of granulosa cell proliferation,P
15998,221,10592,positive regulation of lamellipodium assembly,P
15999,221,46889,positive regulation of lipid biosynthetic process,P
16000,221,10831,positive regulation of myotube differentiation,P
16001,221,1901216,positive regulation of neuron death,P
16002,221,14042,positive regulation of neuron maturation,P
16003,221,45429,positive regulation of nitric oxide biosynthetic process,P
16004,221,48714,positive regulation of oligodendrocyte differentiation,P
16005,221,50731,positive regulation of peptidyl-tyrosine phosphorylation,P
16006,221,51897,positive regulation of protein kinase B signaling,P
16007,221,1934,positive regulation of protein phosphorylation,P
16008,221,1904058,positive regulation of sensory perception of pain,P
16009,221,1904206,positive regulation of skeletal muscle hypertrophy,P
16010,221,48661,positive regulation of smooth muscle cell proliferation,P
16011,221,51496,positive regulation of stress fiber assembly,P
16012,221,45945,positive regulation of transcription from RNA polymerase III promoter,P
16013,221,1901838,positive regulation of transcription of nuclear large rRNA transcript from RNA polymerase I promoter,P
16014,221,45727,positive regulation of translation,P
16015,221,9791,post-embryonic development,P
16016,221,46777,protein autophosphorylation,P
16017,221,30163,protein catabolic process,P
16018,221,6468,protein phosphorylation,P
16019,221,6468,protein phosphorylation,P
16020,221,43087,regulation of GTPase activity,P
16021,221,32956,regulation of actin cytoskeleton organization,P
16022,221,90335,regulation of brown fat cell differentiation,P
16023,221,43610,regulation of carbohydrate utilization,P
16024,221,1900034,regulation of cellular response to heat,P
16025,221,31998,regulation of fatty acid beta-oxidation,P
16026,221,5979,regulation of glycogen biosynthetic process,P
16027,221,90559,regulation of membrane permeability,P
16028,221,31641,regulation of myelination,P
16029,221,45670,regulation of osteoclast differentiation,P
16030,221,45859,regulation of protein kinase activity,P
16031,221,32095,regulation of response to food,P
16032,221,43200,response to amino acid,P
16033,221,42220,response to cocaine,P
16034,221,32868,response to insulin,P
16035,221,43278,response to morphine,P
16036,221,7584,response to nutrient,P
16037,221,6950,response to stress,P
16038,221,31529,ruffle organization,P
16039,221,7165,signal transduction,P
16040,221,35176,social behavior,P
16041,221,21510,spinal cord development,P
16042,221,8542,visual learning,P
16043,221,50882,voluntary musculoskeletal movement,P
16044,221,42060,wound healing,P
16045,221,139,Golgi membrane,C
16046,221,16605,PML body,C
16047,221,31931,TORC1 complex,C
16048,221,31931,TORC1 complex,C
16049,221,31932,TORC2 complex,C
16050,221,5737,cytoplasm,C
16051,221,5829,cytosol,C
16052,221,30425,dendrite,C
16053,221,12505,endomembrane system,C
16054,221,5789,endoplasmic reticulum membrane,C
16055,221,5765,lysosomal membrane,C
16056,221,5764,lysosome,C
16057,221,16020,membrane,C
16058,221,5741,mitochondrial outer membrane,C
16059,221,43025,neuronal cell body,C
16060,221,5654,nucleoplasm,C
16061,221,5634,nucleus,C
16062,221,5942,phosphatidylinositol 3-kinase complex,C
16088,220,45429,positive regulation of nitric oxide biosynthetic process,P
16089,220,32436,positive regulation of proteasomal ubiquitin-dependent protein catabolic process,P
16090,220,2000060,positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process,P
16091,220,1902949,positive regulation of tau-protein kinase activity,P
16092,220,32760,positive regulation of tumor necrosis factor production,P
16093,220,17038,protein import,P
16094,220,50821,protein stabilization,P
16095,220,1900221,regulation of beta-amyloid clearance,P
16096,220,1901214,regulation of neuron death,P
16097,220,1901214,regulation of neuron death,P
16098,220,1902847,regulation of neuronal signal transduction,P
16099,220,1836,release of cytochrome c from mitochondria,P
16100,220,51788,response to misfolded protein,P
16101,220,9615,response to virus,P
16102,220,43691,reverse cholesterol transport,P
16103,220,5794,Golgi apparatus,C
16104,220,97440,apical dendrite,C
16105,220,72562,blood microparticle,C
16106,220,9986,cell surface,C
16107,220,42583,chromaffin granule,C
16108,220,5737,cytoplasm,C
16109,220,5829,cytosol,C
16110,220,5783,endoplasmic reticulum,C
16111,220,70062,extracellular exosome,C
16112,220,31012,extracellular matrix,C
16113,220,31012,extracellular matrix,C
16114,220,5576,extracellular region,C
16115,220,5615,extracellular space,C
16116,220,31966,mitochondrial membrane,C
16117,220,5739,mitochondrion,C
16118,220,97418,neurofibrillary tangle,C
16119,220,5634,nucleus,C
16120,220,48471,perinuclear region of cytoplasm,C
16121,220,31093,platelet alpha granule lumen,C
16122,220,43234,protein complex,C
16123,220,34366,spherical high-density lipoprotein particle,C
16164,219,2223,stimulatory C-type lectin receptor signaling pathway,P
16165,219,34142,toll-like receptor 4 signaling pathway,P
16166,219,16032,viral process,P
16167,219,33256,I-kappaB/NF-kappaB complex,C
16168,219,5737,cytoplasm,C
16169,219,5829,cytosol,C
16170,219,5634,nucleus,C
16171,219,5886,plasma membrane,C
16182,218,42593,glucose homeostasis,P
16183,218,33210,leptin-mediated signaling pathway,P
16184,218,7275,multicellular organism development,P
16185,218,10507,negative regulation of autophagy,P
16186,218,45721,negative regulation of gluconeogenesis,P
16187,218,51346,negative regulation of hydrolase activity,P
16188,218,6909,phagocytosis,P
16189,218,46850,regulation of bone remodeling,P
16190,218,2000505,regulation of energy homeostasis,P
16191,218,60259,regulation of feeding behavior,P
16192,218,44321,response to leptin,P
16193,218,19953,sexual reproduction,P
16194,218,16323,basolateral plasma membrane,C
16195,218,5576,extracellular region,C
16196,218,16021,integral component of membrane,C
16197,218,5886,plasma membrane,C
16198,218,43235,receptor complex,C
16243,217,122,negative regulation of transcription from RNA polymerase II promoter,P
16244,217,45906,negative regulation of vasoconstriction,P
16245,217,1542,ovulation from ovarian follicle,P
16246,217,6909,phagocytosis,P
16247,217,1890,placenta development,P
16248,217,46427,positive regulation of JAK-STAT cascade,P
16249,217,43410,positive regulation of MAPK cascade,P
16250,217,43410,positive regulation of MAPK cascade,P
16251,217,2000366,positive regulation of STAT protein import into nucleus,P
16252,217,42102,positive regulation of T cell proliferation,P
16253,217,32008,positive regulation of TOR signaling,P
16254,217,48639,positive regulation of developmental growth,P
16255,217,1904651,positive regulation of fat cell apoptotic process,P
16256,217,46881,positive regulation of follicle-stimulating hormone secretion,P
16257,217,2000491,positive regulation of hepatic stellate cell activation,P
16258,217,46628,positive regulation of insulin receptor signaling pathway,P
16259,217,43270,positive regulation of ion transport,P
16260,217,33686,positive regulation of luteinizing hormone secretion,P
16261,217,45639,positive regulation of myeloid cell differentiation,P
16262,217,1900745,positive regulation of p38MAPK cascade,P
16263,217,35360,positive regulation of peroxisome proliferator activated receptor signaling pathway,P
16264,217,14068,positive regulation of phosphatidylinositol 3-kinase signaling,P
16265,217,14068,positive regulation of phosphatidylinositol 3-kinase signaling,P
16266,217,51897,positive regulation of protein kinase B signaling,P
16267,217,2000379,positive regulation of reactive oxygen species metabolic process,P
16268,217,32760,positive regulation of tumor necrosis factor production,P
16269,217,42517,positive regulation of tyrosine phosphorylation of Stat3 protein,P
16270,217,32310,prostaglandin secretion,P
16271,217,45765,regulation of angiogenesis,P
16272,217,8217,regulation of blood pressure,P
16273,217,46850,regulation of bone remodeling,P
16274,217,90335,regulation of brown fat cell differentiation,P
16275,217,51726,regulation of cell cycle,P
16276,217,1900015,regulation of cytokine production involved in inflammatory response,P
16277,217,1936,regulation of endothelial cell proliferation,P
16278,217,6111,regulation of gluconeogenesis,P
16279,217,50796,regulation of insulin secretion,P
16280,217,30300,regulation of intestinal cholesterol absorption,P
16281,217,60587,regulation of lipoprotein lipid oxidation,P
16282,217,32814,regulation of natural killer cell activation,P
16283,217,42269,regulation of natural killer cell mediated cytotoxicity,P
16284,217,32817,regulation of natural killer cell proliferation,P
16285,217,50999,regulation of nitric-oxide synthase activity,P
16286,217,50810,regulation of steroid biosynthetic process,P
16287,217,14823,response to activity,P
16288,217,2021,response to dietary excess,P
16289,217,32355,response to estradiol,P
16290,217,45471,response to ethanol,P
16291,217,1666,response to hypoxia,P
16292,217,32868,response to insulin,P
16293,217,33197,response to vitamin E,P
16294,217,19953,sexual reproduction,P
16295,217,7260,tyrosine phosphorylation of STAT protein,P
16296,217,5737,cytoplasm,C
16297,217,5576,extracellular region,C
16298,217,5615,extracellular space,C
16335,216,122,negative regulation of transcription from RNA polymerase II promoter,P
16336,216,7200,phospholipase C-activating G-protein coupled receptor signaling pathway,P
16337,216,7204,positive regulation of cytosolic calcium ion concentration,P
16338,216,48146,positive regulation of fibroblast proliferation,P
16339,216,10863,positive regulation of phospholipase C activity,P
16340,216,51091,positive regulation of sequence-specific DNA binding transcription factor activity,P
16341,216,45944,positive regulation of transcription from RNA polymerase II promoter,P
16342,216,45893,"positive regulation of transcription, DNA-templated",P
16343,216,60527,prostate epithelial cord arborization involved in prostate glandular acinus morphogenesis,P
16344,216,60523,prostate epithelial cord elongation,P
16345,216,71168,protein localization to chromatin,P
16346,216,42981,regulation of apoptotic process,P
16347,216,60687,regulation of branching involved in prostate gland morphogenesis,P
16348,216,50727,regulation of inflammatory response,P
16349,216,34121,regulation of toll-like receptor signaling pathway,P
16350,216,6355,"regulation of transcription, DNA-templated",P
16351,216,32355,response to estradiol,P
16352,216,43627,response to estrogen,P
16353,216,7165,signal transduction,P
16354,216,6366,transcription from RNA polymerase II promoter,P
16355,216,6367,transcription initiation from RNA polymerase II promoter,P
16356,216,6351,"transcription, DNA-templated",P
16357,216,60065,uterus development,P
16358,216,60068,vagina development,P
16359,216,5794,Golgi apparatus,C
16360,216,5737,cytoplasm,C
16361,216,16021,integral component of membrane,C
16362,216,16020,membrane,C
16363,216,790,nuclear chromatin,C
16364,216,5654,nucleoplasm,C
16365,216,5634,nucleus,C
16366,216,5886,plasma membrane,C
16367,216,35327,transcriptionally active chromatin,C
16443,215,7204,positive regulation of cytosolic calcium ion concentration,P
16444,215,1904037,positive regulation of epithelial cell apoptotic process,P
16445,215,1902728,positive regulation of growth factor dependent skeletal muscle satellite cell proliferation,P
16446,215,60399,positive regulation of growth hormone receptor signaling pathway,P
16447,215,50729,positive regulation of inflammatory response,P
16448,215,32024,positive regulation of insulin secretion,P
16449,215,32731,positive regulation of interleukin-1 beta production,P
16450,215,45429,positive regulation of nitric oxide biosynthetic process,P
16451,215,51770,positive regulation of nitric-oxide synthase biosynthetic process,P
16452,215,50731,positive regulation of peptidyl-tyrosine phosphorylation,P
16453,215,14068,positive regulation of phosphatidylinositol 3-kinase signaling,P
16454,215,32516,positive regulation of phosphoprotein phosphatase activity,P
16455,215,33160,"positive regulation of protein import into nucleus, translocation",P
16456,215,51091,positive regulation of sequence-specific DNA binding transcription factor activity,P
16457,215,32760,positive regulation of tumor necrosis factor production,P
16458,215,42517,positive regulation of tyrosine phosphorylation of Stat3 protein,P
16459,215,42523,positive regulation of tyrosine phosphorylation of Stat5 protein,P
16460,215,1904707,positive regulation of vascular smooth muscle cell proliferation,P
16461,215,46777,protein autophosphorylation,P
16462,215,6468,protein phosphorylation,P
16463,215,42981,regulation of apoptotic process,P
16464,215,42127,regulation of cell proliferation,P
16465,215,50727,regulation of inflammatory response,P
16466,215,60334,regulation of interferon-gamma-mediated signaling pathway,P
16467,215,46677,response to antibiotic,P
16468,215,33194,response to hydroperoxide,P
16469,215,70671,response to interleukin-12,P
16470,215,32496,response to lipopolysaccharide,P
16471,215,34612,response to tumor necrosis factor,P
16472,215,7165,signal transduction,P
16473,215,33209,tumor necrosis factor-mediated signaling pathway,P
16474,215,7260,tyrosine phosphorylation of STAT protein,P
16475,215,7260,tyrosine phosphorylation of STAT protein,P
16476,215,42508,tyrosine phosphorylation of Stat1 protein,P
16477,215,42503,tyrosine phosphorylation of Stat3 protein,P
16478,215,42506,tyrosine phosphorylation of Stat5 protein,P
16479,215,5901,caveola,C
16480,215,5737,cytoplasm,C
16481,215,5856,cytoskeleton,C
16482,215,5829,cytosol,C
16483,215,31904,endosome lumen,C
16484,215,31234,extrinsic component of cytoplasmic side of plasma membrane,C
16485,215,45121,membrane raft,C
16486,215,16363,nuclear matrix,C
16487,215,5654,nucleoplasm,C
16488,215,5634,nucleus,C
16496,214,6355,"regulation of transcription, DNA-templated",P
16497,214,6351,"transcription, DNA-templated",P
16498,214,5634,nucleus,C
16507,213,6355,"regulation of transcription, DNA-templated",P
16508,213,6351,"transcription, DNA-templated",P
16509,213,5737,cytoplasm,C
16510,213,5654,nucleoplasm,C
16511,213,5634,nucleus,C
16528,212,51321,meiotic cell cycle,P
16529,212,6334,nucleosome assembly,P
16530,212,45739,positive regulation of DNA repair,P
16531,212,10212,response to ionizing radiation,P
16532,212,7283,spermatogenesis,P
16533,212,16032,viral process,P
16534,212,1741,XY body,C
16535,212,781,"chromosome, telomeric region",C
16536,212,794,condensed nuclear chromosome,C
16537,212,70062,extracellular exosome,C
16538,212,1673,male germ cell nucleus,C
16539,212,790,nuclear chromatin,C
16540,212,5654,nucleoplasm,C
16541,212,5654,nucleoplasm,C
16542,212,786,nucleosome,C
16543,212,5634,nucleus,C
16544,212,5657,replication fork,C
16545,212,35861,site of double-strand break,C
16564,211,45892,"negative regulation of transcription, DNA-templated",P
16565,211,60021,palate development,P
16566,211,1901896,positive regulation of calcium-transporting ATPase activity,P
16567,211,32436,positive regulation of proteasomal ubiquitin-dependent protein catabolic process,P
16568,211,31334,positive regulation of protein complex assembly,P
16569,211,90204,protein localization to nuclear pore,P
16570,211,50821,protein stabilization,P
16571,211,16925,protein sumoylation,P
16572,211,16925,protein sumoylation,P
16573,211,86004,regulation of cardiac muscle cell contraction,P
16574,211,60334,regulation of interferon-gamma-mediated signaling pathway,P
16575,211,32880,regulation of protein localization,P
16576,211,16032,viral process,P
16577,211,16605,PML body,C
16578,211,16605,PML body,C
16579,211,1741,XY body,C
16580,211,5737,cytoplasm,C
16581,211,30425,dendrite,C
16582,211,1650,fibrillar center,C
16583,211,792,heterochromatin,C
16584,211,16604,nuclear body,C
16585,211,31965,nuclear membrane,C
16586,211,5643,nuclear pore,C
16587,211,16607,nuclear speck,C
16588,211,97165,nuclear stress granule,C
16589,211,5730,nucleolus,C
16590,211,5654,nucleoplasm,C
16591,211,5634,nucleus,C
16592,211,5886,plasma membrane,C
16593,211,45202,synapse,C
16594,211,8076,voltage-gated potassium channel complex,C
16637,210,8284,positive regulation of cell proliferation,P
16638,210,10628,positive regulation of gene expression,P
16639,210,45931,positive regulation of mitotic cell cycle,P
16640,210,32436,positive regulation of proteasomal ubiquitin-dependent protein catabolic process,P
16641,210,46827,positive regulation of protein export from nucleus,P
16642,210,1904754,positive regulation of vascular associated smooth muscle cell migration,P
16643,210,1904707,positive regulation of vascular smooth muscle cell proliferation,P
16644,210,51865,protein autoubiquitination,P
16645,210,6461,protein complex assembly,P
16646,210,31648,protein destabilization,P
16647,210,34504,protein localization to nucleus,P
16648,210,16925,protein sumoylation,P
16649,210,16567,protein ubiquitination,P
16650,210,42787,protein ubiquitination involved in ubiquitin-dependent protein catabolic process,P
16651,210,42787,protein ubiquitination involved in ubiquitin-dependent protein catabolic process,P
16652,210,42787,protein ubiquitination involved in ubiquitin-dependent protein catabolic process,P
16653,210,2027,regulation of heart rate,P
16654,210,42176,regulation of protein catabolic process,P
16655,210,1901796,regulation of signal transduction by p53 class mediator,P
16656,210,46677,response to antibiotic,P
16657,210,42220,response to cocaine,P
16658,210,42493,response to drug,P
16659,210,45472,response to ether,P
16660,210,1904404,response to formaldehyde,P
16661,210,10039,response to iron ion,P
16662,210,32026,response to magnesium ion,P
16663,210,43278,response to morphine,P
16664,210,48545,response to steroid hormone,P
16665,210,9636,response to toxic substance,P
16666,210,1990785,response to water-immersion restraint stress,P
16667,210,36369,transcription factor catabolic process,P
16668,210,7089,traversing start control point of mitotic cell cycle,P
16669,210,3281,ventricular septum development,P
16670,210,16032,viral process,P
16671,210,5737,cytoplasm,C
16672,210,5829,cytosol,C
16673,210,30666,endocytic vesicle membrane,C
16674,210,16604,nuclear body,C
16675,210,5730,nucleolus,C
16676,210,5654,nucleoplasm,C
16677,210,5654,nucleoplasm,C
16678,210,5634,nucleus,C
16679,210,5634,nucleus,C
16680,210,5886,plasma membrane,C
16681,210,43234,protein complex,C
16682,210,45202,synapse,C
16689,209,1078,"transcriptional repressor activity, RNA polymerase II core promoter proximal region sequence-specific binding",F
16690,209,8283,cell proliferation,P
16691,209,7275,multicellular organism development,P
16692,209,122,negative regulation of transcription from RNA polymerase II promoter,P
16693,209,6351,"transcription, DNA-templated",P
16694,209,790,nuclear chromatin,C
16695,209,5634,nucleus,C
16708,208,51402,neuron apoptotic process,P
16709,208,6461,protein complex assembly,P
16710,208,6357,regulation of transcription from RNA polymerase II promoter,P
16711,208,48678,response to axon injury,P
16712,208,32868,response to insulin,P
16713,208,60041,retina development in camera-type eye,P
16714,208,6366,transcription from RNA polymerase II promoter,P
16715,208,71339,MLL1 complex,C
16716,208,16605,PML body,C
16717,208,5737,cytoplasm,C
16718,208,30425,dendrite,C
16719,208,5654,nucleoplasm,C
16720,208,5634,nucleus,C
16766,207,43433,negative regulation of sequence-specific DNA binding transcription factor activity,P
16767,207,122,negative regulation of transcription from RNA polymerase II promoter,P
16768,207,45892,"negative regulation of transcription, DNA-templated",P
16769,207,45892,"negative regulation of transcription, DNA-templated",P
16770,207,42475,odontogenesis of dentin-containing tooth,P
16771,207,8284,positive regulation of cell proliferation,P
16772,207,32967,positive regulation of collagen biosynthetic process,P
16773,207,10718,positive regulation of epithelial to mesenchymal transition,P
16774,207,32732,positive regulation of interleukin-1 production,P
16775,207,48714,positive regulation of oligodendrocyte differentiation,P
16776,207,45862,positive regulation of proteolysis,P
16777,207,10870,positive regulation of receptor biosynthetic process,P
16778,207,45944,positive regulation of transcription from RNA polymerase II promoter,P
16779,207,45893,"positive regulation of transcription, DNA-templated",P
16780,207,32760,positive regulation of tumor necrosis factor production,P
16781,207,42517,positive regulation of tyrosine phosphorylation of Stat3 protein,P
16782,207,1901796,regulation of signal transduction by p53 class mediator,P
16783,207,1975,response to amphetamine,P
16784,207,31000,response to caffeine,P
16785,207,42220,response to cocaine,P
16786,207,42493,response to drug,P
16787,207,55093,response to hyperoxia,P
16788,207,32496,response to lipopolysaccharide,P
16789,207,35094,response to nicotine,P
16790,207,6351,"transcription, DNA-templated",P
16791,207,35098,ESC/E(Z) complex,C
16792,207,16581,NuRD complex,C
16793,207,16580,Sin3 complex,C
16794,207,5737,cytoplasm,C
16795,207,5737,cytoplasm,C
16796,207,790,nuclear chromatin,C
16797,207,5654,nucleoplasm,C
16798,207,5634,nucleus,C
16799,207,43234,protein complex,C
16841,206,43200,response to amino acid,P
16842,206,34059,response to anoxia,P
16843,206,32355,response to estradiol,P
16844,206,70542,response to fatty acid,P
16845,206,9749,response to glucose,P
16846,206,51385,response to mineralocorticoid,P
16847,206,43434,response to peptide hormone,P
16848,206,9611,response to wounding,P
16849,206,1894,tissue homeostasis,P
16850,206,6367,transcription initiation from RNA polymerase II promoter,P
16851,206,5794,Golgi apparatus,C
16852,206,5938,cell cortex,C
16853,206,5801,cis-Golgi network,C
16854,206,5829,cytosol,C
16855,206,5576,extracellular region,C
16856,206,5615,extracellular space,C
16857,206,43231,intracellular membrane-bounded organelle,C
16858,206,48471,perinuclear region of cytoplasm,C
16859,206,5886,plasma membrane,C
16860,206,5578,proteinaceous extracellular matrix,C
16883,205,7613,memory,P
16884,205,1774,microglial cell activation,P
16885,205,226,microtubule cytoskeleton organization,P
16886,205,1903748,negative regulation of establishment of protein localization to mitochondrion,P
16887,205,33673,negative regulation of kinase activity,P
16888,205,90258,negative regulation of mitochondrial fission,P
16889,205,10917,negative regulation of mitochondrial membrane potential,P
16890,205,1902988,neurofibrillary tangle assembly,P
16891,205,31175,neuron projection development,P
16892,205,72386,plus-end-directed organelle transport along microtubule,P
16893,205,45773,positive regulation of axon extension,P
16894,205,1905689,positive regulation of diacylglycerol kinase activity,P
16895,205,31116,positive regulation of microtubule polymerization,P
16896,205,1901216,positive regulation of neuron death,P
16897,205,1902474,positive regulation of protein localization to synapse,P
16898,205,32930,positive regulation of superoxide anion generation,P
16899,205,51259,protein oligomerization,P
16900,205,10506,regulation of autophagy,P
16901,205,50848,regulation of calcium-mediated signaling,P
16902,205,1900034,regulation of cellular response to heat,P
16903,205,31113,regulation of microtubule polymerization,P
16904,205,90140,regulation of mitochondrial fission,P
16905,205,2001020,regulation of response to DNA damage stimulus,P
16906,205,7165,signal transduction,P
16907,205,50808,synapse organization,P
16908,205,30424,axon,C
16909,205,30424,axon,C
16910,205,1904115,axon cytoplasm,C
16911,205,44297,cell body,C
16912,205,36464,cytoplasmic ribonucleoprotein granule,C
16913,205,5829,cytosol,C
16914,205,5829,cytosol,C
16915,205,30425,dendrite,C
16916,205,30426,growth cone,C
16917,205,16020,membrane,C
16918,205,5874,microtubule,C
16919,205,97418,neurofibrillary tangle,C
16920,205,43025,neuronal cell body,C
16921,205,34399,nuclear periphery,C
16922,205,5634,nucleus,C
16923,205,5886,plasma membrane,C
16924,205,36477,somatodendritic compartment,C
16925,205,45298,tubulin complex,C
16958,204,5658,alpha DNA polymerase:primase complex,C
16959,204,785,chromatin,C
16960,204,5737,cytoplasm,C
16961,204,5635,nuclear envelope,C
16962,204,16363,nuclear matrix,C
16963,204,5730,nucleolus,C
16964,204,5654,nucleoplasm,C
16965,204,5654,nucleoplasm,C
16966,204,5634,nucleus,C
16995,203,70059,intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress,P
16996,203,1990442,intrinsic apoptotic signaling pathway in response to nitrosative stress,P
16997,203,42789,mRNA transcription from RNA polymerase II promoter,P
16998,203,32792,negative regulation of CREB transcription factor activity,P
16999,203,32792,negative regulation of CREB transcription factor activity,P
17000,203,1903026,negative regulation of RNA polymerase II regulatory region sequence-specific DNA binding,P
17001,203,90090,negative regulation of canonical Wnt signaling pathway,P
17002,203,2000016,negative regulation of determination of dorsal identity,P
17003,203,45599,negative regulation of fat cell differentiation,P
17004,203,45662,negative regulation of myoblast differentiation,P
17005,203,51898,negative regulation of protein kinase B signaling,P
17006,203,43433,negative regulation of sequence-specific DNA binding transcription factor activity,P
17007,203,122,negative regulation of transcription from RNA polymerase II promoter,P
17008,203,122,negative regulation of transcription from RNA polymerase II promoter,P
17009,203,45892,"negative regulation of transcription, DNA-templated",P
17010,203,1902237,positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway,P
17011,203,32757,positive regulation of interleukin-8 production,P
17012,203,43525,positive regulation of neuron apoptotic process,P
17013,203,45944,positive regulation of transcription from RNA polymerase II promoter,P
17014,203,45944,positive regulation of transcription from RNA polymerase II promoter,P
17015,203,1990440,positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress,P
17016,203,1990440,positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress,P
17017,203,1990440,positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress,P
17018,203,1990440,positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress,P
17019,203,45893,"positive regulation of transcription, DNA-templated",P
17020,203,43161,proteasome-mediated ubiquitin-dependent protein catabolic process,P
17021,203,43620,regulation of DNA-templated transcription in response to stress,P
17022,203,44324,regulation of transcription involved in anterior/posterior axis specification,P
17023,203,6355,"regulation of transcription, DNA-templated",P
17024,203,51209,release of sequestered calcium ion into cytosol,P
17025,203,34976,response to endoplasmic reticulum stress,P
17026,203,42594,response to starvation,P
17027,203,6986,response to unfolded protein,P
17028,203,1990622,CHOP-ATF3 complex,C
17029,203,1990617,CHOP-ATF4 complex,C
17030,203,1990617,CHOP-ATF4 complex,C
17031,203,36488,CHOP-C/EBP complex,C
17032,203,36488,CHOP-C/EBP complex,C
17033,203,5829,cytosol,C
17034,203,5770,late endosome,C
17035,203,5654,nucleoplasm,C
17036,203,5634,nucleus,C
17037,203,32993,protein-DNA complex,C
17038,203,35976,transcription factor AP-1 complex,C
17049,202,1900740,positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway,P
17050,202,45944,positive regulation of transcription from RNA polymerase II promoter,P
17051,202,6357,regulation of transcription from RNA polymerase II promoter,P
17052,202,6351,"transcription, DNA-templated",P
17053,202,5739,mitochondrion,C
17054,202,5654,nucleoplasm,C
17055,202,5634,nucleus,C
17056,202,5667,transcription factor complex,C
17112,201,51439,regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle,P
17113,201,14823,response to activity,P
17114,201,14075,response to amine,P
17115,201,48678,response to axon injury,P
17116,201,46686,response to cadmium ion,P
17117,201,46688,response to copper ion,P
17118,201,42493,response to drug,P
17119,201,45471,response to ethanol,P
17120,201,14070,response to organic cyclic compound,P
17121,201,9636,response to toxic substance,P
17122,201,55015,ventricular cardiac muscle cell development,P
17123,201,5813,centrosome,C
17124,201,5737,cytoplasm,C
17125,201,5829,cytosol,C
17126,201,70062,extracellular exosome,C
17127,201,16020,membrane,C
17128,201,30496,midbody,C
17129,201,5739,mitochondrion,C
17130,201,72686,mitotic spindle,C
17131,201,784,"nuclear chromosome, telomeric region",C
17132,201,5654,nucleoplasm,C
17133,201,5634,nucleus,C
17134,201,5876,spindle microtubule,C
17163,200,10971,positive regulation of G2/M transition of mitotic cell cycle,P
17164,200,31937,positive regulation of chromatin silencing,P
17165,200,2230,positive regulation of defense response to virus by host,P
17166,200,45944,positive regulation of transcription from RNA polymerase II promoter,P
17167,200,6476,protein deacetylation,P
17168,200,10817,regulation of hormone levels,P
17169,200,43619,regulation of transcription from RNA polymerase II promoter in response to oxidative stress,P
17170,200,51595,response to methylglyoxal,P
17171,200,48511,rhythmic process,P
17172,200,6351,"transcription, DNA-templated",P
17173,200,16580,Sin3 complex,C
17174,200,16580,Sin3 complex,C
17175,200,5737,cytoplasm,C
17176,200,45171,intercellular bridge,C
17177,200,776,kinetochore,C
17178,200,5730,nucleolus,C
17179,200,5654,nucleoplasm,C
17180,200,5654,nucleoplasm,C
17181,200,5634,nucleus,C
17182,200,5634,nucleus,C
17183,200,5667,transcription factor complex,C
17184,200,17053,transcriptional repressor complex,C
17205,199,1904764,chaperone-mediated autophagy translocation complex disassembly,P
17206,199,61741,chaperone-mediated protein transport involved in chaperone-mediated autophagy,P
17207,199,72318,clathrin coat disassembly,P
17208,199,61738,late endosomal microautophagy,P
17209,199,398,"mRNA splicing, via spliceosome",P
17210,199,1902904,negative regulation of supramolecular fiber organization,P
17211,199,45892,"negative regulation of transcription, DNA-templated",P
17212,199,7269,neurotransmitter secretion,P
17213,199,44829,positive regulation by host of viral genome replication,P
17214,199,48026,"positive regulation of mRNA splicing, via spliceosome",P
17215,199,6457,protein folding,P
17216,199,42026,protein refolding,P
17217,199,61740,protein targeting to lysosome involved in chaperone-mediated autophagy,P
17218,199,61740,protein targeting to lysosome involved in chaperone-mediated autophagy,P
17219,199,51726,regulation of cell cycle,P
17220,199,1900034,regulation of cellular response to heat,P
17221,199,43488,regulation of mRNA stability,P
17222,199,43254,regulation of protein complex assembly,P
17223,199,61635,regulation of protein complex stability,P
17224,199,1904589,regulation of protein import,P
17225,199,31647,regulation of protein stability,P
17226,199,6986,response to unfolded protein,P
17227,199,6351,"transcription, DNA-templated",P
17228,199,16032,viral process,P
17229,199,974,Prp19 complex,C
17230,199,72562,blood microparticle,C
17231,199,5913,cell-cell adherens junction,C
17232,199,61202,clathrin-sculpted gamma-aminobutyric acid transport vesicle membrane,C
17233,199,5829,cytosol,C
17234,199,5829,cytosol,C
17235,199,70062,extracellular exosome,C
17236,199,31012,extracellular matrix,C
17237,199,5615,extracellular space,C
17238,199,5925,focal adhesion,C
17239,199,5622,intracellular,C
17240,199,5622,intracellular,C
17241,199,30529,intracellular ribonucleoprotein complex,C
17242,199,5770,late endosome,C
17243,199,98575,lumenal side of lysosomal membrane,C
17244,199,43202,lysosomal lumen,C
17245,199,5765,lysosomal membrane,C
17246,199,42470,melanosome,C
17247,199,16020,membrane,C
17248,199,43209,myelin sheath,C
17249,199,5730,nucleolus,C
17250,199,5654,nucleoplasm,C
17251,199,5634,nucleus,C
17252,199,5886,plasma membrane,C
17253,199,98793,presynapse,C
17254,199,5681,spliceosomal complex,C
17255,199,151,ubiquitin ligase complex,C
17304,198,48661,positive regulation of smooth muscle cell proliferation,P
17305,198,45987,positive regulation of smooth muscle contraction,P
17306,198,31915,positive regulation of synaptic plasticity,P
17307,198,51968,"positive regulation of synaptic transmission, glutamatergic",P
17308,198,71636,positive regulation of transforming growth factor beta production,P
17309,198,10575,positive regulation of vascular endothelial growth factor production,P
17310,198,45907,positive regulation of vasoconstriction,P
17311,198,1516,prostaglandin biosynthetic process,P
17312,198,1516,prostaglandin biosynthetic process,P
17313,198,6693,prostaglandin metabolic process,P
17314,198,8217,regulation of blood pressure,P
17315,198,50727,regulation of inflammatory response,P
17316,198,42493,response to drug,P
17317,198,32355,response to estradiol,P
17318,198,70542,response to fatty acid,P
17319,198,9750,response to fructose,P
17320,198,51384,response to glucocorticoid,P
17321,198,32496,response to lipopolysaccharide,P
17322,198,10226,response to lithium ion,P
17323,198,10042,response to manganese ion,P
17324,198,6979,response to oxidative stress,P
17325,198,34612,response to tumor necrosis factor,P
17326,198,33280,response to vitamin D,P
17327,198,19233,sensory perception of pain,P
17328,198,5901,caveola,C
17329,198,5737,cytoplasm,C
17330,198,5737,cytoplasm,C
17331,198,5783,endoplasmic reticulum,C
17332,198,5788,endoplasmic reticulum lumen,C
17333,198,5789,endoplasmic reticulum membrane,C
17334,198,43005,neuron projection,C
17335,198,5634,nucleus,C
17336,198,31090,organelle membrane,C
17337,198,43234,protein complex,C
17357,197,5680,anaphase-promoting complex,C
17358,197,777,condensed chromosome kinetochore,C
17359,197,940,condensed chromosome outer kinetochore,C
17360,197,778,condensed nuclear chromosome kinetochore,C
17361,197,5737,cytoplasm,C
17362,197,5829,cytosol,C
17363,197,776,kinetochore,C
17364,197,776,kinetochore,C
17365,197,776,kinetochore,C
17366,197,776,kinetochore,C
17367,197,5815,microtubule organizing center,C
17368,197,48471,perinuclear region of cytoplasm,C
17369,197,51233,spindle midzone,C
17376,196,6351,"transcription, DNA-templated",P
17377,196,5654,nucleoplasm,C
17407,195,7568,aging,P
17408,195,6284,base-excision repair,P
17409,195,6284,base-excision repair,P
17410,195,6286,"base-excision repair, base-free sugar-phosphate removal",P
17411,195,45454,cell redox homeostasis,P
17412,195,71320,cellular response to cAMP,P
17413,195,70301,cellular response to hydrogen peroxide,P
17414,195,71375,cellular response to peptide hormone stimulus,P
17415,195,1903507,negative regulation of nucleic acid-templated transcription,P
17416,195,14912,negative regulation of smooth muscle cell migration,P
17417,195,55114,oxidation-reduction process,P
17418,195,45739,positive regulation of DNA repair,P
17419,195,1900087,positive regulation of G1/S transition of mitotic cell cycle,P
17420,195,43488,regulation of mRNA stability,P
17421,195,6355,"regulation of transcription, DNA-templated",P
17422,195,42493,response to drug,P
17423,195,723,telomere maintenance,P
17424,195,6351,"transcription, DNA-templated",P
17425,195,5813,centrosome,C
17426,195,5737,cytoplasm,C
17427,195,5783,endoplasmic reticulum,C
17428,195,5739,mitochondrion,C
17429,195,784,"nuclear chromosome, telomeric region",C
17430,195,16607,nuclear speck,C
17431,195,5730,nucleolus,C
17432,195,5654,nucleoplasm,C
17433,195,5654,nucleoplasm,C
17434,195,5634,nucleus,C
17435,195,48471,perinuclear region of cytoplasm,C
17436,195,5840,ribosome,C
17437,195,5667,transcription factor complex,C
17452,194,7283,spermatogenesis,P
17453,194,6363,termination of RNA polymerase I transcription,P
17454,194,6362,transcription elongation from RNA polymerase I promoter,P
17455,194,6368,transcription elongation from RNA polymerase II promoter,P
17456,194,6366,transcription from RNA polymerase II promoter,P
17457,194,6366,transcription from RNA polymerase II promoter,P
17458,194,6366,transcription from RNA polymerase II promoter,P
17459,194,6366,transcription from RNA polymerase II promoter,P
17460,194,6383,transcription from RNA polymerase III promoter,P
17461,194,6383,transcription from RNA polymerase III promoter,P
17462,194,6361,transcription initiation from RNA polymerase I promoter,P
17463,194,6367,transcription initiation from RNA polymerase II promoter,P
17464,194,6367,transcription initiation from RNA polymerase II promoter,P
17465,194,16032,viral process,P
17466,194,5737,cytoplasm,C
17467,194,1939,female pronucleus,C
17468,194,1940,male pronucleus,C
17469,194,790,nuclear chromatin,C
17470,194,5719,nuclear euchromatin,C
17471,194,5654,nucleoplasm,C
17472,194,5654,nucleoplasm,C
17473,194,5634,nucleus,C
17474,194,5672,transcription factor TFIIA complex,C
17475,194,5669,transcription factor TFIID complex,C
17509,193,32915,positive regulation of transforming growth factor beta2 production,P
17510,193,51090,regulation of sequence-specific DNA binding transcription factor activity,P
17511,193,6357,regulation of transcription from RNA polymerase II promoter,P
17512,193,6355,"regulation of transcription, DNA-templated",P
17513,193,6970,response to osmotic stress,P
17514,193,9414,response to water deprivation,P
17515,193,6366,transcription from RNA polymerase II promoter,P
17516,193,5737,cytoplasm,C
17517,193,5741,mitochondrial outer membrane,C
17518,193,5654,nucleoplasm,C
17519,193,5654,nucleoplasm,C
17520,193,5634,nucleus,C
17521,193,35861,site of double-strand break,C
17558,192,46887,positive regulation of hormone secretion,P
17559,192,46889,positive regulation of lipid biosynthetic process,P
17560,192,1900273,positive regulation of long-term synaptic potentiation,P
17561,192,40018,positive regulation of multicellular organism growth,P
17562,192,45672,positive regulation of osteoclast differentiation,P
17563,192,45944,positive regulation of transcription from RNA polymerase II promoter,P
17564,192,45893,"positive regulation of transcription, DNA-templated",P
17565,192,32916,positive regulation of transforming growth factor beta3 production,P
17566,192,6468,protein phosphorylation,P
17567,192,50821,protein stabilization,P
17568,192,8361,regulation of cell size,P
17569,192,42752,regulation of circadian rhythm,P
17570,192,48145,regulation of fibroblast proliferation,P
17571,192,60251,regulation of glial cell proliferation,P
17572,192,1902065,response to L-glutamate,P
17573,192,14823,response to activity,P
17574,192,42493,response to drug,P
17575,192,33762,response to glucagon,P
17576,192,1666,response to hypoxia,P
17577,192,35094,response to nicotine,P
17578,192,10033,response to organic substance,P
17579,192,33363,secretory granule organization,P
17580,192,7165,signal transduction,P
17581,192,6366,transcription from RNA polymerase II promoter,P
17582,192,7179,transforming growth factor beta receptor signaling pathway,P
17583,192,16032,viral process,P
17584,192,8542,visual learning,P
17585,192,1990589,ATF4-CREB1 transcription factor complex,C
17586,192,30424,axon,C
17587,192,5759,mitochondrial matrix,C
17588,192,5719,nuclear euchromatin,C
17589,192,5654,nucleoplasm,C
17590,192,5654,nucleoplasm,C
17591,192,5634,nucleus,C
17678,189,5829,cytosol,C
17679,189,5829,cytosol,C
17680,189,5853,eukaryotic translation elongation factor 1 complex,C
17681,189,70062,extracellular exosome,C
17682,189,5615,extracellular space,C
17683,189,16020,membrane,C
17684,189,43209,myelin sheath,C
17685,189,5730,nucleolus,C
17686,189,5634,nucleus,C
17687,189,32587,ruffle membrane,C
17698,188,16925,protein sumoylation,P
17699,188,10468,regulation of gene expression,P
17700,188,7379,segment specification,P
17701,188,6351,"transcription, DNA-templated",P
17702,188,35102,PRC1 complex,C
17703,188,31519,PcG protein complex,C
17704,188,5737,cytoplasm,C
17705,188,5654,nucleoplasm,C
17706,188,5634,nucleus,C
17707,188,151,ubiquitin ligase complex,C
17719,187,19432,triglyceride biosynthetic process,P
17720,187,5783,endoplasmic reticulum,C
17721,187,5789,endoplasmic reticulum membrane,C
17722,187,16021,integral component of membrane,C
17729,186,50995,negative regulation of lipid catabolic process,P
17730,186,30176,integral component of endoplasmic reticulum membrane,C
17766,185,43066,negative regulation of apoptotic process,P
17767,185,1953,negative regulation of cell-matrix adhesion,P
17768,185,45671,negative regulation of osteoclast differentiation,P
17769,185,14065,phosphatidylinositol 3-kinase signaling,P
17770,185,14065,phosphatidylinositol 3-kinase signaling,P
17771,185,6661,phosphatidylinositol biosynthetic process,P
17772,185,46854,phosphatidylinositol phosphorylation,P
17773,185,46854,phosphatidylinositol phosphorylation,P
17774,185,36092,phosphatidylinositol-3-phosphate biosynthetic process,P
17775,185,48015,phosphatidylinositol-mediated signaling,P
17776,185,30168,platelet activation,P
17777,185,33120,positive regulation of RNA splicing,P
17778,185,30335,positive regulation of cell migration,P
17779,185,1900103,positive regulation of endoplasmic reticulum unfolded protein response,P
17780,185,90004,positive regulation of establishment of protein localization to plasma membrane,P
17781,185,46326,positive regulation of glucose import,P
17782,185,2001275,positive regulation of glucose import in response to insulin stimulus,P
17783,185,42993,positive regulation of transcription factor import into nucleus,P
17784,185,42993,positive regulation of transcription factor import into nucleus,P
17785,185,45944,positive regulation of transcription from RNA polymerase II promoter,P
17786,185,45944,positive regulation of transcription from RNA polymerase II promoter,P
17787,185,32760,positive regulation of tumor necrosis factor production,P
17788,185,6468,protein phosphorylation,P
17789,185,50821,protein stabilization,P
17790,185,46626,regulation of insulin receptor signaling pathway,P
17791,185,43551,regulation of phosphatidylinositol 3-kinase activity,P
17792,185,43551,regulation of phosphatidylinositol 3-kinase activity,P
17793,185,14066,regulation of phosphatidylinositol 3-kinase signaling,P
17794,185,51492,regulation of stress fiber assembly,P
17795,185,34976,response to endoplasmic reticulum stress,P
17796,185,34976,response to endoplasmic reticulum stress,P
17797,185,48010,vascular endothelial growth factor receptor signaling pathway,P
17798,185,16032,viral process,P
17799,185,5911,cell-cell junction,C
17800,185,5801,cis-Golgi network,C
17801,185,5737,cytoplasm,C
17802,185,5829,cytosol,C
17803,185,16020,membrane,C
17804,185,5634,nucleus,C
17805,185,1990578,perinuclear endoplasmic reticulum membrane,C
17806,185,5942,phosphatidylinositol 3-kinase complex,C
17807,185,5942,phosphatidylinositol 3-kinase complex,C
17808,185,5943,"phosphatidylinositol 3-kinase complex, class IA",C
17809,185,5886,plasma membrane,C
17810,185,43234,protein complex,C
17820,184,43584,nose development,P
17821,184,30916,otic vesicle formation,P
17822,184,6351,"transcription, DNA-templated",P
17823,184,5634,nucleus,C
17845,183,45944,positive regulation of transcription from RNA polymerase II promoter,P
17846,183,6355,"regulation of transcription, DNA-templated",P
17847,183,31667,response to nutrient levels,P
17848,183,1990785,response to water-immersion restraint stress,P
17849,183,48863,stem cell differentiation,P
17850,183,6366,transcription from RNA polymerase II promoter,P
17851,183,5737,cytoplasm,C
17852,183,5829,cytosol,C
17853,183,5829,cytosol,C
17854,183,5654,nucleoplasm,C
17855,183,5654,nucleoplasm,C
17856,183,5634,nucleus,C
17857,183,5634,nucleus,C
17870,182,5749,"mitochondrial respiratory chain complex II, succinate dehydrogenase complex (ubiquinone)",C
17871,182,5749,"mitochondrial respiratory chain complex II, succinate dehydrogenase complex (ubiquinone)",C
17872,182,5739,mitochondrion,C
17873,182,45273,respiratory chain complex II,C
17881,181,16363,nuclear matrix,C
17882,181,31965,nuclear membrane,C
17883,181,5654,nucleoplasm,C
17907,180,7049,cell cycle,P
17908,180,71318,cellular response to ATP,P
17909,180,6974,cellular response to DNA damage stimulus,P
17910,180,6974,cellular response to DNA damage stimulus,P
17911,180,34644,cellular response to UV,P
17912,180,16573,histone acetylation,P
17913,180,30901,midbrain development,P
17914,180,1903026,negative regulation of RNA polymerase II regulatory region sequence-specific DNA binding,P
17915,180,10629,negative regulation of gene expression,P
17916,180,1905524,negative regulation of protein autoubiquitination,P
17917,180,2000059,negative regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process,P
17918,180,18105,peptidyl-serine phosphorylation,P
17919,180,18107,peptidyl-threonine phosphorylation,P
17920,180,2000825,positive regulation of androgen receptor activity,P
17921,180,8284,positive regulation of cell proliferation,P
17922,180,32436,positive regulation of proteasomal ubiquitin-dependent protein catabolic process,P
17923,180,32092,positive regulation of protein binding,P
17924,180,45943,positive regulation of transcription from RNA polymerase I promoter,P
17925,180,45944,positive regulation of transcription from RNA polymerase II promoter,P
17926,180,45944,positive regulation of transcription from RNA polymerase II promoter,P
17927,180,60261,positive regulation of transcription initiation from RNA polymerase II promoter,P
17928,180,46777,protein autophosphorylation,P
17929,180,46777,protein autophosphorylation,P
17930,180,6468,protein phosphorylation,P
17931,180,209,protein polyubiquitination,P
17932,180,50821,protein stabilization,P
17933,180,42787,protein ubiquitination involved in ubiquitin-dependent protein catabolic process,P
17934,180,1902806,regulation of cell cycle G1/S phase transition,P
17935,180,1901796,regulation of signal transduction by p53 class mediator,P
17936,180,10767,regulation of transcription from RNA polymerase II promoter in response to UV-induced DNA damage,P
17937,180,60260,regulation of transcription initiation from RNA polymerase II promoter,P
17938,180,6368,transcription elongation from RNA polymerase II promoter,P
17939,180,36369,transcription factor catabolic process,P
17940,180,6366,transcription from RNA polymerase II promoter,P
17941,180,6367,transcription initiation from RNA polymerase II promoter,P
17942,180,16032,viral process,P
17943,180,71339,MLL1 complex,C
17944,180,790,nuclear chromatin,C
17945,180,5730,nucleolus,C
17946,180,5654,nucleoplasm,C
17947,180,5654,nucleoplasm,C
17948,180,5654,nucleoplasm,C
17949,180,5634,nucleus,C
17950,180,5669,transcription factor TFIID complex,C
17951,180,5669,transcription factor TFIID complex,C
17952,180,5667,transcription factor complex,C
17972,179,70059,intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress,P
17973,179,8631,intrinsic apoptotic signaling pathway in response to oxidative stress,P
17974,179,38066,p38MAPK cascade,P
17975,179,46330,positive regulation of JNK cascade,P
17976,179,43507,positive regulation of JUN kinase activity,P
17977,179,43065,positive regulation of apoptotic process,P
17978,179,10666,positive regulation of cardiac muscle cell apoptotic process,P
17979,179,43280,positive regulation of cysteine-type endopeptidase activity involved in apoptotic process,P
17980,179,45663,positive regulation of myoblast differentiation,P
17981,179,1901216,positive regulation of neuron death,P
17982,179,1901216,positive regulation of neuron death,P
17983,179,1900745,positive regulation of p38MAPK cascade,P
17984,179,1904707,positive regulation of vascular smooth muscle cell proliferation,P
17985,179,97300,programmed necrotic cell death,P
17986,179,6468,protein phosphorylation,P
17987,179,34976,response to endoplasmic reticulum stress,P
17988,179,2931,response to ischemia,P
17989,179,16032,viral process,P
17990,179,42060,wound healing,P
17991,179,1990604,IRE1-TRAF2-ASK1 complex,C
17992,179,5829,cytosol,C
17993,179,9897,external side of plasma membrane,C
17994,179,1902911,protein kinase complex,C
18027,178,45892,"negative regulation of transcription, DNA-templated",P
18028,178,6334,nucleosome assembly,P
18029,178,50918,positive chemotaxis,P
18030,178,43388,positive regulation of DNA binding,P
18031,178,1938,positive regulation of endothelial cell proliferation,P
18032,178,45648,positive regulation of erythrocyte differentiation,P
18033,178,45089,positive regulation of innate immune response,P
18034,178,32728,positive regulation of interferon-beta production,P
18035,178,45654,positive regulation of megakaryocyte differentiation,P
18036,178,32075,positive regulation of nuclease activity,P
18037,178,45944,positive regulation of transcription from RNA polymerase II promoter,P
18038,178,45893,"positive regulation of transcription, DNA-templated",P
18039,178,50767,regulation of neurogenesis,P
18040,178,72091,regulation of stem cell proliferation,P
18041,178,6357,regulation of transcription from RNA polymerase II promoter,P
18042,178,42493,response to drug,P
18043,178,32496,response to lipopolysaccharide,P
18044,178,48545,response to steroid hormone,P
18045,178,7289,spermatid nucleus differentiation,P
18046,178,6351,"transcription, DNA-templated",P
18047,178,5623,cell,C
18048,178,793,condensed chromosome,C
18049,178,5737,cytoplasm,C
18050,178,5615,extracellular space,C
18051,178,790,nuclear chromatin,C
18052,178,5730,nucleolus,C
18053,178,5654,nucleoplasm,C
18054,178,5634,nucleus,C
18055,178,48471,perinuclear region of cytoplasm,C
18056,178,43234,protein complex,C
18067,177,1990314,cellular response to insulin-like growth factor stimulus,P
18068,177,44320,cellular response to leptin stimulus,P
18069,177,71373,cellular response to luteinizing hormone stimulus,P
18070,177,71732,cellular response to nitric oxide,P
18071,177,36120,cellular response to platelet-derived growth factor stimulus,P
18072,177,90102,cochlea development,P
18073,177,7067,mitotic nuclear division,P
18074,177,48146,positive regulation of fibroblast proliferation,P
18075,177,45893,"positive regulation of transcription, DNA-templated",P
18076,177,10389,regulation of G2/M transition of mitotic cell cycle,P
18077,177,79,regulation of cyclin-dependent protein serine/threonine kinase activity,P
18078,177,1903463,regulation of mitotic cell cycle DNA replication,P
18079,177,33762,response to glucagon,P
18080,177,16032,viral process,P
18081,177,5794,Golgi apparatus,C
18082,177,97124,cyclin A2-CDK2 complex,C
18083,177,5737,cytoplasm,C
18084,177,1939,female pronucleus,C
18085,177,1940,male pronucleus,C
18086,177,5654,nucleoplasm,C
18087,177,5654,nucleoplasm,C
18088,177,5634,nucleus,C
18125,176,45087,innate immune response,P
18126,176,1773,myeloid dendritic cell activation,P
18127,176,43371,"negative regulation of CD4-positive, alpha-beta T cell differentiation",P
18128,176,17055,negative regulation of RNA polymerase II transcriptional preinitiation complex assembly,P
18129,176,43537,negative regulation of blood vessel endothelial cell migration,P
18130,176,32689,negative regulation of interferon-gamma production,P
18131,176,122,negative regulation of transcription from RNA polymerase II promoter,P
18132,176,31175,neuron projection development,P
18133,176,97350,neutrophil clearance,P
18134,176,50918,positive chemotaxis,P
18135,176,43388,positive regulation of DNA binding,P
18136,176,51106,positive regulation of DNA ligation,P
18137,176,70374,positive regulation of ERK1 and ERK2 cascade,P
18138,176,46330,positive regulation of JNK cascade,P
18139,176,43410,positive regulation of MAPK cascade,P
18140,176,42104,positive regulation of activated T cell proliferation,P
18141,176,43065,positive regulation of apoptotic process,P
18142,176,43280,positive regulation of cysteine-type endopeptidase activity involved in apoptotic process,P
18143,176,7204,positive regulation of cytosolic calcium ion concentration,P
18144,176,2001200,positive regulation of dendritic cell differentiation,P
18145,176,50716,positive regulation of interleukin-1 secretion,P
18146,176,32733,positive regulation of interleukin-10 production,P
18147,176,32735,positive regulation of interleukin-12 production,P
18148,176,2000778,positive regulation of interleukin-6 secretion,P
18149,176,32425,positive regulation of mismatch repair,P
18150,176,90026,positive regulation of monocyte chemotaxis,P
18151,176,34165,positive regulation of toll-like receptor 9 signaling pathway,P
18152,176,45944,positive regulation of transcription from RNA polymerase II promoter,P
18153,176,2840,regulation of T cell mediated immune response to tumor cell,P
18154,176,10506,regulation of autophagy,P
18155,176,32072,regulation of restriction endodeoxyribonuclease activity,P
18156,176,2643,regulation of tolerance induction,P
18157,176,6357,regulation of transcription from RNA polymerase II promoter,P
18158,176,1990774,tumor necrosis factor secretion,P
18159,176,9986,cell surface,C
18160,176,793,condensed chromosome,C
18161,176,5793,endoplasmic reticulum-Golgi intermediate compartment,C
18162,176,5768,endosome,C
18163,176,5576,extracellular region,C
18164,176,5615,extracellular space,C
18165,176,5654,nucleoplasm,C
18166,176,5634,nucleus,C
18167,176,5886,plasma membrane,C
18168,176,17053,transcriptional repressor complex,C
18226,175,30278,regulation of ossification,P
18227,175,14066,regulation of phosphatidylinositol 3-kinase signaling,P
18228,175,51090,regulation of sequence-specific DNA binding transcription factor activity,P
18229,175,32872,regulation of stress-activated MAPK cascade,P
18230,175,70849,response to epidermal growth factor,P
18231,175,43330,response to exogenous dsRNA,P
18232,175,9636,response to toxic substance,P
18233,175,19233,sensory perception of pain,P
18234,175,48538,thymus development,P
18235,175,30878,thyroid gland development,P
18236,175,60440,trachea formation,P
18237,175,6361,transcription initiation from RNA polymerase I promoter,P
18238,175,16032,viral process,P
18239,175,5794,Golgi apparatus,C
18240,175,5901,caveola,C
18241,175,5856,cytoskeleton,C
18242,175,5829,cytosol,C
18243,175,5769,early endosome,C
18244,175,70062,extracellular exosome,C
18245,175,5925,focal adhesion,C
18246,175,5770,late endosome,C
18247,175,15630,microtubule cytoskeleton,C
18248,175,5739,mitochondrion,C
18249,175,5635,nuclear envelope,C
18250,175,5654,nucleoplasm,C
18251,175,5654,nucleoplasm,C
18252,175,5634,nucleus,C
18253,175,43234,protein complex,C
18254,175,31143,pseudopodium,C
18358,173,70562,regulation of vitamin D receptor signaling pathway,P
18359,173,3406,retinal pigment epithelium development,P
18360,173,6590,thyroid hormone generation,P
18361,173,2154,thyroid hormone mediated signaling pathway,P
18362,173,6367,transcription initiation from RNA polymerase II promoter,P
18363,173,6367,transcription initiation from RNA polymerase II promoter,P
18364,173,3222,ventricular trabecula myocardium morphogenesis,P
18365,173,785,chromatin,C
18366,173,16592,mediator complex,C
18367,173,16592,mediator complex,C
18368,173,16020,membrane,C
18369,173,5730,nucleolus,C
18370,173,5654,nucleoplasm,C
18371,173,5654,nucleoplasm,C
18372,173,5634,nucleus,C
18373,173,32993,protein-DNA complex,C
18374,173,151,ubiquitin ligase complex,C
18430,172,43547,positive regulation of GTPase activity,P
18431,172,45597,positive regulation of cell differentiation,P
18432,172,1938,positive regulation of endothelial cell proliferation,P
18433,172,10634,positive regulation of epithelial cell migration,P
18434,172,48146,positive regulation of fibroblast proliferation,P
18435,172,45657,positive regulation of monocyte differentiation,P
18436,172,43525,positive regulation of neuron apoptotic process,P
18437,172,1902895,positive regulation of pri-miRNA transcription from RNA polymerase II promoter,P
18438,172,1902895,positive regulation of pri-miRNA transcription from RNA polymerase II promoter,P
18439,172,48661,positive regulation of smooth muscle cell proliferation,P
18440,172,45944,positive regulation of transcription from RNA polymerase II promoter,P
18441,172,45944,positive regulation of transcription from RNA polymerase II promoter,P
18442,172,45893,"positive regulation of transcription, DNA-templated",P
18443,172,51726,regulation of cell cycle,P
18444,172,10941,regulation of cell death,P
18445,172,42127,regulation of cell proliferation,P
18446,172,51090,regulation of sequence-specific DNA binding transcription factor activity,P
18447,172,1836,release of cytochrome c from mitochondria,P
18448,172,51591,response to cAMP,P
18449,172,34097,response to cytokine,P
18450,172,42493,response to drug,P
18451,172,42542,response to hydrogen peroxide,P
18452,172,32496,response to lipopolysaccharide,P
18453,172,9612,response to mechanical stimulus,P
18454,172,35994,response to muscle stretch,P
18455,172,9314,response to radiation,P
18456,172,6366,transcription from RNA polymerase II promoter,P
18457,172,7179,transforming growth factor beta receptor signaling pathway,P
18458,172,5829,cytosol,C
18459,172,228,nuclear chromosome,C
18460,172,5719,nuclear euchromatin,C
18461,172,5654,nucleoplasm,C
18462,172,5654,nucleoplasm,C
18463,172,5634,nucleus,C
18464,172,5667,transcription factor complex,C
18465,172,17053,transcriptional repressor complex,C
18496,171,48010,vascular endothelial growth factor receptor signaling pathway,P
18497,171,36323,vascular endothelial growth factor receptor-1 signaling pathway,P
18498,171,38084,vascular endothelial growth factor signaling pathway,P
18499,171,5768,endosome,C
18500,171,5615,extracellular space,C
18501,171,5925,focal adhesion,C
18502,171,5887,integral component of plasma membrane,C
18503,171,5886,plasma membrane,C
18504,171,43235,receptor complex,C
18533,170,100057,regulation of phenotypic switching by transcription from RNA polymerase II promoter,P
18534,170,6355,"regulation of transcription, DNA-templated",P
18535,170,48511,rhythmic process,P
18536,170,42795,snRNA transcription from RNA polymerase II promoter,P
18537,170,16032,viral process,P
18538,170,5737,cytoplasm,C
18539,170,790,nuclear chromatin,C
18540,170,5654,nucleoplasm,C
18541,170,5654,nucleoplasm,C
18542,170,5634,nucleus,C
18543,170,32993,protein-DNA complex,C
18595,169,8284,positive regulation of cell proliferation,P
18596,169,2000546,positive regulation of endothelial cell chemotaxis to fibroblast growth factor,P
18597,169,2053,positive regulation of mesenchymal cell proliferation,P
18598,169,1903465,positive regulation of mitotic cell cycle DNA replication,P
18599,169,45666,positive regulation of neuron differentiation,P
18600,169,10976,positive regulation of neuron projection development,P
18601,169,2000830,positive regulation of parathyroid hormone secretion,P
18602,169,14068,positive regulation of phosphatidylinositol 3-kinase signaling,P
18603,169,10863,positive regulation of phospholipase C activity,P
18604,169,10518,positive regulation of phospholipase activity,P
18605,169,46777,protein autophosphorylation,P
18606,169,6468,protein phosphorylation,P
18607,169,60665,regulation of branching involved in salivary gland morphogenesis by mesenchymal-epithelial signaling,P
18608,169,45595,regulation of cell differentiation,P
18609,169,2001239,regulation of extrinsic apoptotic signaling pathway in absence of ligand,P
18610,169,48378,regulation of lateral mesodermal cell fate specification,P
18611,169,14066,regulation of phosphatidylinositol 3-kinase signaling,P
18612,169,7605,sensory perception of sound,P
18613,169,1501,skeletal system development,P
18614,169,48705,skeletal system morphogenesis,P
18615,169,6351,"transcription, DNA-templated",P
18616,169,1657,ureteric bud development,P
18617,169,7037,vacuolar phosphate transport,P
18618,169,21847,ventricular zone neuroblast division,P
18619,169,70640,vitamin D3 metabolic process,P
18620,169,31410,cytoplasmic vesicle,C
18621,169,5829,cytosol,C
18622,169,5576,extracellular region,C
18623,169,16021,integral component of membrane,C
18624,169,5887,integral component of plasma membrane,C
18625,169,5634,nucleus,C
18626,169,5886,plasma membrane,C
18627,169,5886,plasma membrane,C
18628,169,43235,receptor complex,C
18678,168,1900015,regulation of cytokine production involved in inflammatory response,P
18679,168,30278,regulation of ossification,P
18680,168,51090,regulation of sequence-specific DNA binding transcription factor activity,P
18681,168,1901796,regulation of signal transduction by p53 class mediator,P
18682,168,6357,regulation of transcription from RNA polymerase II promoter,P
18683,168,32495,response to muramyl dipeptide,P
18684,168,35994,response to muscle stretch,P
18685,168,7165,signal transduction,P
18686,168,42770,signal transduction in response to DNA damage,P
18687,168,7519,skeletal muscle tissue development,P
18688,168,90400,stress-induced premature senescence,P
18689,168,51146,striated muscle cell differentiation,P
18690,168,6351,"transcription, DNA-templated",P
18691,168,7178,transmembrane receptor protein serine/threonine kinase signaling pathway,P
18692,168,48010,vascular endothelial growth factor receptor signaling pathway,P
18693,168,48010,vascular endothelial growth factor receptor signaling pathway,P
18694,168,5737,cytoplasm,C
18695,168,5829,cytosol,C
18696,168,70062,extracellular exosome,C
18697,168,5739,mitochondrion,C
18698,168,5654,nucleoplasm,C
18699,168,5654,nucleoplasm,C
18700,168,5634,nucleus,C
18701,168,922,spindle pole,C
18716,167,30890,positive regulation of B cell proliferation,P
18717,167,45582,positive regulation of T cell differentiation,P
18718,167,45582,positive regulation of T cell differentiation,P
18719,167,8284,positive regulation of cell proliferation,P
18720,167,46622,positive regulation of organ growth,P
18721,167,10468,regulation of gene expression,P
18722,167,5576,extracellular region,C
18723,167,5615,extracellular space,C
18782,166,8360,regulation of cell shape,P
18783,166,51493,regulation of cytoskeleton organization,P
18784,166,10594,regulation of endothelial cell migration,P
18785,166,10632,regulation of epithelial cell migration,P
18786,166,51893,regulation of focal adhesion assembly,P
18787,166,51893,regulation of focal adhesion assembly,P
18788,166,45667,regulation of osteoblast differentiation,P
18789,166,1932,regulation of protein phosphorylation,P
18790,166,1900024,regulation of substrate adhesion-dependent cell spreading,P
18791,166,7172,signal complex assembly,P
18792,166,7179,transforming growth factor beta receptor signaling pathway,P
18793,166,48010,vascular endothelial growth factor receptor signaling pathway,P
18794,166,1570,vasculogenesis,P
18795,166,16324,apical plasma membrane,C
18796,166,5938,cell cortex,C
18797,166,5737,cytoplasm,C
18798,166,5856,cytoskeleton,C
18799,166,5829,cytosol,C
18800,166,5829,cytosol,C
18801,166,31234,extrinsic component of cytoplasmic side of plasma membrane,C
18802,166,5925,focal adhesion,C
18803,166,30027,lamellipodium,C
18804,166,5815,microtubule organizing center,C
18805,166,5634,nucleus,C
18806,166,5886,plasma membrane,C
18807,166,1725,stress fiber,C
18871,165,45860,positive regulation of protein kinase activity,P
18872,165,2000060,positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process,P
18873,165,51968,"positive regulation of synaptic transmission, glutamatergic",P
18874,165,45727,positive regulation of translation,P
18875,165,46777,protein autophosphorylation,P
18876,165,6461,protein complex assembly,P
18877,165,6468,protein phosphorylation,P
18878,165,2000310,regulation of N-methyl-D-aspartate selective glutamate receptor activity,P
18879,165,2000249,regulation of actin cytoskeleton reorganization,P
18880,165,30826,regulation of cGMP biosynthetic process,P
18881,165,10752,regulation of cGMP-mediated signaling,P
18882,165,50848,regulation of calcium-mediated signaling,P
18883,165,30155,regulation of cell adhesion,P
18884,165,8360,regulation of cell shape,P
18885,165,2000114,regulation of establishment of cell polarity,P
18886,165,32960,regulation of inositol trisphosphate biosynthetic process,P
18887,165,10758,regulation of macrophage chemotaxis,P
18888,165,2000058,regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process,P
18889,165,51279,regulation of release of sequestered calcium ion into cytosol,P
18890,165,51591,response to cAMP,P
18891,165,51592,response to calcium ion,P
18892,165,42220,response to cocaine,P
18893,165,42493,response to drug,P
18894,165,45471,response to ethanol,P
18895,165,9749,response to glucose,P
18896,165,9725,response to hormone,P
18897,165,42542,response to hydrogen peroxide,P
18898,165,1666,response to hypoxia,P
18899,165,35902,response to immobilization stress,P
18900,165,10226,response to lithium ion,P
18901,165,9612,response to mechanical stimulus,P
18902,165,6970,response to osmotic stress,P
18903,165,6950,response to stress,P
18904,165,7172,signal complex assembly,P
18905,165,7165,signal transduction,P
18906,165,2040,sprouting angiogenesis,P
18907,165,43149,stress fiber assembly,P
18908,165,33209,tumor necrosis factor-mediated signaling pathway,P
18909,165,48010,vascular endothelial growth factor receptor signaling pathway,P
18910,165,48010,vascular endothelial growth factor receptor signaling pathway,P
18911,165,17146,NMDA selective glutamate receptor complex,C
18912,165,97440,apical dendrite,C
18913,165,30424,axon,C
18914,165,44297,cell body,C
18915,165,5938,cell cortex,C
18916,165,5737,cytoplasm,C
18917,165,5856,cytoskeleton,C
18918,165,5829,cytosol,C
18919,165,30425,dendrite,C
18920,165,31234,extrinsic component of cytoplasmic side of plasma membrane,C
18921,165,5925,focal adhesion,C
18922,165,30426,growth cone,C
18923,165,30027,lamellipodium,C
18924,165,45121,membrane raft,C
18925,165,43025,neuronal cell body,C
18926,165,5654,nucleoplasm,C
18927,165,5634,nucleus,C
18928,165,48471,perinuclear region of cytoplasm,C
18929,165,14069,postsynaptic density,C
18946,164,7165,signal transduction,P
18947,164,72562,blood microparticle,C
18948,164,5913,cell-cell adherens junction,C
18949,164,5737,cytoplasm,C
18950,164,30659,cytoplasmic vesicle membrane,C
18951,164,5829,cytosol,C
18952,164,70062,extracellular exosome,C
18953,164,5615,extracellular space,C
18954,164,5925,focal adhesion,C
18955,164,42470,melanosome,C
18956,164,5739,mitochondrion,C
18957,164,5654,nucleoplasm,C
18958,164,5634,nucleus,C
18997,163,5634,nucleus,C
19001,162,4719,protein-L-isoaspartate (D-aspartate) O-methyltransferase activity,F
19002,162,98609,cell-cell adhesion,P
19003,162,6479,protein methylation,P
19004,162,30091,protein repair,P
19005,162,5913,cell-cell adherens junction,C
19006,162,5737,cytoplasm,C
19007,162,5737,cytoplasm,C
19008,162,5829,cytosol,C
19009,162,70062,extracellular exosome,C
19010,162,1903561,extracellular vesicle,C
19032,161,2001240,negative regulation of extrinsic apoptotic signaling pathway in absence of ligand,P
19033,161,90084,negative regulation of inclusion body assembly,P
19034,161,31397,negative regulation of protein ubiquitination,P
19035,161,51092,positive regulation of NF-kappaB transcription factor activity,P
19036,161,10628,positive regulation of gene expression,P
19037,161,32757,positive regulation of interleukin-8 production,P
19038,161,70434,positive regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway,P
19039,161,1903265,positive regulation of tumor necrosis factor-mediated signaling pathway,P
19040,161,42026,protein refolding,P
19041,161,50821,protein stabilization,P
19042,161,50821,protein stabilization,P
19043,161,10941,regulation of cell death,P
19044,161,1900034,regulation of cellular response to heat,P
19045,161,31396,regulation of protein ubiquitination,P
19046,161,46718,viral entry into host cell,P
19047,161,72562,blood microparticle,C
19048,161,5814,centriole,C
19049,161,5737,cytoplasm,C
19050,161,5829,cytosol,C
19051,161,5829,cytosol,C
19052,161,5925,focal adhesion,C
19053,161,16234,inclusion body,C
19054,161,5654,nucleoplasm,C
19055,161,48471,perinuclear region of cytoplasm,C
19056,161,151,ubiquitin ligase complex,C
19057,160,5524,ATP binding,F
19058,160,16887,ATPase activity,F
19059,160,42623,"ATPase activity, coupled",F
19060,160,55131,C3HC4-type RING finger domain binding,F
19061,160,1664,G-protein coupled receptor binding,F
19062,160,98641,cadherin binding involved in cell-cell adhesion,F
19063,160,19899,enzyme binding,F
19064,160,31072,heat shock protein binding,F
19065,160,42826,histone deacetylase binding,F
19066,160,5515,protein binding,F
19067,160,44183,protein binding involved in protein folding,F
19068,160,5102,receptor binding,F
19069,160,31625,ubiquitin protein ligase binding,F
19070,160,51082,unfolded protein binding,F
19071,160,51082,unfolded protein binding,F
19072,160,1618,virus receptor activity,F
19073,160,46034,ATP metabolic process,P
19074,160,98609,cell-cell adhesion,P
19075,160,70370,cellular heat acclimation,P
19076,160,34605,cellular response to heat,P
19077,160,34599,cellular response to oxidative stress,P
19078,160,60548,negative regulation of cell death,P
19079,160,1902236,negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway,P
19080,160,2001240,negative regulation of extrinsic apoptotic signaling pathway in absence of ligand,P
19081,160,90084,negative regulation of inclusion body assembly,P
19082,160,1901029,negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway,P
19083,160,31397,negative regulation of protein ubiquitination,P
19084,160,30512,negative regulation of transforming growth factor beta receptor signaling pathway,P
19085,160,51092,positive regulation of NF-kappaB transcription factor activity,P
19086,160,1902380,positive regulation of endoribonuclease activity,P
19087,160,10628,positive regulation of gene expression,P
19088,160,32757,positive regulation of interleukin-8 production,P
19089,160,1904722,positive regulation of mRNA endonucleolytic cleavage involved in unfolded protein response,P
19090,160,70434,positive regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway,P
19091,160,32436,positive regulation of proteasomal ubiquitin-dependent protein catabolic process,P
19092,160,1903265,positive regulation of tumor necrosis factor-mediated signaling pathway,P
19093,160,42026,protein refolding,P
19094,160,50821,protein stabilization,P
19095,160,50821,protein stabilization,P
19096,160,10941,regulation of cell death,P
19097,160,1900034,regulation of cellular response to heat,P
19098,160,43488,regulation of mRNA stability,P
19099,160,31396,regulation of protein ubiquitination,P
19100,160,46718,viral entry into host cell,P
19101,160,72562,blood microparticle,C
19102,160,5913,cell-cell adherens junction,C
19103,160,5814,centriole,C
19104,160,5737,cytoplasm,C
19105,160,5829,cytosol,C
19106,160,5829,cytosol,C
19107,160,5925,focal adhesion,C
19108,160,16234,inclusion body,C
19109,160,5739,mitochondrion,C
19110,160,5654,nucleoplasm,C
19111,160,48471,perinuclear region of cytoplasm,C
19112,160,151,ubiquitin ligase complex,C
19148,159,32733,positive regulation of interleukin-10 production,P
19149,159,32735,positive regulation of interleukin-12 production,P
19150,159,32755,positive regulation of interleukin-6 production,P
19151,159,43032,positive regulation of macrophage activation,P
19152,159,45041,protein import into mitochondrial intermembrane space,P
19153,159,51604,protein maturation,P
19154,159,42026,protein refolding,P
19155,159,50821,protein stabilization,P
19156,159,50821,protein stabilization,P
19157,159,9409,response to cold,P
19158,159,6986,response to unfolded protein,P
19159,159,16032,viral process,P
19160,159,9986,cell surface,C
19161,159,5905,clathrin-coated pit,C
19162,159,30135,coated vesicle,C
19163,159,19907,cyclin-dependent protein kinase activating kinase holoenzyme complex,C
19164,159,5737,cytoplasm,C
19165,159,5829,cytosol,C
19166,159,5769,early endosome,C
19167,159,70062,extracellular exosome,C
19168,159,31012,extracellular matrix,C
19169,159,5615,extracellular space,C
19170,159,46696,lipopolysaccharide receptor complex,C
19171,159,16020,membrane,C
19172,159,5743,mitochondrial inner membrane,C
19173,159,5759,mitochondrial matrix,C
19174,159,5739,mitochondrion,C
19175,159,43209,myelin sheath,C
19176,159,5886,plasma membrane,C
19177,159,43234,protein complex,C
19178,159,30141,secretory granule,C
19213,157,70664,negative regulation of leukocyte proliferation,P
19214,157,71638,negative regulation of monocyte chemotactic protein-1 production,P
19215,157,51771,negative regulation of nitric-oxide synthase biosynthetic process,P
19216,157,6469,negative regulation of protein kinase activity,P
19217,157,71672,negative regulation of smooth muscle cell chemotaxis,P
19218,157,32873,negative regulation of stress-activated MAPK cascade,P
19219,157,32720,negative regulation of tumor necrosis factor production,P
19220,157,10804,negative regulation of tumor necrosis factor-mediated signaling pathway,P
19221,157,1904706,negative regulation of vascular smooth muscle cell proliferation,P
19222,157,35732,nitric oxide storage,P
19223,157,14003,oligodendrocyte development,P
19224,157,32930,positive regulation of superoxide anion generation,P
19225,157,70372,regulation of ERK1 and ERK2 cascade,P
19226,157,32872,regulation of stress-activated MAPK cascade,P
19227,157,33591,response to L-ascorbic acid,P
19228,157,43200,response to amino acid,P
19229,157,32355,response to estradiol,P
19230,157,45471,response to ethanol,P
19231,157,302,response to reactive oxygen species,P
19232,157,302,response to reactive oxygen species,P
19233,157,6805,xenobiotic metabolic process,P
19234,157,97057,TRAF2-GSTP1 complex,C
19235,157,5737,cytoplasm,C
19236,157,5737,cytoplasm,C
19237,157,5829,cytosol,C
19238,157,70062,extracellular exosome,C
19239,157,5615,extracellular space,C
19240,157,5622,intracellular,C
19241,157,5739,mitochondrion,C
19242,157,5634,nucleus,C
19243,157,5886,plasma membrane,C
19244,157,31982,vesicle,C
19251,156,6749,glutathione metabolic process,P
19252,156,6805,xenobiotic metabolic process,P
19253,156,5829,cytosol,C
19269,155,31667,response to nutrient levels,P
19270,155,6979,response to oxidative stress,P
19271,155,34612,response to tumor necrosis factor,P
19272,155,9410,response to xenobiotic stimulus,P
19273,155,5829,cytosol,C
19274,155,5829,cytosol,C
19275,155,70062,extracellular exosome,C
19284,154,55114,oxidation-reduction process,P
19285,154,302,response to reactive oxygen species,P
19286,154,5829,cytosol,C
19287,154,9897,external side of plasma membrane,C
19288,154,70062,extracellular exosome,C
19289,154,5759,mitochondrial matrix,C
19320,153,61136,regulation of proteasomal protein catabolic process,P
19321,153,10332,response to gamma radiation,P
19322,153,42542,response to hydrogen peroxide,P
19323,153,33194,response to hydroperoxide,P
19324,153,302,response to reactive oxygen species,P
19325,153,10269,response to selenium ion,P
19326,153,9609,response to symbiotic bacterium,P
19327,153,9410,response to xenobiotic stimulus,P
19328,153,7605,sensory perception of sound,P
19329,153,48741,skeletal muscle fiber development,P
19330,153,43403,skeletal muscle tissue regeneration,P
19331,153,1659,temperature homeostasis,P
19332,153,6641,triglyceride metabolic process,P
19333,153,42311,vasodilation,P
19334,153,97413,Lewy body,C
19335,153,5737,cytoplasm,C
19336,153,5829,cytosol,C
19337,153,70062,extracellular exosome,C
19338,153,5759,mitochondrial matrix,C
19339,153,5739,mitochondrion,C
19348,152,1902037,negative regulation of hematopoietic stem cell differentiation,P
19349,152,6611,protein export from nucleus,P
19350,152,6457,protein folding,P
19351,152,5737,cytoplasm,C
19352,152,70062,extracellular exosome,C
19353,152,31012,extracellular matrix,C
19354,152,5925,focal adhesion,C
19355,152,42645,mitochondrial nucleoid,C
19356,152,5739,mitochondrion,C
19357,152,5739,mitochondrion,C
19358,152,43209,myelin sheath,C
19359,152,5730,nucleolus,C
19402,151,60766,negative regulation of androgen receptor signaling pathway,P
19403,151,43066,negative regulation of apoptotic process,P
19404,151,90090,negative regulation of canonical Wnt signaling pathway,P
19405,151,10629,negative regulation of gene expression,P
19406,151,10832,negative regulation of myotube differentiation,P
19407,151,122,negative regulation of transcription from RNA polymerase II promoter,P
19408,151,122,negative regulation of transcription from RNA polymerase II promoter,P
19409,151,122,negative regulation of transcription from RNA polymerase II promoter,P
19410,151,122,negative regulation of transcription from RNA polymerase II promoter,P
19411,151,45892,"negative regulation of transcription, DNA-templated",P
19412,151,45892,"negative regulation of transcription, DNA-templated",P
19413,151,42475,odontogenesis of dentin-containing tooth,P
19414,151,8284,positive regulation of cell proliferation,P
19415,151,10870,positive regulation of receptor biosynthetic process,P
19416,151,45944,positive regulation of transcription from RNA polymerase II promoter,P
19417,151,45893,"positive regulation of transcription, DNA-templated",P
19418,151,6476,protein deacetylation,P
19419,151,1901796,regulation of signal transduction by p53 class mediator,P
19420,151,6351,"transcription, DNA-templated",P
19421,151,16032,viral process,P
19422,151,16581,NuRD complex,C
19423,151,16580,Sin3 complex,C
19424,151,785,chromatin,C
19425,151,5737,cytoplasm,C
19426,151,5829,cytosol,C
19427,151,118,histone deacetylase complex,C
19428,151,790,nuclear chromatin,C
19429,151,5654,nucleoplasm,C
19430,151,5654,nucleoplasm,C
19431,151,5634,nucleus,C
19432,151,43234,protein complex,C
19525,150,43524,negative regulation of neuron apoptotic process,P
19526,150,1902176,negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway,P
19527,150,2000757,negative regulation of peptidyl-lysine acetylation,P
19528,150,42326,negative regulation of phosphorylation,P
19529,150,31393,negative regulation of prostaglandin biosynthetic process,P
19530,150,1901984,negative regulation of protein acetylation,P
19531,150,51898,negative regulation of protein kinase B signaling,P
19532,150,1900181,negative regulation of protein localization to nucleus,P
19533,150,1903427,negative regulation of reactive oxygen species biosynthetic process,P
19534,150,43433,negative regulation of sequence-specific DNA binding transcription factor activity,P
19535,150,43433,negative regulation of sequence-specific DNA binding transcription factor activity,P
19536,150,122,negative regulation of transcription from RNA polymerase II promoter,P
19537,150,122,negative regulation of transcription from RNA polymerase II promoter,P
19538,150,45892,"negative regulation of transcription, DNA-templated",P
19539,150,30512,negative regulation of transforming growth factor beta receptor signaling pathway,P
19540,150,32720,negative regulation of tumor necrosis factor production,P
19541,150,1542,ovulation from ovarian follicle,P
19542,150,18394,peptidyl-lysine acetylation,P
19543,150,34983,peptidyl-lysine deacetylation,P
19544,150,45739,positive regulation of DNA repair,P
19545,150,45348,positive regulation of MHC class II biosynthetic process,P
19546,150,2821,positive regulation of adaptive immune response,P
19547,150,1904179,positive regulation of adipose tissue development,P
19548,150,45766,positive regulation of angiogenesis,P
19549,150,43065,positive regulation of apoptotic process,P
19550,150,43065,positive regulation of apoptotic process,P
19551,150,2000481,positive regulation of cAMP-dependent protein kinase activity,P
19552,150,8284,positive regulation of cell proliferation,P
19553,150,2000774,positive regulation of cellular senescence,P
19554,150,10875,positive regulation of cholesterol efflux,P
19555,150,31937,positive regulation of chromatin silencing,P
19556,150,43280,positive regulation of cysteine-type endopeptidase activity involved in apoptotic process,P
19557,150,1902237,positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway,P
19558,150,1938,positive regulation of endothelial cell proliferation,P
19559,150,45722,positive regulation of gluconeogenesis,P
19560,150,10460,positive regulation of heart rate,P
19561,150,51574,positive regulation of histone H3-K9 methylation,P
19562,150,46628,positive regulation of insulin receptor signaling pathway,P
19563,150,35774,positive regulation of insulin secretion involved in cellular response to glucose stimulus,P
19564,150,16239,positive regulation of macroautophagy,P
19565,150,2000111,positive regulation of macrophage apoptotic process,P
19566,150,10976,positive regulation of neuron projection development,P
19567,150,14068,positive regulation of phosphatidylinositol 3-kinase signaling,P
19568,150,90312,positive regulation of protein deacetylation,P
19569,150,1934,positive regulation of protein phosphorylation,P
19570,150,14858,positive regulation of skeletal muscle cell proliferation,P
19571,150,51152,positive regulation of smooth muscle cell differentiation,P
19572,150,2000614,positive regulation of thyroid-stimulating hormone secretion,P
19573,150,45944,positive regulation of transcription from RNA polymerase II promoter,P
19574,150,45909,positive regulation of vasodilation,P
19575,150,43161,proteasome-mediated ubiquitin-dependent protein catabolic process,P
19576,150,6471,protein ADP-ribosylation,P
19577,150,6476,protein deacetylation,P
19578,150,6476,protein deacetylation,P
19579,150,31648,protein destabilization,P
19580,150,31648,protein destabilization,P
19581,150,16567,protein ubiquitination,P
19582,150,16567,protein ubiquitination,P
19583,150,720,pyrimidine dimer repair by nucleotide-excision repair,P
19584,150,6364,rRNA processing,P
19585,150,70857,regulation of bile acid biosynthetic process,P
19586,150,90335,regulation of brown fat cell differentiation,P
19587,150,42127,regulation of cell proliferation,P
19588,150,1900034,regulation of cellular response to heat,P
19589,150,32071,regulation of endodeoxyribonuclease activity,P
19590,150,2000505,regulation of energy homeostasis,P
19591,150,10906,regulation of glucose metabolic process,P
19592,150,10883,regulation of lipid storage,P
19593,150,7346,regulation of mitotic cell cycle,P
19594,150,35358,regulation of peroxisome proliferator activated receptor signaling pathway,P
19595,150,33158,"regulation of protein import into nucleus, translocation",P
19596,150,71900,regulation of protein serine/threonine kinase activity,P
19597,150,34391,regulation of smooth muscle cell apoptotic process,P
19598,150,45471,response to ethanol,P
19599,150,1902617,response to fluoride,P
19600,150,42542,response to hydrogen peroxide,P
19601,150,32868,response to insulin,P
19602,150,1904373,response to kainic acid,P
19603,150,44321,response to leptin,P
19604,150,10046,response to mycotoxin,P
19605,150,6979,response to oxidative stress,P
19606,150,1904638,response to resveratrol,P
19607,150,12,single strand break repair,P
19608,150,7283,spermatogenesis,P
19609,150,90400,stress-induced premature senescence,P
19610,150,6366,transcription from RNA polymerase II promoter,P
19611,150,6642,triglyceride mobilization,P
19612,150,16032,viral process,P
19613,150,50872,white fat cell differentiation,P
19614,150,35098,ESC/E(Z) complex,C
19615,150,16605,PML body,C
19616,150,30424,axon,C
19617,150,5677,chromatin silencing complex,C
19618,150,5737,cytoplasm,C
19619,150,5737,cytoplasm,C
19620,150,30426,growth cone,C
19621,150,5739,mitochondrion,C
19622,150,790,nuclear chromatin,C
19623,150,5635,nuclear envelope,C
19624,150,5719,nuclear euchromatin,C
19625,150,5720,nuclear heterochromatin,C
19626,150,5637,nuclear inner membrane,C
19627,150,5730,nucleolus,C
19628,150,5730,nucleolus,C
19629,150,5654,nucleoplasm,C
19630,150,5654,nucleoplasm,C
19631,150,5634,nucleus,C
19632,150,33553,rDNA heterochromatin,C
19662,149,6296,"nucleotide-excision repair, DNA incision, 5'-to lesion",P
19663,149,6296,"nucleotide-excision repair, DNA incision, 5'-to lesion",P
19664,149,6293,"nucleotide-excision repair, preincision complex stabilization",P
19665,149,48477,oogenesis,P
19666,149,1904431,positive regulation of t-circle formation,P
19667,149,35166,post-embryonic hemopoiesis,P
19668,149,720,pyrimidine dimer repair by nucleotide-excision repair,P
19669,149,1302,replicative cell aging,P
19670,149,10165,response to X-ray,P
19671,149,7584,response to nutrient,P
19672,149,6979,response to oxidative stress,P
19673,149,9744,response to sucrose,P
19674,149,7283,spermatogenesis,P
19675,149,6949,syncytium formation,P
19676,149,90656,t-circle formation,P
19677,149,6283,transcription-coupled nucleotide-excision repair,P
19678,149,70522,ERCC4-ERCC1 complex,C
19679,149,5737,cytoplasm,C
19680,149,784,"nuclear chromosome, telomeric region",C
19681,149,5654,nucleoplasm,C
19682,149,5654,nucleoplasm,C
19683,149,109,nucleotide-excision repair complex,C
19684,149,110,nucleotide-excision repair factor 1 complex,C
19685,149,5669,transcription factor TFIID complex,C
19691,148,6265,DNA topological change,P
19692,148,7059,chromosome segregation,P
19693,148,793,condensed chromosome,C
19694,148,5829,cytosol,C
19695,148,5634,nucleus,C
19696,148,5634,nucleus,C
19704,147,34599,cellular response to oxidative stress,P
19705,147,6302,double-strand break repair,P
19706,147,16925,protein sumoylation,P
19707,147,2000819,regulation of nucleotide-excision repair,P
19708,147,5654,nucleoplasm,C
19709,147,5634,nucleus,C
19710,147,43234,protein complex,C
19724,146,5743,mitochondrial inner membrane,C
19725,146,5753,mitochondrial proton-transporting ATP synthase complex,C
19726,146,5753,mitochondrial proton-transporting ATP synthase complex,C
19727,146,5739,mitochondrion,C
19728,146,5634,nucleus,C
19729,146,5886,plasma membrane,C
19738,145,1822,kidney development,P
19739,145,97421,liver regeneration,P
19740,145,2000279,negative regulation of DNA biosynthetic process,P
19741,145,1903625,negative regulation of DNA catabolic process,P
19742,145,34260,negative regulation of GTPase activity,P
19743,145,1902679,negative regulation of RNA biosynthetic process,P
19744,145,43066,negative regulation of apoptotic process,P
19745,145,1903011,negative regulation of bone development,P
19746,145,1903611,negative regulation of calcium-dependent ATPase activity,P
19747,145,51344,negative regulation of cyclic-nucleotide phosphodiesterase activity,P
19748,145,50680,negative regulation of epithelial cell proliferation,P
19749,145,1901318,negative regulation of flagellated sperm motility,P
19750,145,1903634,negative regulation of leucine-tRNA ligase activity,P
19751,145,45019,negative regulation of nitric oxide biosynthetic process,P
19752,145,32515,negative regulation of phosphoprotein phosphatase activity,P
19753,145,6469,negative regulation of protein kinase activity,P
19754,145,32781,positive regulation of ATPase activity,P
19755,145,43547,positive regulation of GTPase activity,P
19756,145,1901896,positive regulation of calcium-transporting ATPase activity,P
19757,145,1903629,positive regulation of dUTP diphosphatase activity,P
19758,145,45723,positive regulation of fatty acid biosynthetic process,P
19759,145,10907,positive regulation of glucose metabolic process,P
19760,145,10922,positive regulation of phosphatase activity,P
19761,145,1903052,positive regulation of proteolysis involved in cellular protein catabolic process,P
19762,145,1901671,positive regulation of superoxide dismutase activity,P
19763,145,10867,positive regulation of triglyceride biosynthetic process,P
19764,145,50848,regulation of calcium-mediated signaling,P
19765,145,7283,spermatogenesis,P
19766,145,5737,cytoplasm,C
19767,145,5829,cytosol,C
19768,145,5576,extracellular region,C
19769,145,5654,nucleoplasm,C
19770,145,5634,nucleus,C
19771,145,5634,nucleus,C
19845,144,8284,positive regulation of cell proliferation,P
19846,144,8284,positive regulation of cell proliferation,P
19847,144,71864,positive regulation of cell proliferation in bone marrow,P
19848,144,32722,positive regulation of chemokine production,P
19849,144,32722,positive regulation of chemokine production,P
19850,144,50679,positive regulation of epithelial cell proliferation,P
19851,144,10628,positive regulation of gene expression,P
19852,144,51024,positive regulation of immunoglobulin secretion,P
19853,144,32755,positive regulation of interleukin-6 production,P
19854,144,2690,positive regulation of leukocyte chemotaxis,P
19855,144,10976,positive regulation of neuron projection development,P
19856,144,45429,positive regulation of nitric oxide biosynthetic process,P
19857,144,45669,positive regulation of osteoblast differentiation,P
19858,144,33138,positive regulation of peptidyl-serine phosphorylation,P
19859,144,50731,positive regulation of peptidyl-tyrosine phosphorylation,P
19860,144,33160,"positive regulation of protein import into nucleus, translocation",P
19861,144,51897,positive regulation of protein kinase B signaling,P
19862,144,51091,positive regulation of sequence-specific DNA binding transcription factor activity,P
19863,144,48661,positive regulation of smooth muscle cell proliferation,P
19864,144,45944,positive regulation of transcription from RNA polymerase II promoter,P
19865,144,45944,positive regulation of transcription from RNA polymerase II promoter,P
19866,144,45893,"positive regulation of transcription, DNA-templated",P
19867,144,45727,positive regulation of translation,P
19868,144,51971,positive regulation of transmission of nerve impulse,P
19869,144,2000676,positive regulation of type B pancreatic cell apoptotic process,P
19870,144,42517,positive regulation of tyrosine phosphorylation of Stat3 protein,P
19871,144,45765,regulation of angiogenesis,P
19872,144,8360,regulation of cell shape,P
19873,144,45188,"regulation of circadian sleep/wake cycle, non-REM sleep",P
19874,144,10574,regulation of vascular endothelial growth factor production,P
19875,144,43200,response to amino acid,P
19876,144,46677,response to antibiotic,P
19877,144,10996,response to auditory stimulus,P
19878,144,31000,response to caffeine,P
19879,144,51592,response to calcium ion,P
19880,144,9409,response to cold,P
19881,144,42493,response to drug,P
19882,144,51602,response to electrical stimulus,P
19883,144,51384,response to glucocorticoid,P
19884,144,9408,response to heat,P
19885,144,32868,response to insulin,P
19886,144,32494,response to peptidoglycan,P
19887,144,1878,response to yeast,P
19888,144,5737,cytoplasm,C
19889,144,9897,external side of plasma membrane,C
19890,144,5576,extracellular region,C
19891,144,5615,extracellular space,C
19892,144,5896,interleukin-6 receptor complex,C
19947,143,43066,negative regulation of apoptotic process,P
19948,143,2001237,negative regulation of extrinsic apoptotic signaling pathway,P
19949,143,46627,negative regulation of insulin receptor signaling pathway,P
19950,143,42177,negative regulation of protein catabolic process,P
19951,143,122,negative regulation of transcription from RNA polymerase II promoter,P
19952,143,45892,"negative regulation of transcription, DNA-templated",P
19953,143,70431,nucleotide-binding oligomerization domain containing 2 signaling pathway,P
19954,143,43123,positive regulation of I-kappaB kinase/NF-kappaB signaling,P
19955,143,51092,positive regulation of NF-kappaB transcription factor activity,P
19956,143,51092,positive regulation of NF-kappaB transcription factor activity,P
19957,143,14040,positive regulation of Schwann cell differentiation,P
19958,143,8284,positive regulation of cell proliferation,P
19959,143,32332,positive regulation of chondrocyte differentiation,P
19960,143,45084,positive regulation of interleukin-12 biosynthetic process,P
19961,143,2000630,positive regulation of miRNA metabolic process,P
19962,143,1902895,positive regulation of pri-miRNA transcription from RNA polymerase II promoter,P
19963,143,45944,positive regulation of transcription from RNA polymerase II promoter,P
19964,143,45944,positive regulation of transcription from RNA polymerase II promoter,P
19965,143,45893,"positive regulation of transcription, DNA-templated",P
19966,143,32481,positive regulation of type I interferon production,P
19967,143,50727,regulation of inflammatory response,P
19968,143,10224,response to UV-B,P
19969,143,43200,response to amino acid,P
19970,143,51591,response to cAMP,P
19971,143,33590,response to cobalamin,P
19972,143,42493,response to drug,P
19973,143,32868,response to insulin,P
19974,143,70555,response to interleukin-1,P
19975,143,43278,response to morphine,P
19976,143,32495,response to muramyl dipeptide,P
19977,143,35994,response to muscle stretch,P
19978,143,10033,response to organic substance,P
19979,143,32570,response to progesterone,P
19980,143,2223,stimulatory C-type lectin receptor signaling pathway,P
19981,143,6366,transcription from RNA polymerase II promoter,P
19982,143,33256,I-kappaB/NF-kappaB complex,C
19983,143,71159,NF-kappaB complex,C
19984,143,5737,cytoplasm,C
19985,143,5829,cytosol,C
19986,143,5829,cytosol,C
19987,143,790,nuclear chromatin,C
19988,143,5654,nucleoplasm,C
19989,143,5634,nucleus,C
19990,143,5667,transcription factor complex,C
20007,142,32411,positive regulation of transporter activity,P
20008,142,9605,response to external stimulus,P
20009,142,70542,response to fatty acid,P
20010,142,1902617,response to fluoride,P
20011,142,31667,response to nutrient levels,P
20012,142,9636,response to toxic substance,P
20013,142,72562,blood microparticle,C
20014,142,70062,extracellular exosome,C
20015,142,5576,extracellular region,C
20016,142,5615,extracellular space,C
20017,142,34364,high-density lipoprotein particle,C
20018,142,34364,high-density lipoprotein particle,C
20019,142,43231,intracellular membrane-bounded organelle,C
20020,142,34366,spherical high-density lipoprotein particle,C
20034,141,55114,oxidation-reduction process,P
20035,141,42345,regulation of NF-kappaB import into nucleus,P
20036,141,32872,regulation of stress-activated MAPK cascade,P
20037,141,19430,removal of superoxide radicals,P
20038,141,302,response to reactive oxygen species,P
20039,141,1895,retina homeostasis,P
20040,141,1501,skeletal system development,P
20041,141,5913,cell-cell adherens junction,C
20042,141,5737,cytoplasm,C
20043,141,5829,cytosol,C
20044,141,70062,extracellular exosome,C
20045,141,31012,extracellular matrix,C
20046,141,5615,extracellular space,C
20047,141,42470,melanosome,C
20048,141,5739,mitochondrion,C
20049,141,43209,myelin sheath,C
20050,141,5634,nucleus,C
20062,140,43025,neuronal cell body,C
20063,140,48471,perinuclear region of cytoplasm,C
20064,140,5819,spindle,C
20080,139,2576,platelet degranulation,P
20081,139,43547,positive regulation of GTPase activity,P
20082,139,51056,regulation of small GTPase mediated signal transduction,P
20083,139,48863,stem cell differentiation,P
20084,139,72562,blood microparticle,C
20085,139,5829,cytosol,C
20086,139,70062,extracellular exosome,C
20087,139,5576,extracellular region,C
20088,139,5576,extracellular region,C
20089,139,31093,platelet alpha granule lumen,C
20157,138,60999,positive regulation of dendritic spine development,P
20158,138,1902952,positive regulation of dendritic spine maintenance,P
20159,138,46889,positive regulation of lipid biosynthetic process,P
20160,138,1903002,positive regulation of lipid transport across blood brain barrier,P
20161,138,32805,positive regulation of low-density lipoprotein particle receptor catabolic process,P
20162,138,51044,positive regulation of membrane protein ectodomain proteolysis,P
20163,138,51000,positive regulation of nitric-oxide synthase activity,P
20164,138,1902995,positive regulation of phospholipid efflux,P
20165,138,1901628,positive regulation of postsynaptic membrane organization,P
20166,138,17038,protein import,P
20167,138,6898,receptor-mediated endocytosis,P
20168,138,6898,receptor-mediated endocytosis,P
20169,138,32489,regulation of Cdc42 protein signal transduction,P
20170,138,30516,regulation of axon extension,P
20171,138,1900221,regulation of beta-amyloid clearance,P
20172,138,10468,regulation of gene expression,P
20173,138,48168,regulation of neuronal synaptic plasticity,P
20174,138,2021,response to dietary excess,P
20175,138,302,response to reactive oxygen species,P
20176,138,1523,retinoid metabolic process,P
20177,138,43691,reverse cholesterol transport,P
20178,138,7271,"synaptic transmission, cholinergic",P
20179,138,19433,triglyceride catabolic process,P
20180,138,70328,triglyceride homeostasis,P
20181,138,6641,triglyceride metabolic process,P
20182,138,6641,triglyceride metabolic process,P
20183,138,42311,vasodilation,P
20184,138,34447,very-low-density lipoprotein particle clearance,P
20185,138,34447,very-low-density lipoprotein particle clearance,P
20186,138,34372,very-low-density lipoprotein particle remodeling,P
20187,138,34372,very-low-density lipoprotein particle remodeling,P
20188,138,19068,virion assembly,P
20189,138,5794,Golgi apparatus,C
20190,138,72562,blood microparticle,C
20191,138,42627,chylomicron,C
20192,138,5737,cytoplasm,C
20193,138,5737,cytoplasm,C
20194,138,30425,dendrite,C
20195,138,5769,early endosome,C
20196,138,71682,endocytic vesicle lumen,C
20197,138,5783,endoplasmic reticulum,C
20198,138,70062,extracellular exosome,C
20199,138,31012,extracellular matrix,C
20200,138,5576,extracellular region,C
20201,138,5615,extracellular space,C
20202,138,1903561,extracellular vesicle,C
20203,138,34364,high-density lipoprotein particle,C
20204,138,34363,intermediate-density lipoprotein particle,C
20205,138,34362,low-density lipoprotein particle,C
20206,138,16020,membrane,C
20207,138,43025,neuronal cell body,C
20208,138,5634,nucleus,C
20209,138,5886,plasma membrane,C
20210,138,34361,very-low-density lipoprotein particle,C
20259,137,7176,regulation of epidermal growth factor-activated receptor activity,P
20260,137,40014,regulation of multicellular organism growth,P
20261,137,43393,regulation of protein binding,P
20262,137,50803,regulation of synapse structure or activity,P
20263,137,6417,regulation of translation,P
20264,137,10288,response to lead ion,P
20265,137,6979,response to oxidative stress,P
20266,137,51563,smooth endoplasmic reticulum calcium ion homeostasis,P
20267,137,1967,suckling behavior,P
20268,137,51124,synaptic growth at neuromuscular junction,P
20269,137,8542,visual learning,P
20270,137,30134,ER to Golgi transport vesicle,C
20271,137,5794,Golgi apparatus,C
20272,137,5794,Golgi apparatus,C
20273,137,45177,apical part of cell,C
20274,137,97449,astrocyte projection,C
20275,137,30424,axon,C
20276,137,9986,cell surface,C
20277,137,5911,cell-cell junction,C
20278,137,35253,ciliary rootlet,C
20279,137,5905,clathrin-coated pit,C
20280,137,5737,cytoplasm,C
20281,137,5737,cytoplasm,C
20282,137,5829,cytosol,C
20283,137,43198,dendritic shaft,C
20284,137,43197,dendritic spine,C
20285,137,5768,endosome,C
20286,137,31904,endosome lumen,C
20287,137,70062,extracellular exosome,C
20288,137,5576,extracellular region,C
20289,137,5615,extracellular space,C
20290,137,1990812,growth cone filopodium,C
20291,137,1990761,growth cone lamellipodium,C
20292,137,16021,integral component of membrane,C
20293,137,5887,integral component of plasma membrane,C
20294,137,43231,intracellular membrane-bounded organelle,C
20295,137,44304,main axon,C
20296,137,45121,membrane raft,C
20297,137,31594,neuromuscular junction,C
20298,137,5641,nuclear envelope lumen,C
20299,137,48471,perinuclear region of cytoplasm,C
20300,137,5886,plasma membrane,C
20301,137,31093,platelet alpha granule lumen,C
20302,137,43235,receptor complex,C
20303,137,5791,rough endoplasmic reticulum,C
20304,137,5790,smooth endoplasmic reticulum,C
20305,137,51233,spindle midzone,C
20306,137,45202,synapse,C
20307,137,43195,terminal bouton,C
20308,137,32588,trans-Golgi network membrane,C
20326,136,16579,protein deubiquitination,P
20327,136,16241,regulation of macroautophagy,P
20328,136,2931,response to ischemia,P
20329,136,19233,sensory perception of pain,P
20330,136,1904115,axon cytoplasm,C
20331,136,5737,cytoplasm,C
20332,136,5737,cytoplasm,C
20333,136,5737,cytoplasm,C
20334,136,5829,cytosol,C
20335,136,5789,endoplasmic reticulum membrane,C
20336,136,70062,extracellular exosome,C
20337,136,43209,myelin sheath,C
20338,136,44306,neuron projection terminus,C
20339,136,43025,neuronal cell body,C
20340,136,5654,nucleoplasm,C
20341,136,5886,plasma membrane,C
20356,135,30261,chromosome condensation,P
20357,135,70059,intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress,P
20358,135,51402,neuron apoptotic process,P
20359,135,55114,oxidation-reduction process,P
20360,135,43065,positive regulation of apoptotic process,P
20361,135,43525,positive regulation of neuron apoptotic process,P
20362,135,1902510,regulation of apoptotic DNA fragmentation,P
20363,135,1902065,response to L-glutamate,P
20364,135,2931,response to ischemia,P
20365,135,9636,response to toxic substance,P
20366,135,5829,cytosol,C
20367,135,5743,mitochondrial inner membrane,C
20368,135,5758,mitochondrial intermembrane space,C
20369,135,5739,mitochondrion,C
20370,135,5634,nucleus,C
20371,135,5634,nucleus,C
20372,135,48471,perinuclear region of cytoplasm,C
20390,134,5794,Golgi apparatus,C
20391,134,16324,apical plasma membrane,C
20392,134,31526,brush border membrane,C
20393,134,5905,clathrin-coated pit,C
20394,134,30139,endocytic vesicle,C
20395,134,5783,endoplasmic reticulum,C
20396,134,5768,endosome,C
20397,134,70062,extracellular exosome,C
20398,134,16021,integral component of membrane,C
20399,134,5765,lysosomal membrane,C
20400,134,5764,lysosome,C
20401,134,5886,plasma membrane,C
20402,134,43235,receptor complex,C
20437,133,43113,receptor clustering,P
20438,133,14056,"regulation of acetylcholine secretion, neurotransmission",P
20439,133,50770,regulation of axonogenesis,P
20440,133,17158,regulation of calcium ion-dependent exocytosis,P
20441,133,50796,regulation of insulin secretion,P
20442,133,34765,regulation of ion transmembrane transport,P
20443,133,60024,rhythmic synaptic transmission,P
20444,133,21522,spinal cord motor neuron differentiation,P
20445,133,96,sulfur amino acid metabolic process,P
20446,133,7416,synapse assembly,P
20447,133,35249,"synaptic transmission, glutamatergic",P
20448,133,19226,transmission of nerve impulse,P
20449,133,21750,vestibular nucleus development,P
20450,133,42995,cell projection,C
20451,133,5737,cytoplasm,C
20452,133,30425,dendrite,C
20453,133,16021,integral component of membrane,C
20454,133,16021,integral component of membrane,C
20455,133,43025,neuronal cell body,C
20456,133,5634,nucleus,C
20457,133,5886,plasma membrane,C
20458,133,5886,plasma membrane,C
20459,133,98793,presynapse,C
20460,133,5891,voltage-gated calcium channel complex,C
20555,130,42542,response to hydrogen peroxide,P
20556,130,31667,response to nutrient levels,P
20557,130,10033,response to organic substance,P
20558,130,302,response to reactive oxygen species,P
20559,130,303,response to superoxide,P
20560,130,1895,retina homeostasis,P
20561,130,8090,retrograde axonal transport,P
20562,130,7605,sensory perception of sound,P
20563,130,7283,spermatogenesis,P
20564,130,42554,superoxide anion generation,P
20565,130,6801,superoxide metabolic process,P
20566,130,6801,superoxide metabolic process,P
20567,130,48538,thymus development,P
20568,130,19226,transmission of nerve impulse,P
20569,130,1904115,axon cytoplasm,C
20570,130,5737,cytoplasm,C
20571,130,31410,cytoplasmic vesicle,C
20572,130,5829,cytosol,C
20573,130,5829,cytosol,C
20574,130,32839,dendrite cytoplasm,C
20575,130,31045,dense core granule,C
20576,130,70062,extracellular exosome,C
20577,130,31012,extracellular matrix,C
20578,130,5576,extracellular region,C
20579,130,5615,extracellular space,C
20580,130,5764,lysosome,C
20581,130,5758,mitochondrial intermembrane space,C
20582,130,5759,mitochondrial matrix,C
20583,130,5739,mitochondrion,C
20584,130,43209,myelin sheath,C
20585,130,43025,neuronal cell body,C
20586,130,5654,nucleoplasm,C
20587,130,5634,nucleus,C
20588,130,5777,peroxisome,C
20589,130,5777,peroxisome,C
20590,130,5886,plasma membrane,C
20591,130,43234,protein complex,C
20645,127,5654,nucleoplasm,C
20655,126,35264,multicellular organism growth,P
20656,126,1901255,nucleotide-excision repair involved in interstrand cross-link repair,P
20657,126,715,"nucleotide-excision repair, DNA damage recognition",P
20658,126,717,"nucleotide-excision repair, DNA duplex unwinding",P
20659,126,33683,"nucleotide-excision repair, DNA incision",P
20660,126,33683,"nucleotide-excision repair, DNA incision",P
20661,126,6295,"nucleotide-excision repair, DNA incision, 3'-to lesion",P
20662,126,6296,"nucleotide-excision repair, DNA incision, 5'-to lesion",P
20663,126,6294,"nucleotide-excision repair, preincision complex assembly",P
20664,126,6293,"nucleotide-excision repair, preincision complex stabilization",P
20665,126,10996,response to auditory stimulus,P
20666,126,6979,response to oxidative stress,P
20667,126,9636,response to toxic substance,P
20668,126,6283,transcription-coupled nucleotide-excision repair,P
20669,126,5662,DNA replication factor A complex,C
20670,126,5794,Golgi apparatus,C
20671,126,5737,cytoplasm,C
20672,126,45171,intercellular bridge,C
20673,126,5654,nucleoplasm,C
20674,126,5654,nucleoplasm,C
20675,126,110,nucleotide-excision repair factor 1 complex,C
20676,126,5634,nucleus,C
20690,125,1078,"transcriptional repressor activity, RNA polymerase II core promoter proximal region sequence-specific binding",F
20691,125,1904845,cellular response to L-glutamine,P
20692,125,1904385,cellular response to angiotensin,P
20693,125,71276,cellular response to cadmium ion,P
20694,125,71392,cellular response to estradiol stimulus,P
20695,125,34605,cellular response to heat,P
20696,125,34605,cellular response to heat,P
20697,125,70301,cellular response to hydrogen peroxide,P
20698,125,71222,cellular response to lipopolysaccharide,P
20699,125,1904843,cellular response to nitroglycerin,P
20700,125,35865,cellular response to potassium ion,P
20701,125,71478,cellular response to radiation,P
20702,125,6952,defense response,P
20703,125,1892,embryonic placenta development,P
20704,125,60136,embryonic process involved in female pregnancy,P
20705,125,7143,female meiotic division,P
20706,125,9299,mRNA transcription,P
20707,125,10667,negative regulation of cardiac muscle cell apoptotic process,P
20708,125,8285,negative regulation of cell proliferation,P
20709,125,90084,negative regulation of inclusion body assembly,P
20710,125,1901215,negative regulation of neuron death,P
20711,125,122,negative regulation of transcription from RNA polymerase II promoter,P
20712,125,32720,negative regulation of tumor necrosis factor production,P
20713,125,1902512,positive regulation of apoptotic DNA fragmentation,P
20714,125,43280,positive regulation of cysteine-type endopeptidase activity involved in apoptotic process,P
20715,125,90261,positive regulation of inclusion body assembly,P
20716,125,1900365,positive regulation of mRNA polyadenylation,P
20717,125,1904528,positive regulation of microtubule binding,P
20718,125,40018,positive regulation of multicellular organism growth,P
20719,125,45944,positive regulation of transcription from RNA polymerase II promoter,P
20720,125,61408,positive regulation of transcription from RNA polymerase II promoter in response to heat stress,P
20721,125,42517,positive regulation of tyrosine phosphorylation of Stat3 protein,P
20722,125,51260,protein homooligomerization,P
20723,125,70207,protein homotrimerization,P
20724,125,6468,protein phosphorylation,P
20725,125,1900034,regulation of cellular response to heat,P
20726,125,14823,response to activity,P
20727,125,1990910,response to hypobaric hypoxia,P
20728,125,7584,response to nutrient,P
20729,125,1990911,response to psychosocial stress,P
20730,125,33574,response to testosterone,P
20731,125,7283,spermatogenesis,P
20732,125,16605,PML body,C
20733,125,5737,cytoplasm,C
20734,125,5829,cytosol,C
20735,125,791,euchromatin,C
20736,125,792,heterochromatin,C
20737,125,97165,nuclear stress granule,C
20738,125,5654,nucleoplasm,C
20739,125,5654,nucleoplasm,C
20740,125,5634,nucleus,C
20741,125,45120,pronucleus,C
20742,125,43234,protein complex,C
20773,124,45599,negative regulation of fat cell differentiation,P
20774,124,32873,negative regulation of stress-activated MAPK cascade,P
20775,124,122,negative regulation of transcription from RNA polymerase II promoter,P
20776,124,45892,"negative regulation of transcription, DNA-templated",P
20777,124,97150,neuronal stem cell population maintenance,P
20778,124,43065,positive regulation of apoptotic process,P
20779,124,10508,positive regulation of autophagy,P
20780,124,45722,positive regulation of gluconeogenesis,P
20781,124,45732,positive regulation of protein catabolic process,P
20782,124,45944,positive regulation of transcription from RNA polymerase II promoter,P
20783,124,45893,"positive regulation of transcription, DNA-templated",P
20784,124,6473,protein acetylation,P
20785,124,2000505,regulation of energy homeostasis,P
20786,124,35947,regulation of gluconeogenesis by regulation of transcription from RNA polymerase II promoter,P
20787,124,2000177,regulation of neural precursor cell proliferation,P
20788,124,2000377,regulation of reactive oxygen species metabolic process,P
20789,124,1902617,response to fluoride,P
20790,124,1659,temperature homeostasis,P
20791,124,6351,"transcription, DNA-templated",P
20792,124,5737,cytoplasm,C
20793,124,5829,cytosol,C
20794,124,5829,cytosol,C
20795,124,5739,mitochondrion,C
20796,124,5654,nucleoplasm,C
20797,124,5634,nucleus,C
20819,123,97192,extrinsic apoptotic signaling pathway in absence of ligand,P
20820,123,1544,initiation of primordial ovarian follicle growth,P
20821,123,90090,negative regulation of canonical Wnt signaling pathway,P
20822,123,45665,negative regulation of neuron differentiation,P
20823,123,122,negative regulation of transcription from RNA polymerase II promoter,P
20824,123,122,negative regulation of transcription from RNA polymerase II promoter,P
20825,123,97150,neuronal stem cell population maintenance,P
20826,123,1556,oocyte maturation,P
20827,123,1542,ovulation from ovarian follicle,P
20828,123,43065,positive regulation of apoptotic process,P
20829,123,2000353,positive regulation of endothelial cell apoptotic process,P
20830,123,45648,positive regulation of erythrocyte differentiation,P
20831,123,1901300,positive regulation of hydrogen peroxide-mediated programmed cell death,P
20832,123,43525,positive regulation of neuron apoptotic process,P
20833,123,1903428,positive regulation of reactive oxygen species biosynthetic process,P
20834,123,45944,positive regulation of transcription from RNA polymerase II promoter,P
20835,123,45893,"positive regulation of transcription, DNA-templated",P
20836,123,2000177,regulation of neural precursor cell proliferation,P
20837,123,6357,regulation of transcription from RNA polymerase II promoter,P
20838,123,6417,regulation of translation,P
20839,123,71548,response to dexamethasone,P
20840,123,42493,response to drug,P
20841,123,31667,response to nutrient levels,P
20842,123,1990785,response to water-immersion restraint stress,P
20843,123,6366,transcription from RNA polymerase II promoter,P
20844,123,33209,tumor necrosis factor-mediated signaling pathway,P
20845,123,5737,cytoplasm,C
20846,123,5829,cytosol,C
20847,123,5829,cytosol,C
20848,123,16020,membrane,C
20849,123,5739,mitochondrion,C
20850,123,5654,nucleoplasm,C
20851,123,5654,nucleoplasm,C
20852,123,5634,nucleus,C
20885,122,42059,negative regulation of epidermal growth factor receptor signaling pathway,P
20886,122,46854,phosphatidylinositol phosphorylation,P
20887,122,36092,phosphatidylinositol-3-phosphate biosynthetic process,P
20888,122,48015,phosphatidylinositol-mediated signaling,P
20889,122,43547,positive regulation of GTPase activity,P
20890,122,30838,positive regulation of actin filament polymerization,P
20891,122,2000379,positive regulation of reactive oxygen species metabolic process,P
20892,122,9967,positive regulation of signal transduction,P
20893,122,51291,protein heterooligomerization,P
20894,122,31623,receptor internalization,P
20895,122,43408,regulation of MAPK cascade,P
20896,122,14066,regulation of phosphatidylinositol 3-kinase signaling,P
20897,122,42770,signal transduction in response to DNA damage,P
20898,122,16032,viral process,P
20899,122,8180,COP9 signalosome,C
20900,122,5794,Golgi apparatus,C
20901,122,70436,Grb2-EGFR complex,C
20902,122,5911,cell-cell junction,C
20903,122,5737,cytoplasm,C
20904,122,5829,cytosol,C
20905,122,5768,endosome,C
20906,122,70062,extracellular exosome,C
20907,122,5730,nucleolus,C
20908,122,5654,nucleoplasm,C
20909,122,5634,nucleus,C
20910,122,5886,plasma membrane,C
20911,122,12506,vesicle membrane,C
20926,121,35914,skeletal muscle cell differentiation,P
20927,121,5913,cell-cell adherens junction,C
20928,121,5783,endoplasmic reticulum,C
20929,121,16021,integral component of membrane,C
20930,121,16020,membrane,C
20931,121,5874,microtubule,C
20932,121,5635,nuclear envelope,C
20933,121,5635,nuclear envelope,C
20934,121,5637,nuclear inner membrane,C
20935,121,5637,nuclear inner membrane,C
20936,121,31965,nuclear membrane,C
20937,121,5640,nuclear outer membrane,C
20979,120,31175,neuron projection development,P
20980,120,45651,positive regulation of macrophage differentiation,P
20981,120,45842,positive regulation of mitotic metaphase/anaphase transition,P
20982,120,45944,positive regulation of transcription from RNA polymerase II promoter,P
20983,120,2000679,positive regulation of transcription regulatory region DNA binding,P
20984,120,45893,"positive regulation of transcription, DNA-templated",P
20985,120,71459,"protein localization to chromosome, centromeric region",P
20986,120,1558,regulation of cell growth,P
20987,120,90230,regulation of centromere complex assembly,P
20988,120,71922,regulation of cohesin loading,P
20989,120,43550,regulation of lipid kinase activity,P
20990,120,7346,regulation of mitotic cell cycle,P
20991,120,83,regulation of transcription involved in G1/S transition of mitotic cell cycle,P
20992,120,31134,sister chromatid biorientation,P
20993,120,35914,skeletal muscle cell differentiation,P
20994,120,51146,striated muscle cell differentiation,P
20995,120,1894,tissue homeostasis,P
20996,120,6351,"transcription, DNA-templated",P
20997,120,16032,viral process,P
20998,120,16605,PML body,C
20999,120,35189,Rb-E2F complex,C
21000,120,16514,SWI/SNF complex,C
21001,120,785,chromatin,C
21002,120,8024,cyclin/CDK positive transcription elongation factor complex,C
21003,120,5654,nucleoplasm,C
21004,120,5634,nucleus,C
21005,120,5819,spindle,C
21073,119,1903896,positive regulation of IRE1-mediated unfolded protein response,P
21074,119,1902512,positive regulation of apoptotic DNA fragmentation,P
21075,119,43065,positive regulation of apoptotic process,P
21076,119,60058,positive regulation of apoptotic process involved in mammary gland involution,P
21077,119,48087,positive regulation of developmental pigmentation,P
21078,119,1900103,positive regulation of endoplasmic reticulum unfolded protein response,P
21079,119,2001241,positive regulation of extrinsic apoptotic signaling pathway in absence of ligand,P
21080,119,2001244,positive regulation of intrinsic apoptotic signaling pathway,P
21081,119,1901030,positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway,P
21082,119,43525,positive regulation of neuron apoptotic process,P
21083,119,32461,positive regulation of protein oligomerization,P
21084,119,90200,positive regulation of release of cytochrome c from mitochondria,P
21085,119,51281,positive regulation of release of sequestered calcium ion into cytosol,P
21086,119,48597,post-embryonic camera-type eye morphogenesis,P
21087,119,51260,protein homooligomerization,P
21088,119,1844,protein insertion into mitochondrial membrane involved in apoptotic signaling pathway,P
21089,119,51259,protein oligomerization,P
21090,119,42981,regulation of apoptotic process,P
21091,119,33599,regulation of mammary gland epithelial cell proliferation,P
21092,119,1902445,regulation of mitochondrial membrane permeability involved in programmed necrotic cell death,P
21093,119,51881,regulation of mitochondrial membrane potential,P
21094,119,6808,regulation of nitrogen utilization,P
21095,119,43497,regulation of protein heterodimerization activity,P
21096,119,43496,regulation of protein homodimerization activity,P
21097,119,1836,release of cytochrome c from mitochondria,P
21098,119,32976,release of matrix enzymes from mitochondria,P
21099,119,48678,response to axon injury,P
21100,119,10332,response to gamma radiation,P
21101,119,9651,response to salt stress,P
21102,119,9636,response to toxic substance,P
21103,119,60041,retina development in camera-type eye,P
21104,119,46666,retinal cell programmed cell death,P
21105,119,48515,spermatid differentiation,P
21106,119,70242,thymocyte apoptotic process,P
21107,119,60068,vagina development,P
21108,119,16032,viral process,P
21109,119,97144,BAX complex,C
21110,119,97136,Bcl-2 family protein complex,C
21111,119,5737,cytoplasm,C
21112,119,5829,cytosol,C
21113,119,5829,cytosol,C
21114,119,5783,endoplasmic reticulum,C
21115,119,5789,endoplasmic reticulum membrane,C
21116,119,70062,extracellular exosome,C
21117,119,16020,membrane,C
21118,119,5741,mitochondrial outer membrane,C
21119,119,5741,mitochondrial outer membrane,C
21120,119,5757,mitochondrial permeability transition pore complex,C
21121,119,5739,mitochondrion,C
21122,119,5635,nuclear envelope,C
21123,119,5634,nucleus,C
21124,119,5634,nucleus,C
21125,119,46930,pore complex,C
21151,118,33683,"nucleotide-excision repair, DNA incision",P
21152,118,6296,"nucleotide-excision repair, DNA incision, 5'-to lesion",P
21153,118,9411,response to UV,P
21154,118,723,telomere maintenance,P
21155,118,722,telomere maintenance via recombination,P
21156,118,6283,transcription-coupled nucleotide-excision repair,P
21157,118,19985,translesion synthesis,P
21158,118,16235,aggresome,C
21159,118,5737,cytoplasm,C
21160,118,43625,delta DNA polymerase complex,C
21161,118,16020,membrane,C
21162,118,784,"nuclear chromosome, telomeric region",C
21163,118,5654,nucleoplasm,C
21164,118,5654,nucleoplasm,C
21165,118,109,nucleotide-excision repair complex,C
21166,118,5634,nucleus,C
21190,117,45892,"negative regulation of transcription, DNA-templated",P
21191,117,45944,positive regulation of transcription from RNA polymerase II promoter,P
21192,117,45893,"positive regulation of transcription, DNA-templated",P
21193,117,45893,"positive regulation of transcription, DNA-templated",P
21194,117,32481,positive regulation of type I interferon production,P
21195,117,51290,protein heterotetramerization,P
21196,117,48660,regulation of smooth muscle cell proliferation,P
21197,117,723,telomere maintenance,P
21198,117,6351,"transcription, DNA-templated",P
21199,117,43564,Ku70:Ku80 complex,C
21200,117,5829,cytosol,C
21201,117,16020,membrane,C
21202,117,70419,nonhomologous end joining complex,C
21203,117,784,"nuclear chromosome, telomeric region",C
21204,117,783,nuclear telomere cap complex,C
21205,117,5730,nucleolus,C
21206,117,5654,nucleoplasm,C
21207,117,5654,nucleoplasm,C
21208,117,5634,nucleus,C
21209,117,5667,transcription factor complex,C
21226,116,1904354,negative regulation of telomere capping,P
21227,116,32205,negative regulation of telomere maintenance,P
21228,116,32205,negative regulation of telomere maintenance,P
21229,116,32208,negative regulation of telomere maintenance via recombination,P
21230,116,32214,negative regulation of telomere maintenance via semi-conservative replication,P
21231,116,1903824,negative regulation of telomere single strand break repair,P
21232,116,10628,positive regulation of gene expression,P
21233,116,51000,positive regulation of nitric-oxide synthase activity,P
21234,116,32206,positive regulation of telomere maintenance,P
21235,116,31848,protection from non-homologous end joining at telomere,P
21236,116,31848,protection from non-homologous end joining at telomere,P
21237,116,70198,"protein localization to chromosome, telomeric region",P
21238,116,32204,regulation of telomere maintenance,P
21239,116,32210,regulation of telomere maintenance via telomerase,P
21240,116,16233,telomere capping,P
21241,116,16233,telomere capping,P
21242,116,16233,telomere capping,P
21243,116,723,telomere maintenance,P
21244,116,723,telomere maintenance,P
21245,116,7004,telomere maintenance via telomerase,P
21246,116,7004,telomere maintenance via telomerase,P
21247,116,31627,telomeric loop formation,P
21248,116,5794,Golgi apparatus,C
21249,116,30870,Mre11 complex,C
21250,116,781,"chromosome, telomeric region",C
21251,116,5737,cytoplasm,C
21252,116,784,"nuclear chromosome, telomeric region",C
21253,116,783,nuclear telomere cap complex,C
21254,116,5654,nucleoplasm,C
21255,116,5654,nucleoplasm,C
21256,116,5634,nucleus,C
21257,116,70187,telosome,C
21258,116,70187,telosome,C
21290,115,45060,negative thymic T cell selection,P
21291,115,43410,positive regulation of MAPK cascade,P
21292,115,43065,positive regulation of apoptotic process,P
21293,115,43065,positive regulation of apoptotic process,P
21294,115,2001241,positive regulation of extrinsic apoptotic signaling pathway in absence of ligand,P
21295,115,70230,positive regulation of lymphocyte apoptotic process,P
21296,115,32464,positive regulation of protein homooligomerization,P
21297,115,6461,protein complex assembly,P
21298,115,51260,protein homooligomerization,P
21299,115,42981,regulation of apoptotic process,P
21300,115,42981,regulation of apoptotic process,P
21301,115,42127,regulation of cell proliferation,P
21302,115,43281,regulation of cysteine-type endopeptidase activity involved in apoptotic process,P
21303,115,1902041,regulation of extrinsic apoptotic signaling pathway via death domain receptors,P
21304,115,45619,regulation of lymphocyte differentiation,P
21305,115,45637,regulation of myeloid cell differentiation,P
21306,115,3014,renal system process,P
21307,115,51384,response to glucocorticoid,P
21308,115,32496,response to lipopolysaccharide,P
21309,115,9636,response to toxic substance,P
21310,115,7165,signal transduction,P
21311,115,48536,spleen development,P
21312,115,33209,tumor necrosis factor-mediated signaling pathway,P
21313,115,31265,CD95 death-inducing signaling complex,C
21314,115,9986,cell surface,C
21315,115,5737,cytoplasm,C
21316,115,5829,cytosol,C
21317,115,31264,death-inducing signaling complex,C
21318,115,9897,external side of plasma membrane,C
21319,115,70062,extracellular exosome,C
21320,115,5887,integral component of plasma membrane,C
21321,115,45121,membrane raft,C
21322,115,43005,neuron projection,C
21323,115,5634,nucleus,C
21324,115,5634,nucleus,C
21325,115,5886,plasma membrane,C
21326,115,5886,plasma membrane,C
21327,115,5886,plasma membrane,C
21345,114,90502,"RNA phosphodiester bond hydrolysis, endonucleolytic",P
21346,114,9650,UV protection,P
21347,114,6302,double-strand break repair,P
21348,114,724,double-strand break repair via homologous recombination,P
21349,114,7613,memory,P
21350,114,90305,nucleic acid phosphodiester bond hydrolysis,P
21351,114,45876,positive regulation of sister chromatid cohesion,P
21352,114,722,telomere maintenance via recombination,P
21353,114,16020,membrane,C
21354,114,5739,mitochondrion,C
21355,114,784,"nuclear chromosome, telomeric region",C
21356,114,784,"nuclear chromosome, telomeric region",C
21357,114,5730,nucleolus,C
21358,114,5654,nucleoplasm,C
21359,114,5634,nucleus,C
21360,114,5886,plasma membrane,C
21361,114,43234,protein complex,C
21385,113,44849,estrous cycle,P
21386,113,7507,heart development,P
21387,113,6272,leading strand elongation,P
21388,113,97421,liver regeneration,P
21389,113,6298,mismatch repair,P
21390,113,6298,mismatch repair,P
21391,113,1902990,mitotic telomere maintenance via semi-conservative replication,P
21392,113,6297,"nucleotide-excision repair, DNA gap filling",P
21393,113,33683,"nucleotide-excision repair, DNA incision",P
21394,113,6296,"nucleotide-excision repair, DNA incision, 5'-to lesion",P
21395,113,45739,positive regulation of DNA repair,P
21396,113,45740,positive regulation of DNA replication,P
21397,113,32077,positive regulation of deoxyribonuclease activity,P
21398,113,16925,protein sumoylation,P
21399,113,83,regulation of transcription involved in G1/S transition of mitotic cell cycle,P
21400,113,31297,replication fork processing,P
21401,113,1902065,response to L-glutamate,P
21402,113,46686,response to cadmium ion,P
21403,113,71548,response to dexamethasone,P
21404,113,32355,response to estradiol,P
21405,113,723,telomere maintenance,P
21406,113,722,telomere maintenance via recombination,P
21407,113,6283,transcription-coupled nucleotide-excision repair,P
21408,113,19985,translesion synthesis,P
21409,113,19985,translesion synthesis,P
21410,113,5663,DNA replication factor C complex,C
21411,113,43626,PCNA complex,C
21412,113,70557,PCNA-p21 complex,C
21413,113,5813,centrosome,C
21414,113,5737,cytoplasm,C
21415,113,70062,extracellular exosome,C
21416,113,784,"nuclear chromosome, telomeric region",C
21417,113,43596,nuclear replication fork,C
21418,113,5654,nucleoplasm,C
21419,113,5654,nucleoplasm,C
21420,113,5634,nucleus,C
21421,113,5657,replication fork,C
21422,113,30894,replisome,C
21446,112,6302,double-strand break repair,P
21447,112,6303,double-strand break repair via nonhomologous end joining,P
21448,112,6303,double-strand break repair via nonhomologous end joining,P
21449,112,75713,establishment of integrated proviral latency,P
21450,112,60218,hematopoietic stem cell differentiation,P
21451,112,1904430,negative regulation of t-circle formation,P
21452,112,45892,"negative regulation of transcription, DNA-templated",P
21453,112,50769,positive regulation of neurogenesis,P
21454,112,32481,positive regulation of type I interferon production,P
21455,112,48660,regulation of smooth muscle cell proliferation,P
21456,112,42493,response to drug,P
21457,112,723,telomere maintenance,P
21458,112,6351,"transcription, DNA-templated",P
21459,112,43564,Ku70:Ku80 complex,C
21460,112,5829,cytosol,C
21461,112,16020,membrane,C
21462,112,70419,nonhomologous end joining complex,C
21463,112,784,"nuclear chromosome, telomeric region",C
21464,112,783,nuclear telomere cap complex,C
21465,112,5730,nucleolus,C
21466,112,5654,nucleoplasm,C
21467,112,5654,nucleoplasm,C
21468,112,5634,nucleus,C
21469,112,5886,plasma membrane,C
21490,111,6357,regulation of transcription from RNA polymerase II promoter,P
21491,111,9411,response to UV,P
21492,111,6363,termination of RNA polymerase I transcription,P
21493,111,6362,transcription elongation from RNA polymerase I promoter,P
21494,111,6368,transcription elongation from RNA polymerase II promoter,P
21495,111,6366,transcription from RNA polymerase II promoter,P
21496,111,6366,transcription from RNA polymerase II promoter,P
21497,111,6361,transcription initiation from RNA polymerase I promoter,P
21498,111,6367,transcription initiation from RNA polymerase II promoter,P
21499,111,6283,transcription-coupled nucleotide-excision repair,P
21500,111,6412,translation,P
21501,111,438,core TFIIH complex portion of holo TFIIH complex,C
21502,111,5675,holo TFIIH complex,C
21503,111,5654,nucleoplasm,C
21504,111,5634,nucleus,C
21505,111,5669,transcription factor TFIID complex,C
21559,110,10628,positive regulation of gene expression,P
21560,110,43568,positive regulation of insulin-like growth factor receptor signaling pathway,P
21561,110,45726,positive regulation of integrin biosynthetic process,P
21562,110,33148,positive regulation of intracellular estrogen receptor signaling pathway,P
21563,110,42327,positive regulation of phosphorylation,P
21564,110,45944,positive regulation of transcription from RNA polymerase II promoter,P
21565,110,45944,positive regulation of transcription from RNA polymerase II promoter,P
21566,110,45945,positive regulation of transcription from RNA polymerase III promoter,P
21567,110,45893,"positive regulation of transcription, DNA-templated",P
21568,110,30850,prostate gland development,P
21569,110,60740,prostate gland epithelium morphogenesis,P
21570,110,60736,prostate gland growth,P
21571,110,51259,protein oligomerization,P
21572,110,50790,regulation of catalytic activity,P
21573,110,48638,regulation of developmental growth,P
21574,110,90003,regulation of establishment of protein localization to plasma membrane,P
21575,110,3073,regulation of systemic arterial blood pressure,P
21576,110,72520,seminiferous tubule development,P
21577,110,7548,sex differentiation,P
21578,110,7165,signal transduction,P
21579,110,7338,single fertilization,P
21580,110,7283,spermatogenesis,P
21581,110,60748,tertiary branching involved in mammary gland duct morphogenesis,P
21582,110,6367,transcription initiation from RNA polymerase II promoter,P
21583,110,6351,"transcription, DNA-templated",P
21584,110,6810,transport,P
21585,110,5737,cytoplasm,C
21586,110,5829,cytosol,C
21587,110,790,nuclear chromatin,C
21588,110,5654,nucleoplasm,C
21589,110,5634,nucleus,C
21590,110,5886,plasma membrane,C
21591,110,43234,protein complex,C
21607,109,6296,"nucleotide-excision repair, DNA incision, 5'-to lesion",P
21608,109,6294,"nucleotide-excision repair, preincision complex assembly",P
21609,109,6293,"nucleotide-excision repair, preincision complex stabilization",P
21610,109,9411,response to UV,P
21611,109,9411,response to UV,P
21612,109,10225,response to UV-C,P
21613,109,6283,transcription-coupled nucleotide-excision repair,P
21614,109,6283,transcription-coupled nucleotide-excision repair,P
21615,109,5662,DNA replication factor A complex,C
21616,109,16591,"DNA-directed RNA polymerase II, holoenzyme",C
21617,109,5675,holo TFIIH complex,C
21618,109,5654,nucleoplasm,C
21619,109,5634,nucleus,C
21647,107,6195,purine nucleotide catabolic process,P
21648,107,33591,response to L-ascorbic acid,P
21649,107,14823,response to activity,P
21650,107,46686,response to cadmium ion,P
21651,107,42493,response to drug,P
21652,107,32355,response to estradiol,P
21653,107,45471,response to ethanol,P
21654,107,70542,response to fatty acid,P
21655,107,42542,response to hydrogen peroxide,P
21656,107,55093,response to hyperoxia,P
21657,107,1666,response to hypoxia,P
21658,107,14854,response to inactivity,P
21659,107,32868,response to insulin,P
21660,107,10288,response to lead ion,P
21661,107,9642,response to light intensity,P
21662,107,10193,response to ozone,P
21663,107,80184,response to phenylpropanoid,P
21664,107,302,response to reactive oxygen species,P
21665,107,302,response to reactive oxygen species,P
21666,107,33189,response to vitamin A,P
21667,107,33197,response to vitamin E,P
21668,107,6641,triglyceride metabolic process,P
21669,107,1657,ureteric bud development,P
21670,107,5794,Golgi apparatus,C
21671,107,5829,cytosol,C
21672,107,5783,endoplasmic reticulum,C
21673,107,70062,extracellular exosome,C
21674,107,5615,extracellular space,C
21675,107,5925,focal adhesion,C
21676,107,43231,intracellular membrane-bounded organelle,C
21677,107,5764,lysosome,C
21678,107,16020,membrane,C
21679,107,5758,mitochondrial intermembrane space,C
21680,107,5739,mitochondrion,C
21681,107,5782,peroxisomal matrix,C
21682,107,5778,peroxisomal membrane,C
21683,107,5777,peroxisome,C
21684,107,5886,plasma membrane,C
21710,106,43066,negative regulation of apoptotic process,P
21711,106,2000773,negative regulation of cellular senescence,P
21712,106,2638,negative regulation of immunoglobulin production,P
21713,106,1933,negative regulation of protein phosphorylation,P
21714,106,2001229,negative regulation of response to gamma radiation,P
21715,106,18105,peptidyl-serine phosphorylation,P
21716,106,43065,positive regulation of apoptotic process,P
21717,106,48639,positive regulation of developmental growth,P
21718,106,48146,positive regulation of fibroblast proliferation,P
21719,106,2684,positive regulation of immune system process,P
21720,106,45944,positive regulation of transcription from RNA polymerase II promoter,P
21721,106,32481,positive regulation of type I interferon production,P
21722,106,2328,pro-B cell differentiation,P
21723,106,31648,protein destabilization,P
21724,106,42752,regulation of circadian rhythm,P
21725,106,48660,regulation of smooth muscle cell proliferation,P
21726,106,14823,response to activity,P
21727,106,10332,response to gamma radiation,P
21728,106,48511,rhythmic process,P
21729,106,72431,signal transduction involved in mitotic G1 DNA damage checkpoint,P
21730,106,1756,somitogenesis,P
21731,106,48536,spleen development,P
21732,106,16233,telomere capping,P
21733,106,48538,thymus development,P
21734,106,5958,DNA-dependent protein kinase-DNA ligase 4 complex,C
21735,106,5829,cytosol,C
21736,106,31012,extracellular matrix,C
21737,106,16020,membrane,C
21738,106,70419,nonhomologous end joining complex,C
21739,106,784,"nuclear chromosome, telomeric region",C
21740,106,5730,nucleolus,C
21741,106,5654,nucleoplasm,C
21742,106,5654,nucleoplasm,C
21743,106,5667,transcription factor complex,C
21772,105,784,"nuclear chromosome, telomeric region",C
21773,105,783,nuclear telomere cap complex,C
21774,105,783,nuclear telomere cap complex,C
21775,105,5730,nucleolus,C
21776,105,5654,nucleoplasm,C
21777,105,5634,nucleus,C
21778,105,5634,nucleus,C
21779,105,5819,spindle,C
21780,105,70187,telosome,C
21817,104,43065,positive regulation of apoptotic process,P
21818,104,45944,positive regulation of transcription from RNA polymerase II promoter,P
21819,104,8104,protein localization,P
21820,104,6468,protein phosphorylation,P
21821,104,1901990,regulation of mitotic cell cycle phase transition,P
21822,104,9411,response to UV,P
21823,104,1666,response to hypoxia,P
21824,104,6979,response to oxidative stress,P
21825,104,6363,termination of RNA polymerase I transcription,P
21826,104,6362,transcription elongation from RNA polymerase I promoter,P
21827,104,6368,transcription elongation from RNA polymerase II promoter,P
21828,104,6366,transcription from RNA polymerase II promoter,P
21829,104,6366,transcription from RNA polymerase II promoter,P
21830,104,6366,transcription from RNA polymerase II promoter,P
21831,104,6361,transcription initiation from RNA polymerase I promoter,P
21832,104,6367,transcription initiation from RNA polymerase II promoter,P
21833,104,6283,transcription-coupled nucleotide-excision repair,P
21834,104,6283,transcription-coupled nucleotide-excision repair,P
21835,104,16032,viral process,P
21836,104,439,core TFIIH complex,C
21837,104,5675,holo TFIIH complex,C
21838,104,5675,holo TFIIH complex,C
21839,104,5654,nucleoplasm,C
21840,104,5654,nucleoplasm,C
21841,104,5634,nucleus,C
21842,104,5669,transcription factor TFIID complex,C
21850,103,5515,protein binding,F
21851,103,19901,protein kinase binding,F
21852,103,43022,ribosome binding,F
21853,103,3746,translation elongation factor activity,F
21854,103,7568,aging,P
21855,103,98609,cell-cell adhesion,P
21856,103,1990416,cellular response to brain-derived neurotrophic factor stimulus,P
21857,103,14009,glial cell proliferation,P
21858,103,2244,hematopoietic progenitor cell differentiation,P
21859,103,17183,peptidyl-diphthamide biosynthetic process from peptidyl-histidine,P
21860,103,2000767,positive regulation of cytoplasmic translation,P
21861,103,45727,positive regulation of translation,P
21862,103,42493,response to drug,P
21863,103,34976,response to endoplasmic reticulum stress,P
21864,103,32355,response to estradiol,P
21865,103,45471,response to ethanol,P
21866,103,51593,response to folic acid,P
21867,103,42542,response to hydrogen peroxide,P
21868,103,2931,response to ischemia,P
21869,103,35914,skeletal muscle cell differentiation,P
21870,103,3009,skeletal muscle contraction,P
21871,103,6414,translational elongation,P
21872,103,16235,aggresome,C
21873,103,5913,cell-cell adherens junction,C
21874,103,5737,cytoplasm,C
21875,103,5829,cytosol,C
21876,103,70062,extracellular exosome,C
21877,103,31012,extracellular matrix,C
21878,103,30529,intracellular ribonucleoprotein complex,C
21879,103,16020,membrane,C
21880,103,45121,membrane raft,C
21881,103,5634,nucleus,C
21882,103,5886,plasma membrane,C
21883,103,42788,polysomal ribosome,C
21914,102,34379,very-low-density lipoprotein particle assembly,P
21915,102,42627,chylomicron,C
21916,102,5769,early endosome,C
21917,102,70062,extracellular exosome,C
21918,102,5576,extracellular region,C
21919,102,5615,extracellular space,C
21920,102,34363,intermediate-density lipoprotein particle,C
21921,102,34366,spherical high-density lipoprotein particle,C
21922,102,34361,very-low-density lipoprotein particle,C
21935,101,5634,nucleus,C
21936,101,5721,pericentric heterochromatin,C
21949,100,8285,negative regulation of cell proliferation,P
21950,100,42594,response to starvation,P
21951,100,38170,somatostatin signaling pathway,P
21952,100,7283,spermatogenesis,P
21953,100,60170,ciliary membrane,C
21954,100,5737,cytoplasm,C
21955,100,5887,integral component of plasma membrane,C
21956,100,43005,neuron projection,C
21957,100,97730,non-motile cilium,C
21958,100,5886,plasma membrane,C
22111,97,10822,positive regulation of mitochondrion organization,P
22112,97,1901216,positive regulation of neuron death,P
22113,97,33138,positive regulation of peptidyl-serine phosphorylation,P
22114,97,10800,positive regulation of peptidyl-threonine phosphorylation,P
22115,97,32436,positive regulation of proteasomal ubiquitin-dependent protein catabolic process,P
22116,97,32092,positive regulation of protein binding,P
22117,97,45732,positive regulation of protein catabolic process,P
22118,97,31334,positive regulation of protein complex assembly,P
22119,97,46827,positive regulation of protein export from nucleus,P
22120,97,2000738,positive regulation of stem cell differentiation,P
22121,97,45944,positive regulation of transcription from RNA polymerase II promoter,P
22122,97,43161,proteasome-mediated ubiquitin-dependent protein catabolic process,P
22123,97,46777,protein autophosphorylation,P
22124,97,6611,protein export from nucleus,P
22125,97,35372,protein localization to microtubule,P
22126,97,6468,protein phosphorylation,P
22127,97,6468,protein phosphorylation,P
22128,97,320,re-entry into mitotic cell cycle,P
22129,97,1900034,regulation of cellular response to heat,P
22130,97,6349,regulation of gene expression by genetic imprinting,P
22131,97,32886,regulation of microtubule-based process,P
22132,97,71109,superior temporal gyrus development,P
22133,97,1990909,Wnt signalosome,C
22134,97,30877,beta-catenin destruction complex,C
22135,97,30877,beta-catenin destruction complex,C
22136,97,5813,centrosome,C
22137,97,5737,cytoplasm,C
22138,97,5829,cytosol,C
22139,97,43198,dendritic shaft,C
22140,97,30426,growth cone,C
22141,97,30529,intracellular ribonucleoprotein complex,C
22142,97,5739,mitochondrion,C
22143,97,43025,neuronal cell body,C
22144,97,5634,nucleus,C
22145,97,48471,perinuclear region of cytoplasm,C
22146,97,5886,plasma membrane,C
22147,97,14069,postsynaptic density,C
22194,96,30155,regulation of cell adhesion,P
22195,96,42752,regulation of circadian rhythm,P
22196,96,2000779,regulation of double-strand break repair,P
22197,96,1932,regulation of protein phosphorylation,P
22198,96,1901796,regulation of signal transduction by p53 class mediator,P
22199,96,6355,"regulation of transcription, DNA-templated",P
22200,96,9411,response to UV,P
22201,96,34097,response to cytokine,P
22202,96,10332,response to gamma radiation,P
22203,96,1666,response to hypoxia,P
22204,96,48384,retinoic acid receptor signaling pathway,P
22205,96,6351,"transcription, DNA-templated",P
22206,96,7179,transforming growth factor beta receptor signaling pathway,P
22207,96,16605,PML body,C
22208,96,16605,PML body,C
22209,96,16605,PML body,C
22210,96,5737,cytoplasm,C
22211,96,5829,cytosol,C
22212,96,5829,cytosol,C
22213,96,31901,early endosome membrane,C
22214,96,42406,extrinsic component of endoplasmic reticulum membrane,C
22215,96,784,"nuclear chromosome, telomeric region",C
22216,96,16363,nuclear matrix,C
22217,96,31965,nuclear membrane,C
22218,96,5730,nucleolus,C
22219,96,5654,nucleoplasm,C
22220,96,5654,nucleoplasm,C
22221,96,5634,nucleus,C
22237,95,42542,response to hydrogen peroxide,P
22238,95,12,single strand break repair,P
22239,95,785,chromatin,C
22240,95,5737,cytoplasm,C
22241,95,790,nuclear chromatin,C
22242,95,5730,nucleolus,C
22243,95,5654,nucleoplasm,C
22244,95,5634,nucleus,C
22280,94,1904837,beta-catenin-TCF complex assembly,P
22281,94,34644,cellular response to UV,P
22282,94,7623,circadian rhythm,P
22283,94,45444,fat cell differentiation,P
22284,94,7507,heart development,P
22285,94,43969,histone H2B acetylation,P
22286,94,43967,histone H4 acetylation,P
22287,94,18393,internal peptidyl-lysine acetylation,P
22288,94,6475,internal protein amino acid acetylation,P
22289,94,42771,intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator,P
22290,94,30324,lung development,P
22291,94,10742,macrophage derived foam cell differentiation,P
22292,94,35855,megakaryocyte development,P
22293,94,122,negative regulation of transcription from RNA polymerase II promoter,P
22294,94,7399,nervous system development,P
22295,94,30220,platelet formation,P
22296,94,43923,positive regulation by host of viral transcription,P
22297,94,45815,"positive regulation of gene expression, epigenetic",P
22298,94,32092,positive regulation of protein binding,P
22299,94,51091,positive regulation of sequence-specific DNA binding transcription factor activity,P
22300,94,45944,positive regulation of transcription from RNA polymerase II promoter,P
22301,94,45944,positive regulation of transcription from RNA polymerase II promoter,P
22302,94,6990,positive regulation of transcription from RNA polymerase II promoter involved in unfolded protein response,P
22303,94,32481,positive regulation of type I interferon production,P
22304,94,6473,protein acetylation,P
22305,94,6473,protein acetylation,P
22306,94,50821,protein stabilization,P
22307,94,60765,regulation of androgen receptor signaling pathway,P
22308,94,10506,regulation of autophagy,P
22309,94,51726,regulation of cell cycle,P
22310,94,1900034,regulation of cellular response to heat,P
22311,94,1901796,regulation of signal transduction by p53 class mediator,P
22312,94,61418,regulation of transcription from RNA polymerase II promoter in response to hypoxia,P
22313,94,6355,"regulation of transcription, DNA-templated",P
22314,94,90043,regulation of tubulin deacetylation,P
22315,94,43627,response to estrogen,P
22316,94,1666,response to hypoxia,P
22317,94,7519,skeletal muscle tissue development,P
22318,94,1756,somitogenesis,P
22319,94,2223,stimulatory C-type lectin receptor signaling pathway,P
22320,94,6366,transcription from RNA polymerase II promoter,P
22321,94,6283,transcription-coupled nucleotide-excision repair,P
22322,94,16032,viral process,P
22323,94,5737,cytoplasm,C
22324,94,123,histone acetyltransferase complex,C
22325,94,5654,nucleoplasm,C
22326,94,5654,nucleoplasm,C
22327,94,5634,nucleus,C
22328,94,5667,transcription factor complex,C
22363,93,50772,positive regulation of axonogenesis,P
22364,93,50731,positive regulation of peptidyl-tyrosine phosphorylation,P
22365,93,1900182,positive regulation of protein localization to nucleus,P
22366,93,71902,positive regulation of protein serine/threonine kinase activity,P
22367,93,30511,positive regulation of transforming growth factor beta receptor signaling pathway,P
22368,93,45059,positive thymic T cell selection,P
22369,93,46777,protein autophosphorylation,P
22370,93,6468,protein phosphorylation,P
22371,93,30111,regulation of Wnt signaling pathway,P
22372,93,1558,regulation of cell growth,P
22373,93,48814,regulation of dendrite morphogenesis,P
22374,93,51896,regulation of protein kinase B signaling,P
22375,93,1901796,regulation of signal transduction by p53 class mediator,P
22376,93,10212,response to ionizing radiation,P
22377,93,7283,spermatogenesis,P
22378,93,1894,tissue homeostasis,P
22379,93,1944,vasculature development,P
22380,93,36398,TCR signalosome,C
22381,93,5737,cytoplasm,C
22382,93,5829,cytosol,C
22383,93,5829,cytosol,C
22384,93,70062,extracellular exosome,C
22385,93,16020,membrane,C
22386,93,5739,mitochondrion,C
22387,93,5654,nucleoplasm,C
22388,93,5634,nucleus,C
22410,92,9411,response to UV,P
22411,92,10224,response to UV-B,P
22412,92,10165,response to X-ray,P
22413,92,10332,response to gamma radiation,P
22414,92,6979,response to oxidative stress,P
22415,92,6979,response to oxidative stress,P
22416,92,303,response to superoxide,P
22417,92,9636,response to toxic substance,P
22418,92,6362,transcription elongation from RNA polymerase I promoter,P
22419,92,6366,transcription from RNA polymerase II promoter,P
22420,92,6283,transcription-coupled nucleotide-excision repair,P
22421,92,6283,transcription-coupled nucleotide-excision repair,P
22422,92,5730,nucleolus,C
22423,92,5654,nucleoplasm,C
22424,92,5654,nucleoplasm,C
22425,92,5634,nucleus,C
22426,92,8023,transcription elongation factor complex,C
22545,91,43536,positive regulation of blood vessel endothelial cell migration,P
22546,91,30501,positive regulation of bone mineralization,P
22547,91,90190,positive regulation of branching involved in ureteric bud morphogenesis,P
22548,91,2000727,positive regulation of cardiac muscle cell differentiation,P
22549,91,71158,positive regulation of cell cycle arrest,P
22550,91,51781,positive regulation of cell division,P
22551,91,30335,positive regulation of cell migration,P
22552,91,30335,positive regulation of cell migration,P
22553,91,8284,positive regulation of cell proliferation,P
22554,91,8284,positive regulation of cell proliferation,P
22555,91,32270,positive regulation of cellular protein metabolic process,P
22556,91,50921,positive regulation of chemotaxis,P
22557,91,32967,positive regulation of collagen biosynthetic process,P
22558,91,32967,positive regulation of collagen biosynthetic process,P
22559,91,32967,positive regulation of collagen biosynthetic process,P
22560,91,50679,positive regulation of epithelial cell proliferation,P
22561,91,10718,positive regulation of epithelial to mesenchymal transition,P
22562,91,10718,positive regulation of epithelial to mesenchymal transition,P
22563,91,31536,positive regulation of exit from mitosis,P
22564,91,1901203,positive regulation of extracellular matrix assembly,P
22565,91,10763,positive regulation of fibroblast migration,P
22566,91,48146,positive regulation of fibroblast proliferation,P
22567,91,10628,positive regulation of gene expression,P
22568,91,10628,positive regulation of gene expression,P
22569,91,10628,positive regulation of gene expression,P
22570,91,35066,positive regulation of histone acetylation,P
22571,91,31065,positive regulation of histone deacetylation,P
22572,91,32740,positive regulation of interleukin-17 production,P
22573,91,48298,positive regulation of isotype switching to IgA isotypes,P
22574,91,71677,positive regulation of mononuclear cell migration,P
22575,91,42482,positive regulation of odontogenesis,P
22576,91,10862,positive regulation of pathway-restricted SMAD protein phosphorylation,P
22577,91,33138,positive regulation of peptidyl-serine phosphorylation,P
22578,91,10800,positive regulation of peptidyl-threonine phosphorylation,P
22579,91,50731,positive regulation of peptidyl-tyrosine phosphorylation,P
22580,91,43552,positive regulation of phosphatidylinositol 3-kinase activity,P
22581,91,1902895,positive regulation of pri-miRNA transcription from RNA polymerase II promoter,P
22582,91,31334,positive regulation of protein complex assembly,P
22583,91,35307,positive regulation of protein dephosphorylation,P
22584,91,42307,positive regulation of protein import into nucleus,P
22585,91,51897,positive regulation of protein kinase B signaling,P
22586,91,1934,positive regulation of protein phosphorylation,P
22587,91,50714,positive regulation of protein secretion,P
22588,91,1903911,positive regulation of receptor clustering,P
22589,91,45591,positive regulation of regulatory T cell differentiation,P
22590,91,51152,positive regulation of smooth muscle cell differentiation,P
22591,91,32930,positive regulation of superoxide anion generation,P
22592,91,45944,positive regulation of transcription from RNA polymerase II promoter,P
22593,91,2000679,positive regulation of transcription regulatory region DNA binding,P
22594,91,45893,"positive regulation of transcription, DNA-templated",P
22595,91,45893,"positive regulation of transcription, DNA-templated",P
22596,91,10575,positive regulation of vascular endothelial growth factor production,P
22597,91,43117,positive regulation of vascular permeability,P
22598,91,6611,protein export from nucleus,P
22599,91,60,"protein import into nucleus, translocation",P
22600,91,43491,protein kinase B signaling,P
22601,91,6468,protein phosphorylation,P
22602,91,32801,receptor catabolic process,P
22603,91,51101,regulation of DNA binding,P
22604,91,60390,regulation of SMAD protein import into nucleus,P
22605,91,2000249,regulation of actin cytoskeleton reorganization,P
22606,91,42981,regulation of apoptotic process,P
22607,91,51098,regulation of binding,P
22608,91,60312,regulation of blood vessel remodeling,P
22609,91,60312,regulation of blood vessel remodeling,P
22610,91,60762,regulation of branching involved in mammary gland duct morphogenesis,P
22611,91,61035,regulation of cartilage development,P
22612,91,30334,regulation of cell migration,P
22613,91,1905005,regulation of epithelial to mesenchymal transition involved in endocardial cushion formation,P
22614,91,32667,regulation of interleukin-23 production,P
22615,91,42306,regulation of protein import into nucleus,P
22616,91,2028,regulation of sodium ion transport,P
22617,91,16202,regulation of striated muscle tissue development,P
22618,91,17015,regulation of transforming growth factor beta receptor signaling pathway,P
22619,91,45066,regulatory T cell differentiation,P
22620,91,70723,response to cholesterol,P
22621,91,42493,response to drug,P
22622,91,32355,response to estradiol,P
22623,91,9749,response to glucose,P
22624,91,1666,response to hypoxia,P
22625,91,35902,response to immobilization stress,P
22626,91,34616,response to laminar fluid shear stress,P
22627,91,32570,response to progesterone,P
22628,91,33280,response to vitamin D,P
22629,91,9611,response to wounding,P
22630,91,7435,salivary gland morphogenesis,P
22631,91,2513,tolerance induction to self antigen,P
22632,91,7179,transforming growth factor beta receptor signaling pathway,P
22633,91,7179,transforming growth factor beta receptor signaling pathway,P
22634,91,1905313,transforming growth factor beta receptor signaling pathway involved in heart development,P
22635,91,1657,ureteric bud development,P
22636,91,1570,vasculogenesis,P
22637,91,55010,ventricular cardiac muscle tissue morphogenesis,P
22638,91,5796,Golgi lumen,C
22639,91,30424,axon,C
22640,91,72562,blood microparticle,C
22641,91,9986,cell surface,C
22642,91,5737,cytoplasm,C
22643,91,31012,extracellular matrix,C
22644,91,5576,extracellular region,C
22645,91,5615,extracellular space,C
22646,91,5902,microvillus,C
22647,91,43025,neuronal cell body,C
22648,91,5634,nucleus,C
22649,91,5886,plasma membrane,C
22650,91,31093,platelet alpha granule lumen,C
22651,91,5578,proteinaceous extracellular matrix,C
22658,90,1903507,negative regulation of nucleic acid-templated transcription,P
22659,90,6355,"regulation of transcription, DNA-templated",P
22660,90,6351,"transcription, DNA-templated",P
22661,90,5737,cytoplasm,C
22662,90,5730,nucleolus,C
22663,90,5634,nucleus,C
22685,89,71222,cellular response to lipopolysaccharide,P
22686,89,71407,cellular response to organic cyclic compound,P
22687,89,42742,defense response to bacterium,P
22688,89,1892,embryonic placenta development,P
22689,89,72574,hepatocyte proliferation,P
22690,89,6955,immune response,P
22691,89,6954,inflammatory response,P
22692,89,70059,intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress,P
22693,89,97421,liver regeneration,P
22694,89,60644,mammary gland epithelial cell differentiation,P
22695,89,33598,mammary gland epithelial cell proliferation,P
22696,89,7613,memory,P
22697,89,42130,negative regulation of T cell proliferation,P
22698,89,43524,negative regulation of neuron apoptotic process,P
22699,89,45892,"negative regulation of transcription, DNA-templated",P
22700,89,30182,neuron differentiation,P
22701,89,1541,ovarian follicle development,P
22702,89,45600,positive regulation of fat cell differentiation,P
22703,89,32753,positive regulation of interleukin-4 production,P
22704,89,45669,positive regulation of osteoblast differentiation,P
22705,89,45944,positive regulation of transcription from RNA polymerase II promoter,P
22706,89,1990440,positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress,P
22707,89,45408,regulation of interleukin-6 biosynthetic process,P
22708,89,45670,regulation of osteoclast differentiation,P
22709,89,60850,regulation of transcription involved in cell fate commitment,P
22710,89,6355,"regulation of transcription, DNA-templated",P
22711,89,34976,response to endoplasmic reticulum stress,P
22712,89,6366,transcription from RNA polymerase II promoter,P
22713,89,36488,CHOP-C/EBP complex,C
22714,89,779,"condensed chromosome, centromeric region",C
22715,89,5737,cytoplasm,C
22716,89,790,nuclear chromatin,C
22717,89,16363,nuclear matrix,C
22718,89,5654,nucleoplasm,C
22719,89,5654,nucleoplasm,C
22720,89,5634,nucleus,C
22749,88,30324,lung development,P
22750,88,30225,macrophage differentiation,P
22751,88,7005,mitochondrion organization,P
22752,88,30099,myeloid cell differentiation,P
22753,88,8285,negative regulation of cell proliferation,P
22754,88,8285,negative regulation of cell proliferation,P
22755,88,45736,negative regulation of cyclin-dependent protein serine/threonine kinase activity,P
22756,88,122,negative regulation of transcription from RNA polymerase II promoter,P
22757,88,45892,"negative regulation of transcription, DNA-templated",P
22758,88,45600,positive regulation of fat cell differentiation,P
22759,88,45669,positive regulation of osteoblast differentiation,P
22760,88,32436,positive regulation of proteasomal ubiquitin-dependent protein catabolic process,P
22761,88,45944,positive regulation of transcription from RNA polymerase II promoter,P
22762,88,45944,positive regulation of transcription from RNA polymerase II promoter,P
22763,88,45945,positive regulation of transcription from RNA polymerase III promoter,P
22764,88,6366,transcription from RNA polymerase II promoter,P
22765,88,6351,"transcription, DNA-templated",P
22766,88,6351,"transcription, DNA-templated",P
22767,88,50,urea cycle,P
22768,88,16032,viral process,P
22769,88,50872,white fat cell differentiation,P
22770,88,90575,RNA polymerase II transcription factor complex,C
22771,88,5730,nucleolus,C
22772,88,5634,nucleus,C
22773,88,5634,nucleus,C
22806,87,30512,negative regulation of transforming growth factor beta receptor signaling pathway,P
22807,87,18105,peptidyl-serine phosphorylation,P
22808,87,18107,peptidyl-threonine phosphorylation,P
22809,87,48015,phosphatidylinositol-mediated signaling,P
22810,87,30168,platelet activation,P
22811,87,90004,positive regulation of establishment of protein localization to plasma membrane,P
22812,87,10518,positive regulation of phospholipase activity,P
22813,87,51281,positive regulation of release of sequestered calcium ion into cytosol,P
22814,87,46777,protein autophosphorylation,P
22815,87,6468,protein phosphorylation,P
22816,87,43122,regulation of I-kappaB kinase/NF-kappaB signaling,P
22817,87,10594,regulation of endothelial cell migration,P
22818,87,43304,regulation of mast cell degranulation,P
22819,87,6355,"regulation of transcription, DNA-templated",P
22820,87,2223,stimulatory C-type lectin receptor signaling pathway,P
22821,87,6351,"transcription, DNA-templated",P
22822,87,3323,type B pancreatic cell development,P
22823,87,42995,cell projection,C
22824,87,5737,cytoplasm,C
22825,87,5737,cytoplasm,C
22826,87,31410,cytoplasmic vesicle,C
22827,87,5829,cytosol,C
22828,87,5925,focal adhesion,C
22829,87,5622,intracellular,C
22830,87,16020,membrane,C
22831,87,5654,nucleoplasm,C
22832,87,43204,perikaryon,C
22833,87,5886,plasma membrane,C
22834,87,5886,plasma membrane,C
22835,87,14069,postsynaptic density,C
22924,86,1904999,positive regulation of leukocyte adhesion to arterial endothelial cell,P
22925,86,1904996,positive regulation of leukocyte adhesion to vascular endothelial cell,P
22926,86,51044,positive regulation of membrane protein ectodomain proteolysis,P
22927,86,71677,positive regulation of mononuclear cell migration,P
22928,86,45429,positive regulation of nitric oxide biosynthetic process,P
22929,86,45672,positive regulation of osteoclast differentiation,P
22930,86,33138,positive regulation of peptidyl-serine phosphorylation,P
22931,86,50766,positive regulation of phagocytosis,P
22932,86,71803,positive regulation of podosome assembly,P
22933,86,43068,positive regulation of programmed cell death,P
22934,86,31334,positive regulation of protein complex assembly,P
22935,86,43243,positive regulation of protein complex disassembly,P
22936,86,51897,positive regulation of protein kinase B signaling,P
22937,86,45860,positive regulation of protein kinase activity,P
22938,86,2000010,positive regulation of protein localization to cell surface,P
22939,86,1934,positive regulation of protein phosphorylation,P
22940,86,51222,positive regulation of protein transport,P
22941,86,51091,positive regulation of sequence-specific DNA binding transcription factor activity,P
22942,86,48661,positive regulation of smooth muscle cell proliferation,P
22943,86,1901671,positive regulation of superoxide dismutase activity,P
22944,86,45944,positive regulation of transcription from RNA polymerase II promoter,P
22945,86,45944,positive regulation of transcription from RNA polymerase II promoter,P
22946,86,45893,"positive regulation of transcription, DNA-templated",P
22947,86,45994,positive regulation of translational initiation by iron,P
22948,86,1904707,positive regulation of vascular smooth muscle cell proliferation,P
22949,86,60557,positive regulation of vitamin D biosynthetic process,P
22950,86,60,"protein import into nucleus, translocation",P
22951,86,43491,protein kinase B signaling,P
22952,86,32800,receptor biosynthetic process,P
22953,86,43122,regulation of I-kappaB kinase/NF-kappaB signaling,P
22954,86,60693,regulation of branching involved in salivary gland morphogenesis,P
22955,86,1903140,regulation of establishment of endothelial barrier,P
22956,86,51023,regulation of immunoglobulin secretion,P
22957,86,50796,regulation of insulin secretion,P
22958,86,10803,regulation of tumor necrosis factor-mediated signaling pathway,P
22959,86,51384,response to glucocorticoid,P
22960,86,9651,response to salt stress,P
22961,86,9615,response to virus,P
22962,86,30730,sequestering of triglyceride,P
22963,86,33209,tumor necrosis factor-mediated signaling pathway,P
22964,86,33209,tumor necrosis factor-mediated signaling pathway,P
22965,86,9986,cell surface,C
22966,86,9897,external side of plasma membrane,C
22967,86,5576,extracellular region,C
22968,86,5615,extracellular space,C
22969,86,5887,integral component of plasma membrane,C
22970,86,45121,membrane raft,C
22971,86,1891,phagocytic cup,C
22972,86,5886,plasma membrane,C
22973,86,55037,recycling endosome,C
22995,85,1903755,positive regulation of SUMO transferase activity,P
22996,85,16925,protein sumoylation,P
22997,85,16925,protein sumoylation,P
22998,85,16925,protein sumoylation,P
22999,85,6511,ubiquitin-dependent protein catabolic process,P
23000,85,16032,viral process,P
23001,85,16605,PML body,C
23002,85,5737,cytoplasm,C
23003,85,5829,cytosol,C
23004,85,5635,nuclear envelope,C
23005,85,5654,nucleoplasm,C
23006,85,5634,nucleus,C
23007,85,1990356,sumoylated E2 ligase complex,C
23008,85,795,synaptonemal complex,C
23009,85,1990234,transferase complex,C
23036,84,72711,cellular response to hydroxyurea,P
23037,84,71479,cellular response to ionizing radiation,P
23038,84,70192,chromosome organization involved in meiotic cell cycle,P
23039,84,724,double-strand break repair via homologous recombination,P
23040,84,724,double-strand break repair via homologous recombination,P
23041,84,724,double-strand break repair via homologous recombination,P
23042,84,36297,interstrand cross-link repair,P
23043,84,7126,meiotic nuclear division,P
23044,84,6312,mitotic recombination,P
23045,84,1990426,mitotic recombination-dependent replication fork processing,P
23046,84,51106,positive regulation of DNA ligation,P
23047,84,51260,protein homooligomerization,P
23048,84,7131,reciprocal meiotic recombination,P
23049,84,10569,regulation of double-strand break repair via homologous recombination,P
23050,84,1932,regulation of protein phosphorylation,P
23051,84,31297,replication fork processing,P
23052,84,31297,replication fork processing,P
23053,84,1990414,replication-born double-strand break repair via sister chromatid exchange,P
23054,84,10165,response to X-ray,P
23055,84,42493,response to drug,P
23056,84,1904631,response to glucoside,P
23057,84,9636,response to toxic substance,P
23058,84,732,strand displacement,P
23059,84,42148,strand invasion,P
23060,84,722,telomere maintenance via recombination,P
23061,84,10833,telomere maintenance via telomere lengthening,P
23062,84,16605,PML body,C
23063,84,785,chromatin,C
23064,84,793,condensed chromosome,C
23065,84,794,condensed nuclear chromosome,C
23066,84,794,condensed nuclear chromosome,C
23067,84,5737,cytoplasm,C
23068,84,800,lateral element,C
23069,84,5815,microtubule organizing center,C
23070,84,5759,mitochondrial matrix,C
23071,84,5739,mitochondrion,C
23072,84,790,nuclear chromatin,C
23073,84,228,nuclear chromosome,C
23074,84,784,"nuclear chromosome, telomeric region",C
23075,84,5730,nucleolus,C
23076,84,5654,nucleoplasm,C
23077,84,5634,nucleus,C
23078,84,5634,nucleus,C
23079,84,48471,perinuclear region of cytoplasm,C
23080,84,35861,site of double-strand break,C
23097,83,16925,protein sumoylation,P
23098,83,42493,response to drug,P
23099,83,16032,viral process,P
23100,83,932,P-body,C
23101,83,228,nuclear chromosome,C
23102,83,5730,nucleolus,C
23103,83,5654,nucleoplasm,C
23104,83,5654,nucleoplasm,C
23105,83,5634,nucleus,C
23106,83,43204,perikaryon,C
23107,83,31298,replication fork protection complex,C
23149,82,51092,positive regulation of NF-kappaB transcription factor activity,P
23150,82,90263,positive regulation of canonical Wnt signaling pathway,P
23151,82,1900127,positive regulation of hyaluronan biosynthetic process,P
23152,82,10884,positive regulation of lipid storage,P
23153,82,10744,positive regulation of macrophage derived foam cell differentiation,P
23154,82,2000630,positive regulation of miRNA metabolic process,P
23155,82,45944,positive regulation of transcription from RNA polymerase II promoter,P
23156,82,45944,positive regulation of transcription from RNA polymerase II promoter,P
23157,82,45893,"positive regulation of transcription, DNA-templated",P
23158,82,45893,"positive regulation of transcription, DNA-templated",P
23159,82,45893,"positive regulation of transcription, DNA-templated",P
23160,82,32481,positive regulation of type I interferon production,P
23161,82,35994,response to muscle stretch,P
23162,82,2223,stimulatory C-type lectin receptor signaling pathway,P
23163,82,51403,stress-activated MAPK cascade,P
23164,82,6366,transcription from RNA polymerase II promoter,P
23165,82,33256,I-kappaB/NF-kappaB complex,C
23166,82,5737,cytoplasm,C
23167,82,5829,cytosol,C
23168,82,5829,cytosol,C
23169,82,5739,mitochondrion,C
23170,82,5654,nucleoplasm,C
23171,82,5654,nucleoplasm,C
23172,82,5634,nucleus,C
23190,81,16925,protein sumoylation,P
23191,81,712,resolution of meiotic recombination intermediates,P
23192,81,819,sister chromatid segregation,P
23193,81,9330,DNA topoisomerase complex (ATP-hydrolyzing),C
23194,81,5737,cytoplasm,C
23195,81,5829,cytosol,C
23196,81,792,heterochromatin,C
23197,81,9295,nucleoid,C
23198,81,5730,nucleolus,C
23199,81,5654,nucleoplasm,C
23200,81,5654,nucleoplasm,C
23201,81,5634,nucleus,C
23231,80,45944,positive regulation of transcription from RNA polymerase II promoter,P
23232,80,45070,positive regulation of viral genome replication,P
23233,80,16925,protein sumoylation,P
23234,80,42752,regulation of circadian rhythm,P
23235,80,712,resolution of meiotic recombination intermediates,P
23236,80,48511,rhythmic process,P
23237,80,819,sister chromatid segregation,P
23238,80,9330,DNA topoisomerase complex (ATP-hydrolyzing),C
23239,80,5814,centriole,C
23240,80,793,condensed chromosome,C
23241,80,228,nuclear chromosome,C
23242,80,9295,nucleoid,C
23243,80,5730,nucleolus,C
23244,80,5730,nucleolus,C
23245,80,5654,nucleoplasm,C
23246,80,5654,nucleoplasm,C
23247,80,5634,nucleus,C
23248,80,43234,protein complex,C
23249,80,19035,viral integration complex,C
23277,79,33600,negative regulation of mammary gland epithelial cell proliferation,P
23278,79,6289,nucleotide-excision repair,P
23279,79,1556,oocyte maturation,P
23280,79,45931,positive regulation of mitotic cell cycle,P
23281,79,45893,"positive regulation of transcription, DNA-templated",P
23282,79,32465,regulation of cytokinesis,P
23283,79,48478,replication fork protection,P
23284,79,10225,response to UV-C,P
23285,79,10165,response to X-ray,P
23286,79,10332,response to gamma radiation,P
23287,79,7283,spermatogenesis,P
23288,79,732,strand displacement,P
23289,79,722,telomere maintenance via recombination,P
23290,79,33593,BRCA2-MAGE-D1 complex,C
23291,79,5813,centrosome,C
23292,79,5737,cytoplasm,C
23293,79,800,lateral element,C
23294,79,784,"nuclear chromosome, telomeric region",C
23295,79,5654,nucleoplasm,C
23296,79,5654,nucleoplasm,C
23297,79,5634,nucleus,C
23298,79,43234,protein complex,C
23299,79,30141,secretory granule,C
23338,78,70301,cellular response to hydrogen peroxide,P
23339,78,71222,cellular response to lipopolysaccharide,P
23340,78,34599,cellular response to oxidative stress,P
23341,78,21587,cerebellum morphogenesis,P
23342,78,48668,collateral sprouting,P
23343,78,7173,epidermal growth factor receptor signaling pathway,P
23344,78,45184,establishment of protein localization,P
23345,78,45087,innate immune response,P
23346,78,8630,intrinsic apoptotic signaling pathway in response to DNA damage,P
23347,78,30035,microspike assembly,P
23348,78,6298,mismatch repair,P
23349,78,51882,mitochondrial depolarization,P
23350,78,7067,mitotic nuclear division,P
23351,78,30514,negative regulation of BMP signaling pathway,P
23352,78,70373,negative regulation of ERK1 and ERK2 cascade,P
23353,78,43124,negative regulation of I-kappaB kinase/NF-kappaB signaling,P
23354,78,22408,negative regulation of cell-cell adhesion,P
23355,78,2000773,negative regulation of cellular senescence,P
23356,78,2000352,negative regulation of endothelial cell apoptotic process,P
23357,78,45930,negative regulation of mitotic cell cycle,P
23358,78,1900275,negative regulation of phospholipase C activity,P
23359,78,71901,negative regulation of protein serine/threonine kinase activity,P
23360,78,51444,negative regulation of ubiquitin-protein transferase activity,P
23361,78,51444,negative regulation of ubiquitin-protein transferase activity,P
23362,78,50885,neuromuscular process controlling balance,P
23363,78,38083,peptidyl-tyrosine autophosphorylation,P
23364,78,38083,peptidyl-tyrosine autophosphorylation,P
23365,78,18108,peptidyl-tyrosine phosphorylation,P
23366,78,18108,peptidyl-tyrosine phosphorylation,P
23367,78,18108,peptidyl-tyrosine phosphorylation,P
23368,78,35791,platelet-derived growth factor receptor-beta signaling pathway,P
23369,78,70374,positive regulation of ERK1 and ERK2 cascade,P
23370,78,43123,positive regulation of I-kappaB kinase/NF-kappaB signaling,P
23371,78,2000096,"positive regulation of Wnt signaling pathway, planar cell polarity pathway",P
23372,78,1904531,positive regulation of actin filament binding,P
23373,78,43065,positive regulation of apoptotic process,P
23374,78,7204,positive regulation of cytosolic calcium ion concentration,P
23375,78,1902715,positive regulation of interferon-gamma secretion,P
23376,78,1900042,positive regulation of interleukin-2 secretion,P
23377,78,1904528,positive regulation of microtubule binding,P
23378,78,45931,positive regulation of mitotic cell cycle,P
23379,78,51149,positive regulation of muscle cell differentiation,P
23380,78,1901216,positive regulation of neuron death,P
23381,78,33690,positive regulation of osteoblast proliferation,P
23382,78,51353,positive regulation of oxidoreductase activity,P
23383,78,50731,positive regulation of peptidyl-tyrosine phosphorylation,P
23384,78,1934,positive regulation of protein phosphorylation,P
23385,78,51281,positive regulation of release of sequestered calcium ion into cytosol,P
23386,78,46777,protein autophosphorylation,P
23387,78,32956,regulation of actin cytoskeleton organization,P
23388,78,2000249,regulation of actin cytoskeleton reorganization,P
23389,78,10506,regulation of autophagy,P
23390,78,30516,regulation of axon extension,P
23391,78,30155,regulation of cell adhesion,P
23392,78,2000145,regulation of cell motility,P
23393,78,42127,regulation of cell proliferation,P
23394,78,30100,regulation of endocytosis,P
23395,78,1903053,regulation of extracellular matrix organization,P
23396,78,31113,regulation of microtubule polymerization,P
23397,78,2001020,regulation of response to DNA damage stimulus,P
23398,78,6355,"regulation of transcription, DNA-templated",P
23399,78,6979,response to oxidative stress,P
23400,78,42770,signal transduction in response to DNA damage,P
23401,78,48536,spleen development,P
23402,78,34446,substrate adhesion-dependent cell spreading,P
23403,78,48538,thymus development,P
23404,78,2333,transitional one stage B cell differentiation,P
23405,78,15629,actin cytoskeleton,C
23406,78,31252,cell leading edge,C
23407,78,5737,cytoplasm,C
23408,78,5829,cytosol,C
23409,78,5829,cytosol,C
23410,78,31234,extrinsic component of cytoplasmic side of plasma membrane,C
23411,78,5739,mitochondrion,C
23412,78,31965,nuclear membrane,C
23413,78,5730,nucleolus,C
23414,78,5654,nucleoplasm,C
23415,78,5654,nucleoplasm,C
23416,78,5634,nucleus,C
23417,78,5634,nucleus,C
23418,78,5634,nucleus,C
23419,78,48471,perinuclear region of cytoplasm,C
23505,77,33138,positive regulation of peptidyl-serine phosphorylation,P
23506,77,1900086,positive regulation of peptidyl-tyrosine autophosphorylation,P
23507,77,50731,positive regulation of peptidyl-tyrosine phosphorylation,P
23508,77,50927,positive regulation of positive chemotaxis,P
23509,77,31954,positive regulation of protein autophosphorylation,P
23510,77,31334,positive regulation of protein complex assembly,P
23511,77,90037,positive regulation of protein kinase C signaling,P
23512,77,1903572,positive regulation of protein kinase D signaling,P
23513,77,1934,positive regulation of protein phosphorylation,P
23514,77,2092,positive regulation of receptor internalization,P
23515,77,1902336,positive regulation of retinal ganglion cell axon guidance,P
23516,77,45944,positive regulation of transcription from RNA polymerase II promoter,P
23517,77,45944,positive regulation of transcription from RNA polymerase II promoter,P
23518,77,61419,positive regulation of transcription from RNA polymerase II promoter in response to hypoxia,P
23519,77,42517,positive regulation of tyrosine phosphorylation of Stat3 protein,P
23520,77,30949,positive regulation of vascular endothelial growth factor receptor signaling pathway,P
23521,77,31077,post-embryonic camera-type eye development,P
23522,77,60319,primitive erythrocyte differentiation,P
23523,77,30823,regulation of cGMP metabolic process,P
23524,77,8360,regulation of cell shape,P
23525,77,90259,regulation of retinal ganglion cell axon guidance,P
23526,77,61418,regulation of transcription from RNA polymerase II promoter in response to hypoxia,P
23527,77,1666,response to hypoxia,P
23528,77,43129,surfactant homeostasis,P
23529,77,35148,tube formation,P
23530,77,48010,vascular endothelial growth factor receptor signaling pathway,P
23531,77,48010,vascular endothelial growth factor receptor signaling pathway,P
23532,77,1570,vasculogenesis,P
23533,77,9986,cell surface,C
23534,77,5737,cytoplasm,C
23535,77,5576,extracellular region,C
23536,77,5615,extracellular space,C
23537,77,5615,extracellular space,C
23538,77,16020,membrane,C
23539,77,31093,platelet alpha granule lumen,C
23540,77,5578,proteinaceous extracellular matrix,C
23541,77,30141,secretory granule,C
23580,76,2931,response to ischemia,P
23581,76,35914,skeletal muscle cell differentiation,P
23582,76,6366,transcription from RNA polymerase II promoter,P
23583,76,60337,type I interferon signaling pathway,P
23584,76,5737,cytoplasm,C
23585,76,5737,cytoplasm,C
23586,76,5654,nucleoplasm,C
23587,76,5654,nucleoplasm,C
23588,76,5634,nucleus,C
23589,76,5634,nucleus,C
23603,75,7059,chromosome segregation,P
23604,75,16569,covalent chromatin modification,P
23605,75,43402,glucocorticoid mediated signaling pathway,P
23606,75,42921,glucocorticoid receptor signaling pathway,P
23607,75,7067,mitotic nuclear division,P
23608,75,45944,positive regulation of transcription from RNA polymerase II promoter,P
23609,75,6355,"regulation of transcription, DNA-templated",P
23610,75,7165,signal transduction,P
23611,75,6366,transcription from RNA polymerase II promoter,P
23612,75,6367,transcription initiation from RNA polymerase II promoter,P
23613,75,6351,"transcription, DNA-templated",P
23614,75,5737,cytoplasm,C
23615,75,5815,microtubule organizing center,C
23616,75,5759,mitochondrial matrix,C
23617,75,5654,nucleoplasm,C
23618,75,5654,nucleoplasm,C
23619,75,5634,nucleus,C
23620,75,43234,protein complex,C
23621,75,5819,spindle,C
23658,74,9409,response to cold,P
23659,74,9408,response to heat,P
23660,74,6986,response to unfolded protein,P
23661,74,7165,signal transduction,P
23662,74,48010,vascular endothelial growth factor receptor signaling pathway,P
23663,74,5737,cytoplasm,C
23664,74,5737,cytoplasm,C
23665,74,5829,cytosol,C
23666,74,5829,cytosol,C
23667,74,71682,endocytic vesicle lumen,C
23668,74,70062,extracellular exosome,C
23669,74,5576,extracellular region,C
23670,74,43202,lysosomal lumen,C
23671,74,42470,melanosome,C
23672,74,16020,membrane,C
23673,74,43209,myelin sheath,C
23674,74,5654,nucleoplasm,C
23675,74,5654,nucleoplasm,C
23676,74,5634,nucleus,C
23677,74,5634,nucleus,C
23678,74,5886,plasma membrane,C
23679,74,32587,ruffle membrane,C
23697,73,43085,positive regulation of catalytic activity,P
23698,73,43568,positive regulation of insulin-like growth factor receptor signaling pathway,P
23699,73,45663,positive regulation of myoblast differentiation,P
23700,73,6468,protein phosphorylation,P
23701,73,42981,regulation of apoptotic process,P
23702,73,1558,regulation of cell growth,P
23703,73,10906,regulation of glucose metabolic process,P
23704,73,43567,regulation of insulin-like growth factor receptor signaling pathway,P
23705,73,44342,type B pancreatic cell proliferation,P
23706,73,70062,extracellular exosome,C
23707,73,5576,extracellular region,C
23708,73,5576,extracellular region,C
23709,73,5615,extracellular space,C
23710,73,16942,insulin-like growth factor binding protein complex,C
23711,73,42567,insulin-like growth factor ternary complex,C
23712,73,5634,nucleus,C
23723,72,6287,"base-excision repair, gap-filling",P
23724,72,71333,cellular response to glucose stimulus,P
23725,72,6264,mitochondrial DNA replication,P
23726,72,90305,nucleic acid phosphodiester bond hydrolysis,P
23727,72,10332,response to gamma radiation,P
23728,72,55093,response to hyperoxia,P
23729,72,9416,response to light stimulus,P
23730,72,70062,extracellular exosome,C
23731,72,5760,gamma DNA polymerase complex,C
23732,72,42645,mitochondrial nucleoid,C
23733,72,5739,mitochondrion,C
23734,72,43234,protein complex,C
23735,72,43195,terminal bouton,C
23764,71,6919,activation of cysteine-type endopeptidase activity involved in apoptotic process,P
23765,71,70842,aggresome assembly,P
23766,71,97352,autophagosome maturation,P
23767,71,6914,autophagy,P
23768,71,6974,cellular response to DNA damage stimulus,P
23769,71,6302,double-strand break repair,P
23770,71,30968,endoplasmic reticulum unfolded protein response,P
23771,71,70987,error-free translesion synthesis,P
23772,71,45184,establishment of protein localization,P
23773,71,72389,flavin adenine dinucleotide catabolic process,P
23774,71,2001171,positive regulation of ATP biosynthetic process,P
23775,71,1903007,positive regulation of Lys63-specific deubiquitinase activity,P
23776,71,10918,positive regulation of mitochondrial membrane potential,P
23777,71,1903862,positive regulation of oxidative phosphorylation,P
23778,71,32436,positive regulation of proteasomal ubiquitin-dependent protein catabolic process,P
23779,71,1903006,positive regulation of protein K63-linked deubiquitination,P
23780,71,45732,positive regulation of protein catabolic process,P
23781,71,31334,positive regulation of protein complex assembly,P
23782,71,2000158,positive regulation of ubiquitin-specific protease activity,P
23783,71,43161,proteasome-mediated ubiquitin-dependent protein catabolic process,P
23784,71,43161,proteasome-mediated ubiquitin-dependent protein catabolic process,P
23785,71,18279,protein N-linked glycosylation via asparagine,P
23786,71,34214,protein hexamerization,P
23787,71,51260,protein homooligomerization,P
23788,71,16567,protein ubiquitination,P
23789,71,16567,protein ubiquitination,P
23790,71,1903715,regulation of aerobic respiration,P
23791,71,42981,regulation of apoptotic process,P
23792,71,30970,"retrograde protein transport, ER to cytosol",P
23793,71,30970,"retrograde protein transport, ER to cytosol",P
23794,71,19985,translesion synthesis,P
23795,71,19079,viral genome replication,P
23796,71,36513,Derlin-1 retrotranslocation complex,C
23797,71,34098,VCP-NPL4-UFD1 AAA ATPase complex,C
23798,71,34098,VCP-NPL4-UFD1 AAA ATPase complex,C
23799,71,1990730,VCP-NSFL1C complex,C
23800,71,5737,cytoplasm,C
23801,71,5829,cytosol,C
23802,71,5829,cytosol,C
23803,71,5783,endoplasmic reticulum,C
23804,71,5789,endoplasmic reticulum membrane,C
23805,71,70062,extracellular exosome,C
23806,71,43231,intracellular membrane-bounded organelle,C
23807,71,5811,lipid particle,C
23808,71,43209,myelin sheath,C
23809,71,5654,nucleoplasm,C
23810,71,5654,nucleoplasm,C
23811,71,5634,nucleus,C
23812,71,5634,nucleus,C
23813,71,48471,perinuclear region of cytoplasm,C
23814,71,502,proteasome complex,C
23815,71,35861,site of double-strand break,C
23837,70,43065,positive regulation of apoptotic process,P
23838,70,8284,positive regulation of cell proliferation,P
23839,70,8360,regulation of cell shape,P
23840,70,48168,regulation of neuronal synaptic plasticity,P
23841,70,51384,response to glucocorticoid,P
23842,70,51597,response to methylmercury,P
23843,70,5737,cytoplasm,C
23844,70,5737,cytoplasm,C
23845,70,5576,extracellular region,C
23846,70,5615,extracellular space,C
23847,70,43231,intracellular membrane-bounded organelle,C
23848,70,43025,neuronal cell body,C
23849,70,5634,nucleus,C
23850,70,48471,perinuclear region of cytoplasm,C
23851,70,1726,ruffle,C
23942,69,1900740,positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway,P
23943,69,48743,positive regulation of skeletal muscle fiber development,P
23944,69,14911,positive regulation of smooth muscle cell migration,P
23945,69,9791,post-embryonic development,P
23946,69,6470,protein dephosphorylation,P
23947,69,209,protein polyubiquitination,P
23948,69,72593,reactive oxygen species metabolic process,P
23949,69,51924,regulation of calcium ion transport,P
23950,69,1952,regulation of cell-matrix adhesion,P
23951,69,10468,regulation of gene expression,P
23952,69,10559,regulation of glycoprotein biosynthetic process,P
23953,69,46902,regulation of mitochondrial membrane permeability,P
23954,69,51881,regulation of mitochondrial membrane potential,P
23955,69,6808,regulation of nitrogen utilization,P
23956,69,43497,regulation of protein heterodimerization activity,P
23957,69,43496,regulation of protein homodimerization activity,P
23958,69,31647,regulation of protein stability,P
23959,69,22898,regulation of transmembrane transporter activity,P
23960,69,45069,regulation of viral genome replication,P
23961,69,1836,release of cytochrome c from mitochondria,P
23962,69,1836,release of cytochrome c from mitochondria,P
23963,69,3014,renal system process,P
23964,69,10224,response to UV-B,P
23965,69,34097,response to cytokine,P
23966,69,42493,response to drug,P
23967,69,42493,response to drug,P
23968,69,10332,response to gamma radiation,P
23969,69,51384,response to glucocorticoid,P
23970,69,42542,response to hydrogen peroxide,P
23971,69,10039,response to iron ion,P
23972,69,2931,response to ischemia,P
23973,69,35094,response to nicotine,P
23974,69,9314,response to radiation,P
23975,69,9636,response to toxic substance,P
23976,69,48536,spleen development,P
23977,69,48538,thymus development,P
23978,69,55085,transmembrane transport,P
23979,69,5737,cytoplasm,C
23980,69,5829,cytosol,C
23981,69,5783,endoplasmic reticulum,C
23982,69,5789,endoplasmic reticulum membrane,C
23983,69,16020,membrane,C
23984,69,5741,mitochondrial outer membrane,C
23985,69,5741,mitochondrial outer membrane,C
23986,69,5739,mitochondrion,C
23987,69,43209,myelin sheath,C
23988,69,31965,nuclear membrane,C
23989,69,5634,nucleus,C
23990,69,46930,pore complex,C
24024,68,16925,protein sumoylation,P
24025,68,79,regulation of cyclin-dependent protein serine/threonine kinase activity,P
24026,68,1901796,regulation of signal transduction by p53 class mediator,P
24027,68,31297,replication fork processing,P
24028,68,48478,replication fork protection,P
24029,68,10165,response to X-ray,P
24030,68,732,strand displacement,P
24031,68,16605,PML body,C
24032,68,16605,PML body,C
24033,68,781,"chromosome, telomeric region",C
24034,68,5737,cytoplasm,C
24035,68,5737,cytoplasm,C
24036,68,800,lateral element,C
24037,68,228,nuclear chromosome,C
24038,68,16363,nuclear matrix,C
24039,68,5730,nucleolus,C
24040,68,5654,nucleoplasm,C
24041,68,5634,nucleus,C
24064,67,6296,"nucleotide-excision repair, DNA incision, 5'-to lesion",P
24065,67,6294,"nucleotide-excision repair, preincision complex assembly",P
24066,67,6293,"nucleotide-excision repair, preincision complex stabilization",P
24067,67,16925,protein sumoylation,P
24068,67,1900034,regulation of cellular response to heat,P
24069,67,1901796,regulation of signal transduction by p53 class mediator,P
24070,67,723,telomere maintenance,P
24071,67,722,telomere maintenance via recombination,P
24072,67,6283,transcription-coupled nucleotide-excision repair,P
24073,67,19985,translesion synthesis,P
24074,67,5662,DNA replication factor A complex,C
24075,67,5662,DNA replication factor A complex,C
24076,67,16605,PML body,C
24077,67,16605,PML body,C
24078,67,784,"nuclear chromosome, telomeric region",C
24079,67,5654,nucleoplasm,C
24080,67,5654,nucleoplasm,C
24081,67,5634,nucleus,C
24133,66,45742,positive regulation of epidermal growth factor receptor signaling pathway,P
24134,66,1902255,positive regulation of intrinsic apoptotic signaling pathway by p53 class mediator,P
24135,66,1902527,positive regulation of protein monoubiquitination,P
24136,66,31398,positive regulation of protein ubiquitination,P
24137,66,45944,positive regulation of transcription from RNA polymerase II promoter,P
24138,66,51437,positive regulation of ubiquitin-protein ligase activity involved in regulation of mitotic cell cycle transition,P
24139,66,43161,proteasome-mediated ubiquitin-dependent protein catabolic process,P
24140,66,209,protein polyubiquitination,P
24141,66,42787,protein ubiquitination involved in ubiquitin-dependent protein catabolic process,P
24142,66,43488,regulation of mRNA stability,P
24143,66,51881,regulation of mitochondrial membrane potential,P
24144,66,10939,regulation of necrotic cell death,P
24145,66,1901214,regulation of neuron death,P
24146,66,61136,regulation of proteasomal protein catabolic process,P
24147,66,1901796,regulation of signal transduction by p53 class mediator,P
24148,66,61418,regulation of transcription from RNA polymerase II promoter in response to hypoxia,P
24149,66,10803,regulation of tumor necrosis factor-mediated signaling pathway,P
24150,66,32479,regulation of type I interferon production,P
24151,66,2223,stimulatory C-type lectin receptor signaling pathway,P
24152,66,51403,stress-activated MAPK cascade,P
24153,66,6283,transcription-coupled nucleotide-excision repair,P
24154,66,7179,transforming growth factor beta receptor signaling pathway,P
24155,66,19985,translesion synthesis,P
24156,66,33209,tumor necrosis factor-mediated signaling pathway,P
24157,66,19058,viral life cycle,P
24158,66,19068,virion assembly,P
24159,66,5829,cytosol,C
24160,66,30666,endocytic vesicle membrane,C
24161,66,10008,endosome membrane,C
24162,66,70062,extracellular exosome,C
24163,66,5615,extracellular space,C
24164,66,5739,mitochondrion,C
24165,66,43005,neuron projection,C
24166,66,43025,neuronal cell body,C
24167,66,5654,nucleoplasm,C
24168,66,5634,nucleus,C
24169,66,5886,plasma membrane,C
24239,65,45821,positive regulation of glycolytic process,P
24240,65,46886,positive regulation of hormone biosynthetic process,P
24241,65,35774,positive regulation of insulin secretion involved in cellular response to glucose stimulus,P
24242,65,16239,positive regulation of macroautophagy,P
24243,65,1903599,positive regulation of mitophagy,P
24244,65,2052,positive regulation of neuroblast proliferation,P
24245,65,51000,positive regulation of nitric-oxide synthase activity,P
24246,65,1902895,positive regulation of pri-miRNA transcription from RNA polymerase II promoter,P
24247,65,10870,positive regulation of receptor biosynthetic process,P
24248,65,45944,positive regulation of transcription from RNA polymerase II promoter,P
24249,65,45944,positive regulation of transcription from RNA polymerase II promoter,P
24250,65,61419,positive regulation of transcription from RNA polymerase II promoter in response to hypoxia,P
24251,65,61419,positive regulation of transcription from RNA polymerase II promoter in response to hypoxia,P
24252,65,45893,"positive regulation of transcription, DNA-templated",P
24253,65,45893,"positive regulation of transcription, DNA-templated",P
24254,65,10575,positive regulation of vascular endothelial growth factor production,P
24255,65,10575,positive regulation of vascular endothelial growth factor production,P
24256,65,30949,positive regulation of vascular endothelial growth factor receptor signaling pathway,P
24257,65,1903715,regulation of aerobic respiration,P
24258,65,10468,regulation of gene expression,P
24259,65,61418,regulation of transcription from RNA polymerase II promoter in response to hypoxia,P
24260,65,43619,regulation of transcription from RNA polymerase II promoter in response to oxidative stress,P
24261,65,6355,"regulation of transcription, DNA-templated",P
24262,65,32909,regulation of transforming growth factor beta2 production,P
24263,65,1666,response to hypoxia,P
24264,65,1666,response to hypoxia,P
24265,65,14850,response to muscle activity,P
24266,65,61298,retina vasculature development in camera-type eye,P
24267,65,7165,signal transduction,P
24268,65,6366,transcription from RNA polymerase II promoter,P
24269,65,10573,vascular endothelial growth factor production,P
24270,65,8542,visual learning,P
24271,65,90575,RNA polymerase II transcription factor complex,C
24272,65,1904115,axon cytoplasm,C
24273,65,5737,cytoplasm,C
24274,65,5829,cytosol,C
24275,65,5829,cytosol,C
24276,65,31514,motile cilium,C
24277,65,16607,nuclear speck,C
24278,65,5654,nucleoplasm,C
24279,65,5634,nucleus,C
24280,65,5667,transcription factor complex,C
24316,64,6473,protein acetylation,P
24317,64,6461,protein complex assembly,P
24318,64,42981,regulation of apoptotic process,P
24319,64,1900034,regulation of cellular response to heat,P
24320,64,8589,regulation of smoothened signaling pathway,P
24321,64,61418,regulation of transcription from RNA polymerase II promoter in response to hypoxia,P
24322,64,6355,"regulation of transcription, DNA-templated",P
24323,64,6355,"regulation of transcription, DNA-templated",P
24324,64,1666,response to hypoxia,P
24325,64,48511,rhythmic process,P
24326,64,7165,signal transduction,P
24327,64,2223,stimulatory C-type lectin receptor signaling pathway,P
24328,64,6367,transcription initiation from RNA polymerase II promoter,P
24329,64,16032,viral process,P
24330,64,5737,cytoplasm,C
24331,64,123,histone acetyltransferase complex,C
24332,64,16604,nuclear body,C
24333,64,790,nuclear chromatin,C
24334,64,5654,nucleoplasm,C
24335,64,5654,nucleoplasm,C
24336,64,5634,nucleus,C
24337,64,5634,nucleus,C
24413,63,7270,neuron-neuron synaptic transmission,P
24414,63,35335,peptidyl-tyrosine dephosphorylation,P
24415,63,6661,phosphatidylinositol biosynthetic process,P
24416,63,46856,phosphatidylinositol dephosphorylation,P
24417,63,46856,phosphatidylinositol dephosphorylation,P
24418,63,48015,phosphatidylinositol-mediated signaling,P
24419,63,48008,platelet-derived growth factor receptor signaling pathway,P
24420,63,70374,positive regulation of ERK1 and ERK2 cascade,P
24421,63,1903984,positive regulation of TRAIL-activated apoptotic signaling pathway,P
24422,63,8284,positive regulation of cell proliferation,P
24423,63,2000463,positive regulation of excitatory postsynaptic potential,P
24424,63,2000060,positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process,P
24425,63,51091,positive regulation of sequence-specific DNA binding transcription factor activity,P
24426,63,1904668,positive regulation of ubiquitin protein ligase activity,P
24427,63,97107,postsynaptic density assembly,P
24428,63,60134,prepulse inhibition,P
24429,63,97105,presynaptic membrane assembly,P
24430,63,60736,prostate gland growth,P
24431,63,6470,protein dephosphorylation,P
24432,63,6470,protein dephosphorylation,P
24433,63,43491,protein kinase B signaling,P
24434,63,50821,protein stabilization,P
24435,63,2902,regulation of B cell apoptotic process,P
24436,63,32535,regulation of cellular component size,P
24437,63,79,regulation of cyclin-dependent protein serine/threonine kinase activity,P
24438,63,33032,regulation of myeloid cell apoptotic process,P
24439,63,10975,regulation of neuron projection development,P
24440,63,31647,regulation of protein stability,P
24441,63,32228,"regulation of synaptic transmission, GABAergic",P
24442,63,33198,response to ATP,P
24443,63,46685,response to arsenic-containing substance,P
24444,63,42493,response to drug,P
24445,63,32355,response to estradiol,P
24446,63,45471,response to ethanol,P
24447,63,9749,response to glucose,P
24448,63,7584,response to nutrient,P
24449,63,10043,response to zinc ion,P
24450,63,60024,rhythmic synaptic transmission,P
24451,63,35176,social behavior,P
24452,63,7416,synapse assembly,P
24453,63,60074,synapse maturation,P
24454,63,16605,PML body,C
24455,63,43220,Schmidt-Lanterman incisure,C
24456,63,16324,apical plasma membrane,C
24457,63,42995,cell projection,C
24458,63,5737,cytoplasm,C
24459,63,5737,cytoplasm,C
24460,63,9898,cytoplasmic side of plasma membrane,C
24461,63,5829,cytosol,C
24462,63,43197,dendritic spine,C
24463,63,5576,extracellular region,C
24464,63,5739,mitochondrion,C
24465,63,35749,myelin sheath adaxonal region,C
24466,63,43005,neuron projection,C
24467,63,5654,nucleoplasm,C
24468,63,5634,nucleus,C
24469,63,5886,plasma membrane,C
24470,63,45211,postsynaptic membrane,C
24489,62,32480,negative regulation of type I interferon production,P
24490,62,30182,neuron differentiation,P
24491,62,43547,positive regulation of GTPase activity,P
24492,62,90263,positive regulation of canonical Wnt signaling pathway,P
24493,62,61051,positive regulation of cell growth involved in cardiac muscle cell development,P
24494,62,43525,positive regulation of neuron apoptotic process,P
24495,62,35307,positive regulation of protein dephosphorylation,P
24496,62,1934,positive regulation of protein phosphorylation,P
24497,62,45944,positive regulation of transcription from RNA polymerase II promoter,P
24498,62,51443,positive regulation of ubiquitin-protein transferase activity,P
24499,62,413,protein peptidyl-prolyl isomerization,P
24500,62,50821,protein stabilization,P
24501,62,50821,protein stabilization,P
24502,62,32465,regulation of cytokinesis,P
24503,62,32465,regulation of cytokinesis,P
24504,62,7088,regulation of mitotic nuclear division,P
24505,62,60393,regulation of pathway-restricted SMAD protein phosphorylation,P
24506,62,1900180,regulation of protein localization to nucleus,P
24507,62,1901796,regulation of signal transduction by p53 class mediator,P
24508,62,50808,synapse organization,P
24509,62,5829,cytosol,C
24510,62,30496,midbody,C
24511,62,5739,mitochondrion,C
24512,62,43005,neuron projection,C
24513,62,16607,nuclear speck,C
24514,62,5654,nucleoplasm,C
24515,62,5634,nucleus,C
24558,61,45739,positive regulation of DNA repair,P
24559,61,45766,positive regulation of angiogenesis,P
24560,61,71158,positive regulation of cell cycle arrest,P
24561,61,10628,positive regulation of gene expression,P
24562,61,51571,positive regulation of histone H3-K4 methylation,P
24563,61,2000617,positive regulation of histone H3-K9 acetylation,P
24564,61,51574,positive regulation of histone H3-K9 methylation,P
24565,61,2000620,positive regulation of histone H4-K16 acetylation,P
24566,61,70512,positive regulation of histone H4-K20 methylation,P
24567,61,35066,positive regulation of histone acetylation,P
24568,61,31398,positive regulation of protein ubiquitination,P
24569,61,45944,positive regulation of transcription from RNA polymerase II promoter,P
24570,61,45944,positive regulation of transcription from RNA polymerase II promoter,P
24571,61,45893,"positive regulation of transcription, DNA-templated",P
24572,61,45893,"positive regulation of transcription, DNA-templated",P
24573,61,45893,"positive regulation of transcription, DNA-templated",P
24574,61,10575,positive regulation of vascular endothelial growth factor production,P
24575,61,6301,postreplication repair,P
24576,61,85020,protein K6-linked ubiquitination,P
24577,61,51865,protein autoubiquitination,P
24578,61,16925,protein sumoylation,P
24579,61,16567,protein ubiquitination,P
24580,61,44030,regulation of DNA methylation,P
24581,61,42981,regulation of apoptotic process,P
24582,61,42127,regulation of cell proliferation,P
24583,61,6349,regulation of gene expression by genetic imprinting,P
24584,61,1901796,regulation of signal transduction by p53 class mediator,P
24585,61,6357,regulation of transcription from RNA polymerase II promoter,P
24586,61,6359,regulation of transcription from RNA polymerase III promoter,P
24587,61,43627,response to estrogen,P
24588,61,10212,response to ionizing radiation,P
24589,61,732,strand displacement,P
24590,61,6351,"transcription, DNA-templated",P
24591,61,70531,BRCA1-A complex,C
24592,61,31436,BRCA1-BARD1 complex,C
24593,61,5694,chromosome,C
24594,61,5737,cytoplasm,C
24595,61,8274,gamma-tubulin ring complex,C
24596,61,30529,intracellular ribonucleoprotein complex,C
24597,61,800,lateral element,C
24598,61,5654,nucleoplasm,C
24599,61,5634,nucleus,C
24600,61,5886,plasma membrane,C
24601,61,43234,protein complex,C
24602,61,151,ubiquitin ligase complex,C
24624,60,1904646,cellular response to beta-amyloid,P
24625,60,32869,cellular response to insulin stimulus,P
24626,60,34599,cellular response to oxidative stress,P
24627,60,71294,cellular response to zinc ion,P
24628,60,6302,double-strand break repair,P
24629,60,724,double-strand break repair via homologous recombination,P
24630,60,70911,global genome nucleotide-excision repair,P
24631,60,6273,lagging strand elongation,P
24632,60,30225,macrophage differentiation,P
24633,60,32042,mitochondrial DNA metabolic process,P
24634,60,43504,mitochondrial DNA repair,P
24635,60,7005,mitochondrion organization,P
24636,60,2001170,negative regulation of ATP biosynthetic process,P
24637,60,1904357,negative regulation of telomere maintenance via telomere lengthening,P
24638,60,122,negative regulation of transcription from RNA polymerase II promoter,P
24639,60,715,"nucleotide-excision repair, DNA damage recognition",P
24640,60,717,"nucleotide-excision repair, DNA duplex unwinding",P
24641,60,33683,"nucleotide-excision repair, DNA incision",P
24642,60,6295,"nucleotide-excision repair, DNA incision, 3'-to lesion",P
24643,60,6296,"nucleotide-excision repair, DNA incision, 5'-to lesion",P
24644,60,6294,"nucleotide-excision repair, preincision complex assembly",P
24645,60,6293,"nucleotide-excision repair, preincision complex stabilization",P
24646,60,60391,positive regulation of SMAD protein import into nucleus,P
24647,60,10613,positive regulation of cardiac muscle hypertrophy,P
24648,60,33148,positive regulation of intracellular estrogen receptor signaling pathway,P
24649,60,51901,positive regulation of mitochondrial depolarization,P
24650,60,1904762,positive regulation of myofibroblast differentiation,P
24651,60,1901216,positive regulation of neuron death,P
24652,60,45944,positive regulation of transcription from RNA polymerase II promoter,P
24653,60,2000679,positive regulation of transcription regulatory region DNA binding,P
24654,60,6471,protein ADP-ribosylation,P
24655,60,16540,protein autoprocessing,P
24656,60,36211,protein modification process,P
24657,60,70212,protein poly-ADP-ribosylation,P
24658,60,16925,protein sumoylation,P
24659,60,44030,regulation of DNA methylation,P
24660,60,10990,regulation of SMAD protein complex assembly,P
24661,60,1903827,regulation of cellular protein localization,P
24662,60,1903376,regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway,P
24663,60,1904044,response to aldosterone,P
24664,60,10332,response to gamma radiation,P
24665,60,23019,signal transduction involved in regulation of gene expression,P
24666,60,6366,transcription from RNA polymerase II promoter,P
24667,60,7179,transforming growth factor beta receptor signaling pathway,P
24668,60,16020,membrane,C
24669,60,5739,mitochondrion,C
24670,60,784,"nuclear chromosome, telomeric region",C
24671,60,5635,nuclear envelope,C
24672,60,5730,nucleolus,C
24673,60,5654,nucleoplasm,C
24674,60,5634,nucleus,C
24675,60,43234,protein complex,C
24676,60,5667,transcription factor complex,C
24709,59,45893,"positive regulation of transcription, DNA-templated",P
24710,59,6355,"regulation of transcription, DNA-templated",P
24711,59,6351,"transcription, DNA-templated",P
24712,59,90575,RNA polymerase II transcription factor complex,C
24713,59,5737,cytoplasm,C
24714,59,790,nuclear chromatin,C
24715,59,5654,nucleoplasm,C
24716,59,5634,nucleus,C
24717,59,5634,nucleus,C
24718,59,5667,transcription factor complex,C
24762,57,2223,stimulatory C-type lectin receptor signaling pathway,P
24763,57,5829,cytosol,C
24764,57,70062,extracellular exosome,C
24765,57,5886,plasma membrane,C
24766,57,5886,plasma membrane,C
24792,56,72300,positive regulation of metanephric glomerulus development,P
24793,56,14042,positive regulation of neuron maturation,P
24794,56,10976,positive regulation of neuron projection development,P
24795,56,1903263,positive regulation of serine phosphorylation of STAT3 protein,P
24796,56,45893,"positive regulation of transcription, DNA-templated",P
24797,56,7497,posterior midgut development,P
24798,56,6468,protein phosphorylation,P
24799,56,50770,regulation of axonogenesis,P
24800,56,30155,regulation of cell adhesion,P
24801,56,42493,response to drug,P
24802,56,48265,response to pain,P
24803,56,60041,retina development in camera-type eye,P
24804,56,7165,signal transduction,P
24805,56,7169,transmembrane receptor protein tyrosine kinase signaling pathway,P
24806,56,35799,ureter maturation,P
24807,56,1657,ureteric bud development,P
24808,56,30424,axon,C
24809,56,5737,cytoplasm,C
24810,56,30425,dendrite,C
24811,56,5769,early endosome,C
24812,56,10008,endosome membrane,C
24813,56,5887,integral component of plasma membrane,C
24814,56,43231,intracellular membrane-bounded organelle,C
24815,56,45121,membrane raft,C
24816,56,43025,neuronal cell body,C
24817,56,5886,plasma membrane,C
24818,56,5886,plasma membrane,C
24819,56,43235,receptor complex,C
24858,55,50728,negative regulation of inflammatory response,P
24859,55,1903038,negative regulation of leukocyte cell-cell adhesion,P
24860,55,10745,negative regulation of macrophage derived foam cell differentiation,P
24861,55,10745,negative regulation of macrophage derived foam cell differentiation,P
24862,55,1901215,negative regulation of neuron death,P
24863,55,1902894,negative regulation of pri-miRNA transcription from RNA polymerase II promoter,P
24864,55,32091,negative regulation of protein binding,P
24865,55,10871,negative regulation of receptor biosynthetic process,P
24866,55,10891,negative regulation of sequestering of triglyceride,P
24867,55,122,negative regulation of transcription from RNA polymerase II promoter,P
24868,55,2000678,negative regulation of transcription regulatory region DNA binding,P
24869,55,32000,positive regulation of fatty acid beta-oxidation,P
24870,55,46321,positive regulation of fatty acid oxidation,P
24871,55,45722,positive regulation of gluconeogenesis,P
24872,55,45944,positive regulation of transcription from RNA polymerase II promoter,P
24873,55,45893,"positive regulation of transcription, DNA-templated",P
24874,55,72366,regulation of cellular ketone metabolic process by positive regulation of transcription from RNA polymerase II promoter,P
24875,55,42752,regulation of circadian rhythm,P
24876,55,72363,regulation of glycolytic process by positive regulation of transcription from RNA polymerase II promoter,P
24877,55,72369,regulation of lipid transport by positive regulation of transcription from RNA polymerase II promoter,P
24878,55,1666,response to hypoxia,P
24879,55,32868,response to insulin,P
24880,55,43401,steroid hormone mediated signaling pathway,P
24881,55,6367,transcription initiation from RNA polymerase II promoter,P
24882,55,42060,wound healing,P
24883,55,5654,nucleoplasm,C
24884,55,5634,nucleus,C
24885,55,5634,nucleus,C
24943,54,35307,positive regulation of protein dephosphorylation,P
24944,54,42307,positive regulation of protein import into nucleus,P
24945,54,2001022,positive regulation of response to DNA damage stimulus,P
24946,54,2000755,positive regulation of sphingomyelin catabolic process,P
24947,54,32930,positive regulation of superoxide anion generation,P
24948,54,6468,protein phosphorylation,P
24949,54,50821,protein stabilization,P
24950,54,32956,regulation of actin cytoskeleton organization,P
24951,54,43488,regulation of mRNA stability,P
24952,54,10469,regulation of receptor activity,P
24953,54,7165,signal transduction,P
24954,54,2223,stimulatory C-type lectin receptor signaling pathway,P
24955,54,23021,termination of signal transduction,P
24956,54,5911,cell-cell junction,C
24957,54,5737,cytoplasm,C
24958,54,5829,cytosol,C
24959,54,5829,cytosol,C
24960,54,5783,endoplasmic reticulum,C
24961,54,70062,extracellular exosome,C
24962,54,16363,nuclear matrix,C
24963,54,5654,nucleoplasm,C
24964,54,5634,nucleus,C
24965,54,48471,perinuclear region of cytoplasm,C
24966,54,5886,plasma membrane,C
24967,54,5886,plasma membrane,C
24981,53,9408,response to heat,P
24982,53,7584,response to nutrient,P
24983,53,48545,response to steroid hormone,P
24984,53,5576,extracellular region,C
24985,53,5615,extracellular space,C
24986,53,43025,neuronal cell body,C
24995,52,5576,extracellular region,C
24996,52,5887,integral component of plasma membrane,C
25058,51,45840,positive regulation of mitotic nuclear division,P
25059,51,43552,positive regulation of phosphatidylinositol 3-kinase activity,P
25060,51,14068,positive regulation of phosphatidylinositol 3-kinase signaling,P
25061,51,10863,positive regulation of phospholipase C activity,P
25062,51,32516,positive regulation of phosphoprotein phosphatase activity,P
25063,51,2000379,positive regulation of reactive oxygen species metabolic process,P
25064,51,14911,positive regulation of smooth muscle cell migration,P
25065,51,14911,positive regulation of smooth muscle cell migration,P
25066,51,48661,positive regulation of smooth muscle cell proliferation,P
25067,51,48661,positive regulation of smooth muscle cell proliferation,P
25068,51,46777,protein autophosphorylation,P
25069,51,32956,regulation of actin cytoskeleton organization,P
25070,51,14066,regulation of phosphatidylinositol 3-kinase signaling,P
25071,51,32355,response to estradiol,P
25072,51,43627,response to estrogen,P
25073,51,34405,response to fluid shear stress,P
25074,51,42542,response to hydrogen peroxide,P
25075,51,55093,response to hyperoxia,P
25076,51,32526,response to retinoic acid,P
25077,51,9636,response to toxic substance,P
25078,51,61298,retina vasculature development in camera-type eye,P
25079,51,7165,signal transduction,P
25080,51,71670,smooth muscle cell chemotaxis,P
25081,51,42060,wound healing,P
25082,51,16324,apical plasma membrane,C
25083,51,9986,cell surface,C
25084,51,5737,cytoplasm,C
25085,51,31410,cytoplasmic vesicle,C
25086,51,70062,extracellular exosome,C
25087,51,5925,focal adhesion,C
25088,51,16021,integral component of membrane,C
25089,51,31226,intrinsic component of plasma membrane,C
25090,51,43202,lysosomal lumen,C
25091,51,16020,membrane,C
25092,51,5634,nucleus,C
25093,51,5886,plasma membrane,C
25128,50,9629,response to gravity,P
25129,50,35902,response to immobilization stress,P
25130,50,9416,response to light stimulus,P
25131,50,32496,response to lipopolysaccharide,P
25132,50,35994,response to muscle stretch,P
25133,50,32570,response to progesterone,P
25134,50,9636,response to toxic substance,P
25135,50,35914,skeletal muscle cell differentiation,P
25136,50,30431,sleep,P
25137,50,6366,transcription from RNA polymerase II promoter,P
25138,50,7179,transforming growth factor beta receptor signaling pathway,P
25139,50,5829,cytosol,C
25140,50,5783,endoplasmic reticulum,C
25141,50,16020,membrane,C
25142,50,43005,neuron projection,C
25143,50,5654,nucleoplasm,C
25144,50,5654,nucleoplasm,C
25145,50,5634,nucleus,C
25146,50,5667,transcription factor complex,C
25157,49,38111,interleukin-7-mediated signaling pathway,P
25158,49,43547,positive regulation of GTPase activity,P
25159,49,7165,signal transduction,P
25160,49,16032,viral process,P
25161,49,9897,external side of plasma membrane,C
25162,49,5887,integral component of plasma membrane,C
25163,49,5622,intracellular,C
25164,49,16020,membrane,C
25165,49,5886,plasma membrane,C
25204,48,45741,positive regulation of epidermal growth factor-activated receptor activity,P
25205,48,45741,positive regulation of epidermal growth factor-activated receptor activity,P
25206,48,45741,positive regulation of epidermal growth factor-activated receptor activity,P
25207,48,1900127,positive regulation of hyaluronan biosynthetic process,P
25208,48,45840,positive regulation of mitotic nuclear division,P
25209,48,10800,positive regulation of peptidyl-threonine phosphorylation,P
25210,48,42327,positive regulation of phosphorylation,P
25211,48,2000060,positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process,P
25212,48,2092,positive regulation of receptor internalization,P
25213,48,45893,"positive regulation of transcription, DNA-templated",P
25214,48,90279,regulation of calcium ion import,P
25215,48,2000145,regulation of cell motility,P
25216,48,14066,regulation of phosphatidylinositol 3-kinase signaling,P
25217,48,2000008,regulation of protein localization to cell surface,P
25218,48,7165,signal transduction,P
25219,48,70062,extracellular exosome,C
25220,48,5576,extracellular region,C
25221,48,5576,extracellular region,C
25222,48,5615,extracellular space,C
25223,48,16021,integral component of membrane,C
25224,48,5765,lysosomal membrane,C
25225,48,5886,plasma membrane,C
25226,48,31093,platelet alpha granule lumen,C
25227,48,43235,receptor complex,C
25292,47,50731,positive regulation of peptidyl-tyrosine phosphorylation,P
25293,47,43552,positive regulation of phosphatidylinositol 3-kinase activity,P
25294,47,14068,positive regulation of phosphatidylinositol 3-kinase signaling,P
25295,47,1902895,positive regulation of pri-miRNA transcription from RNA polymerase II promoter,P
25296,47,31954,positive regulation of protein autophosphorylation,P
25297,47,61098,positive regulation of protein tyrosine kinase activity,P
25298,47,2000379,positive regulation of reactive oxygen species metabolic process,P
25299,47,14911,positive regulation of smooth muscle cell migration,P
25300,47,48661,positive regulation of smooth muscle cell proliferation,P
25301,47,45893,"positive regulation of transcription, DNA-templated",P
25302,47,1904754,positive regulation of vascular associated smooth muscle cell migration,P
25303,47,1905176,positive regulation of vascular smooth muscle cell dedifferentiation,P
25304,47,1904707,positive regulation of vascular smooth muscle cell proliferation,P
25305,47,70528,protein kinase C signaling,P
25306,47,6468,protein phosphorylation,P
25307,47,72593,reactive oxygen species metabolic process,P
25308,47,14066,regulation of phosphatidylinositol 3-kinase signaling,P
25309,47,9611,response to wounding,P
25310,47,9611,response to wounding,P
25311,47,7179,transforming growth factor beta receptor signaling pathway,P
25312,47,139,Golgi membrane,C
25313,47,16323,basolateral plasma membrane,C
25314,47,9986,cell surface,C
25315,47,5737,cytoplasm,C
25316,47,5788,endoplasmic reticulum lumen,C
25317,47,31012,extracellular matrix,C
25318,47,5576,extracellular region,C
25319,47,5576,extracellular region,C
25320,47,5615,extracellular space,C
25321,47,31093,platelet alpha granule lumen,C
25350,46,7204,positive regulation of cytosolic calcium ion concentration,P
25351,46,60999,positive regulation of dendritic spine development,P
25352,46,51024,positive regulation of immunoglobulin secretion,P
25353,46,50729,positive regulation of inflammatory response,P
25354,46,32729,positive regulation of interferon-gamma production,P
25355,46,32740,positive regulation of interleukin-17 production,P
25356,46,48304,positive regulation of isotype switching to IgG isotypes,P
25357,46,45591,positive regulation of regulatory T cell differentiation,P
25358,46,34105,positive regulation of tissue remodeling,P
25359,46,45944,positive regulation of transcription from RNA polymerase II promoter,P
25360,46,42523,positive regulation of tyrosine phosphorylation of Stat5 protein,P
25361,46,7205,protein kinase C-activating G-protein coupled receptor signaling pathway,P
25362,46,46013,regulation of T cell homeostatic proliferation,P
25363,46,45471,response to ethanol,P
25364,46,5576,extracellular region,C
25365,46,5615,extracellular space,C
25366,46,5622,intracellular,C
25380,45,2076,osteoblast development,P
25381,45,45597,positive regulation of cell differentiation,P
25382,45,45669,positive regulation of osteoblast differentiation,P
25383,45,45944,positive regulation of transcription from RNA polymerase II promoter,P
25384,45,51726,regulation of cell cycle,P
25385,45,10941,regulation of cell death,P
25386,45,42127,regulation of cell proliferation,P
25387,45,6357,regulation of transcription from RNA polymerase II promoter,P
25388,45,51591,response to cAMP,P
25389,45,34097,response to cytokine,P
25390,45,42493,response to drug,P
25391,45,9416,response to light stimulus,P
25392,45,32496,response to lipopolysaccharide,P
25393,45,9612,response to mechanical stimulus,P
25394,45,43434,response to peptide hormone,P
25395,45,9314,response to radiation,P
25396,45,6366,transcription from RNA polymerase II promoter,P
25397,45,785,chromatin,C
25398,45,790,nuclear chromatin,C
25399,45,5634,nucleus,C
25400,45,32993,protein-DNA complex,C
25401,45,5667,transcription factor complex,C
25421,44,97193,intrinsic apoptotic signaling pathway,P
25422,44,45190,isotype switching,P
25423,44,51321,meiotic cell cycle,P
25424,44,7095,mitotic G2 DNA damage checkpoint,P
25425,44,7093,mitotic cell cycle checkpoint,P
25426,44,1904354,negative regulation of telomere capping,P
25427,44,50885,neuromuscular process controlling balance,P
25428,44,33674,positive regulation of kinase activity,P
25429,44,31954,positive regulation of protein autophosphorylation,P
25430,44,32206,positive regulation of telomere maintenance,P
25431,44,30174,regulation of DNA-dependent DNA replication initiation,P
25432,44,1901796,regulation of signal transduction by p53 class mediator,P
25433,44,732,strand displacement,P
25434,44,723,telomere maintenance,P
25435,44,31860,telomeric 3' overhang formation,P
25436,44,30870,Mre11 complex,C
25437,44,16605,PML body,C
25438,44,5829,cytosol,C
25439,44,784,"nuclear chromosome, telomeric region",C
25440,44,784,"nuclear chromosome, telomeric region",C
25441,44,42405,nuclear inclusion body,C
25442,44,5730,nucleolus,C
25443,44,5654,nucleoplasm,C
25444,44,5634,nucleus,C
25445,44,5657,replication fork,C
25446,44,35861,site of double-strand break,C
25519,42,45725,positive regulation of glycogen biosynthetic process,P
25520,42,45821,positive regulation of glycolytic process,P
25521,42,51446,positive regulation of meiotic cell cycle,P
25522,42,45840,positive regulation of mitotic nuclear division,P
25523,42,45429,positive regulation of nitric oxide biosynthetic process,P
25524,42,51897,positive regulation of protein kinase B signaling,P
25525,42,1934,positive regulation of protein phosphorylation,P
25526,42,60267,positive regulation of respiratory burst,P
25527,42,45893,"positive regulation of transcription, DNA-templated",P
25528,42,46777,protein autophosphorylation,P
25529,42,46777,protein autophosphorylation,P
25530,42,51290,protein heterotetramerization,P
25531,42,45995,regulation of embryonic development,P
25532,42,2000194,regulation of female gonad development,P
25533,42,6355,"regulation of transcription, DNA-templated",P
25534,42,23014,signal transduction by protein phosphorylation,P
25535,42,19087,transformation of host cell by virus,P
25536,42,5901,caveola,C
25537,42,10008,endosome membrane,C
25538,42,70062,extracellular exosome,C
25539,42,5899,insulin receptor complex,C
25540,42,5887,integral component of plasma membrane,C
25541,42,43231,intracellular membrane-bounded organelle,C
25542,42,16020,membrane,C
25543,42,5886,plasma membrane,C
25544,42,5886,plasma membrane,C
25545,42,43235,receptor complex,C
25591,41,45945,positive regulation of transcription from RNA polymerase III promoter,P
25592,41,45727,positive regulation of translation,P
25593,41,46777,protein autophosphorylation,P
25594,41,6468,protein phosphorylation,P
25595,41,70372,regulation of ERK1 and ERK2 cascade,P
25596,41,45765,regulation of angiogenesis,P
25597,41,2000145,regulation of cell motility,P
25598,41,32886,regulation of microtubule-based process,P
25599,41,14066,regulation of phosphatidylinositol 3-kinase signaling,P
25600,41,7165,signal transduction,P
25601,41,6351,"transcription, DNA-templated",P
25602,41,7169,transmembrane receptor protein tyrosine kinase signaling pathway,P
25603,41,7169,transmembrane receptor protein tyrosine kinase signaling pathway,P
25604,41,42060,wound healing,P
25605,41,16324,apical plasma membrane,C
25606,41,16323,basolateral plasma membrane,C
25607,41,5737,cytoplasm,C
25608,41,10008,endosome membrane,C
25609,41,16021,integral component of membrane,C
25610,41,43209,myelin sheath,C
25611,41,5634,nucleus,C
25612,41,48471,perinuclear region of cytoplasm,C
25613,41,5886,plasma membrane,C
25614,41,5886,plasma membrane,C
25615,41,5886,plasma membrane,C
25616,41,43235,receptor complex,C
25617,41,43235,receptor complex,C
25679,40,1905208,negative regulation of cardiocyte differentiation,P
25680,40,42059,negative regulation of epidermal growth factor receptor signaling pathway,P
25681,40,45930,negative regulation of mitotic cell cycle,P
25682,40,42177,negative regulation of protein catabolic process,P
25683,40,48812,neuron projection morphogenesis,P
25684,40,1503,ossification,P
25685,40,42698,ovulation cycle,P
25686,40,38083,peptidyl-tyrosine autophosphorylation,P
25687,40,18108,peptidyl-tyrosine phosphorylation,P
25688,40,46854,phosphatidylinositol phosphorylation,P
25689,40,48015,phosphatidylinositol-mediated signaling,P
25690,40,45739,positive regulation of DNA repair,P
25691,40,45740,positive regulation of DNA replication,P
25692,40,70374,positive regulation of ERK1 and ERK2 cascade,P
25693,40,70374,positive regulation of ERK1 and ERK2 cascade,P
25694,40,43547,positive regulation of GTPase activity,P
25695,40,43406,positive regulation of MAP kinase activity,P
25696,40,45780,positive regulation of bone resorption,P
25697,40,35413,positive regulation of catenin import into nucleus,P
25698,40,30307,positive regulation of cell growth,P
25699,40,30335,positive regulation of cell migration,P
25700,40,8284,positive regulation of cell proliferation,P
25701,40,8284,positive regulation of cell proliferation,P
25702,40,31659,positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle,P
25703,40,50679,positive regulation of epithelial cell proliferation,P
25704,40,48146,positive regulation of fibroblast proliferation,P
25705,40,50729,positive regulation of inflammatory response,P
25706,40,45429,positive regulation of nitric oxide biosynthetic process,P
25707,40,42327,positive regulation of phosphorylation,P
25708,40,1903800,positive regulation of production of miRNAs involved in gene silencing by miRNA,P
25709,40,1902722,positive regulation of prolactin secretion,P
25710,40,51897,positive regulation of protein kinase B signaling,P
25711,40,1900020,positive regulation of protein kinase C activity,P
25712,40,1903078,positive regulation of protein localization to plasma membrane,P
25713,40,1934,positive regulation of protein phosphorylation,P
25714,40,48661,positive regulation of smooth muscle cell proliferation,P
25715,40,32930,positive regulation of superoxide anion generation,P
25716,40,51968,"positive regulation of synaptic transmission, glutamatergic",P
25717,40,45944,positive regulation of transcription from RNA polymerase II promoter,P
25718,40,45907,positive regulation of vasoconstriction,P
25719,40,45909,positive regulation of vasodilation,P
25720,40,46777,protein autophosphorylation,P
25721,40,51205,protein insertion into membrane,P
25722,40,2000145,regulation of cell motility,P
25723,40,50999,regulation of nitric-oxide synthase activity,P
25724,40,50730,regulation of peptidyl-tyrosine phosphorylation,P
25725,40,14066,regulation of phosphatidylinositol 3-kinase signaling,P
25726,40,70141,response to UV-A,P
25727,40,51592,response to calcium ion,P
25728,40,33590,response to cobalamin,P
25729,40,33594,response to hydroxyisoflavone,P
25730,40,6970,response to osmotic stress,P
25731,40,6979,response to oxidative stress,P
25732,40,6950,response to stress,P
25733,40,7435,salivary gland morphogenesis,P
25734,40,7165,signal transduction,P
25735,40,7165,signal transduction,P
25736,40,16337,single organismal cell-cell adhesion,P
25737,40,43586,tongue development,P
25738,40,6412,translation,P
25739,40,42060,wound healing,P
25740,40,30122,AP-2 adaptor complex,C
25741,40,139,Golgi membrane,C
25742,40,70435,Shc-EGFR complex,C
25743,40,16324,apical plasma membrane,C
25744,40,16323,basolateral plasma membrane,C
25745,40,9986,cell surface,C
25746,40,5913,cell-cell adherens junction,C
25747,40,5737,cytoplasm,C
25748,40,31901,early endosome membrane,C
25749,40,5789,endoplasmic reticulum membrane,C
25750,40,5768,endosome,C
25751,40,5768,endosome,C
25752,40,10008,endosome membrane,C
25753,40,5615,extracellular space,C
25754,40,5925,focal adhesion,C
25755,40,16021,integral component of membrane,C
25756,40,16020,membrane,C
25757,40,45121,membrane raft,C
25758,40,97489,"multivesicular body, internal vesicle lumen",C
25759,40,31965,nuclear membrane,C
25760,40,5634,nucleus,C
25761,40,48471,perinuclear region of cytoplasm,C
25762,40,5886,plasma membrane,C
25763,40,5886,plasma membrane,C
25764,40,43235,receptor complex,C
25765,40,45202,synapse,C
25802,39,48146,positive regulation of fibroblast proliferation,P
25803,39,48146,positive regulation of fibroblast proliferation,P
25804,39,10628,positive regulation of gene expression,P
25805,39,2053,positive regulation of mesenchymal cell proliferation,P
25806,39,90096,positive regulation of metanephric cap mesenchymal cell proliferation,P
25807,39,2001022,positive regulation of response to DNA damage stimulus,P
25808,39,51973,positive regulation of telomerase activity,P
25809,39,45944,positive regulation of transcription from RNA polymerase II promoter,P
25810,39,45944,positive regulation of transcription from RNA polymerase II promoter,P
25811,39,45944,positive regulation of transcription from RNA polymerase II promoter,P
25812,39,45893,"positive regulation of transcription, DNA-templated",P
25813,39,10468,regulation of gene expression,P
25814,39,32204,regulation of telomere maintenance,P
25815,39,42493,response to drug,P
25816,39,10332,response to gamma radiation,P
25817,39,70848,response to growth factor,P
25818,39,6366,transcription from RNA polymerase II promoter,P
25819,39,5829,cytosol,C
25820,39,5730,nucleolus,C
25821,39,5654,nucleoplasm,C
25822,39,5654,nucleoplasm,C
25823,39,5634,nucleus,C
25824,39,43234,protein complex,C
25870,38,45944,positive regulation of transcription from RNA polymerase II promoter,P
25871,38,90303,positive regulation of wound healing,P
25872,38,51291,protein heterooligomerization,P
25873,38,48169,regulation of long-term neuronal synaptic plasticity,P
25874,38,35900,response to isolation stress,P
25875,38,7165,signal transduction,P
25876,38,2223,stimulatory C-type lectin receptor signaling pathway,P
25877,38,5794,Golgi apparatus,C
25878,38,139,Golgi membrane,C
25879,38,5737,cytoplasm,C
25880,38,5829,cytosol,C
25881,38,5634,nucleus,C
25882,38,48471,perinuclear region of cytoplasm,C
25883,38,5886,plasma membrane,C
25884,38,5886,plasma membrane,C
25909,37,43410,positive regulation of MAPK cascade,P
25910,37,43065,positive regulation of apoptotic process,P
25911,37,50772,positive regulation of axonogenesis,P
25912,37,1902895,positive regulation of pri-miRNA transcription from RNA polymerase II promoter,P
25913,37,1900182,positive regulation of protein localization to nucleus,P
25914,37,42981,regulation of apoptotic process,P
25915,37,42127,regulation of cell proliferation,P
25916,37,43281,regulation of cysteine-type endopeptidase activity involved in apoptotic process,P
25917,37,2001273,regulation of glucose import in response to insulin stimulus,P
25918,37,32496,response to lipopolysaccharide,P
25919,37,33209,tumor necrosis factor-mediated signaling pathway,P
25920,37,9986,cell surface,C
25921,37,5829,cytosol,C
25922,37,5768,endosome,C
25923,37,5576,extracellular region,C
25924,37,5887,integral component of plasma membrane,C
25925,37,43005,neuron projection,C
25926,37,5654,nucleoplasm,C
25927,37,5634,nucleus,C
25928,37,5886,plasma membrane,C
25953,36,6661,phosphatidylinositol biosynthetic process,P
25954,36,46854,phosphatidylinositol phosphorylation,P
25955,36,36092,phosphatidylinositol-3-phosphate biosynthetic process,P
25956,36,48015,phosphatidylinositol-mediated signaling,P
25957,36,16310,phosphorylation,P
25958,36,30168,platelet activation,P
25959,36,70527,platelet aggregation,P
25960,36,10508,positive regulation of autophagy,P
25961,36,10628,positive regulation of gene expression,P
25962,36,1952,regulation of cell-matrix adhesion,P
25963,36,2000369,regulation of clathrin-dependent endocytosis,P
25964,36,14066,regulation of phosphatidylinositol 3-kinase signaling,P
25965,36,7165,signal transduction,P
25966,36,7169,transmembrane receptor protein tyrosine kinase signaling pathway,P
25967,36,48010,vascular endothelial growth factor receptor signaling pathway,P
25968,36,5829,cytosol,C
25969,36,45171,intercellular bridge,C
25970,36,5730,nucleolus,C
25971,36,5634,nucleus,C
25972,36,5942,phosphatidylinositol 3-kinase complex,C
25973,36,5886,plasma membrane,C
26062,35,30307,positive regulation of cell growth,P
26063,35,32270,positive regulation of cellular protein metabolic process,P
26064,35,31659,positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle,P
26065,35,32079,positive regulation of endodeoxyribonuclease activity,P
26066,35,1938,positive regulation of endothelial cell proliferation,P
26067,35,45742,positive regulation of epidermal growth factor receptor signaling pathway,P
26068,35,90004,positive regulation of establishment of protein localization to plasma membrane,P
26069,35,45600,positive regulation of fat cell differentiation,P
26070,35,10763,positive regulation of fibroblast migration,P
26071,35,46326,positive regulation of glucose import,P
26072,35,10907,positive regulation of glucose metabolic process,P
26073,35,45725,positive regulation of glycogen biosynthetic process,P
26074,35,45725,positive regulation of glycogen biosynthetic process,P
26075,35,46889,positive regulation of lipid biosynthetic process,P
26076,35,45429,positive regulation of nitric oxide biosynthetic process,P
26077,35,51000,positive regulation of nitric-oxide synthase activity,P
26078,35,46622,positive regulation of organ growth,P
26079,35,33138,positive regulation of peptidyl-serine phosphorylation,P
26080,35,32436,positive regulation of proteasomal ubiquitin-dependent protein catabolic process,P
26081,35,1900182,positive regulation of protein localization to nucleus,P
26082,35,1934,positive regulation of protein phosphorylation,P
26083,35,51091,positive regulation of sequence-specific DNA binding transcription factor activity,P
26084,35,48661,positive regulation of smooth muscle cell proliferation,P
26085,35,10765,positive regulation of sodium ion transport,P
26086,35,45944,positive regulation of transcription from RNA polymerase II promoter,P
26087,35,45907,positive regulation of vasoconstriction,P
26088,35,46777,protein autophosphorylation,P
26089,35,30163,protein catabolic process,P
26090,35,60,"protein import into nucleus, translocation",P
26091,35,43491,protein kinase B signaling,P
26092,35,6468,protein phosphorylation,P
26093,35,16567,protein ubiquitination,P
26094,35,1901976,regulation of cell cycle checkpoint,P
26095,35,30334,regulation of cell migration,P
26096,35,30334,regulation of cell migration,P
26097,35,5979,regulation of glycogen biosynthetic process,P
26098,35,43488,regulation of mRNA stability,P
26099,35,31641,regulation of myelination,P
26100,35,10975,regulation of neuron projection development,P
26101,35,50999,regulation of nitric-oxide synthase activity,P
26102,35,14066,regulation of phosphatidylinositol 3-kinase signaling,P
26103,35,1901796,regulation of signal transduction by p53 class mediator,P
26104,35,6417,regulation of translation,P
26105,35,70141,response to UV-A,P
26106,35,34405,response to fluid shear stress,P
26107,35,32094,response to food,P
26108,35,60416,response to growth hormone,P
26109,35,9408,response to heat,P
26110,35,1990418,response to insulin-like growth factor stimulus,P
26111,35,6979,response to oxidative stress,P
26112,35,7165,signal transduction,P
26113,35,21510,spinal cord development,P
26114,35,51146,striated muscle cell differentiation,P
26115,35,6412,translation,P
26116,35,5911,cell-cell junction,C
26117,35,36064,ciliary basal body,C
26118,35,5737,cytoplasm,C
26119,35,5737,cytoplasm,C
26120,35,5737,cytoplasm,C
26121,35,5829,cytosol,C
26122,35,5829,cytosol,C
26123,35,15630,microtubule cytoskeleton,C
26124,35,5739,mitochondrion,C
26125,35,5654,nucleoplasm,C
26126,35,5634,nucleus,C
26127,35,5634,nucleus,C
26128,35,5886,plasma membrane,C
26129,35,5886,plasma membrane,C
26130,35,98794,postsynapse,C
26131,35,43234,protein complex,C
26132,35,5819,spindle,C
26133,35,31982,vesicle,C
26163,34,30335,positive regulation of cell migration,P
26164,34,8284,positive regulation of cell proliferation,P
26165,34,32000,positive regulation of fatty acid beta-oxidation,P
26166,34,46326,positive regulation of glucose import,P
26167,34,10907,positive regulation of glucose metabolic process,P
26168,34,45725,positive regulation of glycogen biosynthetic process,P
26169,34,45725,positive regulation of glycogen biosynthetic process,P
26170,34,32024,positive regulation of insulin secretion,P
26171,34,2053,positive regulation of mesenchymal cell proliferation,P
26172,34,19216,regulation of lipid metabolic process,P
26173,34,14066,regulation of phosphatidylinositol 3-kinase signaling,P
26174,34,9749,response to glucose,P
26175,34,7165,signal transduction,P
26176,34,5829,cytosol,C
26177,34,5829,cytosol,C
26178,34,5886,plasma membrane,C
26179,34,5886,plasma membrane,C
26180,34,43234,protein complex,C
26203,33,1903898,negative regulation of PERK-mediated unfolded protein response,P
26204,33,1902236,negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway,P
26205,33,46627,negative regulation of insulin receptor signaling pathway,P
26206,33,9968,negative regulation of signal transduction,P
26207,33,30948,negative regulation of vascular endothelial growth factor receptor signaling pathway,P
26208,33,35335,peptidyl-tyrosine dephosphorylation,P
26209,33,35335,peptidyl-tyrosine dephosphorylation,P
26210,33,1990264,peptidyl-tyrosine dephosphorylation involved in inactivation of protein kinase activity,P
26211,33,35791,platelet-derived growth factor receptor-beta signaling pathway,P
26212,33,1903896,positive regulation of IRE1-mediated unfolded protein response,P
26213,33,61098,positive regulation of protein tyrosine kinase activity,P
26214,33,2000646,positive regulation of receptor catabolic process,P
26215,33,6470,protein dephosphorylation,P
26216,33,30100,regulation of endocytosis,P
26217,33,1902202,regulation of hepatocyte growth factor receptor signaling pathway,P
26218,33,33157,regulation of intracellular protein transport,P
26219,33,9966,regulation of signal transduction,P
26220,33,60338,regulation of type I interferon-mediated signaling pathway,P
26221,33,5913,cell-cell adherens junction,C
26222,33,98554,cytoplasmic side of endoplasmic reticulum membrane,C
26223,33,5829,cytosol,C
26224,33,5769,early endosome,C
26225,33,5783,endoplasmic reticulum,C
26226,33,5886,plasma membrane,C
26227,33,97443,sorting endosome,C
26262,32,43552,positive regulation of phosphatidylinositol 3-kinase activity,P
26263,32,14066,regulation of phosphatidylinositol 3-kinase signaling,P
26264,32,32868,response to insulin,P
26265,32,43434,response to peptide hormone,P
26266,32,7165,signal transduction,P
26267,32,5901,caveola,C
26268,32,5737,cytoplasm,C
26269,32,5829,cytosol,C
26270,32,5829,cytosol,C
26271,32,5899,insulin receptor complex,C
26272,32,43231,intracellular membrane-bounded organelle,C
26273,32,5634,nucleus,C
26274,32,5886,plasma membrane,C
26356,30,46889,positive regulation of lipid biosynthetic process,P
26357,30,45840,positive regulation of mitotic nuclear division,P
26358,30,45429,positive regulation of nitric oxide biosynthetic process,P
26359,30,51000,positive regulation of nitric-oxide synthase activity,P
26360,30,90277,positive regulation of peptide hormone secretion,P
26361,30,50731,positive regulation of peptidyl-tyrosine phosphorylation,P
26362,30,14068,positive regulation of phosphatidylinositol 3-kinase signaling,P
26363,30,31954,positive regulation of protein autophosphorylation,P
26364,30,51897,positive regulation of protein kinase B signaling,P
26365,30,1900182,positive regulation of protein localization to nucleus,P
26366,30,60267,positive regulation of respiratory burst,P
26367,30,45909,positive regulation of vasodilation,P
26368,30,6521,regulation of cellular amino acid metabolic process,P
26369,30,32880,regulation of protein localization,P
26370,30,50708,regulation of protein secretion,P
26371,30,6355,"regulation of transcription, DNA-templated",P
26372,30,22898,regulation of transmembrane transporter activity,P
26373,30,42060,wound healing,P
26374,30,5796,Golgi lumen,C
26375,30,139,Golgi membrane,C
26376,30,5788,endoplasmic reticulum lumen,C
26377,30,33116,endoplasmic reticulum-Golgi intermediate compartment membrane,C
26378,30,31904,endosome lumen,C
26379,30,5576,extracellular region,C
26380,30,5576,extracellular region,C
26381,30,5615,extracellular space,C
26382,30,34774,secretory granule lumen,C
26383,30,30133,transport vesicle,C
26408,29,51897,positive regulation of protein kinase B signaling,P
26409,29,1934,positive regulation of protein phosphorylation,P
26410,29,71902,positive regulation of protein serine/threonine kinase activity,P
26411,29,2000273,positive regulation of receptor activity,P
26412,29,6349,regulation of gene expression by genetic imprinting,P
26413,29,6355,"regulation of transcription, DNA-templated",P
26414,29,1501,skeletal system development,P
26415,29,70062,extracellular exosome,C
26416,29,5576,extracellular region,C
26417,29,5615,extracellular space,C
26418,29,5886,plasma membrane,C
26419,29,31093,platelet alpha granule lumen,C
26479,28,50714,positive regulation of protein secretion,P
26480,28,14911,positive regulation of smooth muscle cell migration,P
26481,28,48661,positive regulation of smooth muscle cell proliferation,P
26482,28,45944,positive regulation of transcription from RNA polymerase II promoter,P
26483,28,2000679,positive regulation of transcription regulatory region DNA binding,P
26484,28,45893,"positive regulation of transcription, DNA-templated",P
26485,28,45893,"positive regulation of transcription, DNA-templated",P
26486,28,1904075,positive regulation of trophectodermal cell proliferation,P
26487,28,42523,positive regulation of tyrosine phosphorylation of Stat5 protein,P
26488,28,43491,protein kinase B signaling,P
26489,28,50821,protein stabilization,P
26490,28,30166,proteoglycan biosynthetic process,P
26491,28,30166,proteoglycan biosynthetic process,P
26492,28,10468,regulation of gene expression,P
26493,28,40014,regulation of multicellular organism growth,P
26494,28,9408,response to heat,P
26495,28,7165,signal transduction,P
26496,28,14834,skeletal muscle satellite cell maintenance involved in skeletal muscle regeneration,P
26497,28,1501,skeletal system development,P
26498,28,35867,alphav-beta3 integrin-IGF-1-IGF1R complex,C
26499,28,70382,exocytic vesicle,C
26500,28,5576,extracellular region,C
26501,28,5576,extracellular region,C
26502,28,5615,extracellular space,C
26503,28,16942,insulin-like growth factor binding protein complex,C
26504,28,42567,insulin-like growth factor ternary complex,C
26505,28,5886,plasma membrane,C
26506,28,31093,platelet alpha granule lumen,C
26524,27,8361,regulation of cell size,P
26525,27,7165,signal transduction,P
26526,27,9897,external side of plasma membrane,C
26527,27,5576,extracellular region,C
26528,27,16021,integral component of membrane,C
26529,27,5886,plasma membrane,C
26549,26,50731,positive regulation of peptidyl-tyrosine phosphorylation,P
26550,26,14068,positive regulation of phosphatidylinositol 3-kinase signaling,P
26551,26,2092,positive regulation of receptor internalization,P
26552,26,42517,positive regulation of tyrosine phosphorylation of Stat3 protein,P
26553,26,42523,positive regulation of tyrosine phosphorylation of Stat5 protein,P
26554,26,32355,response to estradiol,P
26555,26,5576,extracellular region,C
26556,26,5615,extracellular space,C
26557,26,5622,intracellular,C
26585,25,42993,positive regulation of transcription factor import into nucleus,P
26586,25,45944,positive regulation of transcription from RNA polymerase II promoter,P
26587,25,6476,protein deacetylation,P
26588,25,31647,regulation of protein stability,P
26589,25,51225,spindle assembly,P
26590,25,6351,"transcription, DNA-templated",P
26591,25,5794,Golgi apparatus,C
26592,25,5737,cytoplasm,C
26593,25,5737,cytoplasm,C
26594,25,5829,cytosol,C
26595,25,118,histone deacetylase complex,C
26596,25,5654,nucleoplasm,C
26597,25,5654,nucleoplasm,C
26598,25,5634,nucleus,C
26599,25,5634,nucleus,C
26600,25,5886,plasma membrane,C
26601,25,5876,spindle microtubule,C
26602,25,17053,transcriptional repressor complex,C
26650,24,45773,positive regulation of axon extension,P
26651,24,70886,positive regulation of calcineurin-NFAT signaling cascade,P
26652,24,2000727,positive regulation of cardiac muscle cell differentiation,P
26653,24,8284,positive regulation of cell proliferation,P
26654,24,60999,positive regulation of dendritic spine development,P
26655,24,31643,positive regulation of myelination,P
26656,24,50731,positive regulation of peptidyl-tyrosine phosphorylation,P
26657,24,14068,positive regulation of phosphatidylinositol 3-kinase signaling,P
26658,24,51897,positive regulation of protein kinase B signaling,P
26659,24,2000010,positive regulation of protein localization to cell surface,P
26660,24,1903955,positive regulation of protein targeting to mitochondrion,P
26661,24,51155,positive regulation of striated muscle cell differentiation,P
26662,24,45944,positive regulation of transcription from RNA polymerase II promoter,P
26663,24,2000145,regulation of cell motility,P
26664,24,14066,regulation of phosphatidylinositol 3-kinase signaling,P
26665,24,43497,regulation of protein heterodimerization activity,P
26666,24,43496,regulation of protein homodimerization activity,P
26667,24,1964,startle response,P
26668,24,7416,synapse assembly,P
26669,24,3222,ventricular trabecula myocardium morphogenesis,P
26670,24,42060,wound healing,P
26671,24,30673,axolemma,C
26672,24,44297,cell body,C
26673,24,5737,cytoplasm,C
26674,24,30425,dendrite,C
26675,24,9897,external side of plasma membrane,C
26676,24,5576,extracellular region,C
26677,24,5576,extracellular region,C
26678,24,5887,integral component of plasma membrane,C
26679,24,16020,membrane,C
26680,24,31594,neuromuscular junction,C
26681,24,5634,nucleus,C
26760,22,122,negative regulation of transcription from RNA polymerase II promoter,P
26761,22,7399,nervous system development,P
26762,22,16310,phosphorylation,P
26763,22,2001171,positive regulation of ATP biosynthetic process,P
26764,22,45747,positive regulation of Notch signaling pathway,P
26765,22,8284,positive regulation of cell proliferation,P
26766,22,10628,positive regulation of gene expression,P
26767,22,10628,positive regulation of gene expression,P
26768,22,2000637,positive regulation of gene silencing by miRNA,P
26769,22,1902728,positive regulation of growth factor dependent skeletal muscle satellite cell proliferation,P
26770,22,1904685,positive regulation of metalloendopeptidase activity,P
26771,22,1902895,positive regulation of pri-miRNA transcription from RNA polymerase II promoter,P
26772,22,45944,positive regulation of transcription from RNA polymerase II promoter,P
26773,22,45944,positive regulation of transcription from RNA polymerase II promoter,P
26774,22,45944,positive regulation of transcription from RNA polymerase II promoter,P
26775,22,45893,"positive regulation of transcription, DNA-templated",P
26776,22,45893,"positive regulation of transcription, DNA-templated",P
26777,22,45893,"positive regulation of transcription, DNA-templated",P
26778,22,42517,positive regulation of tyrosine phosphorylation of Stat3 protein,P
26779,22,6606,protein import into nucleus,P
26780,22,60019,radial glial cell differentiation,P
26781,22,51726,regulation of cell cycle,P
26782,22,60259,regulation of feeding behavior,P
26783,22,46902,regulation of mitochondrial membrane permeability,P
26784,22,40014,regulation of multicellular organism growth,P
26785,22,6357,regulation of transcription from RNA polymerase II promoter,P
26786,22,6355,"regulation of transcription, DNA-templated",P
26787,22,42493,response to drug,P
26788,22,32355,response to estradiol,P
26789,22,45471,response to ethanol,P
26790,22,44321,response to leptin,P
26791,22,19953,sexual reproduction,P
26792,22,7165,signal transduction,P
26793,22,35019,somatic stem cell population maintenance,P
26794,22,1659,temperature homeostasis,P
26795,22,16032,viral process,P
26796,22,90575,RNA polymerase II transcription factor complex,C
26797,22,90575,RNA polymerase II transcription factor complex,C
26798,22,5737,cytoplasm,C
26799,22,5737,cytoplasm,C
26800,22,5829,cytosol,C
26801,22,5743,mitochondrial inner membrane,C
26802,22,790,nuclear chromatin,C
26803,22,5654,nucleoplasm,C
26804,22,5654,nucleoplasm,C
26805,22,5634,nucleus,C
26806,22,5634,nucleus,C
26807,22,5886,plasma membrane,C
26854,21,32825,positive regulation of natural killer cell differentiation,P
26855,21,45954,positive regulation of natural killer cell mediated cytotoxicity,P
26856,21,32819,positive regulation of natural killer cell proliferation,P
26857,21,45944,positive regulation of transcription from RNA polymerase II promoter,P
26858,21,42448,progesterone metabolic process,P
26859,21,38161,prolactin signaling pathway,P
26860,21,30856,regulation of epithelial cell differentiation,P
26861,21,40014,regulation of multicellular organism growth,P
26862,21,19218,regulation of steroid metabolic process,P
26863,21,6357,regulation of transcription from RNA polymerase II promoter,P
26864,21,32355,response to estradiol,P
26865,21,70672,response to interleukin-15,P
26866,21,70669,response to interleukin-2,P
26867,21,70670,response to interleukin-4,P
26868,21,6105,succinate metabolic process,P
26869,21,19530,taurine metabolic process,P
26870,21,6366,transcription from RNA polymerase II promoter,P
26871,21,6573,valine metabolic process,P
26872,21,5737,cytoplasm,C
26873,21,5829,cytosol,C
26874,21,5654,nucleoplasm,C
26875,21,5634,nucleus,C
26895,20,6355,"regulation of transcription, DNA-templated",P
26896,20,34097,response to cytokine,P
26897,20,32496,response to lipopolysaccharide,P
26898,20,48511,rhythmic process,P
26899,20,48536,spleen development,P
26900,20,6366,transcription from RNA polymerase II promoter,P
26901,20,33257,Bcl3/NF-kappaB2 complex,C
26902,20,5737,cytoplasm,C
26903,20,5829,cytosol,C
26904,20,5829,cytosol,C
26905,20,5654,nucleoplasm,C
26906,20,5654,nucleoplasm,C
26907,20,5634,nucleus,C
26949,19,35855,megakaryocyte development,P
26950,19,32528,microvillus organization,P
26951,19,35264,multicellular organism growth,P
26952,19,48609,multicellular organismal reproductive process,P
26953,19,33629,negative regulation of cell adhesion mediated by integrin,P
26954,19,51463,negative regulation of cortisol secretion,P
26955,19,60125,negative regulation of growth hormone secretion,P
26956,19,46676,negative regulation of insulin secretion,P
26957,19,48011,neurotrophin TRK receptor signaling pathway,P
26958,19,35265,organ growth,P
26959,19,35335,peptidyl-tyrosine dephosphorylation,P
26960,19,35335,peptidyl-tyrosine dephosphorylation,P
26961,19,46854,phosphatidylinositol phosphorylation,P
26962,19,36092,phosphatidylinositol-3-phosphate biosynthetic process,P
26963,19,48015,phosphatidylinositol-mediated signaling,P
26964,19,30168,platelet activation,P
26965,19,30220,platelet formation,P
26966,19,48008,platelet-derived growth factor receptor signaling pathway,P
26967,19,70374,positive regulation of ERK1 and ERK2 cascade,P
26968,19,2001275,positive regulation of glucose import in response to insulin stimulus,P
26969,19,46887,positive regulation of hormone secretion,P
26970,19,45931,positive regulation of mitotic cell cycle,P
26971,19,33628,regulation of cell adhesion mediated by integrin,P
26972,19,40014,regulation of multicellular organism growth,P
26973,19,14066,regulation of phosphatidylinositol 3-kinase signaling,P
26974,19,43254,regulation of protein complex assembly,P
26975,19,46825,regulation of protein export from nucleus,P
26976,19,60338,regulation of type I interferon-mediated signaling pathway,P
26977,19,6641,triglyceride metabolic process,P
26978,19,5737,cytoplasm,C
26979,19,5829,cytosol,C
26980,19,5739,mitochondrion,C
26981,19,5634,nucleus,C
26982,19,43234,protein complex,C
27007,18,70345,negative regulation of fat cell proliferation,P
27008,18,122,negative regulation of transcription from RNA polymerase II promoter,P
27009,18,71930,negative regulation of transcription involved in G1/S transition of mitotic cell cycle,P
27010,18,45892,"negative regulation of transcription, DNA-templated",P
27011,18,45892,"negative regulation of transcription, DNA-templated",P
27012,18,48146,positive regulation of fibroblast proliferation,P
27013,18,10628,positive regulation of gene expression,P
27014,18,1900740,positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway,P
27015,18,45944,positive regulation of transcription from RNA polymerase II promoter,P
27016,18,45893,"positive regulation of transcription, DNA-templated",P
27017,18,45893,"positive regulation of transcription, DNA-templated",P
27018,18,2000045,regulation of G1/S transition of mitotic cell cycle,P
27019,18,6355,"regulation of transcription, DNA-templated",P
27020,18,7283,spermatogenesis,P
27021,18,6351,"transcription, DNA-templated",P
27022,18,35189,Rb-E2F complex,C
27023,18,5739,mitochondrion,C
27024,18,790,nuclear chromatin,C
27025,18,5654,nucleoplasm,C
27026,18,5634,nucleus,C
27045,17,8286,insulin receptor signaling pathway,P
27046,17,46854,phosphatidylinositol phosphorylation,P
27047,17,36092,phosphatidylinositol-3-phosphate biosynthetic process,P
27048,17,48015,phosphatidylinositol-mediated signaling,P
27049,17,43547,positive regulation of GTPase activity,P
27050,17,90080,positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway,P
27051,17,30501,positive regulation of bone mineralization,P
27052,17,14066,regulation of phosphatidylinositol 3-kinase signaling,P
27053,17,16324,apical plasma membrane,C
27054,17,70062,extracellular exosome,C
27055,17,5576,extracellular region,C
27056,17,5615,extracellular space,C
27057,17,5887,integral component of plasma membrane,C
27058,17,5622,intracellular,C
27059,17,5886,plasma membrane,C
27083,16,33158,"regulation of protein import into nucleus, translocation",P
27084,16,9314,response to radiation,P
27085,16,302,response to reactive oxygen species,P
27086,16,7165,signal transduction,P
27087,16,6351,"transcription, DNA-templated",P
27088,16,5737,cytoplasm,C
27089,16,5737,cytoplasm,C
27090,16,5829,cytosol,C
27091,16,70062,extracellular exosome,C
27092,16,5739,mitochondrion,C
27093,16,5654,nucleoplasm,C
27094,16,5634,nucleus,C
27129,15,5886,plasma membrane,C
27130,15,43235,receptor complex,C
27149,14,31012,extracellular matrix,C
27150,14,5638,lamin filament,C
27151,14,5635,nuclear envelope,C
27152,14,5635,nuclear envelope,C
27153,14,31965,nuclear membrane,C
27154,14,16607,nuclear speck,C
27155,14,5654,nucleoplasm,C
27156,14,5654,nucleoplasm,C
27157,14,5634,nucleus,C
27193,13,10259,multicellular organism aging,P
27194,13,90305,nucleic acid phosphodiester bond hydrolysis,P
27195,13,32066,nucleolus to nucleoplasm transport,P
27196,13,51345,positive regulation of hydrolase activity,P
27197,13,16925,protein sumoylation,P
27198,13,42981,regulation of apoptotic process,P
27199,13,40009,regulation of growth rate,P
27200,13,1901796,regulation of signal transduction by p53 class mediator,P
27201,13,31297,replication fork processing,P
27202,13,31297,replication fork processing,P
27203,13,1302,replicative cell aging,P
27204,13,10225,response to UV-C,P
27205,13,6979,response to oxidative stress,P
27206,13,732,strand displacement,P
27207,13,723,telomere maintenance,P
27208,13,722,telomere maintenance via recombination,P
27209,13,32389,MutLalpha complex,C
27210,13,5813,centrosome,C
27211,13,5737,cytoplasm,C
27212,13,43005,neuron projection,C
27213,13,784,"nuclear chromosome, telomeric region",C
27214,13,5730,nucleolus,C
27215,13,5654,nucleoplasm,C
27216,13,5654,nucleoplasm,C
27235,12,16363,nuclear matrix,C
27236,12,5654,nucleoplasm,C
27237,12,109,nucleotide-excision repair complex,C
27238,12,5634,nucleus,C
27239,12,43234,protein complex,C
27285,11,1901990,regulation of mitotic cell cycle phase transition,P
27286,11,1666,response to hypoxia,P
27287,11,6979,response to oxidative stress,P
27288,11,21510,spinal cord development,P
27289,11,6363,termination of RNA polymerase I transcription,P
27290,11,6362,transcription elongation from RNA polymerase I promoter,P
27291,11,6368,transcription elongation from RNA polymerase II promoter,P
27292,11,6366,transcription from RNA polymerase II promoter,P
27293,11,6366,transcription from RNA polymerase II promoter,P
27294,11,6361,transcription initiation from RNA polymerase I promoter,P
27295,11,6367,transcription initiation from RNA polymerase II promoter,P
27296,11,6283,transcription-coupled nucleotide-excision repair,P
27297,11,6283,transcription-coupled nucleotide-excision repair,P
27298,11,16032,viral process,P
27299,11,71817,MMXD complex,C
27300,11,439,core TFIIH complex,C
27301,11,19907,cyclin-dependent protein kinase activating kinase holoenzyme complex,C
27302,11,5737,cytoplasm,C
27303,11,5675,holo TFIIH complex,C
27304,11,5675,holo TFIIH complex,C
27305,11,5654,nucleoplasm,C
27306,11,5634,nucleus,C
27307,11,5819,spindle,C
27308,11,5669,transcription factor TFIID complex,C
27322,10,61041,regulation of wound healing,P
27323,10,1666,response to hypoxia,P
27324,10,7165,signal transduction,P
27325,10,14909,smooth muscle cell migration,P
27326,10,9986,cell surface,C
27327,10,70062,extracellular exosome,C
27328,10,5576,extracellular region,C
27329,10,5615,extracellular space,C
27330,10,5925,focal adhesion,C
27331,10,5886,plasma membrane,C
27364,9,16572,histone phosphorylation,P
27365,9,2377,immunoglobulin production,P
27366,9,8630,intrinsic apoptotic signaling pathway in response to DNA damage,P
27367,9,42159,lipoprotein catabolic process,P
27368,9,7140,male meiosis,P
27369,9,45141,meiotic telomere clustering,P
27370,9,7094,mitotic spindle assembly checkpoint,P
27371,9,35264,multicellular organism growth,P
27372,9,30889,negative regulation of B cell proliferation,P
27373,9,1904262,negative regulation of TORC1 signaling,P
27374,9,1904354,negative regulation of telomere capping,P
27375,9,51402,neuron apoptotic process,P
27376,9,48599,oocyte development,P
27377,9,1541,ovarian follicle development,P
27378,9,36289,peptidyl-serine autophosphorylation,P
27379,9,18105,peptidyl-serine phosphorylation,P
27380,9,36092,phosphatidylinositol-3-phosphate biosynthetic process,P
27381,9,43517,"positive regulation of DNA damage response, signal transduction by p53 class mediator",P
27382,9,43065,positive regulation of apoptotic process,P
27383,9,33129,positive regulation of histone phosphorylation,P
27384,9,43525,positive regulation of neuron apoptotic process,P
27385,9,1904884,positive regulation of telomerase catalytic core complex assembly,P
27386,9,32212,positive regulation of telomere maintenance via telomerase,P
27387,9,1904358,positive regulation of telomere maintenance via telomere lengthening,P
27388,9,9791,post-embryonic development,P
27389,9,2331,pre-B cell allelic exclusion,P
27390,9,46777,protein autophosphorylation,P
27391,9,46777,protein autophosphorylation,P
27392,9,6468,protein phosphorylation,P
27393,9,6468,protein phosphorylation,P
27394,9,7131,reciprocal meiotic recombination,P
27395,9,42981,regulation of apoptotic process,P
27396,9,10506,regulation of autophagy,P
27397,9,1900034,regulation of cellular response to heat,P
27398,9,1901796,regulation of signal transduction by p53 class mediator,P
27399,9,51972,regulation of telomerase activity,P
27400,9,90399,replicative senescence,P
27401,9,1666,response to hypoxia,P
27402,9,10212,response to ionizing radiation,P
27403,9,7165,signal transduction,P
27404,9,72434,signal transduction involved in mitotic G2 DNA damage checkpoint,P
27405,9,1756,somitogenesis,P
27406,9,732,strand displacement,P
27407,9,7004,telomere maintenance via telomerase,P
27408,9,48538,thymus development,P
27409,9,1990391,DNA repair complex,C
27410,9,781,"chromosome, telomeric region",C
27411,9,31410,cytoplasmic vesicle,C
27412,9,784,"nuclear chromosome, telomeric region",C
27413,9,5654,nucleoplasm,C
27414,9,5634,nucleus,C
27415,9,5634,nucleus,C
27416,9,5819,spindle,C
27433,8,3720,telomerase activity,F
27434,8,3720,telomerase activity,F
27435,8,3720,telomerase activity,F
27436,8,42162,telomeric DNA binding,F
27437,8,1223,transcription coactivator binding,F
27438,8,71897,DNA biosynthetic process,P
27439,8,22616,DNA strand elongation,P
27440,8,32774,RNA biosynthetic process,P
27441,8,6278,RNA-dependent DNA biosynthetic process,P
27442,8,1904837,beta-catenin-TCF complex assembly,P
27443,8,71456,cellular response to hypoxia,P
27444,8,70200,establishment of protein localization to telomere,P
27445,8,7005,mitochondrion organization,P
27446,8,2000773,negative regulation of cellular senescence,P
27447,8,2000773,negative regulation of cellular senescence,P
27448,8,2000352,negative regulation of endothelial cell apoptotic process,P
27449,8,2001240,negative regulation of extrinsic apoptotic signaling pathway in absence of ligand,P
27450,8,10629,negative regulation of gene expression,P
27451,8,60253,negative regulation of glial cell proliferation,P
27452,8,43524,negative regulation of neuron apoptotic process,P
27453,8,1903704,negative regulation of production of siRNA involved in RNA interference,P
27454,8,1900087,positive regulation of G1/S transition of mitotic cell cycle,P
27455,8,30177,positive regulation of Wnt signaling pathway,P
27456,8,45766,positive regulation of angiogenesis,P
27457,8,46326,positive regulation of glucose import,P
27458,8,42635,positive regulation of hair cycle,P
27459,8,51000,positive regulation of nitric-oxide synthase activity,P
27460,8,1902895,positive regulation of pri-miRNA transcription from RNA polymerase II promoter,P
27461,8,32092,positive regulation of protein binding,P
27462,8,1904751,positive regulation of protein localization to nucleolus,P
27463,8,2000648,positive regulation of stem cell proliferation,P
27464,8,1903620,positive regulation of transdifferentiation,P
27465,8,1904754,positive regulation of vascular associated smooth muscle cell migration,P
27466,8,1904707,positive regulation of vascular smooth muscle cell proliferation,P
27467,8,30422,production of siRNA involved in RNA interference,P
27468,8,31647,regulation of protein stability,P
27469,8,31647,regulation of protein stability,P
27470,8,90399,replicative senescence,P
27471,8,46686,response to cadmium ion,P
27472,8,723,telomere maintenance,P
27473,8,7004,telomere maintenance via telomerase,P
27474,8,7004,telomere maintenance via telomerase,P
27475,8,7004,telomere maintenance via telomerase,P
27476,8,7004,telomere maintenance via telomerase,P
27477,8,1172,"transcription, RNA-templated",P
27478,8,16605,PML body,C
27479,8,31379,RNA-directed RNA polymerase complex,C
27480,8,1990572,TERT-RMRP complex,C
27481,8,781,"chromosome, telomeric region",C
27482,8,42645,mitochondrial nucleoid,C
27483,8,784,"nuclear chromosome, telomeric region",C
27484,8,783,nuclear telomere cap complex,C
27485,8,5730,nucleolus,C
27486,8,5730,nucleolus,C
27487,8,5654,nucleoplasm,C
27488,8,5654,nucleoplasm,C
27489,8,5634,nucleus,C
27490,8,5886,plasma membrane,C
27491,8,333,telomerase catalytic core complex,C
27492,8,333,telomerase catalytic core complex,C
27493,8,333,telomerase catalytic core complex,C
27494,8,5697,telomerase holoenzyme complex,C
27495,8,5697,telomerase holoenzyme complex,C
27585,6,45944,positive regulation of transcription from RNA polymerase II promoter,P
27586,6,1990440,positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress,P
27587,6,45893,"positive regulation of transcription, DNA-templated",P
27588,6,45893,"positive regulation of transcription, DNA-templated",P
27589,6,43161,proteasome-mediated ubiquitin-dependent protein catabolic process,P
27590,6,6461,protein complex assembly,P
27591,6,8104,protein localization,P
27592,6,16925,protein sumoylation,P
27593,6,51262,protein tetramerization,P
27594,6,42981,regulation of apoptotic process,P
27595,6,42981,regulation of apoptotic process,P
27596,6,1902749,regulation of cell cycle G2/M phase transition,P
27597,6,46902,regulation of mitochondrial membrane permeability,P
27598,6,1901796,regulation of signal transduction by p53 class mediator,P
27599,6,6355,"regulation of transcription, DNA-templated",P
27600,6,90399,replicative senescence,P
27601,6,10165,response to X-ray,P
27602,6,46677,response to antibiotic,P
27603,6,10332,response to gamma radiation,P
27604,6,6366,transcription from RNA polymerase II promoter,P
27605,6,16032,viral process,P
27606,6,16605,PML body,C
27607,6,5737,cytoplasm,C
27608,6,5829,cytosol,C
27609,6,5829,cytosol,C
27610,6,5783,endoplasmic reticulum,C
27611,6,5759,mitochondrial matrix,C
27612,6,5739,mitochondrion,C
27613,6,16604,nuclear body,C
27614,6,790,nuclear chromatin,C
27615,6,16363,nuclear matrix,C
27616,6,5730,nucleolus,C
27617,6,5654,nucleoplasm,C
27618,6,5654,nucleoplasm,C
27619,6,5634,nucleus,C
27620,6,43234,protein complex,C
27621,6,5657,replication fork,C
27622,6,5669,transcription factor TFIID complex,C
27634,5,9953,dorsal/ventral pattern formation,P
27635,5,48850,hypophysis morphogenesis,P
27636,5,21979,hypothalamus cell differentiation,P
27637,5,43066,negative regulation of apoptotic process,P
27638,5,122,negative regulation of transcription from RNA polymerase II promoter,P
27639,5,45944,positive regulation of transcription from RNA polymerase II promoter,P
27640,5,60126,somatotropin secreting cell differentiation,P
27641,5,6366,transcription from RNA polymerase II promoter,P
27642,5,5634,nucleus,C
27643,5,5667,transcription factor complex,C
27659,4,8284,positive regulation of cell proliferation,P
27660,4,32962,positive regulation of inositol trisphosphate biosynthetic process,P
27661,4,40018,positive regulation of multicellular organism growth,P
27662,4,45944,positive regulation of transcription from RNA polymerase II promoter,P
27663,4,45893,"positive regulation of transcription, DNA-templated",P
27664,4,43567,regulation of insulin-like growth factor receptor signaling pathway,P
27665,4,6355,"regulation of transcription, DNA-templated",P
27666,4,60133,somatotropin secreting cell development,P
27667,4,6366,transcription from RNA polymerase II promoter,P
27668,4,5737,cytoplasm,C
27669,4,5654,nucleoplasm,C
27670,4,5634,nucleus,C
27671,4,5667,transcription factor complex,C
27700,3,8284,positive regulation of cell proliferation,P
27701,3,7176,regulation of epidermal growth factor-activated receptor activity,P
27702,3,40008,regulation of growth,P
27703,3,16337,single organismal cell-cell adhesion,P
27704,3,16032,viral process,P
27705,3,70435,Shc-EGFR complex,C
27706,3,5829,cytosol,C
27707,3,5759,mitochondrial matrix,C
27708,3,5886,plasma membrane,C
27709,3,5886,plasma membrane,C
27725,2,60124,positive regulation of growth hormone secretion,P
27726,2,43568,positive regulation of insulin-like growth factor receptor signaling pathway,P
27727,2,40018,positive regulation of multicellular organism growth,P
27728,2,32094,response to food,P
27729,2,5576,extracellular region,C
27730,2,5576,extracellular region,C
27731,2,5615,extracellular space,C
27732,2,5622,intracellular,C
27733,2,43195,terminal bouton,C
27775,1,43235,receptor complex,C
27812,261,9411,response to UV,P
27813,261,723,telomere maintenance,P
27814,261,723,telomere maintenance,P
27815,261,722,telomere maintenance via recombination,P
27816,261,6283,transcription-coupled nucleotide-excision repair,P
27817,261,70522,ERCC4-ERCC1 complex,C
27818,261,781,"chromosome, telomeric region",C
27819,261,784,"nuclear chromosome, telomeric region",C
27820,261,5654,nucleoplasm,C
27821,261,109,nucleotide-excision repair complex,C
27822,261,110,nucleotide-excision repair factor 1 complex,C
27823,261,5634,nucleus,C
27824,261,5669,transcription factor TFIID complex,C
27842,260,5578,proteinaceous extracellular matrix,C
27875,259,5796,Golgi lumen,C
27876,259,5576,extracellular region,C
27877,259,5615,extracellular space,C
27878,259,5615,extracellular space,C